{"meta":{"query_hash":"0d39423ffff8","filters":{"venue":"Transplantation and Cellular Therapy"},"cohort_total":218,"direct_labels_cover":0,"predictions_cover":218,"exported":218,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/0d39423ffff8","api":"https://metacan.xera.ac/api/v1/cohort?venue=Transplantation+and+Cellular+Therapy"},"results":[{"id":"W3089905216","doi":"10.1016/j.bbmt.2020.09.031","title":"UM171-Expanded Cord Blood Transplants Support Robust T Cell Reconstitution with Low Rates of Severe Infections","year":2020,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Cord blood; Hematopoietic stem cell transplantation; Transplantation; Immunology; T cell; Medicine; Progenitor cell; Immune system; Stem cell; Incidence (geometry); Graft-versus-host disease; Internal medicine; Haematopoiesis; Gastroenterology; Biology","score_opus":0.027823942913031387,"score_gpt":0.2478349455561861,"score_spread":0.2200110026431547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089905216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652593,0.00022684786,0.030132076,0.0002904455,0.000055748307,0.0007292494,0.000117737,0.00009611699,0.0030924748],"genre_scores_gemma":[0.99223435,0.0054180697,0.0011655262,0.000349148,0.000040826195,0.000025565529,0.0006330813,0.000030586045,0.00010286067],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99870425,0.00007041932,0.00041551437,0.0003326775,0.0002710413,0.0002061183],"domain_scores_gemma":[0.9993659,0.000071627604,0.00012396305,0.00013392782,0.00009484728,0.0002096966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011473053,0.00024151923,0.00038290702,0.00010022482,0.00009879016,0.000018512357,0.000055152635,0.0001332305,0.0003726424],"category_scores_gemma":[0.0000018029696,0.00020221682,0.00008408794,0.0002557015,0.00012779921,0.00014475407,0.0000012484151,0.00017450334,0.00001644846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007917112,0.0009347601,0.07074102,0.004270484,0.00039779712,0.00043629922,0.010465134,0.000484779,0.9016404,0.00027831376,0.00003250834,0.0024013785],"study_design_scores_gemma":[0.015013569,0.002808555,0.009762398,0.00039291565,0.0007214946,0.0010579706,0.00042324502,0.0002584045,0.96901864,0.000016795437,0.00017837281,0.00034764202],"about_ca_topic_score_codex":0.00003048355,"about_ca_topic_score_gemma":0.000015938109,"teacher_disagreement_score":0.06737822,"about_ca_system_score_codex":0.000008586078,"about_ca_system_score_gemma":0.00013336893,"threshold_uncertainty_score":0.82461625},"labels":[],"label_agreement":null},{"id":"W3091044444","doi":"10.1016/j.bbmt.2020.09.026","title":"Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study","year":2020,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; Health Resources and Services Administration","keywords":"Medicine; Myelodysplastic syndromes; Hazard ratio; Internal medicine; Transplantation; Cohort; International Prognostic Scoring System; Oncology; Lower risk; Hematopoietic stem cell transplantation; Leukemia; Confidence interval; Surgery; Bone marrow","score_opus":0.028910315712245494,"score_gpt":0.2975582630253778,"score_spread":0.2686479473131323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091044444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9588046,0.0002484165,0.018558178,0.0012915086,0.00010142156,0.005507526,0.015435402,0.000047902497,0.000005054559],"genre_scores_gemma":[0.9860032,0.006566878,0.0005386952,0.0002051112,0.00018743594,0.0012640968,0.0051047686,0.000080061494,0.000049742903],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9971428,0.00026170362,0.000566853,0.0009096968,0.0005749378,0.0005439988],"domain_scores_gemma":[0.9976265,0.0010952911,0.00012055765,0.0002039185,0.00041920017,0.0005345365],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007720965,0.00037630316,0.000527689,0.00034070198,0.00034920537,0.000112804984,0.00019219851,0.000120594996,0.000010482986],"category_scores_gemma":[0.0001410488,0.00032021047,0.00009278449,0.00019141237,0.00029250965,0.00024019138,0.000014861591,0.00034892702,6.273494e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62357295,0.0016241288,0.23708989,0.0046831677,0.00422993,0.0027849863,0.050433993,0.00054221094,0.06920889,0.00036333033,0.0000483484,0.005418183],"study_design_scores_gemma":[0.18302882,0.009274886,0.76633877,0.00084784674,0.0026411775,0.00014386595,0.0026959174,0.017453913,0.016035467,0.0005039136,0.00010453728,0.0009309105],"about_ca_topic_score_codex":0.000112991795,"about_ca_topic_score_gemma":0.00021479647,"teacher_disagreement_score":0.52924883,"about_ca_system_score_codex":0.00010214961,"about_ca_system_score_gemma":0.00034583997,"threshold_uncertainty_score":0.999925},"labels":[],"label_agreement":null},{"id":"W3091239812","doi":"10.1016/j.bbmt.2020.09.035","title":"Acute Respiratory Failure Outcomes in Patients with Hematologic Malignancies and Hematopoietic Cell Transplant: A Secondary Analysis of the EFRAIM Study","year":2020,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Odds ratio; Hematopoietic stem cell transplantation; Cohort; Cohort study; Hematopoietic cell; Haematopoiesis; Stem cell","score_opus":0.012884778106740175,"score_gpt":0.22748662159033534,"score_spread":0.21460184348359515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091239812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974926,0.00024209481,0.0005042011,0.00038210236,0.000014810565,0.0011399018,0.00011700056,0.00002850539,0.00007878681],"genre_scores_gemma":[0.998872,0.0001937281,0.00009907726,0.0006936823,0.0000033895292,0.000029247794,0.000075545126,0.000020774614,0.000012583629],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849254,0.00014793339,0.00046340466,0.00035266168,0.00036618634,0.00017726894],"domain_scores_gemma":[0.9994289,0.00008438719,0.00013417793,0.00019660173,0.00005045565,0.00010542095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013390898,0.00024463236,0.0006666366,0.0001835239,0.00006920282,0.000016291471,0.000091027265,0.00009326806,0.000055050477],"category_scores_gemma":[0.0000014841837,0.00015242821,0.000104094885,0.00060515973,0.00010911405,0.0000801533,0.000004527843,0.00018268921,0.0000010823337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012171458,0.00039894044,0.956252,0.0005348312,0.00071177137,0.00007768788,0.027648993,0.000013084677,0.013051897,0.000030378716,0.000001602793,0.00006168559],"study_design_scores_gemma":[0.012220078,0.0009032944,0.94101506,0.00010128368,0.0023295004,0.000012817982,0.0014889898,0.000045207962,0.041666307,0.0000068264676,0.0000107255055,0.00019987626],"about_ca_topic_score_codex":0.000010779686,"about_ca_topic_score_gemma":0.000054264467,"teacher_disagreement_score":0.02861441,"about_ca_system_score_codex":0.000008651737,"about_ca_system_score_gemma":0.000042523,"threshold_uncertainty_score":0.6215842},"labels":[],"label_agreement":null},{"id":"W3120188320","doi":"10.1016/j.jtct.2021.01.009","title":"Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Health Resources and Services Administration","keywords":"Medicine; Incidence (geometry); Donation; Adverse effect; Prospective cohort study; Observational study; Cohort; Blood donor; Surgery; Internal medicine; Immunology","score_opus":0.014874939483782676,"score_gpt":0.2577139433149158,"score_spread":0.24283900383113313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120188320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954857,0.000947765,0.00034782552,0.0007418375,0.00018120698,0.0010558998,0.000018816383,0.00006271248,0.0011581867],"genre_scores_gemma":[0.9941427,0.0036618686,0.00016093045,0.00024496389,0.000022519785,0.00004509983,0.00087087916,0.000030719893,0.0008203009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980583,0.00033999942,0.0006640605,0.00042764487,0.00031405667,0.00019593323],"domain_scores_gemma":[0.99920946,0.00017225218,0.000118337135,0.0003466727,0.00006272078,0.000090563146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045811146,0.00020229715,0.00031990654,0.000068182526,0.000095239586,0.000009034765,0.00006656119,0.00015364216,0.00040366658],"category_scores_gemma":[0.0000108389,0.00015462433,0.00008644943,0.00035467988,0.000038742113,0.000089524765,0.000003992616,0.0002975181,0.00003668463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020119133,0.0012406488,0.8317025,0.00014454892,0.000613469,0.014891659,0.05752838,0.00006553729,0.088036254,0.000089314606,0.000016039254,0.0036597403],"study_design_scores_gemma":[0.020417502,0.00025838145,0.93650657,0.00040349958,0.0004128079,0.0020307316,0.006273,0.00019405097,0.032360822,0.00040322292,0.00042049773,0.00031890717],"about_ca_topic_score_codex":0.00045539933,"about_ca_topic_score_gemma":0.00032948342,"teacher_disagreement_score":0.10480408,"about_ca_system_score_codex":0.000032676042,"about_ca_system_score_gemma":0.00010352908,"threshold_uncertainty_score":0.6305397},"labels":[],"label_agreement":null},{"id":"W3127692206","doi":"10.1016/s2666-6367(21)00475-9","title":"Efficacy of Oral Ribavirin in Respiratory Syncytial Virus Infection in Hematopoietic Stem Cell Transplant Patients: A Single-Centre Experience","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ribavirin; Medicine; Hematopoietic stem cell transplantation; Retrospective cohort study; Internal medicine; Transplantation; Virus; Immunology; Hepatitis C virus","score_opus":0.044001538878363444,"score_gpt":0.3062873682368084,"score_spread":0.26228582935844497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127692206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790686,0.00068156334,0.00046152613,0.000022053333,0.000062964,0.00052214257,0.000012037615,0.000023241677,0.00030761684],"genre_scores_gemma":[0.9983753,0.0013410702,0.000020071388,0.00010965183,0.000011817197,0.000028961978,0.000047596688,0.000019568995,0.00004595826],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839056,0.0002938404,0.0004896809,0.0003084018,0.00029522085,0.00022231188],"domain_scores_gemma":[0.9995268,0.00006241189,0.00006649091,0.00017115838,0.000086249434,0.00008686254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018998752,0.00015936301,0.00030252239,0.00027936534,0.000041895135,0.000019457138,0.00004239036,0.000122589,0.00011723249],"category_scores_gemma":[0.000004630162,0.00015352185,0.000069702975,0.00051372295,0.000084229105,0.00014282276,0.0000044458734,0.00022671597,0.000006653217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00147251,0.0019377051,0.38337117,0.0003224203,0.000015517366,0.00024764615,0.008447213,0.00006117489,0.5967521,0.000034591667,0.00000189159,0.0073360414],"study_design_scores_gemma":[0.010276475,0.0004725403,0.19950321,0.00022778111,0.000018025748,0.0000092614655,0.00021070974,0.000053073993,0.78881454,0.0000064232095,0.00026576052,0.00014219107],"about_ca_topic_score_codex":0.00017935956,"about_ca_topic_score_gemma":0.00046532258,"teacher_disagreement_score":0.19206242,"about_ca_system_score_codex":0.00007688664,"about_ca_system_score_gemma":0.00009472676,"threshold_uncertainty_score":0.6260439},"labels":[],"label_agreement":null},{"id":"W3127826581","doi":"10.1016/s2666-6367(21)00386-9","title":"Engaging Gay, Bisexual, and Other Men Who Have Sex with Men (MSM) to Register As Stem Cell Donors in Canada: A Pilot Campaign","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Men who have sex with men; Register (sociolinguistics); Demography; Gerontology; Family medicine; Human immunodeficiency virus (HIV)","score_opus":0.04177904081193914,"score_gpt":0.27438794551685813,"score_spread":0.232608904704919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127826581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848203,0.0011959319,0.0022625206,0.0038977154,0.00001561938,0.0003641296,0.000013551261,0.000012930986,0.007417295],"genre_scores_gemma":[0.9903775,0.0014194773,0.00009951918,0.0024849928,0.000030819476,0.000013949634,0.00004148427,0.00002185767,0.005510396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99904686,0.00009842054,0.00018216463,0.0002588099,0.0002536736,0.00016009665],"domain_scores_gemma":[0.99960005,0.00004441101,0.00003799848,0.000114075294,0.000034079752,0.0001693855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021032021,0.00012870468,0.00020247452,0.00006617267,0.00006631745,0.000024974997,0.000027482276,0.00006280299,0.00006254106],"category_scores_gemma":[5.117125e-7,0.0000952799,0.000011020265,0.00011792755,0.00007194446,0.000032301894,0.0000034804937,0.00016886283,9.2184524e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008121269,0.00068262714,0.124982715,0.0025511868,0.0005050131,0.002719878,0.1539726,0.00021443085,0.57126117,0.0016829972,0.0016363604,0.13166976],"study_design_scores_gemma":[0.047786143,0.004223978,0.11391515,0.0019827709,0.00045036338,0.0008639656,0.08542573,0.013593793,0.67003566,0.0005428343,0.059238426,0.0019411533],"about_ca_topic_score_codex":0.113104284,"about_ca_topic_score_gemma":0.14536315,"teacher_disagreement_score":0.1297286,"about_ca_system_score_codex":0.000052331587,"about_ca_system_score_gemma":0.00035142383,"threshold_uncertainty_score":0.89280164},"labels":[],"label_agreement":null},{"id":"W3128235746","doi":"10.1016/s2666-6367(21)00311-0","title":"Unrelated Donor Usage for Allogeneic HCT in Canada during the First 6 Months of the COVID-19 Pandemic: A Canadian Blood Services Stem Cell Registry Analysis","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pandemic; Coronavirus disease 2019 (COVID-19); Stem cell; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Internal medicine; Outbreak; Disease; Genetics; Infectious disease (medical specialty)","score_opus":0.014712397554430778,"score_gpt":0.2265765781854453,"score_spread":0.21186418063101453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128235746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99372536,0.0034606198,0.000028681372,0.0021327473,0.000029467066,0.00037050952,0.00013988357,0.000006529618,0.00010620611],"genre_scores_gemma":[0.9931283,0.0050380016,0.000021268283,0.0011663149,0.000010174982,0.000027234426,0.00014373567,0.000009688339,0.00045525486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924237,0.00006320395,0.00021650271,0.00018666926,0.00012738514,0.0001638896],"domain_scores_gemma":[0.99947757,0.00008250097,0.00007589838,0.0002074382,0.000031231626,0.00012539435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010444399,0.000115624694,0.00020415042,0.000050583007,0.00016666889,0.000010910672,0.00007760423,0.000059949012,0.000057657053],"category_scores_gemma":[9.653734e-7,0.00007126189,0.000098116696,0.00030616752,0.00003147124,0.000014937595,0.0000027038498,0.000087281354,1.4944962e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022171819,0.00007065141,0.97397774,0.00069116027,0.00058648986,0.00023652194,0.0040245457,0.0007130166,0.019250354,0.0000096456315,0.000008530898,0.00020959959],"study_design_scores_gemma":[0.023482218,0.00017176518,0.6241576,0.00029067197,0.004075381,0.0003504804,0.011020556,0.00110427,0.32484567,0.0000252973,0.009971687,0.0005043907],"about_ca_topic_score_codex":0.8807187,"about_ca_topic_score_gemma":0.9955807,"teacher_disagreement_score":0.34982014,"about_ca_system_score_codex":0.00015901598,"about_ca_system_score_gemma":0.0008647872,"threshold_uncertainty_score":0.2905976},"labels":[],"label_agreement":null},{"id":"W3129197373","doi":"10.1016/j.jtct.2021.02.007","title":"Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Thymoglobulin; Cumulative incidence; Anti-thymocyte globulin; Transplantation; Gastroenterology; Hematopoietic stem cell transplantation; Cyclophosphamide; Internal medicine; Graft-versus-host disease; Incidence (geometry); Surgery; Tacrolimus; Chemotherapy","score_opus":0.02005923419507962,"score_gpt":0.26179915193930847,"score_spread":0.24173991774422884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129197373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94718915,0.0022153992,0.048182253,0.00016558342,0.00020354823,0.0015983897,0.0002502433,0.00010060709,0.00009483236],"genre_scores_gemma":[0.98066425,0.013231922,0.004064151,0.00021664191,0.000067453606,0.00017267084,0.0013975594,0.00008867281,0.000096654636],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99710184,0.00017760196,0.0007286267,0.000847433,0.0006117124,0.0005327942],"domain_scores_gemma":[0.9987675,0.00018197765,0.00014540492,0.00028957127,0.00026455676,0.00035100672],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022287891,0.0004812927,0.0005434436,0.00020377856,0.00022685874,0.000110722714,0.000107658896,0.00021297377,0.00007730067],"category_scores_gemma":[0.0000037895404,0.00045052494,0.00016913499,0.0004617077,0.00015637951,0.00041258286,0.0000031299546,0.00025106923,0.0000045152124],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030453917,0.0010470954,0.056669887,0.005670505,0.00018807937,0.0050073583,0.022513503,0.0006452644,0.87532973,0.00036452338,4.597741e-7,0.0021096591],"study_design_scores_gemma":[0.035531357,0.001340165,0.14111008,0.0010147534,0.0012639932,0.0008163133,0.0026941067,0.0014532345,0.81382436,0.000023711254,0.000058543854,0.00086937135],"about_ca_topic_score_codex":0.000105036335,"about_ca_topic_score_gemma":0.00011907149,"teacher_disagreement_score":0.084440194,"about_ca_system_score_codex":0.000070407565,"about_ca_system_score_gemma":0.00032346413,"threshold_uncertainty_score":0.99979466},"labels":[],"label_agreement":null},{"id":"W3134469664","doi":"10.1016/j.jtct.2021.03.006","title":"Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health; Bayer Fund; St. Baldrick's Foundation; Alex's Lemonade Stand Foundation for Childhood Cancer; Novartis; Loxo Oncology; Dougherty Foundation; Roche","keywords":"Medicine; Busulfan; Melphalan; Induction chemotherapy; Surgery; Tolerability; Internal medicine; Chemotherapy; Oncology; Hematopoietic stem cell transplantation; Transplantation; Adverse effect","score_opus":0.011034182582685584,"score_gpt":0.2599738957661657,"score_spread":0.24893971318348013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134469664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884047,0.00016594732,0.00851897,0.00031817847,0.00021158475,0.0021602914,0.00010060052,0.00007988052,0.000039849434],"genre_scores_gemma":[0.9928005,0.0026522847,0.0012089999,0.00021707226,0.00014130895,0.00018741676,0.002686126,0.00004869008,0.00005765136],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99846303,0.0002369791,0.0002576828,0.00046508067,0.00030266063,0.00027454685],"domain_scores_gemma":[0.99922407,0.00024138752,0.00010657607,0.00014978908,0.00012250064,0.00015565549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012748002,0.00023560469,0.0003371191,0.00013461696,0.00021736063,0.000059665927,0.000040078576,0.00012295449,0.00005134861],"category_scores_gemma":[0.000015431193,0.0001904392,0.00012134101,0.00023413672,0.00006244569,0.00023257865,0.0000028252468,0.00018795111,0.0000029778357],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25227234,0.0056171403,0.05634051,0.00020144047,0.0028006241,0.0009089898,0.0034319554,0.000034236935,0.06784925,0.0002882641,0.000099778335,0.61015546],"study_design_scores_gemma":[0.45395473,0.020169333,0.42019293,0.0001491705,0.00051144883,0.00008165852,0.00015523961,0.00013960348,0.10315147,0.00014251679,0.0009267598,0.00042513618],"about_ca_topic_score_codex":0.00006562373,"about_ca_topic_score_gemma":0.000031901232,"teacher_disagreement_score":0.60973036,"about_ca_system_score_codex":0.000053376854,"about_ca_system_score_gemma":0.00014068179,"threshold_uncertainty_score":0.7765885},"labels":[],"label_agreement":null},{"id":"W3135541068","doi":"10.1016/j.jtct.2021.02.030","title":"Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Janssen Biotech; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Biomedical Advanced Research and Development Authority; U.S. Navy; National Institutes of Health; Kyowa Kirin Pharmaceutical Development; Bayer Fund; Jazz Pharmaceuticals; National Heart, Lung, and Blood Institute; Shire; CSL Behring; AbbVie; Sanofi Genzyme; Kite Pharma; Stanford University; Pfizer; Daiichi-Sankyo; Falk Foundation; U.S. Department of Defense; U.S. Public Health Service; Alexion Pharmaceuticals; Health Resources and Services Administration; Astellas Pharma US; Boston Children's Hospital; National Cancer Institute; Gilead Sciences","keywords":"Medicine; Transplantation; Hazard ratio; Internal medicine; Cohort; Dialysis; Renal function; Hematopoietic stem cell transplantation; Kidney transplantation; Population; Incidence (geometry); Oncology; Confidence interval","score_opus":0.01546700294401437,"score_gpt":0.2661724896296553,"score_spread":0.2507054866856409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135541068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97731984,0.00076288055,0.019093791,0.00010657769,0.00013179232,0.0006268459,0.00017680049,0.000082593644,0.0016988803],"genre_scores_gemma":[0.98738724,0.009798586,0.00080703886,0.00021636821,0.000039061644,0.00006674331,0.0013102215,0.0000568638,0.00031787067],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773586,0.0001897023,0.00067177333,0.00052393053,0.0005657596,0.0003129504],"domain_scores_gemma":[0.99897,0.00017509382,0.00016962945,0.00030854647,0.00018625497,0.00019052843],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020965995,0.00039505478,0.00054962916,0.00025279974,0.000088882865,0.0000314491,0.0000607123,0.00024033918,0.0006742914],"category_scores_gemma":[0.0000037285472,0.00033231874,0.00036443814,0.00031456412,0.00008473496,0.00016650894,0.000001921036,0.00022067958,0.00003793905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00819166,0.0009283218,0.25626767,0.0022910205,0.0004173799,0.00086428033,0.0059922854,0.00027160952,0.7215759,0.00021458957,0.0000145398935,0.002970759],"study_design_scores_gemma":[0.0071570734,0.0007007461,0.45936427,0.00032778148,0.00045586226,0.00050334365,0.000092989634,0.00005352617,0.53096366,0.000085462736,0.00002002714,0.0002752556],"about_ca_topic_score_codex":0.000036889836,"about_ca_topic_score_gemma":0.000014997848,"teacher_disagreement_score":0.20309661,"about_ca_system_score_codex":0.000051198098,"about_ca_system_score_gemma":0.00016354809,"threshold_uncertainty_score":0.99991286},"labels":[],"label_agreement":null},{"id":"W3135738459","doi":"10.1016/j.jtct.2021.02.035","title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report","year":2021,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Graft-versus-host disease; Intensive care medicine; Disease; Etiology; Transplantation; Clinical trial; Immune system; Immunology; Intervention (counseling); Chronic disease; Internal medicine; Psychiatry","score_opus":0.410621616559488,"score_gpt":0.520370479022987,"score_spread":0.10974886246349908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135738459","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034172197,0.98761356,0.0034228514,0.00031047562,0.00048523225,0.0046016285,0.00007759508,0.000019111298,0.00005231709],"genre_scores_gemma":[0.0019740395,0.9918996,0.0013605689,0.000067648325,0.00018208622,0.00042436423,0.004024727,0.000028141243,0.000038792463],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945863,0.0021366954,0.0023245637,0.0004872971,0.00028432382,0.00018083118],"domain_scores_gemma":[0.99633074,0.0024864497,0.00088065723,0.00015017792,0.000078642996,0.000073312374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074035604,0.00027851432,0.0017613695,0.00016710404,0.00010353572,0.000021604115,0.000055595487,0.00021624591,0.000015872101],"category_scores_gemma":[0.00017446371,0.00019488252,0.00030369585,0.00018098652,0.00012369463,0.00002181305,0.00000403695,0.00023158753,6.012117e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033557105,0.00035241098,0.00021155943,0.04206785,0.0009477411,0.00022617307,0.001224596,0.0000013840718,0.00010248391,0.0014669007,0.00012338071,0.9499198],"study_design_scores_gemma":[0.02537208,0.0020130158,0.003501739,0.0750901,0.002319482,0.00083860423,0.0002482502,0.000101091275,0.0001985098,0.00015750741,0.8893598,0.00079985725],"about_ca_topic_score_codex":0.000010318899,"about_ca_topic_score_gemma":0.000034350658,"teacher_disagreement_score":0.9491199,"about_ca_system_score_codex":0.0001114713,"about_ca_system_score_gemma":0.002281276,"threshold_uncertainty_score":0.7947079},"labels":[],"label_agreement":null},{"id":"W3135819089","doi":"10.1016/j.jtct.2021.02.034","title":"The Future of Chronic Graft-Versus-Host Disease: Introduction to the 2020 National Institutes of Health Consensus Development Project Reports","year":2021,"lang":"en","type":"editorial","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"British Columbia Children's Hospital","funders":"National Cancer Institute; National Institutes of Health; AstraZeneca; Amgen","keywords":"Host (biology); Consensus conference; Medicine; Political science; Biology; Internal medicine","score_opus":0.015624389575063688,"score_gpt":0.28884730884133814,"score_spread":0.27322291926627446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135819089","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04556262,0.1182021,0.004036477,0.027382594,0.7963388,0.0072808657,0.0007781622,0.00011922825,0.00029918563],"genre_scores_gemma":[0.071786344,0.20774531,0.0016583236,0.00028820062,0.695358,0.0005366524,0.021225994,0.00016882253,0.0012323702],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970509,0.00024016808,0.00092825794,0.00041492493,0.0011649434,0.00020082959],"domain_scores_gemma":[0.99819344,0.00038472546,0.0004937978,0.00029779394,0.0005369402,0.00009331614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010919076,0.0002607767,0.00045361012,0.000100060526,0.00025868835,0.00002689108,0.0000942746,0.0001866139,0.00002267943],"category_scores_gemma":[0.000051929306,0.00016857772,0.00010989192,0.0002982234,0.00013179102,0.000029367882,0.0000059472404,0.0003008555,0.0000015627714],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014683435,0.00076348765,0.00028542118,0.015024515,0.0022494802,0.00036843124,0.019374415,0.00014698629,0.017783655,0.0009973242,0.8798969,0.048425965],"study_design_scores_gemma":[0.0024838198,0.00032350532,0.00060965214,0.0006608303,0.00018305347,0.00005530688,0.00047364822,0.000012605353,0.013714689,0.000013271824,0.98127663,0.00019295911],"about_ca_topic_score_codex":0.0000412783,"about_ca_topic_score_gemma":0.00016813476,"teacher_disagreement_score":0.101379775,"about_ca_system_score_codex":0.00013879352,"about_ca_system_score_gemma":0.0039647236,"threshold_uncertainty_score":0.703325},"labels":[],"label_agreement":null},{"id":"W3138143327","doi":"10.1016/j.jtct.2021.03.023","title":"Efficacy of Allogeneic Hematopoietic Cell Transplantation for Autoimmune Diseases","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Psoriasis; Rheumatoid arthritis; Discontinuation; Transplantation; Ulcerative colitis; Internal medicine; Hematopoietic stem cell transplantation; Immunology; Disease; Autoimmune disease; Multiple sclerosis; Arthritis; Methotrexate; Systemic lupus erythematosus","score_opus":0.017380308771326854,"score_gpt":0.2514653091268231,"score_spread":0.23408500035549623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138143327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95896983,0.034801643,0.0051745456,0.00013860928,0.000094647774,0.00047418263,0.000101378704,0.000039632563,0.00020550679],"genre_scores_gemma":[0.95872647,0.039680086,0.00024967242,0.00014048327,0.00003344558,0.00003268751,0.0008810457,0.000020409248,0.0002357139],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991463,0.000053600495,0.0003108089,0.0002093539,0.00015426676,0.00012565842],"domain_scores_gemma":[0.99949133,0.00011728524,0.000078433666,0.00013659868,0.00008497181,0.000091356036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006387261,0.00012713186,0.0002703386,0.000051049214,0.00006363898,0.000011492602,0.000032793145,0.00008385688,0.00012391646],"category_scores_gemma":[0.0000036575814,0.00010525267,0.00016985898,0.000095240495,0.00004367509,0.000035865363,0.0000011511679,0.00004266216,0.0000037567675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021439968,0.00062552746,0.0058973343,0.0019098829,0.0001684992,0.000060650462,0.002345349,0.00003559055,0.9780225,0.0002760224,0.00002897144,0.008485659],"study_design_scores_gemma":[0.014038677,0.0002432144,0.1513283,0.0006605398,0.0008299003,0.00011533658,0.0004462585,0.00007488522,0.8317549,0.000075058146,0.00025206557,0.00018087709],"about_ca_topic_score_codex":0.0000061661344,"about_ca_topic_score_gemma":5.574998e-7,"teacher_disagreement_score":0.14626762,"about_ca_system_score_codex":0.0000066626053,"about_ca_system_score_gemma":0.00007442015,"threshold_uncertainty_score":0.42920792},"labels":[],"label_agreement":null},{"id":"W3141737467","doi":"10.1016/j.jtct.2021.03.027","title":"Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in Myelofibrosis","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Princess Margaret Cancer Foundation; Pfizer","keywords":"Myelofibrosis; Hematopoietic stem cell transplantation; Hematopoietic cell; Medicine; Selection (genetic algorithm); Oncology; Transplantation; Internal medicine; Haematopoiesis; Biology; Stem cell; Genetics; Computer science; Bone marrow","score_opus":0.014824591476890104,"score_gpt":0.24446419568533495,"score_spread":0.22963960420844484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3141737467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99655193,0.00110586,0.0013709797,0.00014025152,0.000082161896,0.00037295508,0.000055320845,0.000020581521,0.0002999559],"genre_scores_gemma":[0.98195404,0.01685087,0.00059456786,0.00003361776,0.000014446035,0.000028300636,0.00044841095,0.000017971666,0.000057768622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985739,0.00014532711,0.000544499,0.00024633488,0.0003243105,0.0001656154],"domain_scores_gemma":[0.9992184,0.00022572835,0.00024286794,0.00008452908,0.00017444529,0.000054018732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001802868,0.00018956873,0.00039669528,0.00016392833,0.000053216034,0.000013282664,0.000027272266,0.00013898546,0.0001229086],"category_scores_gemma":[0.000005794694,0.00017108076,0.000104569524,0.00027744914,0.000026870362,0.00013647116,0.0000011814251,0.00010726213,0.0000012052539],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020755413,0.00040055008,0.4446209,0.000758953,0.00020607526,0.000021184369,0.016535405,0.00008029462,0.53403485,0.00014908651,0.0000021097571,0.0011150236],"study_design_scores_gemma":[0.006541456,0.00034818254,0.3061546,0.00016696424,0.00022174866,0.000009007814,0.0007966328,0.00004948996,0.6855727,0.000024940284,0.000014059585,0.000100244804],"about_ca_topic_score_codex":0.00016830044,"about_ca_topic_score_gemma":0.00032234937,"teacher_disagreement_score":0.1515378,"about_ca_system_score_codex":0.000079887825,"about_ca_system_score_gemma":0.00009217626,"threshold_uncertainty_score":0.69764704},"labels":[],"label_agreement":null},{"id":"W3143839826","doi":"10.1016/j.jtct.2021.03.024","title":"Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft-versus-Host Disease","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute; National Institutes of Health; National Cancer Center","keywords":"Spirometry; Medicine; Bronchiolitis obliterans; Interquartile range; Spirometer; Cohort; Pulmonary function testing; Internal medicine; Physical therapy; Lung transplantation; Asthma; Transplantation; Exhaled nitric oxide","score_opus":0.013623793923080989,"score_gpt":0.25624045421755354,"score_spread":0.24261666029447254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143839826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97667944,0.0012647129,0.02116483,0.00004655812,0.00018228391,0.0005061461,0.00011491757,0.000024378227,0.000016704134],"genre_scores_gemma":[0.9966166,0.0014510016,0.0014692642,0.000027190474,0.000041005853,0.0000337007,0.00029697557,0.000025174206,0.000039108123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904865,0.000060184004,0.00026307724,0.00024456476,0.00020276476,0.0001807434],"domain_scores_gemma":[0.99951065,0.000107537206,0.000061226805,0.00012670048,0.00008558822,0.00010829552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009370627,0.00015012133,0.00026782713,0.00016339048,0.00005438787,0.00001816794,0.000032158565,0.00006084954,0.000018664141],"category_scores_gemma":[0.0000032579946,0.00012943424,0.000079985424,0.00025323732,0.00003784605,0.00013327962,0.0000012550533,0.00009440382,6.029964e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009453652,0.000275769,0.9167302,0.0014697005,0.00016950826,0.00014858757,0.0012845292,0.000009995261,0.046868075,0.00013563388,7.784061e-8,0.023454273],"study_design_scores_gemma":[0.01778528,0.0009200092,0.93480957,0.00026306394,0.00014799966,0.000011885071,0.000037747373,0.000017525317,0.045786276,0.000032849504,0.000041562453,0.0001462063],"about_ca_topic_score_codex":0.000037345544,"about_ca_topic_score_gemma":0.000037620346,"teacher_disagreement_score":0.023308067,"about_ca_system_score_codex":0.000035294986,"about_ca_system_score_gemma":0.000059031783,"threshold_uncertainty_score":0.5278175},"labels":[],"label_agreement":null},{"id":"W3146762921","doi":"10.1016/j.jtct.2021.03.029","title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; British Columbia Children's Hospital; CancerCare Manitoba","funders":"Pharmacyclics; Universität Hamburg; Meiji Seika Pharma; Compass Therapeutics; Syndax Pharmaceuticals; CTI Biopharma; Alvin J. Siteman Cancer Center; Jazz Pharmaceuticals; National Institutes of Health; Regeneron Pharmaceuticals; Omeros Corporation; Anthony Nolan; Huntsman Cancer Institute; Takeda Pharmaceuticals U.S.A.; Massachusetts General Hospital; University of Minnesota; Janssen Pharmaceuticals; Memorial Sloan-Kettering Cancer Center; University at Buffalo; AbbVie; Clinical Science Research and Development; Universidad de Sevilla; National Cancer Institute; Gilead Sciences; Dana-Farber Cancer Institute; Roche; Novartis; Celgene; Bristol-Myers Squibb; AstraZeneca; CareDx; Incyte; Pfizer; Amgen; U.S. Department of Veterans Affairs","keywords":"Medicine; Graft-versus-host disease; Intensive care medicine; Clinical trial; Disease; Hematopoietic stem cell transplantation; Hematopoietic cell; Psychological intervention; Transplantation; Malignancy; Immunology; Internal medicine; Haematopoiesis; Stem cell","score_opus":0.28739428915932314,"score_gpt":0.4623925765223438,"score_spread":0.17499828736302064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3146762921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766769,0.008733793,0.0076673916,0.0025253028,0.0005899548,0.0034016133,0.000080478785,0.00003803555,0.000286521],"genre_scores_gemma":[0.97026217,0.02527855,0.002151715,0.0004879233,0.00020549717,0.00025796366,0.0012618531,0.000026547204,0.0000677524],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99652904,0.0010254527,0.0014392178,0.0003955562,0.00041349986,0.00019721653],"domain_scores_gemma":[0.99727017,0.0018505343,0.0004936234,0.00016076613,0.0001447673,0.00008012767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00509806,0.00019258799,0.00062061654,0.000094694115,0.00012886542,0.00002392352,0.00005760047,0.00009188538,0.000034535853],"category_scores_gemma":[0.00016911577,0.00013927944,0.0001704601,0.00020699894,0.00010912125,0.000034399036,0.0000026258488,0.00015302286,0.0000011164639],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21212164,0.0071379035,0.10222912,0.010538943,0.0053656446,0.0034189234,0.06595068,0.00016196955,0.23599872,0.014769545,0.0018013075,0.3405056],"study_design_scores_gemma":[0.13950635,0.0049012844,0.5639795,0.0069647753,0.0005292071,0.00060187565,0.0026503268,0.0017266495,0.22394834,0.00067883893,0.0531664,0.0013464589],"about_ca_topic_score_codex":0.000017795148,"about_ca_topic_score_gemma":0.00004988564,"teacher_disagreement_score":0.46175036,"about_ca_system_score_codex":0.000095393036,"about_ca_system_score_gemma":0.0016976872,"threshold_uncertainty_score":0.56796503},"labels":[],"label_agreement":null},{"id":"W3147838034","doi":"10.1016/j.jtct.2021.03.033","title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"British Columbia Children's Hospital; CancerCare Manitoba; University of Manitoba","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute; AbbVie; University at Buffalo; Janssen Pharmaceuticals; Memorial Sloan-Kettering Cancer Center; American Society for Transplantation and Cellular Therapy; National Institutes of Health; Alvin J. Siteman Cancer Center; Universidad de Sevilla; Anthony Nolan; Huntsman Cancer Institute; Takeda Pharmaceuticals U.S.A.; University of Minnesota; Massachusetts General Hospital; Novartis; Celgene; Universität Hamburg; Bristol-Myers Squibb; AstraZeneca; CareDx; Government of South Australia; Dana-Farber Cancer Institute; Pfizer; Amgen; U.S. Department of Veterans Affairs","keywords":"Medicine; Clinical trial; Intensive care medicine; Disease; Standardization; Graft-versus-host disease; Clinical Practice; Consensus conference; MEDLINE; Chronic disease; Pathology; Physical therapy; Internal medicine","score_opus":0.3148686311107944,"score_gpt":0.5038273522807666,"score_spread":0.1889587211699722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3147838034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891837,0.0038972213,0.0023738674,0.0020419513,0.00039621707,0.0019926445,0.000057956302,0.000018802275,0.000037631755],"genre_scores_gemma":[0.9680322,0.028410146,0.0018399445,0.00032828777,0.00018185521,0.00027431367,0.00090188667,0.000018338445,0.000013017954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99597514,0.0011405732,0.0019695575,0.00039725567,0.00034263553,0.00017484094],"domain_scores_gemma":[0.99648637,0.0027210277,0.00045906426,0.00012414207,0.00011380991,0.00009556729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007088631,0.00016126908,0.0006098811,0.000087140084,0.0001256993,0.00003131519,0.0000395607,0.00008813231,0.000025720394],"category_scores_gemma":[0.00018479285,0.00012460578,0.00014258974,0.00016154323,0.000111749265,0.000042169497,0.0000038848093,0.0001433642,5.922684e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021820836,0.0014424087,0.72816455,0.0032767483,0.0011313335,0.0006411547,0.011344341,0.0000074048708,0.0065351627,0.0019623127,0.000745095,0.22292864],"study_design_scores_gemma":[0.028572034,0.0012353054,0.94698346,0.0011254295,0.00025965445,0.00008684525,0.0008565295,0.000115495444,0.010631101,0.0000821936,0.009786647,0.00026533604],"about_ca_topic_score_codex":0.000037849237,"about_ca_topic_score_gemma":0.00012522718,"teacher_disagreement_score":0.22266331,"about_ca_system_score_codex":0.00006210396,"about_ca_system_score_gemma":0.001063572,"threshold_uncertainty_score":0.5081276},"labels":[],"label_agreement":null},{"id":"W3151577537","doi":"10.1016/j.jtct.2021.03.028","title":"Breaking the Age Barrier: Physicians’ Perceptions of Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Janssen Pharmaceuticals; National Center for Advancing Translational Sciences; Abbott Laboratories; National Institute on Aging; U.S. Public Health Service; Genentech; Daiichi-Sankyo; Kyowa Kirin Pharmaceutical Development; National Institute of Allergy and Infectious Diseases; Angiocrine Bioscience; Medical College of Wisconsin; Novartis; Merck; GlaxoSmithKline; Takeda Pharmaceuticals U.S.A.; Amgen; National Heart, Lung, and Blood Institute; Pfizer; Health Resources and Services Administration; Astellas Pharma US; Office of Naval Research; Jazz Pharmaceuticals; Intel Corporation; National Cancer Institute; AbbVie; Sanofi","keywords":"Candidacy; Medicine; Hematopoietic cell; Transplantation; Young adult; Regimen; Family medicine; Gerontology; Internal medicine; Stem cell; Haematopoiesis","score_opus":0.03162625551612509,"score_gpt":0.3247208810890929,"score_spread":0.29309462557296784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3151577537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985175,0.0040934305,0.009660696,0.00021737049,0.000041940115,0.0003968424,0.00008046919,0.000009798253,0.00032444578],"genre_scores_gemma":[0.97680265,0.021792954,0.0005558578,0.0002464709,0.000029347895,0.00003659604,0.00040418864,0.000013984025,0.00011793924],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992683,0.000062900916,0.00025720804,0.00016144835,0.00013033996,0.000119782555],"domain_scores_gemma":[0.9996018,0.00011872426,0.00006754775,0.00010675274,0.00007804786,0.00002715017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009441397,0.00010858674,0.00023272427,0.000056401386,0.000049479917,0.0000063856824,0.000039904884,0.000058070265,0.00005259111],"category_scores_gemma":[0.000002580201,0.00008532405,0.00010427715,0.00013472322,0.00006063209,0.000042678847,0.0000011281309,0.000067875335,5.9708685e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013260313,0.00033759762,0.051678006,0.002322006,0.000090548296,0.00009911076,0.120255776,0.000049026945,0.8110197,0.00030858736,0.0000152066295,0.012498391],"study_design_scores_gemma":[0.0077412776,0.00016666373,0.09130151,0.0013889007,0.00020705952,0.000029753544,0.0082081,0.000106305706,0.8902337,0.00013282981,0.0003286405,0.00015528804],"about_ca_topic_score_codex":0.00007623666,"about_ca_topic_score_gemma":0.00015811478,"teacher_disagreement_score":0.11204768,"about_ca_system_score_codex":0.000009249377,"about_ca_system_score_gemma":0.000039628158,"threshold_uncertainty_score":0.34794137},"labels":[],"label_agreement":null},{"id":"W3157866779","doi":"10.1016/j.jtct.2021.04.013","title":"Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; University of Calgary","funders":"National Center for Advancing Translational Sciences; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Sanofi Genzyme; Merck Sharp and Dohme; U.S. Public Health Service; Genentech; Health Resources and Services Administration; National Institutes of Health; Astellas Pharma; Kite Pharma; Meiji Seika Pharma; Daiichi-Sankyo; Vertex Pharmaceuticals; Omeros Corporation; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Kyowa Kirin Pharmaceutical Development; National Institute of Allergy and Infectious Diseases; Angiocrine Bioscience; Cancer Moonshot; Medical College of Wisconsin; StemCyte; Bristol-Myers Squibb; CSL Behring; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Celgene; Actinium Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; Servier; Gilead Sciences; AbbVie; Moonshot Research and Development Program; Sanofi; Amgen; Jazz Pharmaceuticals; Intel Corporation; Astellas Pharma US","keywords":"Medicine; Psychosocial; Transplantation; Hematopoietic cell; Confidence interval; Young adult; Odds ratio; Population; Comorbidity; Logistic regression; Gerontology; Internal medicine; Psychiatry; Haematopoiesis; Stem cell","score_opus":0.0172365986715323,"score_gpt":0.25990559683192477,"score_spread":0.24266899816039247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157866779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923634,0.0009923624,0.0037824654,0.0019754209,0.00008368747,0.0005001311,0.00003651368,0.000029542398,0.00023651199],"genre_scores_gemma":[0.98551,0.010461599,0.00027203953,0.0026092806,0.000031259013,0.000028467028,0.0009795651,0.000023906083,0.00008391603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982508,0.00039554076,0.00046836882,0.0002808499,0.00040063952,0.00020382901],"domain_scores_gemma":[0.9992318,0.00020355183,0.00009359933,0.00023829106,0.000118922755,0.00011384374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004935923,0.00018248663,0.00030024382,0.00015970547,0.00006302017,0.000025437836,0.00009752514,0.00009314514,0.00007433215],"category_scores_gemma":[0.000008421893,0.00014750639,0.00008421282,0.00069793785,0.000068260626,0.00005734737,0.0000025773927,0.00017607416,0.0000040249556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028716598,0.0006548474,0.6196849,0.0022466623,0.00014045145,0.00055591186,0.32097965,0.00039539588,0.05111379,0.00040540015,0.00008922655,0.0008620959],"study_design_scores_gemma":[0.008074515,0.00043872575,0.6122298,0.00088366657,0.0002619754,0.00019102247,0.022212591,0.00008222766,0.35443357,0.0003662622,0.00033279107,0.00049282005],"about_ca_topic_score_codex":0.0018892483,"about_ca_topic_score_gemma":0.0022473265,"teacher_disagreement_score":0.30331975,"about_ca_system_score_codex":0.000015805623,"about_ca_system_score_gemma":0.000055185705,"threshold_uncertainty_score":0.6015136},"labels":[],"label_agreement":null},{"id":"W3159846033","doi":"10.1016/j.jtct.2021.04.023","title":"Early Warning of Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation Using Heart Rate Variability and Serum Biomarkers","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Internal medicine; Biomarker; Logistic regression; Heart rate variability; Heart transplantation; Prospective cohort study; Ambulatory; Transplantation; Heart rate; Blood pressure","score_opus":0.03210810382118796,"score_gpt":0.26876072985518856,"score_spread":0.2366526260340006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159846033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980322,0.00040445986,0.0010996226,0.000054215365,0.000043448632,0.00028568762,0.000013480474,0.000014101644,0.00005274279],"genre_scores_gemma":[0.9946368,0.0049384763,0.00023221906,0.00006461676,0.000005595974,0.0000071354066,0.00009747473,0.000012437731,0.000005287543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991016,0.00019065136,0.0002592501,0.00022063153,0.000116476986,0.00011143863],"domain_scores_gemma":[0.99963266,0.000120622644,0.00006422557,0.00008034059,0.000049752176,0.000052385134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021607555,0.00011684415,0.00021210976,0.00008446605,0.000055089007,0.00001640761,0.000008906883,0.000067193025,0.00001970669],"category_scores_gemma":[0.0000016745807,0.00010941802,0.000046422007,0.00015075784,0.000027372642,0.00009562857,0.000001613277,0.00006188841,4.588517e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037941933,0.00033772996,0.95336336,0.0006438553,0.000057875408,0.00002136913,0.003024983,0.00004713703,0.040299784,0.000023594479,2.4619555e-7,0.0018006659],"study_design_scores_gemma":[0.005089634,0.00021182827,0.78950095,0.00021566694,0.000107565,0.000014787413,0.00009511483,0.00018409787,0.20446597,0.000033779437,0.0000028973882,0.00007771179],"about_ca_topic_score_codex":0.00013919537,"about_ca_topic_score_gemma":0.000028623688,"teacher_disagreement_score":0.16416618,"about_ca_system_score_codex":0.000028338696,"about_ca_system_score_gemma":0.000040799063,"threshold_uncertainty_score":0.44619372},"labels":[],"label_agreement":null},{"id":"W3161641015","doi":"10.1016/j.jtct.2021.04.030","title":"Donor-Specific Antibodies and Primary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis","year":2021,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Major Science and Technology Projects of China; National Key Research and Development Program of China; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Natural Science Foundation of China","keywords":"Medicine; Cochrane Library; Meta-analysis; Internal medicine; Odds ratio; Hematopoietic stem cell transplantation; Confidence interval; Subgroup analysis; Human leukocyte antigen; Transplantation; Oncology; Surgery; Immunology; Antigen","score_opus":0.05627700125596914,"score_gpt":0.2953017753576976,"score_spread":0.23902477410172845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161641015","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005000104,0.99309886,0.0012330137,0.0001867361,0.00002769199,0.004488768,0.00026996847,0.00006334043,0.00013159263],"genre_scores_gemma":[0.00081012136,0.9949193,0.0004796337,0.0004207332,0.000016530113,0.0005929632,0.0023143978,0.00009798736,0.00034831808],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9949524,0.0010012961,0.0019607516,0.0011332954,0.0005447802,0.00040747467],"domain_scores_gemma":[0.9980437,0.00047960508,0.0005442132,0.0005714977,0.00010320795,0.00025774946],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00086058496,0.0009982561,0.0084448755,0.00068906636,0.0001303044,0.00012405205,0.00014650135,0.00046196856,0.00017901858],"category_scores_gemma":[0.0000015283772,0.00074280746,0.001269764,0.0009934091,0.00014676103,0.00015256868,0.000009739936,0.00046634523,0.000009668298],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003580222,0.00011225198,0.00003470456,0.974077,0.021179598,0.0007598353,0.0021610803,5.3596375e-7,0.00007190927,0.000101414036,0.0000070663805,0.001458819],"study_design_scores_gemma":[0.0021656342,0.00012671869,0.000053419677,0.07488913,0.9132166,0.0034579127,0.00033987683,0.0000024346805,0.00031243672,0.000011300774,0.00434999,0.0010745528],"about_ca_topic_score_codex":0.000014117971,"about_ca_topic_score_gemma":0.000037171914,"teacher_disagreement_score":0.89918786,"about_ca_system_score_codex":0.00004770539,"about_ca_system_score_gemma":0.00012906626,"threshold_uncertainty_score":0.9995023},"labels":[],"label_agreement":null},{"id":"W3169873720","doi":"10.1016/j.jtct.2021.05.027","title":"The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma","year":2021,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Multiple myeloma; Minimal residual disease; Medicine; Hematology; Oncology; Immunology; Flow cytometry; Immune system; Internal medicine; Computational biology; Bone marrow; Biology","score_opus":0.07644627137797783,"score_gpt":0.3392379421358628,"score_spread":0.26279167075788495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169873720","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05095963,0.94686055,0.00003092605,0.00017190317,0.00007468183,0.0016657532,0.0000870197,0.000037385562,0.00011217462],"genre_scores_gemma":[0.01911796,0.97844005,0.00033397047,0.000041001145,0.00014657657,0.0002757632,0.0012460013,0.00006544577,0.0003332612],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997574,0.00041464518,0.00062180514,0.00059341185,0.00037141284,0.00042473766],"domain_scores_gemma":[0.9979114,0.0012774937,0.00015204489,0.00031865074,0.000059032278,0.00028137298],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037616814,0.00045525233,0.00090898626,0.00015816822,0.00027323334,0.00012565692,0.00011912478,0.00017707862,0.000021273738],"category_scores_gemma":[0.00012985956,0.0002952123,0.00018508047,0.0003287233,0.00013804405,0.00006393506,0.000022383845,0.0005540664,0.00000877682],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00162559,0.00018541016,0.0016525022,0.0040105665,0.00028136815,0.0019708513,0.0003098543,5.5767913e-7,0.00028581943,0.000037636637,0.000007019947,0.98963284],"study_design_scores_gemma":[0.08819164,0.0054784766,0.14074695,0.29401016,0.0064299507,0.0026962005,0.0038942948,0.0042658793,0.0073664165,0.000215853,0.4405524,0.006151748],"about_ca_topic_score_codex":0.000024563173,"about_ca_topic_score_gemma":0.000030755484,"teacher_disagreement_score":0.98348105,"about_ca_system_score_codex":0.000059812173,"about_ca_system_score_gemma":0.0002237294,"threshold_uncertainty_score":0.99995},"labels":[],"label_agreement":null},{"id":"W3170028153","doi":"10.1016/j.jtct.2021.06.001","title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"British Columbia Children's Hospital; CancerCare Manitoba; University of Manitoba","funders":"National Eye Institute; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Clinical trial; Disease; Intensive care medicine; Graft-versus-host disease; Quality of life (healthcare); Clinical endpoint; Immunology; Internal medicine","score_opus":0.22161267112126218,"score_gpt":0.45789373577698356,"score_spread":0.23628106465572138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170028153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98362476,0.0033559287,0.005433612,0.0041951253,0.00048829935,0.002400113,0.00014061743,0.000031831998,0.0003297073],"genre_scores_gemma":[0.98454666,0.011059509,0.0016553262,0.00049243297,0.00014332982,0.00018085833,0.0017795782,0.0000218603,0.0001204388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99713784,0.00052956253,0.0014504539,0.00032164418,0.00038351037,0.00017697693],"domain_scores_gemma":[0.9980867,0.0011897292,0.00033154312,0.00015245285,0.00015604614,0.000083528685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041824463,0.0001608216,0.0005660415,0.000085662185,0.00010064868,0.000018035651,0.00004819818,0.00007971702,0.000030953644],"category_scores_gemma":[0.00017230313,0.00011208824,0.00014995348,0.00016694998,0.00008799927,0.000036700516,0.0000022902489,0.0001192278,0.0000018647119],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20249143,0.009085083,0.065118566,0.038094666,0.0060628867,0.007248202,0.05160649,0.00038090284,0.40506172,0.042224277,0.0068099005,0.16581586],"study_design_scores_gemma":[0.12822342,0.0041201185,0.3505273,0.0050980183,0.0008264158,0.0009802609,0.0019836535,0.0024388505,0.43077463,0.0009693364,0.07273044,0.001327553],"about_ca_topic_score_codex":0.000017615468,"about_ca_topic_score_gemma":0.000046145906,"teacher_disagreement_score":0.28540874,"about_ca_system_score_codex":0.00008593811,"about_ca_system_score_gemma":0.0022670685,"threshold_uncertainty_score":0.45708257},"labels":[],"label_agreement":null},{"id":"W3171632039","doi":"10.1016/j.jtct.2021.05.004","title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"National Institutes of Health; Sapienza Università di Roma; CTI Biopharma; Meiji Seika Pharma; Dana-Farber Cancer Institute; Pfizer; CareDx; Government of South Australia; Janssen Pharmaceuticals; Gilead Sciences; Massachusetts General Hospital; Bristol-Myers Squibb; AstraZeneca; Novartis; Amgen; National Cancer Institute; Takeda Pharmaceutical Company","keywords":"Medicine; Clinical trial; Intensive care medicine; Disease; Context (archaeology); Graft-versus-host disease; Systemic therapy; Chronic disease; Internal medicine; Cancer","score_opus":0.2395835741235416,"score_gpt":0.46550490995690214,"score_spread":0.22592133583336055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171632039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98181987,0.009893427,0.002991881,0.0017754156,0.00044450376,0.0027155606,0.00015145453,0.000019235984,0.00018867668],"genre_scores_gemma":[0.97211426,0.025193024,0.0008269421,0.00009362882,0.00013271913,0.00017858019,0.0013413916,0.000016669044,0.000102793274],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972236,0.00056104467,0.0014664251,0.0002891423,0.0003099222,0.0001498715],"domain_scores_gemma":[0.9981017,0.0011482093,0.00038978845,0.00015362116,0.00014125119,0.00006540262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022689558,0.00015800449,0.00066634285,0.00008178609,0.00006790298,0.000008402855,0.000035838293,0.000069569665,0.000057724254],"category_scores_gemma":[0.000073819385,0.00011037059,0.00017032512,0.00014720614,0.000100559504,0.000021500398,0.0000013913359,0.000059904036,8.1714114e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12837759,0.01512547,0.03229736,0.026333967,0.0067091594,0.003488276,0.051213045,0.00046789515,0.326156,0.012243951,0.0012685606,0.39631873],"study_design_scores_gemma":[0.124993145,0.00810239,0.16365857,0.0023600112,0.00081432133,0.0003630706,0.0010770633,0.0015089136,0.6676159,0.00016274503,0.028690044,0.00065384427],"about_ca_topic_score_codex":0.000034036308,"about_ca_topic_score_gemma":0.00007499225,"teacher_disagreement_score":0.3956649,"about_ca_system_score_codex":0.00019269413,"about_ca_system_score_gemma":0.0033893737,"threshold_uncertainty_score":0.6012603},"labels":[],"label_agreement":null},{"id":"W3173042138","doi":"10.1016/j.jtct.2021.05.009","title":"A Timely CIBMTR Analysis of How Cryopreservation Impacts Allogeneic Hematopoietic Cell Transplantation to Apply in the COVID Era","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Canadian Blood Services","funders":"","keywords":"Hematopoietic cell; Coronavirus disease 2019 (COVID-19); Transplantation; Hematopoietic stem cell transplantation; 2019-20 coronavirus outbreak; Medicine; Haematopoiesis; Virology; Biology; Stem cell; Internal medicine; Infectious disease (medical specialty); Disease; Outbreak; Genetics","score_opus":0.02707958227693262,"score_gpt":0.2711998780436176,"score_spread":0.24412029576668498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173042138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9588425,0.0009407206,0.036095418,0.0025789447,0.0000387447,0.00083157764,0.000089124485,0.000031640364,0.0005513118],"genre_scores_gemma":[0.989824,0.005557932,0.0011650943,0.0017347935,0.000022671595,0.00007412055,0.0014964985,0.000025717436,0.00009919498],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793226,0.00031156428,0.00051183486,0.00041513267,0.0005573795,0.00027182436],"domain_scores_gemma":[0.9989679,0.00026808234,0.00013045128,0.00033732993,0.00013625626,0.00016000184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005713655,0.00024753917,0.00051343266,0.00048644873,0.00007942168,0.000055000353,0.00012251567,0.00014395345,0.00015320173],"category_scores_gemma":[0.000009472051,0.00020021397,0.00019002984,0.0016480928,0.00005006438,0.00013156472,0.0000027284125,0.00017598647,0.000006697748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013933645,0.00048532,0.08275947,0.001829683,0.000480239,0.0004973226,0.039647605,0.00068352954,0.8703232,0.000466219,0.000031033367,0.0014030008],"study_design_scores_gemma":[0.0058518997,0.00034307383,0.36724207,0.00019616153,0.0023383652,0.0002972083,0.001769836,0.00048025884,0.62072086,0.00009601168,0.00031075202,0.00035348051],"about_ca_topic_score_codex":0.00008025094,"about_ca_topic_score_gemma":0.0002235806,"teacher_disagreement_score":0.2844826,"about_ca_system_score_codex":0.000029305289,"about_ca_system_score_gemma":0.00013237803,"threshold_uncertainty_score":0.8164488},"labels":[],"label_agreement":null},{"id":"W3175398433","doi":"10.1016/j.jtct.2021.06.013","title":"Recognition of Hematopoietic Stem Cell Transplantation and Cellular Therapy Expertise to Promote Care Accessibility: A Formally Credentialed Area of Focused Competence in Canada","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; McMaster University; Juravinski Hospital; Centre Hospitalier Universitaire Sainte-Justine; Royal College of Physicians and Surgeons of Canada; University of Ottawa; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Royal College of Physicians and Surgeons of Canada","keywords":"Competence (human resources); Economic shortage; Transplantation; Medicine; Hematopoietic stem cell transplantation; Stem cell; Psychology; Surgery","score_opus":0.026331259944009113,"score_gpt":0.24039990294002828,"score_spread":0.21406864299601916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175398433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853756,0.0038594136,0.008937687,0.00009573916,0.000074398034,0.001200525,0.00014575048,0.000021836888,0.00028905203],"genre_scores_gemma":[0.98935324,0.008655488,0.0012004275,0.00013826253,0.000011269136,0.0000642021,0.000522339,0.0000337428,0.00002100567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99777114,0.00017924064,0.00083416456,0.00046555002,0.00048459938,0.00026532574],"domain_scores_gemma":[0.99903405,0.00009816388,0.00019342272,0.0002463838,0.00025165087,0.00017634447],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020663367,0.00028224784,0.00059333985,0.00017874195,0.00006003491,0.000022355869,0.00008697936,0.00012344573,0.00009736147],"category_scores_gemma":[0.0000020338614,0.00027166447,0.00008341269,0.00034947263,0.000057306806,0.00016146962,0.0000044385606,0.0001369917,9.2216106e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00249047,0.00022079765,0.015469641,0.004333426,0.00006130081,0.00034714252,0.04271563,0.00002295153,0.89016557,0.000012924232,0.0000010056181,0.044159118],"study_design_scores_gemma":[0.008172154,0.00035125637,0.01625222,0.00097349443,0.00012471994,0.00009679286,0.0043762554,0.00021109844,0.96912754,0.00003689332,0.000015564696,0.00026203934],"about_ca_topic_score_codex":0.0135672055,"about_ca_topic_score_gemma":0.030488322,"teacher_disagreement_score":0.07896192,"about_ca_system_score_codex":0.000081369464,"about_ca_system_score_gemma":0.00054790115,"threshold_uncertainty_score":0.99997354},"labels":[],"label_agreement":null},{"id":"W3175898740","doi":"10.1016/j.jtct.2021.06.029","title":"Prophylactic or Preemptive Low-Dose Azacitidine and Donor Lymphocyte Infusion to Prevent Disease Relapse following Allogeneic Transplantation in Patients with High-Risk Acute Myelogenous Leukemia or Myelodysplastic Syndrome","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Centre Hospitalier Universitaire de Nantes","keywords":"Medicine; Donor lymphocyte infusion; Transplantation; Cumulative incidence; Internal medicine; Azacitidine; Myelodysplastic syndromes; Hematopoietic stem cell transplantation; Chronic myelogenous leukemia; Leukemia; Oncology; Surgery; Bone marrow","score_opus":0.008411363278042653,"score_gpt":0.23444896193502301,"score_spread":0.22603759865698037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175898740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521905,0.00044914274,0.001605939,0.00014872383,0.00010182833,0.0022094094,0.00019770836,0.000056544424,0.000011678559],"genre_scores_gemma":[0.9881856,0.008533986,0.0010622924,0.00026730675,0.000031858875,0.0001994981,0.0010523361,0.000071919065,0.0005951888],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99754447,0.00028294863,0.00042394907,0.0007228287,0.0005656251,0.00046015176],"domain_scores_gemma":[0.998799,0.00016215541,0.0001113368,0.0002838729,0.00016394311,0.00047963724],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022418244,0.0003985446,0.0005070764,0.00029730072,0.00020354614,0.00006177158,0.00009259344,0.00014750723,0.00008656638],"category_scores_gemma":[0.000035401867,0.00027955425,0.00007309304,0.0005711916,0.00007663669,0.00025807339,0.00001649817,0.00029432113,0.000014360588],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42135486,0.003185901,0.2544094,0.005837455,0.002029575,0.06285658,0.024369307,0.0013627941,0.17634341,0.000047762303,0.000015519121,0.04818742],"study_design_scores_gemma":[0.047126826,0.0055685025,0.89938855,0.0011403162,0.0014458796,0.0005620267,0.00025165555,0.00035767045,0.043351933,0.000028853732,0.000048879843,0.0007288874],"about_ca_topic_score_codex":0.00014043368,"about_ca_topic_score_gemma":0.00017746464,"teacher_disagreement_score":0.6449792,"about_ca_system_score_codex":0.00041880753,"about_ca_system_score_gemma":0.0009509473,"threshold_uncertainty_score":0.99996567},"labels":[],"label_agreement":null},{"id":"W3176205187","doi":"10.1016/j.jtct.2021.06.028","title":"A Prospective Cohort Study Comparing Long-Term Outcomes with and without Palifermin in Patients Receiving Hematopoietic Cell Transplantation for Hematologic Malignancies","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Oral health in cancer treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Health Resources and Services Administration; Swedish Orphan Biovitrum; U.S. Public Health Service; Kiadis Pharma; Daiichi-Sankyo; National Heart, Lung, and Blood Institute; CareDx; Medical College of Wisconsin; Shire; Bristol-Myers Squibb; CSL Behring; National Institute of Allergy and Infectious Diseases; Celgene; Novartis; Karyopharm Therapeutics; Janssen Pharmaceuticals; Gilead Sciences; Office of Naval Research; Jazz Pharmaceuticals; GlaxoSmithKline","keywords":"Medicine; Internal medicine; Dialysis; Transplantation; Mucositis; Relative risk; Univariate analysis; Prospective cohort study; Surgery; Population; Incidence (geometry); Gastroenterology; Confidence interval; Multivariate analysis; Chemotherapy","score_opus":0.031559685694473816,"score_gpt":0.31035691999791165,"score_spread":0.27879723430343784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176205187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523896,0.0005954906,0.0010707682,0.00007982135,0.00003990621,0.0028773611,0.000013434513,0.000033996734,0.00005025786],"genre_scores_gemma":[0.9970287,0.0014265137,0.00079806393,0.000114663766,0.00000776722,0.00037065262,0.0001707804,0.000023800398,0.000059053153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882406,0.00007613735,0.00030665885,0.0003756862,0.00020279635,0.000214668],"domain_scores_gemma":[0.9995769,0.000058835503,0.00008352317,0.00011567907,0.00008061486,0.00008444417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015518889,0.0002004809,0.0004650556,0.000071092385,0.00009521605,0.000025327758,0.000024341905,0.00005435831,0.000008398973],"category_scores_gemma":[0.0000016769544,0.00015237326,0.000030136243,0.00010767117,0.000040239396,0.00007665244,0.0000021702383,0.000086298045,6.2280293e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002029849,0.0007741049,0.9881067,0.0012687326,0.00008204258,0.000103790066,0.006556249,0.0000034685406,0.0005618179,0.000014508591,2.1542046e-7,0.0004984777],"study_design_scores_gemma":[0.018349983,0.0010369642,0.9603541,0.0003157999,0.00021933824,0.00006024322,0.00055969873,0.000020334512,0.018900344,0.000024676103,5.044755e-7,0.00015802898],"about_ca_topic_score_codex":0.00004125585,"about_ca_topic_score_gemma":0.0003364584,"teacher_disagreement_score":0.02775266,"about_ca_system_score_codex":0.000061317725,"about_ca_system_score_gemma":0.000056655823,"threshold_uncertainty_score":0.6213601},"labels":[],"label_agreement":null},{"id":"W3194157976","doi":"10.1016/j.jtct.2021.08.007","title":"Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; National Heart, Lung, and Blood Institute; U.S. Public Health Service; Health Resources and Services Administration; CytoSen Therapeutics; Kiadis Pharma; Pfizer; Incyte; Kyowa Kirin Pharmaceutical Development; Jazz Pharmaceuticals; Medical College of Wisconsin; Takeda Pharmaceuticals U.S.A.; Meso Scale Diagnostics; AbbVie; National Cancer Institute; Gilead Sciences; Karyopharm Therapeutics; Celgene; Novartis; GlaxoSmithKline; Otsuka America; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Roche; Astellas Pharma US; Falk Foundation; CareDx; Daiichi-Sankyo","keywords":"Medicine; Fludarabine; Busulfan; Melphalan; Alemtuzumab; Internal medicine; Transplantation; Regimen; Hematopoietic stem cell transplantation; Cumulative incidence; Incidence (geometry); Surgery; Gastroenterology; Oncology; Chemotherapy; Cyclophosphamide","score_opus":0.011113389530440035,"score_gpt":0.24564307194107604,"score_spread":0.23452968241063601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194157976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974103,0.0006743775,0.00065665296,0.0003707172,0.000021524129,0.000678829,0.00009272002,0.000023958884,0.00007094211],"genre_scores_gemma":[0.9944043,0.0039373897,0.00076513534,0.00009192858,0.000009132086,0.00002854323,0.00062216294,0.000031602965,0.00010978331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864084,0.00009648408,0.000319714,0.00038034376,0.0003357922,0.00022683886],"domain_scores_gemma":[0.9993521,0.00013156737,0.00008270712,0.00014906125,0.00014967877,0.00013488387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001234766,0.00024204246,0.0005047974,0.00018644084,0.00006292712,0.000027479906,0.00003975033,0.000083384584,0.00003549747],"category_scores_gemma":[0.0000053266676,0.00016969882,0.000024995397,0.000238073,0.0001822443,0.00014497082,0.0000043216546,0.00017774056,5.1889e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010364579,0.0005947738,0.630441,0.0016963844,0.00039612027,0.0005709264,0.00701294,0.000018392248,0.34322262,0.00009196906,0.0000033716474,0.0055868845],"study_design_scores_gemma":[0.026015049,0.00095245166,0.8310705,0.00034300121,0.00018492925,0.00020305897,0.00038924284,0.0001789015,0.14043319,0.000016019956,0.000007843891,0.00020580292],"about_ca_topic_score_codex":0.000079742196,"about_ca_topic_score_gemma":0.00009254855,"teacher_disagreement_score":0.20278943,"about_ca_system_score_codex":0.00002528081,"about_ca_system_score_gemma":0.0001076905,"threshold_uncertainty_score":0.69201165},"labels":[],"label_agreement":null},{"id":"W3195493284","doi":"10.1016/j.jtct.2021.08.010","title":"Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Ottawa Hospital","funders":"Janssen Pharmaceuticals; Janssen Biotech; Janssen Research and Development; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Patient-Centered Outcomes Research Institute; Sanofi Genzyme; Celgene; U.S. Navy; Health Resources and Services Administration; CytoSen Therapeutics; Kyowa Hakko Kirin; Daiichi-Sankyo; Janssen Scientific Affairs; CSL Behring; BC Children's Hospital; National Institutes of Health; Seattle Genetics; National Heart, Lung, and Blood Institute; Shire; Bristol-Myers Squibb; University of Wisconsin-Madison; Mayo Clinic; Government of South Australia; Pfizer; GlaxoSmithKline; U.S. Department of Defense; Boston Children's Hospital; National Cancer Institute; Gilead Sciences","keywords":"Medicine; Internal medicine; Myeloid leukemia; Regimen; Transplantation; Myelodysplastic syndromes; Leukemia; Hematopoietic stem cell transplantation; Oncology; Surgery; Bone marrow","score_opus":0.011797659604740352,"score_gpt":0.2508465873082747,"score_spread":0.23904892770353434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195493284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930429,0.0038799164,0.0009580457,0.0006437663,0.00006224418,0.00086975674,0.00006433974,0.00007366884,0.00040538283],"genre_scores_gemma":[0.91542447,0.08209535,0.00042953817,0.00065847277,0.000023666016,0.000068627975,0.0006774561,0.000051433828,0.000570988],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980536,0.00017923502,0.00042324478,0.0005948412,0.00032505541,0.0004240128],"domain_scores_gemma":[0.9992275,0.000121797275,0.000048991566,0.00022453253,0.000090167465,0.0002870111],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021377059,0.00031241993,0.00044199984,0.00031313192,0.00012116055,0.000043188236,0.00008185876,0.00023204758,0.00017949365],"category_scores_gemma":[0.000005156395,0.0002791112,0.00007363419,0.00052142487,0.000087505396,0.000122018166,0.0000067548194,0.00031455903,0.00003135279],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0098336125,0.00020100242,0.008683694,0.0006276989,0.00035356398,0.013661199,0.016917218,0.00012616294,0.89249057,0.00017943038,0.000016968292,0.056908913],"study_design_scores_gemma":[0.05778856,0.0032710964,0.35104176,0.001101543,0.0004814321,0.017987853,0.0010488792,0.0014724624,0.56377715,0.0003026908,0.00055852544,0.0011680546],"about_ca_topic_score_codex":0.00016974952,"about_ca_topic_score_gemma":0.00009330587,"teacher_disagreement_score":0.34235805,"about_ca_system_score_codex":0.00018793883,"about_ca_system_score_gemma":0.00031698664,"threshold_uncertainty_score":0.9999661},"labels":[],"label_agreement":null},{"id":"W3196532656","doi":"10.1016/j.jtct.2021.08.021","title":"Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; American Society of Pediatric Hematology/Oncology; Pediatric Cancer Foundation; American Society of Hematology","keywords":"Medicine; Elafin; Biomarker; Graft-versus-host disease; Internal medicine; Population; Oncology; Hematopoietic stem cell transplantation; Immunology; Disease; Gastroenterology","score_opus":0.04697479699653496,"score_gpt":0.3197217375985809,"score_spread":0.27274694060204596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196532656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935033,0.0025466352,0.0011943273,0.00034750463,0.00010447684,0.0007283923,0.000032272554,0.000024325498,0.0015188038],"genre_scores_gemma":[0.9939895,0.0049897577,0.00023323228,0.00010038751,0.000010278764,0.000061786646,0.000514626,0.000019350655,0.00008107625],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99838436,0.00024712685,0.00032842645,0.00026573957,0.0006230215,0.00015132841],"domain_scores_gemma":[0.9993151,0.00010769125,0.00006399605,0.00016051634,0.00022730176,0.00012540274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005607207,0.00014156302,0.0002188429,0.00013389277,0.00003139243,0.000012820303,0.000032751574,0.0000743936,0.0003651334],"category_scores_gemma":[0.000023833898,0.00013381963,0.00006997548,0.0002864714,0.000051346622,0.00007946722,0.000001803321,0.0000794235,0.000014096684],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008132242,0.0007887954,0.04644413,0.0009416085,0.00054482586,0.0011347295,0.0057594976,0.000027634618,0.9122507,0.0010628714,0.0000073428814,0.02290561],"study_design_scores_gemma":[0.031399433,0.0003592261,0.5730844,0.0007367288,0.0025413684,0.00019004226,0.0005382174,0.0037401416,0.3863663,0.00059495907,0.00012776717,0.00032137884],"about_ca_topic_score_codex":0.000024205776,"about_ca_topic_score_gemma":0.000029417757,"teacher_disagreement_score":0.5266403,"about_ca_system_score_codex":0.000030795367,"about_ca_system_score_gemma":0.00030642998,"threshold_uncertainty_score":0.5457006},"labels":[],"label_agreement":null},{"id":"W3196719306","doi":"10.1016/j.jtct.2021.08.031","title":"Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"National Institute of Allergy and Infectious Diseases; U.S. Department of Health and Human Services; National Cancer Institute; National Heart, Lung, and Blood Institute; U.S. Public Health Service; Health Resources and Services Administration","keywords":"Thymoglobulin; Medicine; Transplantation; Granulocyte colony-stimulating factor; Internal medicine; Hazard ratio; Hematopoietic stem cell transplantation; Immunology; Acute myeloblastic leukemia; Filgrastim; Myeloid; Leukemia; Oncology; Gastroenterology; Chemotherapy; Tacrolimus; Confidence interval","score_opus":0.019382227281520014,"score_gpt":0.25116379829955204,"score_spread":0.23178157101803204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196719306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9599278,0.0014390793,0.035613157,0.00024162591,0.00015672577,0.0015488069,0.0004363842,0.0001246445,0.0005117598],"genre_scores_gemma":[0.98659694,0.0063863806,0.0040342063,0.00031904894,0.00007286471,0.00020804953,0.0019718923,0.00009500801,0.0003155968],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975456,0.00014824519,0.00060272106,0.00064908876,0.0005190223,0.00053529907],"domain_scores_gemma":[0.99876904,0.00029056522,0.00015775213,0.00026671056,0.00022172845,0.00029419412],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023549047,0.0004724748,0.0006119902,0.00014394333,0.00021767168,0.00006886903,0.00007728861,0.0002458798,0.00028860383],"category_scores_gemma":[0.00000517229,0.00040535437,0.00018621,0.0002536941,0.00008390863,0.00020574054,0.000002732654,0.00020052124,0.00001703672],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025060466,0.00054742757,0.15906088,0.008008437,0.0004112633,0.0018414049,0.01636046,0.00018012937,0.78662735,0.00011783832,0.000006889407,0.0017774273],"study_design_scores_gemma":[0.020225171,0.0013733748,0.14148961,0.0008215835,0.0007300513,0.00081592664,0.00081772375,0.00029629923,0.83250266,0.000043863314,0.0002072631,0.00067648874],"about_ca_topic_score_codex":0.00002077621,"about_ca_topic_score_gemma":0.000078374724,"teacher_disagreement_score":0.045875266,"about_ca_system_score_codex":0.00004907077,"about_ca_system_score_gemma":0.00023592947,"threshold_uncertainty_score":0.99983984},"labels":[],"label_agreement":null},{"id":"W3197836939","doi":"10.1016/j.jtct.2021.08.018","title":"Is Haploidentical Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide Feasible in Sub-Saharan Africa?","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Fogarty International Center; National Institutes of Health","keywords":"Medicine; Transplantation; Internal medicine; Hematopoietic stem cell transplantation; Cyclophosphamide; Cumulative incidence; Incidence (geometry); Serostatus; Surgery; Immunology; Chemotherapy","score_opus":0.028024255098287713,"score_gpt":0.26780216486201663,"score_spread":0.23977790976372892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197836939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.966272,0.006731866,0.02370273,0.00047048624,0.00018271877,0.00091337034,0.00020782443,0.00012294708,0.0013960438],"genre_scores_gemma":[0.92647165,0.06875078,0.0021814643,0.00065812573,0.00005583194,0.00004698766,0.0015522784,0.000087948894,0.00019492977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99675685,0.000245424,0.0009155133,0.0007954603,0.0007029567,0.00058376906],"domain_scores_gemma":[0.99882716,0.0001800672,0.00014510415,0.00033047653,0.00022140186,0.00029576538],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003747665,0.0004783125,0.0006227517,0.0003658446,0.00018442913,0.000101299025,0.00010851983,0.0003334677,0.00033963527],"category_scores_gemma":[0.0000055259125,0.0004996777,0.00022063975,0.00066354946,0.0001147816,0.00036432824,0.000004163667,0.00037688573,0.000057378078],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021756364,0.00058249035,0.014318505,0.0034681214,0.00008712145,0.0034140598,0.013911459,0.000085017855,0.9605715,0.00018550758,0.00002345522,0.0011771068],"study_design_scores_gemma":[0.010521012,0.00020685777,0.05137306,0.0008347938,0.0005455192,0.0024769877,0.00059720565,0.00062979595,0.93176305,0.0002578771,0.00021913368,0.000574715],"about_ca_topic_score_codex":0.00016485159,"about_ca_topic_score_gemma":0.00010487383,"teacher_disagreement_score":0.062018912,"about_ca_system_score_codex":0.00008220708,"about_ca_system_score_gemma":0.0002489212,"threshold_uncertainty_score":0.9997455},"labels":[],"label_agreement":null},{"id":"W3201321334","doi":"10.1016/j.jtct.2021.09.009","title":"Haploidentical Allogeneic Stem Cell Transplantation in Sickle Cell Disease: A Systematic Review and Meta-Analysis","year":2021,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Academisch Medisch Centrum","keywords":"Medicine; Meta-analysis; Transplantation; Internal medicine; Odds ratio; Hematopoietic stem cell transplantation; Subgroup analysis; Oncology; Sibling; Cyclophosphamide; Chemotherapy","score_opus":0.04194712540333671,"score_gpt":0.2970603399105952,"score_spread":0.2551132145072585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201321334","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017152065,0.9957424,0.00059784687,0.00013450075,0.000023030361,0.003021099,0.0001702715,0.000034758283,0.00010458683],"genre_scores_gemma":[0.00078795315,0.99547154,0.000041100175,0.00047091077,0.000008308734,0.00034067582,0.0017617941,0.000057264147,0.0010604457],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99674875,0.00074437144,0.0012028972,0.00065689033,0.00036714162,0.0002799678],"domain_scores_gemma":[0.9988532,0.00015058136,0.00029697653,0.00036682922,0.000056844277,0.00027558167],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047496334,0.00057089963,0.0050983266,0.0003625301,0.00007577315,0.000057175952,0.000098007404,0.00031007847,0.0002506866],"category_scores_gemma":[0.000002087336,0.0003887318,0.0016020971,0.0007546195,0.000062967396,0.00006919013,0.0000053925446,0.00037541092,0.0000143185025],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003455923,0.00020446381,0.000007101974,0.9773974,0.019286603,0.00069920626,0.00042045268,0.0000025435593,0.000012602286,0.000028447239,0.0000052665764,0.0019013725],"study_design_scores_gemma":[0.001143858,0.00006481618,0.000007852594,0.0317785,0.9627982,0.00013262374,0.00009502431,0.000015836544,0.000039938397,0.0000037272873,0.0034517078,0.00046794623],"about_ca_topic_score_codex":0.000017171044,"about_ca_topic_score_gemma":0.000011658668,"teacher_disagreement_score":0.94561887,"about_ca_system_score_codex":0.000029353261,"about_ca_system_score_gemma":0.0001384614,"threshold_uncertainty_score":0.9998565},"labels":[],"label_agreement":null},{"id":"W3203453632","doi":"10.1016/j.jtct.2021.09.021","title":"Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Alberta Health Services; University of Calgary","funders":"O'Brien Institute for Public Health, University of Calgary; Alberta Cancer Foundation","keywords":"Serostatus; Medicine; Incidence (geometry); Internal medicine; Risk factor; Gastroenterology; Transplantation; Post-transplant lymphoproliferative disorder; Hematopoietic stem cell transplantation; Lymphoproliferative disorders; Cumulative incidence; Immunology; Complication; Lymphoma; Viral load; Virus","score_opus":0.009878284039741236,"score_gpt":0.2511537374207627,"score_spread":0.24127545338102147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203453632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971091,0.005704206,0.020630859,0.0011182564,0.000053405904,0.0009791292,0.000352213,0.000014843411,0.00005609507],"genre_scores_gemma":[0.97254807,0.02611179,0.000074626776,0.0008718384,0.00001718198,0.00013826626,0.00016848338,0.00001722105,0.000052553205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989555,0.00013597503,0.00028000987,0.00024335267,0.00021944668,0.00016570784],"domain_scores_gemma":[0.9992067,0.00034801394,0.000092203496,0.00015432632,0.00012641591,0.00007229704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026987868,0.0001763428,0.00029663552,0.000034449546,0.00019275182,0.0000294157,0.000053478332,0.000078165765,0.00004549302],"category_scores_gemma":[0.00000963157,0.000100159064,0.00012517728,0.00013519608,0.00014686059,0.00006624937,0.0000025081456,0.00010230914,6.9237535e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037915323,0.0006838065,0.57630587,0.0025225824,0.001392247,0.00020101448,0.29512233,0.0006236309,0.07109212,0.0020386446,0.000028812938,0.0120736],"study_design_scores_gemma":[0.030993108,0.0007602181,0.7191648,0.00025367958,0.0022823724,0.00013017766,0.013889259,0.000937283,0.2297203,0.0011809279,0.00018672482,0.00050117314],"about_ca_topic_score_codex":0.00058302504,"about_ca_topic_score_gemma":0.0005307082,"teacher_disagreement_score":0.28123307,"about_ca_system_score_codex":0.000011432125,"about_ca_system_score_gemma":0.00007527176,"threshold_uncertainty_score":0.4084368},"labels":[],"label_agreement":null},{"id":"W3206827112","doi":"10.1016/j.jtct.2021.10.008","title":"Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Study","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Transplantation; Hazard ratio; Internal medicine; Univariate analysis; Hematopoietic stem cell transplantation; Incidence (geometry); Single Center; Graft-versus-host disease; Surgery; Multivariate analysis; Confidence interval","score_opus":0.021749632186664605,"score_gpt":0.26500723412839433,"score_spread":0.24325760194172974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206827112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99114263,0.0011457736,0.004753379,0.00029576075,0.00017613213,0.0008703124,0.00003190675,0.00010992533,0.0014741799],"genre_scores_gemma":[0.9951397,0.0029588256,0.00064013083,0.00037324845,0.000027504097,0.0000718064,0.0003277391,0.00004617311,0.0004148698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822474,0.00017293457,0.0004703745,0.0005058239,0.0003513148,0.00027481548],"domain_scores_gemma":[0.9992693,0.00015348107,0.0000746112,0.00023413704,0.000070223745,0.00019824387],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000184964,0.00031626396,0.00045978653,0.00014594819,0.00020811507,0.00007945488,0.000045495643,0.00012879082,0.00014643803],"category_scores_gemma":[0.0000033426772,0.00029001778,0.00016184236,0.00023640518,0.00005313397,0.00014085887,0.0000042762595,0.00016963264,0.000014346578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015723381,0.0024756298,0.83534586,0.0007098643,0.00035162154,0.0014988794,0.012407739,0.0000045594807,0.14541218,0.00006725048,0.000003347999,0.0015658024],"study_design_scores_gemma":[0.042986836,0.0019754735,0.47138536,0.0005302569,0.0027441853,0.004297462,0.0076483805,0.00003202754,0.46677008,0.00015082626,0.00041710617,0.0010620013],"about_ca_topic_score_codex":0.000027818125,"about_ca_topic_score_gemma":0.000068263085,"teacher_disagreement_score":0.36396053,"about_ca_system_score_codex":0.000019261293,"about_ca_system_score_gemma":0.00006246192,"threshold_uncertainty_score":0.9999552},"labels":[],"label_agreement":null},{"id":"W3209154226","doi":"10.1016/j.jtct.2021.10.014","title":"Umbilical Cord Blood Transplantation after Graft Failure from a Previous Hematopoietic Stem Cell Transplantation","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Transplantation; Cumulative incidence; Umbilical cord; Pancytopenia; Hematopoietic stem cell transplantation; Surgery; Umbilical Cord Blood Transplantation; Incidence (geometry); Cord blood; Internal medicine; Haematopoiesis; Retrospective cohort study; Stem cell; Gastroenterology; Bone marrow; Immunology; Biology","score_opus":0.012921723588229728,"score_gpt":0.23381708385620775,"score_spread":0.220895360267978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209154226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9635976,0.004621897,0.028510334,0.0005342317,0.0001906007,0.0010627555,0.00040160163,0.00023868353,0.0008423079],"genre_scores_gemma":[0.96131957,0.031685933,0.002379699,0.0007147899,0.00012330957,0.00018928105,0.0030611984,0.00010360354,0.00042259597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99654245,0.00033457583,0.00090587104,0.00097350025,0.0007341422,0.0005094687],"domain_scores_gemma":[0.9985481,0.00026392602,0.0001670212,0.00045520105,0.00018465982,0.00038109065],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023239423,0.00057099597,0.0007112876,0.00018174475,0.00018137605,0.000119747805,0.00012111601,0.0004142686,0.0008020904],"category_scores_gemma":[0.0000017422896,0.0005573463,0.0002922911,0.0003935195,0.000128526,0.00028403316,0.000004255845,0.0004130435,0.00008355477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010329703,0.0015640398,0.019650241,0.00655439,0.00059537776,0.010327848,0.03441135,0.000023294677,0.90357375,0.00042715034,0.000037756537,0.012505092],"study_design_scores_gemma":[0.015758112,0.0005964083,0.028195415,0.00086045737,0.0024719625,0.0039500734,0.0010403681,0.00011372263,0.9454225,0.0002961099,0.0004972787,0.000797625],"about_ca_topic_score_codex":0.00006836564,"about_ca_topic_score_gemma":0.000116363495,"teacher_disagreement_score":0.041848708,"about_ca_system_score_codex":0.000034153996,"about_ca_system_score_gemma":0.00017096163,"threshold_uncertainty_score":0.9996878},"labels":[],"label_agreement":null},{"id":"W3210546731","doi":"10.1016/j.jtct.2021.10.013","title":"Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation","year":2021,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Pharmacyclics; Sanofi Genzyme; Takeda Oncology; U.S. Public Health Service; Genentech; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Daiichi-Sankyo; Seagen; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Kyowa Kirin Pharmaceutical Development; Medac; Jazz Pharmaceuticals; Cancer Moonshot; Medical College of Wisconsin; StemCyte; CareDx; Actinium Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; Moonshot Research and Development Program; Sanofi; Karyopharm Therapeutics; Celgene; Novartis; GlaxoSmithKline; Amgen; Accenture; CSL Behring; Bristol-Myers Squibb; AstraZeneca; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Astellas Pharma US","keywords":"Medicine; Transplantation; Disease; Population; Systematic review; Intensive care medicine; Quality of life (healthcare); Internal medicine; MEDLINE","score_opus":0.07421536235434607,"score_gpt":0.3167009603246929,"score_spread":0.24248559797034686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210546731","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31056994,0.68150586,0.0010063123,0.00020403844,0.00013885752,0.005578611,0.00090870314,0.000012600974,0.00007508734],"genre_scores_gemma":[0.36872545,0.6301785,0.00023134137,0.000070795286,0.000020347657,0.00016475013,0.0005545698,0.000043247284,0.000010974141],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99359936,0.002632702,0.0021085185,0.00061640725,0.0007326484,0.00031034942],"domain_scores_gemma":[0.9944973,0.003524726,0.0010546139,0.00049806887,0.00030690324,0.00011836806],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023484079,0.0005296415,0.0020654942,0.00015331221,0.00020732314,0.00004149433,0.0003289437,0.00026757538,0.000005467598],"category_scores_gemma":[0.000036016583,0.00033381494,0.00041945718,0.00047230374,0.00054476585,0.00008692834,0.000017991119,0.0005477422,1.6400614e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006062528,0.0005614947,0.029036473,0.91957325,0.0012478363,0.000019370116,0.021717107,0.000002524121,0.02163979,0.00045489456,0.0000049912564,0.0051360144],"study_design_scores_gemma":[0.017386533,0.00037758588,0.03411938,0.91368425,0.011753665,0.0005092439,0.0005788829,0.00006998412,0.020424793,0.00012723665,0.00023416597,0.0007342623],"about_ca_topic_score_codex":0.00008129284,"about_ca_topic_score_gemma":0.00007784883,"teacher_disagreement_score":0.058155518,"about_ca_system_score_codex":0.000018055527,"about_ca_system_score_gemma":0.00008656273,"threshold_uncertainty_score":0.99991137},"labels":[],"label_agreement":null},{"id":"W3215472881","doi":"10.1016/j.jtct.2021.11.009","title":"Outcome of Haploidentical Peripheral Blood Allografts Using Post-Transplantation Cyclophosphamide Compared to Matched Sibling and Unrelated Donor Bone Marrow Allografts in Pediatric Patients with Hematologic Malignancies: A Single-Center Analysis","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Cyclophosphamide; Cumulative incidence; Single Center; Transplantation; Cohort; Internal medicine; Hematopoietic stem cell transplantation; Sibling; Graft-versus-host disease; Incidence (geometry); Bone marrow; Retrospective cohort study; Surgery; Chemotherapy","score_opus":0.01966891508687338,"score_gpt":0.24866179877467873,"score_spread":0.22899288368780535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215472881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98784167,0.00060283527,0.010424906,0.00010906476,0.00004540584,0.00081843726,0.00008229069,0.00004790111,0.000027483185],"genre_scores_gemma":[0.9916396,0.001313191,0.005720064,0.00024802866,0.000010594334,0.000024223735,0.0009889482,0.000036852278,0.000018461778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764407,0.0001613022,0.0008769307,0.00053271273,0.00044138072,0.0003436104],"domain_scores_gemma":[0.99905163,0.00012450143,0.00017423263,0.00018457668,0.00026269266,0.00020237267],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021633155,0.0003257022,0.00080807804,0.0005714851,0.00007422939,0.00004931071,0.00005848303,0.00017675912,0.00006759954],"category_scores_gemma":[0.000008525766,0.00028966807,0.00013118892,0.001204681,0.00007469006,0.00014913255,0.0000059389636,0.00016439357,0.0000011160969],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020362777,0.0007476297,0.84236574,0.0010516078,0.00036455083,0.00056075456,0.003924672,0.00029465434,0.1485942,0.000016031263,1.5698653e-7,0.000043749747],"study_design_scores_gemma":[0.017158428,0.0004680822,0.92550397,0.00039823662,0.0031565095,0.0003586374,0.00066704454,0.00063228514,0.051212236,0.000013089918,0.0000019101267,0.0004295835],"about_ca_topic_score_codex":0.00013767515,"about_ca_topic_score_gemma":0.00036881605,"teacher_disagreement_score":0.097381964,"about_ca_system_score_codex":0.000034105786,"about_ca_system_score_gemma":0.000054271186,"threshold_uncertainty_score":0.99995553},"labels":[],"label_agreement":null},{"id":"W4200098179","doi":"10.1016/j.jtct.2021.12.005","title":"Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Cumulative incidence; Internal medicine; Transplantation; Confidence interval; Lymphoma; Refractory (planetary science); Incidence (geometry); Oncology; Retrospective cohort study; Salvage therapy; Disease; Surgery; Chemotherapy","score_opus":0.02074587167349031,"score_gpt":0.26663452494819356,"score_spread":0.24588865327470324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200098179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932245,0.004209023,0.00034594294,0.0009892919,0.000034368146,0.00062731124,0.00015697334,0.000008434278,0.00040414504],"genre_scores_gemma":[0.9806936,0.018263098,0.00046171687,0.00030234669,0.0000080127575,0.000073871975,0.00013001224,0.0000150125425,0.000052363586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909866,0.000082821505,0.00029323294,0.00022504896,0.00014582713,0.0001544037],"domain_scores_gemma":[0.9993533,0.00025964403,0.00009357493,0.0001430718,0.000083772466,0.00006662222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016061253,0.00015764408,0.00034678367,0.00012084207,0.000060174287,0.000011307077,0.000045192122,0.00007750175,0.000013868528],"category_scores_gemma":[0.0000012584533,0.00011055914,0.00009355203,0.00015065735,0.000071382994,0.000042499047,0.0000010260018,0.000051344814,2.3008702e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037888703,0.0046267817,0.40539578,0.0020460123,0.0012351575,0.0007618322,0.2872398,0.00003699666,0.21818192,0.022442807,0.000019956778,0.05422411],"study_design_scores_gemma":[0.018857226,0.0006593084,0.7991777,0.00018737314,0.0003773646,0.00014046348,0.00990926,0.000049213275,0.17005703,0.00024292087,0.00015419355,0.00018792097],"about_ca_topic_score_codex":0.014042023,"about_ca_topic_score_gemma":0.022051426,"teacher_disagreement_score":0.39378196,"about_ca_system_score_codex":0.000067591,"about_ca_system_score_gemma":0.00022993563,"threshold_uncertainty_score":0.9957936},"labels":[],"label_agreement":null},{"id":"W4205522471","doi":"10.1016/j.jtct.2022.01.013","title":"Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; University of Manitoba; CancerCare Manitoba","funders":"Swedish Orphan Biovitrum; Omeros Corporation; Jazz Pharmaceuticals; Sanofi","keywords":"Busulfan; Conditioning regimen; Young adult; Hepatic veno-occlusive disease; Regimen; Hematopoietic stem cell transplantation; Transplantation; Dosing; Hematopoietic cell","score_opus":0.007827591743464946,"score_gpt":0.21522931065114514,"score_spread":0.2074017189076802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205522471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947849,0.0018568104,0.0019918794,0.00013048523,0.000027185413,0.0010250704,0.00013430083,0.000014696498,0.00003465664],"genre_scores_gemma":[0.99280494,0.00580905,0.00061982725,0.000038864662,0.000012779752,0.0000561423,0.00062039174,0.000023009037,0.000015016847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983217,0.0002490986,0.00055671553,0.00027736777,0.00041401922,0.00018107057],"domain_scores_gemma":[0.9992246,0.00023552791,0.00026511765,0.00012998286,0.00005760803,0.000087148466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045940845,0.00018987637,0.00033802705,0.00015901639,0.00018421825,0.000011421829,0.00007655864,0.000065948916,0.000027179252],"category_scores_gemma":[0.0000064876526,0.00016819639,0.000038226284,0.00017812858,0.00006559166,0.00006917507,0.000010274265,0.00017296681,3.8964197e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011351092,0.00017370682,0.90002227,0.0014836845,0.00020091499,0.000025348136,0.0716396,0.00008360842,0.021476699,0.000031055148,4.1179354e-7,0.0037275967],"study_design_scores_gemma":[0.00534401,0.00031431273,0.9353853,0.00024511956,0.0003648464,0.000053720698,0.001614301,0.00006113637,0.05633986,0.00010876252,0.0000020240586,0.00016661373],"about_ca_topic_score_codex":0.000113950795,"about_ca_topic_score_gemma":0.000067490335,"teacher_disagreement_score":0.0700253,"about_ca_system_score_codex":0.000057364072,"about_ca_system_score_gemma":0.00012659443,"threshold_uncertainty_score":0.685885},"labels":[],"label_agreement":null},{"id":"W4206925700","doi":"10.1016/j.jtct.2022.01.018","title":"Optimal Timing of Allogeneic Stem Cell Transplantation for Primary Myelofibrosis","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Myelofibrosis; Medicine; Transplantation; Ruxolitinib; Cohort; Life expectancy; Internal medicine; International Prognostic Scoring System; Confidence interval; Clinical trial; Pediatrics; Myelodysplastic syndromes; Population; Bone marrow","score_opus":0.024606021570595098,"score_gpt":0.25110888320272856,"score_spread":0.22650286163213346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206925700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866166,0.001915789,0.009541214,0.00019638415,0.000060357866,0.00092643854,0.0002507061,0.000027660179,0.00046481483],"genre_scores_gemma":[0.9891227,0.006419515,0.002467215,0.0003038336,0.000024977546,0.00035547995,0.0010049095,0.000026171889,0.00027518894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903417,0.00006984482,0.0002740552,0.00024327346,0.00022769181,0.00015097178],"domain_scores_gemma":[0.9996004,0.000098489356,0.00009428649,0.00009677742,0.00004373118,0.000066292974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015149689,0.00015364945,0.00026944836,0.00009176016,0.00019226741,0.000009548563,0.000042387244,0.0000415331,0.00020977197],"category_scores_gemma":[2.3165738e-7,0.00013856312,0.00011565308,0.000083792176,0.00002994062,0.000049223323,0.0000030116414,0.000072807874,0.0000015363828],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00908252,0.0011674309,0.021381278,0.0018670037,0.00035978554,0.00009187515,0.012603193,0.0011046011,0.8993603,0.0005207381,0.000073225216,0.052388024],"study_design_scores_gemma":[0.009552226,0.0022179612,0.028072715,0.000049976174,0.00039280966,0.00009440325,0.00056236424,0.00037749135,0.9569634,0.000023169645,0.0014797432,0.00021373208],"about_ca_topic_score_codex":0.000010734005,"about_ca_topic_score_gemma":0.0000012093645,"teacher_disagreement_score":0.057603084,"about_ca_system_score_codex":0.00003350705,"about_ca_system_score_gemma":0.00005412314,"threshold_uncertainty_score":0.565044},"labels":[],"label_agreement":null},{"id":"W4207010819","doi":"10.1016/j.jtct.2022.01.017","title":"Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Janssen Pharmaceuticals; National Institute of Allergy and Infectious Diseases; Office of Naval Research; National Heart, Lung, and Blood Institute; U.S. Public Health Service; Health Resources and Services Administration; U.S. Food and Drug Administration; Astellas Pharma; Daiichi-Sankyo; Bayer Fund; Kiadis Pharma; TG Therapeutics; Medical College of Wisconsin; Chimerix; Jazz Pharmaceuticals; Takeda Pharmaceuticals U.S.A.; AbbVie; Merck; Spectrum Pharmaceuticals; National Cancer Institute; Gilead Sciences; Karyopharm Therapeutics; Novartis; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Amgen; Falk Foundation; CareDx; Amyloidosis Foundation; Pfizer; Alexion Pharmaceuticals; Astellas Pharma US","keywords":"Medicine; Internal medicine; Hazard ratio; Transplantation; Prolymphocytic leukemia; Regimen; Cumulative incidence; Gastroenterology; Hematopoietic stem cell transplantation; Alemtuzumab; Oncology; Confidence interval; Leukemia; Surgery; Chronic lymphocytic leukemia","score_opus":0.0394564369277786,"score_gpt":0.3046050989104168,"score_spread":0.2651486619826382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4207010819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99282956,0.003362553,0.00089156756,0.0004005854,0.000081638675,0.0013498247,0.0007536062,0.00001654079,0.00031410626],"genre_scores_gemma":[0.99118376,0.006245491,0.00015033493,0.00022988445,0.0000339482,0.00030989313,0.0016301989,0.000028864471,0.00018762465],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976586,0.000356496,0.0005227872,0.00043835022,0.0007309223,0.0002928587],"domain_scores_gemma":[0.9987274,0.0006964366,0.000102842176,0.0002399094,0.00013923341,0.00009420927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009834758,0.0001942072,0.0004289884,0.00037714685,0.00018205942,0.000029684976,0.00021560272,0.000089361114,0.0001505469],"category_scores_gemma":[0.000008038463,0.00014892285,0.00016704267,0.00042130717,0.00016157948,0.00007517288,0.000015473155,0.00029939137,0.0000011362077],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02158687,0.0019378145,0.610819,0.00200532,0.0026430048,0.00083127967,0.06165198,0.0007167724,0.2959194,0.00022474362,0.00010999102,0.0015538656],"study_design_scores_gemma":[0.23053132,0.0021367732,0.15404926,0.0002773167,0.00275497,0.0003116893,0.007414564,0.014573349,0.58477217,0.00062927837,0.0016548485,0.0008944661],"about_ca_topic_score_codex":0.0011932492,"about_ca_topic_score_gemma":0.00012453044,"teacher_disagreement_score":0.4567697,"about_ca_system_score_codex":0.0005611634,"about_ca_system_score_gemma":0.0009958134,"threshold_uncertainty_score":0.60728973},"labels":[],"label_agreement":null},{"id":"W4210253082","doi":"10.1016/j.jtct.2022.02.002","title":"Multiple Breath Washout Testing to Identify Pulmonary Chronic Graft Versus Host Disease in Children After Hematopoietic Stem Cell Transplantation","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"BC Children's Hospital","keywords":"Medicine; Spirometry; Hematopoietic stem cell transplantation; Interquartile range; Transplantation; Graft-versus-host disease; Pediatrics; Population; Internal medicine; Asthma","score_opus":0.017031602014538794,"score_gpt":0.27791868250927376,"score_spread":0.26088708049473497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210253082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927263,0.0043798634,0.0011078494,0.00016422164,0.00007820694,0.0011777295,0.00023258258,0.000063694744,0.00006955289],"genre_scores_gemma":[0.9970899,0.0014521732,0.00023005494,0.00010059964,0.000048059323,0.000370431,0.0005557722,0.00004032219,0.00011265131],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983149,0.00013957777,0.00029515097,0.000421395,0.0004940126,0.00033493194],"domain_scores_gemma":[0.99931556,0.00016241099,0.000047116235,0.00018965785,0.000031926815,0.00025335667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019170983,0.00020411336,0.00022081466,0.00023152464,0.0001696449,0.000036290578,0.000101740545,0.000033381653,0.00016417238],"category_scores_gemma":[0.000003728448,0.00020249758,0.000067609704,0.00037131747,0.000044357283,0.00013221458,0.000012189742,0.00023537602,0.000015527321],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023133721,0.0005840716,0.4281364,0.0010375549,0.00006412228,0.0014158534,0.0047813314,0.0013181719,0.5271636,0.000011163439,0.0000055882783,0.012348392],"study_design_scores_gemma":[0.011723447,0.0009927802,0.94887704,0.0002351008,0.00013912834,0.0002297847,0.00040069697,0.0018282179,0.035005737,0.000023775434,0.00014575414,0.00039855932],"about_ca_topic_score_codex":0.00013383914,"about_ca_topic_score_gemma":0.000033113934,"teacher_disagreement_score":0.52074057,"about_ca_system_score_codex":0.00012072525,"about_ca_system_score_gemma":0.00009859723,"threshold_uncertainty_score":0.8257612},"labels":[],"label_agreement":null},{"id":"W4210359431","doi":"10.1016/j.jtct.2022.01.025","title":"A Prospective, Multicenter Study of Closed-System Extracorporeal Photopheresis for Children with Steroid-Refractory Acute Graft-versus-Host Disease","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Incyte; Sanofi Genzyme; bluebird bio; Jazz Pharmaceuticals; Pharmacyclics; Sanofi; Sucampo Pharmaceuticals; Mallinckrodt Pharmaceuticals; Gilead Sciences","keywords":"Medicine; Extracorporeal Photopheresis; Adverse effect; Refractory (planetary science); Photopheresis; Clinical endpoint; Immunosuppression; Graft-versus-host disease; Internal medicine; Extracorporeal; Surgery; Gastroenterology; Clinical trial; Disease","score_opus":0.01568047141291025,"score_gpt":0.2536606346793648,"score_spread":0.23798016326645455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210359431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920844,0.00022590134,0.0026546712,0.000028474158,0.00009521657,0.0043036193,0.00043207526,0.00007124942,0.000104410254],"genre_scores_gemma":[0.9980459,0.00020801307,0.0003338472,0.00004134618,0.000031795484,0.0006722503,0.00051796396,0.000049821523,0.00009906438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848443,0.00012769236,0.00036012364,0.0003901562,0.00044541262,0.000192153],"domain_scores_gemma":[0.9993096,0.00008109778,0.0001660686,0.00022328473,0.000075297525,0.00014463153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016441304,0.0002238306,0.00033349099,0.00011765299,0.00019738456,0.000015257131,0.00008249718,0.00003654772,0.00008419757],"category_scores_gemma":[8.081503e-7,0.00018646095,0.00008694779,0.00014506716,0.000048681413,0.00008251334,0.0000044065487,0.000130622,0.0000010495548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17766638,0.0060461457,0.63037133,0.001692046,0.003090341,0.00047857824,0.029315816,0.00007275887,0.14878008,0.00023581345,0.00002235922,0.0022283704],"study_design_scores_gemma":[0.08733086,0.008117835,0.852612,0.00014809232,0.0023236887,0.00009206658,0.007102364,0.00035820255,0.041426472,0.0000058890905,0.00006794393,0.00041458113],"about_ca_topic_score_codex":0.00007778175,"about_ca_topic_score_gemma":0.000030661246,"teacher_disagreement_score":0.22224069,"about_ca_system_score_codex":0.000052402418,"about_ca_system_score_gemma":0.00006124506,"threshold_uncertainty_score":0.76036566},"labels":[],"label_agreement":null},{"id":"W4210743542","doi":"10.1016/j.jtct.2022.02.001","title":"Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Transplantation; Cyclophosphamide; Internal medicine; Hematopoietic stem cell transplantation; Graft-versus-host disease; Hematopoietic cell; Haematopoiesis; Oncology; Surgery; Gastroenterology; Chemotherapy; Stem cell","score_opus":0.0152125342152639,"score_gpt":0.23775853077004502,"score_spread":0.22254599655478113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210743542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831588,0.0015255546,0.013142582,0.00031155028,0.0001452407,0.000791418,0.00011343185,0.00009396632,0.00071740814],"genre_scores_gemma":[0.99437904,0.002854163,0.00082849636,0.0010481203,0.000023888882,0.00020102941,0.00029765905,0.000046421002,0.00032115236],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817026,0.00014220069,0.000469872,0.00048031379,0.00043519904,0.00030215477],"domain_scores_gemma":[0.9993927,0.00009552403,0.00009994786,0.00020268568,0.000034028326,0.0001751015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021035627,0.00028873878,0.00036134225,0.00014678408,0.00029302549,0.00004288699,0.00007772051,0.000078222474,0.00061675627],"category_scores_gemma":[0.0000012330012,0.00026850757,0.00009999455,0.00015951961,0.00009972578,0.00013659264,0.000009126803,0.00020441678,0.000006550603],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008581099,0.0010581241,0.37953693,0.0027910082,0.00015988124,0.0016325533,0.07771544,0.000036559188,0.515519,0.00029376883,0.0000067989513,0.01266878],"study_design_scores_gemma":[0.05731664,0.002592325,0.3589612,0.0004430246,0.0011786604,0.011929622,0.010684837,0.0006545509,0.54882616,0.00018252844,0.004782758,0.0024476924],"about_ca_topic_score_codex":0.000029678466,"about_ca_topic_score_gemma":0.000009203811,"teacher_disagreement_score":0.0670306,"about_ca_system_score_codex":0.000041284566,"about_ca_system_score_gemma":0.000038382124,"threshold_uncertainty_score":0.9999767},"labels":[],"label_agreement":null},{"id":"W4210794959","doi":"10.1016/j.jtct.2022.01.024","title":"Real-World Eligibility for Second-Line Chimeric Antigen Receptor T Cell Therapy in Large B Cell Lymphoma: A Population-Based Analysis","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Chemoimmunotherapy; Population; Oncology; Internal medicine; Autologous stem-cell transplantation; Chimeric antigen receptor; Transplantation; Lymphoma; Surgery; Rituximab; Cancer; Immunotherapy","score_opus":0.024267220530368058,"score_gpt":0.31477420058418687,"score_spread":0.2905069800538188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210794959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993644,0.0012674023,0.0017659629,0.00023922554,0.000085596075,0.0017618904,0.00040837572,0.00007424741,0.0007533144],"genre_scores_gemma":[0.98685884,0.004164122,0.000420178,0.00060821685,0.00006528834,0.00032626078,0.0042900243,0.00006001693,0.0032070423],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975509,0.0003499827,0.0005457765,0.0006153624,0.00048988714,0.00044807186],"domain_scores_gemma":[0.9990018,0.00021158252,0.00014769005,0.0004053428,0.00007884006,0.00015471771],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009945522,0.0002829395,0.00057695515,0.00077854085,0.00029461776,0.000035262616,0.00014853882,0.00008265227,0.0076647955],"category_scores_gemma":[0.0000021769033,0.00027256034,0.00034346775,0.00152414,0.00003744969,0.000070325295,0.0000080212785,0.0002126278,0.000004814556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013083266,0.003471184,0.29186806,0.00030776928,0.0003778051,0.000035769714,0.002652126,0.0006049924,0.67524177,0.000043493226,0.00006222572,0.012251552],"study_design_scores_gemma":[0.0628992,0.002290985,0.28135946,0.000021945334,0.00029956334,0.000005390211,0.0005226933,0.014389364,0.6169384,0.0001444978,0.020327237,0.0008012464],"about_ca_topic_score_codex":0.0009742327,"about_ca_topic_score_gemma":0.0006655611,"teacher_disagreement_score":0.058303334,"about_ca_system_score_codex":0.000178936,"about_ca_system_score_gemma":0.00017071016,"threshold_uncertainty_score":0.99997264},"labels":[],"label_agreement":null},{"id":"W4220683873","doi":"10.1016/j.jtct.2021.12.016","title":"Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"Children's Discovery Institute; National Heart, Lung, and Blood Institute; University of Washington","keywords":"Medicine; Granulocyte colony-stimulating factor; Transplantation; Hematopoietic stem cell transplantation; Absolute neutrophil count; Internal medicine; Gastroenterology; Regimen; Surgery; Neutropenia; Chemotherapy","score_opus":0.006543468642938135,"score_gpt":0.21075240535349313,"score_spread":0.20420893671055498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220683873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961762,0.0019349917,0.00073545135,0.00020773732,0.000048837555,0.0004927525,0.00004024347,0.00002990515,0.0003339201],"genre_scores_gemma":[0.9932604,0.005028124,0.00020282838,0.000571154,0.000008788018,0.000010074881,0.00072514504,0.000025749176,0.0001677413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896544,0.00006878496,0.00024201562,0.00031330946,0.00020998094,0.00020049224],"domain_scores_gemma":[0.9996158,0.000033831337,0.000047007074,0.000096876945,0.00004908458,0.0001574326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055737586,0.00018909664,0.00023918558,0.000076799835,0.00011211027,0.000029889401,0.000022940962,0.000098934936,0.000107221735],"category_scores_gemma":[0.0000013452102,0.00015584618,0.000054466953,0.00018626012,0.000034291596,0.00009769086,0.0000018537899,0.00013980702,0.000003851929],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00418926,0.00043071582,0.94503695,0.0005701768,0.00011074489,0.0006612738,0.006993548,0.00023234465,0.037233207,0.00001218336,0.000004803515,0.0045247716],"study_design_scores_gemma":[0.028847916,0.0004929833,0.915767,0.0003836794,0.00033501678,0.000014352191,0.00036025737,0.0012996343,0.051764805,0.000024296272,0.00028883526,0.0004211886],"about_ca_topic_score_codex":0.00003505541,"about_ca_topic_score_gemma":0.000019536226,"teacher_disagreement_score":0.029269934,"about_ca_system_score_codex":0.00001578091,"about_ca_system_score_gemma":0.000061022045,"threshold_uncertainty_score":0.6355223},"labels":[],"label_agreement":null},{"id":"W4220743267","doi":"10.1016/s2666-6367(22)00436-5","title":"Use of Novel ‘quarter Point’ Assay for Improving CD34 Yield and Reducing Collection Times for HPC, Apheresis","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Apheresis; Yield (engineering); Quarter (Canadian coin); Internal medicine","score_opus":0.024761861557443702,"score_gpt":0.25615004445553574,"score_spread":0.23138818289809204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220743267","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42065984,0.00021380845,0.5782914,0.0001800326,0.000021503098,0.00047374828,0.00013131784,0.000011896645,0.000016479795],"genre_scores_gemma":[0.97171104,0.00041269843,0.027052848,0.00012899855,0.000026046631,0.00013784923,0.00026518592,0.0000136445815,0.00025171277],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99959517,0.000012228522,0.00011290178,0.00016999169,0.000036397985,0.00007328787],"domain_scores_gemma":[0.9997705,0.000039477523,0.000061651255,0.00007722195,0.00003349432,0.000017623197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010062791,0.000066759625,0.00007091457,0.000024995337,0.00018359612,0.000011720238,0.000026124297,0.000039583578,0.000004310052],"category_scores_gemma":[0.000004623656,0.00006671787,0.00003915578,0.00003658703,0.000023400542,0.000005477038,0.000005050766,0.000027317321,1.178084e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034397023,0.00003954138,0.000022012457,0.0000371246,0.000015804257,7.1201804e-8,0.00013348795,0.00004405835,0.9927176,0.00020012699,0.00020747488,0.006238683],"study_design_scores_gemma":[0.0007927219,0.00042532556,0.0000482931,0.000006670844,0.000024112793,0.000009694986,0.00012861629,0.002269073,0.9908992,0.00017013527,0.0051249866,0.00010119329],"about_ca_topic_score_codex":0.000023103139,"about_ca_topic_score_gemma":0.0000059459567,"teacher_disagreement_score":0.55123854,"about_ca_system_score_codex":0.0000038527783,"about_ca_system_score_gemma":0.000009676898,"threshold_uncertainty_score":0.27206758},"labels":[],"label_agreement":null},{"id":"W4220744522","doi":"10.1016/s2666-6367(22)00583-8","title":"Cost-Effectiveness of Brexucabtagene Autoleucel Versus Best Supportive Care for the Treatment of Relapsed/ Refractory Mantle Cell Lymphoma Following Treatment with a Bruton’s Tyrosine Kinase Inhibitor in Canada","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mantle cell lymphoma; Refractory (planetary science); Bruton's tyrosine kinase; Ibrutinib; Internal medicine; Lymphoma; Oncology; Cancer research; Tyrosine kinase; Leukemia; Metallurgy","score_opus":0.033842856003265726,"score_gpt":0.2919828620676587,"score_spread":0.258140006064393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220744522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893752,0.0072370116,0.00009355329,0.000035693458,0.0001372016,0.0026266025,0.00035564363,0.0000072053645,0.00013191224],"genre_scores_gemma":[0.9933897,0.004890814,0.00003692808,0.00001283232,0.00001910279,0.0007489689,0.0005279273,0.00003481567,0.0003388922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875224,0.00018299722,0.00025080633,0.000255685,0.0003432506,0.00021502918],"domain_scores_gemma":[0.9991482,0.0004172235,0.00009436029,0.00021059891,0.000058893274,0.00007073708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014774746,0.0001933236,0.00038992852,0.000098987744,0.00012659635,0.000005321662,0.00005912883,0.00003416313,0.000112116584],"category_scores_gemma":[9.0951386e-7,0.00013310724,0.000113437236,0.00019252159,0.00005032465,0.000030032566,0.0000033631218,0.00005357025,1.5747366e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.084247574,0.0027301747,0.010721339,0.0006609875,0.00066761,0.0005450115,0.018638456,0.00040600158,0.7539477,0.000012057103,0.0000029800212,0.12742014],"study_design_scores_gemma":[0.061935313,0.017109668,0.00613467,0.00009177501,0.00031555115,0.000015014492,0.009321208,0.00017406199,0.898964,0.0000013625419,0.005779471,0.00015791904],"about_ca_topic_score_codex":0.20582387,"about_ca_topic_score_gemma":0.10080304,"teacher_disagreement_score":0.14501631,"about_ca_system_score_codex":0.0012615325,"about_ca_system_score_gemma":0.0011351414,"threshold_uncertainty_score":0.91560495},"labels":[],"label_agreement":null},{"id":"W4220887944","doi":"10.1016/j.jtct.2022.03.016","title":"UM171 Expansion of Cord Blood Improves Donor Availability and HLA Matching For All Patients, Including Minorities","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Cord blood; Transplantation; Stem cell; Human leukocyte antigen; Medicine; Bone marrow; Immunology; Internal medicine; Oncology; Biology; Antigen; Genetics","score_opus":0.02708554488530717,"score_gpt":0.26761664489249104,"score_spread":0.24053110000718386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220887944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945825,0.000881312,0.0031572625,0.00009047553,0.00009454057,0.00090985827,0.0001359321,0.000032308562,0.00011586149],"genre_scores_gemma":[0.99553555,0.0019165577,0.0016662555,0.00017689758,0.000020119125,0.00009486076,0.00048483955,0.000021617978,0.00008332672],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989377,0.00007881733,0.00035073314,0.000253958,0.00022929936,0.0001494923],"domain_scores_gemma":[0.99949664,0.00016369847,0.00010448931,0.00011281272,0.000056111767,0.00006622969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030659654,0.00014240213,0.00025780022,0.00008832094,0.00017853815,0.000012810504,0.000042728545,0.000048339258,0.00006072998],"category_scores_gemma":[0.0000030408912,0.00013507703,0.000059637645,0.00006372379,0.000057525634,0.000077211735,0.0000070772785,0.00009709685,2.863253e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034492726,0.00032462,0.021065213,0.002369482,0.00013377897,0.00001001077,0.016927255,0.000004602609,0.9429518,0.00045676954,0.000008515186,0.012298672],"study_design_scores_gemma":[0.02476808,0.003981895,0.061455715,0.00025186865,0.0008293973,0.00014606123,0.005126839,0.00037739382,0.9002333,0.0013049896,0.0010047121,0.0005197183],"about_ca_topic_score_codex":0.00008038921,"about_ca_topic_score_gemma":0.0000053799527,"teacher_disagreement_score":0.04271848,"about_ca_system_score_codex":0.0000147724895,"about_ca_system_score_gemma":0.000029532623,"threshold_uncertainty_score":0.55082816},"labels":[],"label_agreement":null},{"id":"W4221066457","doi":"10.1016/s2666-6367(22)00599-1","title":"Stable Pulmonary Function in Children and Adolescents with Sickle Cell Disease after Nonmyeloablative Hematopoietic Cell Transplantation- the Calgary Experience","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hematopoietic cell; Hematopoietic stem cell transplantation; Disease; Transplantation; Cell; Pediatrics; Haematopoiesis; Immunology; Internal medicine; Stem cell; Genetics","score_opus":0.003769426073655082,"score_gpt":0.18603336239149956,"score_spread":0.1822639363178445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221066457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918173,0.005682197,0.0012335918,0.00016199985,0.000031744956,0.0007662356,0.000033999226,0.000024572217,0.0002483783],"genre_scores_gemma":[0.9921266,0.006777227,0.000019651296,0.0005281177,0.000010402504,0.00014677373,0.0001908468,0.00002194049,0.00017846435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901044,0.00010388654,0.00017567773,0.00028083145,0.0002412206,0.00018792838],"domain_scores_gemma":[0.9996962,0.00001515187,0.000045683624,0.00011856344,0.00001544253,0.00010897277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009374351,0.00016381178,0.00014132733,0.00007248835,0.00023743158,0.000018927558,0.000045302422,0.000039357634,0.00013062826],"category_scores_gemma":[2.4769943e-7,0.00011385553,0.000033163014,0.00018523252,0.00009673983,0.000097412,0.000005314439,0.00024009448,0.0000020918956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019123208,0.0010778308,0.9211123,0.0007196752,0.000053831915,0.00067782094,0.03747247,0.00051228085,0.015592728,0.000040691306,0.000008160823,0.0036090175],"study_design_scores_gemma":[0.0073508406,0.00046800484,0.97940385,0.00016617637,0.00022014389,0.00022280909,0.004012341,0.0006835539,0.0069528245,0.000069282585,0.00013026957,0.00031988465],"about_ca_topic_score_codex":0.000103183236,"about_ca_topic_score_gemma":0.000006631636,"teacher_disagreement_score":0.058291588,"about_ca_system_score_codex":0.00001713677,"about_ca_system_score_gemma":0.000043375218,"threshold_uncertainty_score":0.46428937},"labels":[],"label_agreement":null},{"id":"W4221100568","doi":"10.1016/s2666-6367(22)00576-0","title":"Saving Lives with Pride: Development and Evaluation of Multimedia Resources to Engage Gay, Bisexual, and Queer Men in Canada As Stem Cell Donors","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Innovative Human-Technology Interaction","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pride; Queer; Medicine; Gender studies; Gerontology; Sociology; Political science; Law","score_opus":0.040479860479309106,"score_gpt":0.27006418241315283,"score_spread":0.22958432193384373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221100568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963393,0.00039157458,0.0026136346,0.00012534494,0.000031883912,0.00033134024,0.0000027143567,0.000014063533,0.00015011981],"genre_scores_gemma":[0.9976203,0.00009481911,0.0020800908,0.00008890025,0.0000022153802,0.00005947303,0.000007527914,0.000005611804,0.00004110293],"study_design_codex":"qualitative","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903697,0.00018516774,0.00017504439,0.00021789316,0.00028824084,0.000096671865],"domain_scores_gemma":[0.9996932,0.00006502829,0.000079959515,0.000081306236,0.000054273503,0.000026208014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000533723,0.00008928876,0.00009825273,0.00017237836,0.00014108817,0.000021918884,0.00009563808,0.000016661243,0.000016195265],"category_scores_gemma":[0.0000011487616,0.00008227487,0.0000036133317,0.00018949724,0.000024295165,0.0001255814,0.000018247276,0.00012186183,2.1820658e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005742687,0.00012711932,0.036629453,0.0001475817,0.000098609526,0.000079643476,0.42335382,0.0016957982,0.2818252,0.00067578256,0.000020820271,0.2547719],"study_design_scores_gemma":[0.0049982783,0.0006776224,0.17097075,0.00009747571,0.00003164298,0.00007461435,0.02621211,0.022390533,0.772673,0.00013122938,0.0012325657,0.00051015546],"about_ca_topic_score_codex":0.023676068,"about_ca_topic_score_gemma":0.051474195,"teacher_disagreement_score":0.4908478,"about_ca_system_score_codex":0.000099801924,"about_ca_system_score_gemma":0.0001859152,"threshold_uncertainty_score":0.98282534},"labels":[],"label_agreement":null},{"id":"W4223534367","doi":"10.1016/j.jtct.2022.03.029","title":"Systematic Scoping Review of Studies Reporting Unexpected Donor-Derived Abnormalities from Recipients of Allogeneic Hematopoietic Cell Transplantation: A Proposed Framework for Donor Disclosure","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Ottawa Hospital; Canadian Blood Services; University of Ottawa","funders":"Canadian Blood Services","keywords":"Transplantation; Medicine; Hematopoietic stem cell transplantation; Systematic review; Hematopoietic cell; Disease; Immunology; Oncology; Internal medicine; MEDLINE; Haematopoiesis; Stem cell; Biology; Genetics","score_opus":0.056264319239792866,"score_gpt":0.3426213310586016,"score_spread":0.28635701181880874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223534367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8588402,0.12810805,0.008569957,0.0002507125,0.000093584706,0.0039388463,0.00013535193,0.000036726964,0.000026513611],"genre_scores_gemma":[0.85111856,0.14339344,0.004032466,0.00018611939,0.000032462834,0.0005774991,0.00056872686,0.000037853046,0.000052852964],"study_design_codex":"systematic_review","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99677587,0.0003934968,0.0017352843,0.000335241,0.00053506263,0.00022502724],"domain_scores_gemma":[0.99754256,0.0006069459,0.0012276802,0.00029086624,0.00025890468,0.00007305793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001055849,0.00022370092,0.001091086,0.00012770896,0.00019451133,0.00001030204,0.00012737252,0.00007095051,0.00011691869],"category_scores_gemma":[0.00009050214,0.00018258471,0.00021295963,0.00026682447,0.00011123704,0.00007159529,0.000011758554,0.00020160088,6.03522e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022276416,0.00022672053,0.0029377702,0.7490152,0.00079703226,0.0001130776,0.027293952,0.000024542094,0.21698941,0.0002152268,0.0000075397497,0.00015189884],"study_design_scores_gemma":[0.007336144,0.0009441357,0.001227892,0.334231,0.0015172762,0.00018652594,0.010387321,0.00007099002,0.6430749,0.00061517477,0.00000376512,0.00040487875],"about_ca_topic_score_codex":0.000040251613,"about_ca_topic_score_gemma":0.0000049449536,"teacher_disagreement_score":0.4260855,"about_ca_system_score_codex":0.00006659106,"about_ca_system_score_gemma":0.00020840742,"threshold_uncertainty_score":0.7445589},"labels":[],"label_agreement":null},{"id":"W4280650301","doi":"10.1016/j.jtct.2022.05.018","title":"Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Frailty in Older Adults","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; Baxter International; Belgian American Educational Foundation; Abbott Laboratories; National Institute on Aging; School of Medicine, Duke University; DSM; U.S. Department of Defense","keywords":"Medicine; Transplantation; Hematopoietic stem cell transplantation; Cognition; Internal medicine; Age limit; Stem cell; Cognitive impairment; Pediatrics; Oncology; Disease; Psychiatry","score_opus":0.015560084575816738,"score_gpt":0.2725051791446464,"score_spread":0.25694509456882964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280650301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957937,0.00041574732,0.0012927605,0.0003571975,0.00014915984,0.0009740512,0.00008746068,0.000053417592,0.00087648694],"genre_scores_gemma":[0.99402255,0.0020424698,0.00047119605,0.0005401753,0.000026739177,0.00020366332,0.0005350946,0.000030116109,0.0021280264],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985905,0.00014509284,0.00032441603,0.00030943236,0.00038871355,0.00024184112],"domain_scores_gemma":[0.9995922,0.000047254358,0.000066319124,0.00015015475,0.00001940647,0.00012468021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000277363,0.00016201136,0.00024008943,0.000261953,0.00012119332,0.000028230479,0.00007672048,0.000049122442,0.00059600343],"category_scores_gemma":[3.804844e-7,0.00017168054,0.000055531247,0.00034824017,0.000016418888,0.00009100621,0.0000057725797,0.00019919695,0.000015019947],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005019732,0.0018168013,0.080324695,0.0020684842,0.00018198547,0.0061926153,0.057747606,0.00207779,0.8212567,0.0001613562,0.0013833677,0.021768898],"study_design_scores_gemma":[0.043859184,0.004240051,0.78574044,0.000423717,0.00046885313,0.0019931968,0.0074781883,0.0007965617,0.14410016,0.00058880757,0.008804232,0.0015066026],"about_ca_topic_score_codex":0.0001842026,"about_ca_topic_score_gemma":0.000027222015,"teacher_disagreement_score":0.7054157,"about_ca_system_score_codex":0.00013491724,"about_ca_system_score_gemma":0.00006432994,"threshold_uncertainty_score":0.700093},"labels":[],"label_agreement":null},{"id":"W4281263083","doi":"10.1016/j.jtct.2022.05.026","title":"Real-World Evidence of Axicabtagene Ciloleucel for the Treatment of Large B Cell Lymphoma in the United States","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Legend Biotech; Pharmacyclics; Kite Pharma; MorphoSys; Daiichi-Sankyo; Miltenyi Biotec; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; TG Therapeutics; bluebird bio; Tessa Therapeutics; BeiGene; Atara Biotherapeutics; Kyowa Kirin Pharmaceutical Development; Janssen Pharmaceuticals; Memorial Sloan-Kettering Cancer Center; National Cancer Institute; Servier; Gilead Sciences; Celgene; Novartis; AbbVie; Merck; Bristol-Myers Squibb; Cidara Therapeutics; AstraZeneca; Amgen; Seagen; Sierra Oncology; Astellas Pharma US","keywords":"Medicine; Internal medicine; Cohort; Odds ratio; Confidence interval; Oncology","score_opus":0.05882848758754067,"score_gpt":0.3396543056612309,"score_spread":0.2808258180736902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281263083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99259704,0.0046221064,0.0005104959,0.0007713343,0.000029424697,0.0011904036,0.00009518535,0.000008150902,0.0001758538],"genre_scores_gemma":[0.9183747,0.07974514,0.00003841231,0.00022656775,0.000018970308,0.00020609537,0.00022441859,0.000014557858,0.001151092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888754,0.00022910487,0.0002534147,0.0001462478,0.0003192033,0.00016450987],"domain_scores_gemma":[0.99891543,0.00069670007,0.000076462056,0.00023408349,0.000048386883,0.000028945291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006137591,0.00010588285,0.00019763006,0.00016306747,0.00012439217,0.0000073862584,0.00012317927,0.000020674788,0.00039433857],"category_scores_gemma":[0.0000014293994,0.00006169817,0.00009783136,0.00042783257,0.00006778174,0.000022145083,0.0000033520105,0.00005628006,3.7839706e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017387534,0.0038581856,0.0067520617,0.00053093716,0.00023373796,0.000057144596,0.062009472,0.00040129648,0.87335104,0.00067451404,0.00007704879,0.03466701],"study_design_scores_gemma":[0.027212216,0.0064107236,0.016614795,0.00008607385,0.00022031342,0.000020852563,0.008475118,0.005289832,0.8844706,0.00018632936,0.05082924,0.00018391213],"about_ca_topic_score_codex":0.0010473158,"about_ca_topic_score_gemma":0.00013798589,"teacher_disagreement_score":0.075123034,"about_ca_system_score_codex":0.000047997357,"about_ca_system_score_gemma":0.000060719867,"threshold_uncertainty_score":0.4317731},"labels":[],"label_agreement":null},{"id":"W4281695451","doi":"10.1016/j.jtct.2022.05.038","title":"Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force","year":2022,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba; BC Children's Hospital; CancerCare Manitoba","funders":"National Cancer Institute; Deutsche Forschungsgemeinschaft; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Disease; Graft-versus-host disease; Immunology; Hematopoietic stem cell transplantation; Chronic disease; Intensive care medicine; Immune system; Pathogenesis; Pathology","score_opus":0.1264042649032465,"score_gpt":0.34646503557703984,"score_spread":0.22006077067379334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281695451","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026603055,0.9907502,0.001641698,0.0008551065,0.00034514882,0.0024079122,0.0010915429,0.000018090108,0.00022997978],"genre_scores_gemma":[0.040759478,0.9568895,0.00009332002,0.0000962778,0.000086275715,0.00007188274,0.0019321768,0.000031221665,0.00003983561],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973926,0.0004493332,0.00095306116,0.00031109725,0.00074045896,0.00015345137],"domain_scores_gemma":[0.9980565,0.00077997963,0.0007772741,0.0002761643,0.000056646786,0.00005343638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052239915,0.0002623351,0.00092506694,0.000086911314,0.0001272,0.000008754082,0.00016091227,0.000114205664,0.000076357035],"category_scores_gemma":[0.000024203055,0.00015633747,0.00038804987,0.00031501256,0.00028237398,0.000024825458,0.000009855362,0.00030383232,3.1094942e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031302307,0.0029654675,0.0045875213,0.4786219,0.01711399,0.0017179362,0.06042994,0.000060658105,0.007399194,0.02539039,0.0045599435,0.36585078],"study_design_scores_gemma":[0.040924568,0.0030808798,0.011708282,0.096737064,0.017219152,0.0034194337,0.0046995017,0.00021105373,0.005669994,0.0022178981,0.81174713,0.0023650215],"about_ca_topic_score_codex":0.00012993685,"about_ca_topic_score_gemma":0.000024378995,"teacher_disagreement_score":0.8071872,"about_ca_system_score_codex":0.00015644012,"about_ca_system_score_gemma":0.0016700914,"threshold_uncertainty_score":0.6375257},"labels":[],"label_agreement":null},{"id":"W4283760456","doi":"10.1016/j.jtct.2022.06.003","title":"When should a Reduced intensity Conditioning (RIC) Hematopoietic Stem Cell Transplant (HSCT) be Considered in Pediatric CML-CP1?","year":2022,"lang":"en","type":"letter","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Conditioning; Hematopoietic stem cell transplantation; Medicine; Stem cell; Hematopoietic stem cell; Haematopoiesis; Internal medicine; Oncology; Transplantation; Biology; Genetics; Mathematics","score_opus":0.045780832704521504,"score_gpt":0.25972984637351026,"score_spread":0.21394901366898877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283760456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8481951,0.0062560625,0.0026168164,0.1316708,0.0011062457,0.0045805727,0.0010689517,0.00050803914,0.003997448],"genre_scores_gemma":[0.8143326,0.021057492,0.00034945816,0.15007319,0.00064002647,0.0004048441,0.0110379895,0.00028109495,0.0018233102],"study_design_codex":"qualitative","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99511683,0.00051895145,0.0013066131,0.0011595552,0.0011228685,0.0007751801],"domain_scores_gemma":[0.9982313,0.00047998616,0.00039782302,0.00054002693,0.00012359495,0.00022729387],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058386626,0.00086539367,0.0013816145,0.00083035213,0.00027251046,0.000092515955,0.00023661306,0.0009738237,0.0014488638],"category_scores_gemma":[0.000002622184,0.0008779027,0.0003450183,0.00044302983,0.00015050924,0.0001611939,0.000011177201,0.0025270146,0.000029516947],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022119138,0.0034243078,0.03182008,0.07340583,0.0023528712,0.11806326,0.3506772,0.00024794956,0.15262114,0.00049805676,0.24193737,0.0028328053],"study_design_scores_gemma":[0.13608603,0.0075883227,0.015952814,0.0076600425,0.016295915,0.032777864,0.014900792,0.0017843432,0.5538001,0.0028944437,0.19576538,0.014493963],"about_ca_topic_score_codex":0.00014982,"about_ca_topic_score_gemma":0.000021132673,"teacher_disagreement_score":0.40117896,"about_ca_system_score_codex":0.00017148093,"about_ca_system_score_gemma":0.0003368428,"threshold_uncertainty_score":0.9997742},"labels":[],"label_agreement":null},{"id":"W4285679625","doi":"10.1016/j.jtct.2022.07.013","title":"Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Defense Systems Management College; National Institute of Allergy and Infectious Diseases; Daiichi Sankyo Europe; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Pharmacyclics; Chugai Pharmaceutical; Merck Sharp and Dohme; U.S. Public Health Service; National Institutes of Health; Daiichi-Sankyo; Omeros Corporation; Astellas Pharma; Astellas Pharma US; Nippon Shinyaku; Incyte; Pfizer; CareDx; Plexxikon; Health Resources and Services Administration; Syndax Pharmaceuticals; Kyowa Kirin Pharmaceutical Development; Legend Biotech; CytoSen Therapeutics; Cancer Moonshot; Medical College of Wisconsin; Cidara Therapeutics; Novartis; Celgene; Moonshot Research and Development Program; Sanofi; Janssen Pharmaceuticals; Fuji Pharma; Merck; Bristol-Myers Squibb","keywords":"Medicine; Graft-versus-host disease; Internal medicine; Transplantation; Gastroenterology; Cyclophosphamide; Hazard ratio; Retrospective cohort study; Immunology; Surgery; Chemotherapy; Confidence interval","score_opus":0.014326780594247208,"score_gpt":0.24376951426468346,"score_spread":0.22944273367043624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285679625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926603,0.0010469902,0.0024557055,0.00022819516,0.00085771445,0.0009133801,0.0011424343,0.00007428665,0.000621027],"genre_scores_gemma":[0.99073315,0.0045927283,0.00030542043,0.00019269543,0.000057740515,0.00021117915,0.0036911375,0.00004912521,0.00016682311],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9978565,0.00017075097,0.0005810096,0.0004114646,0.0007116429,0.00026861439],"domain_scores_gemma":[0.99902666,0.00018240832,0.00018592853,0.00022993088,0.00014872462,0.00022632926],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002515759,0.00028175404,0.00035611782,0.00019444899,0.00019917816,0.000022433338,0.000099027966,0.000085026935,0.00310055],"category_scores_gemma":[0.000007220333,0.00028611903,0.00018286912,0.00024324415,0.00013184558,0.0001352162,0.0000068707486,0.0002513079,0.000016871187],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46878716,0.0033020016,0.21026371,0.010752611,0.0015882902,0.0051479503,0.024552364,0.00009605297,0.22757725,0.0053883875,0.000037351536,0.04250687],"study_design_scores_gemma":[0.026604656,0.002388916,0.9271567,0.00008898013,0.0008319323,0.00011020259,0.0005868706,0.00008682427,0.040721174,0.00005654073,0.0008506743,0.0005165178],"about_ca_topic_score_codex":0.00003916076,"about_ca_topic_score_gemma":0.000006186838,"teacher_disagreement_score":0.716893,"about_ca_system_score_codex":0.00005912843,"about_ca_system_score_gemma":0.0001624544,"threshold_uncertainty_score":0.9999591},"labels":[],"label_agreement":null},{"id":"W4286510763","doi":"10.1016/j.jtct.2022.06.027","title":"Monitoring Neurocognitive Functioning After Pediatric Cellular Therapy or Hematopoietic Cell Transplant: Guidelines From the COG Neurocognition in Cellular Therapies Task Force","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Alberta Children's Hospital; University of Calgary","funders":"National Cancer Institute; Children’s Oncology Group; Purdue University","keywords":"Neurocognitive; Biopsychosocial model; Cog; Medicine; Cognition; Population; Psychiatry","score_opus":0.029638575719311073,"score_gpt":0.261732100763489,"score_spread":0.23209352504417793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286510763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9605222,0.03210716,0.0032821978,0.0011329564,0.0005561739,0.0018615162,0.00021990432,0.0001407937,0.00017714222],"genre_scores_gemma":[0.9376783,0.05820052,0.000065262815,0.001787821,0.00052787695,0.00087144045,0.00034735902,0.00009802386,0.00042344414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99689776,0.0004654961,0.00073232315,0.00071860215,0.0006924274,0.0004933759],"domain_scores_gemma":[0.998767,0.0004625765,0.00021511565,0.00025343176,0.00018274525,0.00011910216],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040174706,0.00052279996,0.000500028,0.0002585037,0.00070676923,0.000079901496,0.00016187024,0.000116822426,0.0006266976],"category_scores_gemma":[0.000009165844,0.00039543395,0.00020892016,0.0006393916,0.00011962375,0.00020529966,0.000022815106,0.00070050993,0.000014840863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050110508,0.0020240848,0.23702411,0.0006709146,0.0010373524,0.0029778886,0.10091177,0.00047149736,0.56944245,0.00002097977,0.00022223021,0.035086185],"study_design_scores_gemma":[0.07075245,0.0064491257,0.19697429,0.0011267235,0.0030751813,0.00045705953,0.034573227,0.0011532671,0.67382216,0.0011865955,0.0073856516,0.003044238],"about_ca_topic_score_codex":0.00014134082,"about_ca_topic_score_gemma":0.000018125556,"teacher_disagreement_score":0.104379706,"about_ca_system_score_codex":0.00006050252,"about_ca_system_score_gemma":0.000097459895,"threshold_uncertainty_score":0.99984974},"labels":[],"label_agreement":null},{"id":"W4288753092","doi":"10.1016/j.jtct.2022.07.024","title":"Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"Public Health Agency of Canada","keywords":"Medicine; Immunogenicity; Interquartile range; CD8; Immunology; Vaccination; Internal medicine; Stem cell; Antibody; Gastroenterology; Antigen; Biology","score_opus":0.028877193235738646,"score_gpt":0.28708346556665737,"score_spread":0.25820627233091875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288753092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895307,0.0083368905,0.0007562248,0.00018891606,0.00008132368,0.00077634735,0.000089950765,0.00004363274,0.00019601786],"genre_scores_gemma":[0.9917726,0.0018773001,0.00005753944,0.006003844,0.000025182817,0.00013242553,0.000066045715,0.00003793093,0.000027157152],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99816006,0.0001914032,0.00041204816,0.00046236592,0.0004122259,0.0003619092],"domain_scores_gemma":[0.99956554,0.000055841396,0.000058561607,0.00024240227,0.00003295996,0.00004468162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050752057,0.0002484086,0.00036009747,0.00024099542,0.00018314974,0.000028515387,0.00012245699,0.00009579793,0.0000497596],"category_scores_gemma":[6.597836e-7,0.00022659668,0.00009819419,0.0003117328,0.00004979328,0.000093385184,0.00001863053,0.00039397946,0.000008168027],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018101495,0.00037455987,0.1345256,0.00015215707,0.000078520825,0.0004843591,0.0035603829,0.0000024363706,0.83500683,0.000022054308,0.0000027092842,0.007688885],"study_design_scores_gemma":[0.018646702,0.0008536345,0.10064212,0.00007824151,0.000096436765,0.0002352055,0.00023778617,0.00060345733,0.8705382,0.00006511117,0.007640692,0.0003624612],"about_ca_topic_score_codex":0.00023858594,"about_ca_topic_score_gemma":0.00027936677,"teacher_disagreement_score":0.03553131,"about_ca_system_score_codex":0.000072458046,"about_ca_system_score_gemma":0.00008599965,"threshold_uncertainty_score":0.9240345},"labels":[],"label_agreement":null},{"id":"W4290851731","doi":"10.1016/j.jtct.2022.08.010","title":"The Cost-Effectiveness of Axicabtagene Ciloleucel as Second-Line Therapy in Patients with Large B-Cell Lymphoma in the United States: An Economic Evaluation of the ZUMA-7 Trial","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institutes of Health; Miltenyi Biotec; Kite Pharma; Division of Cancer Prevention, National Cancer Institute; Gilead Sciences; AstraZeneca; Bristol-Myers Squibb; National Cancer Institute; AbbVie; Merck; Roche; Astellas Pharma US; Amgen","keywords":"Medicine; Chemoimmunotherapy; Cost effectiveness; Quality-adjusted life year; Clinical trial; Oncology; Internal medicine; Lymphoma; Rituximab","score_opus":0.041125326873381204,"score_gpt":0.3165985277671497,"score_spread":0.2754732008937685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290851731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946718,0.00043721846,0.000027660943,0.00009294539,0.000077648576,0.0043938705,0.00010527367,0.0000061380756,0.0001874003],"genre_scores_gemma":[0.9971178,0.0015561833,0.0000021361977,0.00017556675,0.0000165755,0.00039677805,0.0006512914,0.000024617451,0.000059061822],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99585134,0.0026167282,0.00037877486,0.00022885282,0.00071618514,0.0002080939],"domain_scores_gemma":[0.9989165,0.00039476782,0.00016373808,0.00037127975,0.00011802225,0.00003571051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041393405,0.00015696223,0.00025411873,0.00016651551,0.00017887852,0.000019150424,0.00024394081,0.000049237708,0.000525059],"category_scores_gemma":[0.0000044677263,0.000085057596,0.00007213086,0.00040412226,0.00011419475,0.00006181554,0.0000092513255,0.00020148137,6.631718e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.689983,0.010717334,0.05409516,0.00027963982,0.00041953163,0.000019682266,0.036067355,0.006458394,0.09743915,0.00049058016,0.000009959316,0.10402018],"study_design_scores_gemma":[0.5285041,0.01135789,0.27111244,0.00008337739,0.00011487784,0.000011565236,0.0047103525,0.0075179753,0.17383574,0.00044427157,0.0020147816,0.0002926162],"about_ca_topic_score_codex":0.00033872278,"about_ca_topic_score_gemma":0.00020861617,"teacher_disagreement_score":0.2170173,"about_ca_system_score_codex":0.00013908914,"about_ca_system_score_gemma":0.0002595455,"threshold_uncertainty_score":0.57490283},"labels":[],"label_agreement":null},{"id":"W4293652654","doi":"10.1016/j.jtct.2022.08.021","title":"Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Janssen Pharmaceuticals; Incyte; Fondazione IRCCS Policlinico San Matteo; Pharmacyclics; AbbVie; Jazz Pharmaceuticals; Novartis; Teva Pharmaceutical Industries; Gilead Sciences; GlaxoSmithKline; Amgen","keywords":"Ibrutinib; Medicine; Internal medicine; Clinical endpoint; Hematopoietic stem cell transplantation; Adverse effect; Refractory (planetary science); Graft-versus-host disease; Transplantation; Gastroenterology; Clinical trial; Leukemia; Chronic lymphocytic leukemia","score_opus":0.04040375757232324,"score_gpt":0.3183749669695803,"score_spread":0.27797120939725706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293652654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835335,0.0135238925,0.000064194406,0.000506271,0.00012211506,0.0013257146,0.0007210117,0.000035104546,0.00016821426],"genre_scores_gemma":[0.9820392,0.015546508,0.000017566656,0.00007661624,0.0002492371,0.00011795587,0.0016557906,0.000023514753,0.00027360595],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99837816,0.0002120996,0.00032704606,0.0003296162,0.0005509366,0.00020211573],"domain_scores_gemma":[0.99903166,0.00033219543,0.000090540954,0.00038425886,0.000035522775,0.00012580214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022806607,0.00016582041,0.00024305187,0.000070885035,0.0002012136,0.0000149877715,0.000115332376,0.000020709604,0.0003142735],"category_scores_gemma":[0.0000048580946,0.0001131406,0.00009117066,0.0002442808,0.00007666948,0.00004247158,0.00001298599,0.000111198344,0.0000050612543],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5398884,0.034991086,0.024052447,0.00079413,0.0038394928,0.006271279,0.08973291,0.00046480526,0.16729732,0.00019653125,0.0014179567,0.13105367],"study_design_scores_gemma":[0.8875496,0.020722039,0.045799278,0.000035857604,0.0022343807,0.000054535998,0.0028291133,0.003969059,0.020872604,0.000038412178,0.015357147,0.0005379727],"about_ca_topic_score_codex":0.0006114367,"about_ca_topic_score_gemma":0.00002204251,"teacher_disagreement_score":0.34766123,"about_ca_system_score_codex":0.001327677,"about_ca_system_score_gemma":0.0015552595,"threshold_uncertainty_score":0.46137398},"labels":[],"label_agreement":null},{"id":"W4294051557","doi":"10.1016/j.jtct.2022.08.030","title":"Favorable Outcomes with R-CHOP Induction and Consolidative Autologous Stem Cell Transplantation for Double-Hit Lymphoma","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta; Alberta Health Services","funders":"Gilead Sciences; Merck; AstraZeneca; Novartis; Eisai Canada; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Autologous stem-cell transplantation; CHOP; Induction chemotherapy; Internal medicine; Oncology; International Prognostic Index; Transplantation; Lymphoma; Diffuse large B-cell lymphoma; Surgery; Chemotherapy","score_opus":0.02328548444801918,"score_gpt":0.25200732098411066,"score_spread":0.2287218365360915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294051557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942244,0.0010626188,0.0023114833,0.00051755185,0.00007522562,0.0011775048,0.00012173402,0.00006026742,0.00044918392],"genre_scores_gemma":[0.9947221,0.0031091443,0.0003422824,0.00034436097,0.000015293903,0.00048158903,0.0004942304,0.000023638891,0.0004673521],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990766,0.000059441372,0.00019363825,0.00030325222,0.00019427943,0.00017280881],"domain_scores_gemma":[0.9996043,0.000085431864,0.00008772203,0.0000974094,0.00004084063,0.0000842839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011530442,0.00018870391,0.00027191098,0.00009919385,0.00034303198,0.000031514417,0.000030391348,0.000052158844,0.00004752621],"category_scores_gemma":[1.7736158e-7,0.0001445496,0.000052087442,0.00009859432,0.000055928947,0.00009985894,0.0000024189853,0.00005433128,0.0000014257962],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07192906,0.0047659553,0.2823983,0.002375246,0.0022201221,0.0011900634,0.078634515,0.00043696907,0.069812864,0.007821672,0.00019094508,0.47822428],"study_design_scores_gemma":[0.14823622,0.007716352,0.3642518,0.00012284695,0.0017767554,0.0018580162,0.008131786,0.0004974238,0.45985097,0.00029422747,0.0063252575,0.00093835907],"about_ca_topic_score_codex":0.0000966981,"about_ca_topic_score_gemma":0.000014016341,"teacher_disagreement_score":0.47728592,"about_ca_system_score_codex":0.000059765414,"about_ca_system_score_gemma":0.00007335174,"threshold_uncertainty_score":0.5894562},"labels":[],"label_agreement":null},{"id":"W4304690353","doi":"10.1016/j.jtct.2022.10.003","title":"Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Centre Hospitalier Universitaire de Sherbrooke; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Bendamustine; Regimen; Carmustine; Mucositis; Transplantation; Autologous stem-cell transplantation; Oncology; Lymphoma; Internal medicine; Surgery; Chemotherapy; Rituximab; Cyclophosphamide","score_opus":0.024390318959001678,"score_gpt":0.2759682069388299,"score_spread":0.2515778879798282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304690353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971659,0.00071702583,0.00061638496,0.00010761097,0.000039433362,0.000599907,0.00043307344,0.000027997086,0.00029264882],"genre_scores_gemma":[0.99809873,0.00053091923,0.00017720566,0.00009263522,0.000008090115,0.00010865672,0.000917024,0.00002540468,0.000041345644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854577,0.00011564415,0.0005105364,0.0002661114,0.00033026558,0.00023168848],"domain_scores_gemma":[0.99933755,0.00013916472,0.0002630671,0.0001606339,0.000043107924,0.00005646116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024686812,0.00022263416,0.00043948888,0.0002776249,0.00013588756,0.000009035655,0.000064358464,0.00005127698,0.0002736143],"category_scores_gemma":[6.2214235e-7,0.0001853876,0.00020054218,0.00021413337,0.000043152155,0.000056124547,0.000003924764,0.00007039198,7.2152653e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038061708,0.0036128685,0.5415313,0.00050232204,0.00052421674,0.00019836542,0.013018264,0.002460537,0.4204412,0.00045051237,0.000012772839,0.013441411],"study_design_scores_gemma":[0.021688506,0.0020728158,0.60864353,0.000091822505,0.00020554093,0.000020422101,0.0010328045,0.00082826155,0.36515424,0.000015487769,0.000052296586,0.00019429521],"about_ca_topic_score_codex":0.00043581135,"about_ca_topic_score_gemma":0.000016605274,"teacher_disagreement_score":0.06711216,"about_ca_system_score_codex":0.00009775705,"about_ca_system_score_gemma":0.0001118002,"threshold_uncertainty_score":0.7559887},"labels":[],"label_agreement":null},{"id":"W4306894205","doi":"10.1016/j.jtct.2022.10.012","title":"Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research Alliance","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"National Institutes of Health; American Society of Hematology; National Heart, Lung, and Blood Institute; Robert Wood Johnson Foundation","keywords":"Medicine; Internal medicine; Odds ratio; Retrospective cohort study; Organ dysfunction; Transplantation; Confidence interval; Stroke (engine); Gastroenterology; Cohort; Surgery","score_opus":0.022319717466802773,"score_gpt":0.2788681193083324,"score_spread":0.2565484018415296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306894205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809229,0.012541143,0.0036052885,0.0015565128,0.00013286386,0.00094373885,0.00007262465,0.000033839297,0.0001911307],"genre_scores_gemma":[0.98228914,0.0152406385,0.000055991713,0.00068151124,0.00007127792,0.00019540051,0.00066253997,0.000027810529,0.0007757047],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998795,0.00013275203,0.00022185905,0.00031932944,0.00030896586,0.00022213736],"domain_scores_gemma":[0.99951303,0.000123916,0.000045186476,0.00018240647,0.000050322353,0.00008515741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047625176,0.00013063567,0.000157215,0.000042631575,0.00044645628,0.000032515905,0.00005810874,0.00007110835,0.00031445196],"category_scores_gemma":[0.000001976471,0.0000926969,0.00006295204,0.00014553487,0.00009907458,0.00005051477,0.000005811593,0.00031728612,0.0000034148934],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04761293,0.001449768,0.20473623,0.0011994372,0.00071087753,0.0030808516,0.07695189,0.000050385395,0.58818877,0.00018422116,0.0013344396,0.07450018],"study_design_scores_gemma":[0.05887209,0.0067538824,0.6360655,0.0007124048,0.0018012194,0.0024627952,0.014109138,0.0011431245,0.13387094,0.0019619968,0.14060307,0.0016438361],"about_ca_topic_score_codex":0.00011003409,"about_ca_topic_score_gemma":0.000023947614,"teacher_disagreement_score":0.45431784,"about_ca_system_score_codex":0.000017767708,"about_ca_system_score_gemma":0.000083897554,"threshold_uncertainty_score":0.378007},"labels":[],"label_agreement":null},{"id":"W4306894665","doi":"10.1016/j.jtct.2022.10.013","title":"Rituximab Toxicity after Preemptive or Therapeutic Administration for Post-Transplant Lymphoproliferative Disorder","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"O'Brien Institute for Public Health, University of Calgary; Alberta Cancer Foundation","keywords":"Rituximab; Medicine; Neutropenia; Hypogammaglobulinemia; Post-transplant lymphoproliferative disorder; Internal medicine; Gastroenterology; Transplantation; Lymphoproliferative disorders; Immunosuppression; Immunology; Hematopoietic stem cell transplantation; Incidence (geometry); Toxicity; Lymphoma; Antibody","score_opus":0.019866385663078648,"score_gpt":0.27310276290020813,"score_spread":0.2532363772371295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306894665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93886536,0.0010749962,0.05554319,0.0009880859,0.00013610657,0.0023214698,0.0007474174,0.00009705801,0.00022633765],"genre_scores_gemma":[0.9929719,0.001362263,0.0006982967,0.0016017406,0.000056733163,0.0012494734,0.001372018,0.00004954745,0.00063803757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983209,0.00016883475,0.00039516485,0.00043976685,0.000387871,0.00028748796],"domain_scores_gemma":[0.9993334,0.00017230966,0.000092050046,0.0001747299,0.00010295271,0.00012457852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026973666,0.00028015167,0.00036303178,0.00012748428,0.00034906066,0.000037262944,0.00007581506,0.000092543,0.00088081794],"category_scores_gemma":[0.0000025232218,0.00023069057,0.00013520634,0.00016386044,0.00007576975,0.00013084755,0.0000037175757,0.00016678558,0.000007132815],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29026708,0.006521405,0.044596434,0.003765559,0.0015725951,0.0013364817,0.106755964,0.00011796693,0.49530306,0.004693786,0.000055168937,0.045014482],"study_design_scores_gemma":[0.090207316,0.021293191,0.07998091,0.0004217854,0.0020212275,0.0048352294,0.009060017,0.003807624,0.7738112,0.0012126516,0.0111371735,0.002211679],"about_ca_topic_score_codex":0.000022446831,"about_ca_topic_score_gemma":0.000056470493,"teacher_disagreement_score":0.27850813,"about_ca_system_score_codex":0.000055498585,"about_ca_system_score_gemma":0.00020216474,"threshold_uncertainty_score":0.9644339},"labels":[],"label_agreement":null},{"id":"W4307054616","doi":"10.1016/j.jtct.2022.10.011","title":"Profiling the Fungal Microbiome after Fecal Microbiota Transplantation for Graft-versus-Host Disease: Insights from a Phase 1 Interventional Study","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health; DKMS Foundation; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Seres Therapeutics; ZonMw; National Heart, Lung, and Blood Institute; Landsteiner Foundation for Blood Transfusion Research; Ludwig Center at Harvard; Merck; Deutsche Forschungsgemeinschaft; Academisch Medisch Centrum; European Hematology Association; Memorial Sloan-Kettering Cancer Center; National Institute on Aging; Parker Institute for Cancer Immunotherapy; Lymphoma Foundation; ADC Foundation","keywords":"Mycobiota; Microbiome; Biology; Transplantation; Graft-versus-host disease; Hematopoietic stem cell transplantation; Context (archaeology); Gut flora; Feces; Immunology; Microbiology; Medicine; Internal medicine; Ecology; Bioinformatics","score_opus":0.01742214589055315,"score_gpt":0.2839128137242455,"score_spread":0.26649066783369235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307054616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98811615,0.0036459512,0.004301304,0.0001722087,0.00030212817,0.0012106678,0.0022295993,0.000015084362,0.0000068935933],"genre_scores_gemma":[0.9914226,0.000635082,0.00014283335,0.00028034186,0.00012224393,0.0003649225,0.0069028796,0.000027077696,0.00010200483],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988249,0.0002102319,0.0002633109,0.0004025032,0.0001129535,0.00018609209],"domain_scores_gemma":[0.99961394,0.000029655042,0.000075846445,0.000169057,0.000037287347,0.00007420219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014400033,0.00018659631,0.00012978552,0.000054368018,0.00043438547,0.000045866993,0.00014302971,0.000050780505,0.000101554375],"category_scores_gemma":[0.0000010636667,0.00015481134,0.0001367369,0.000076965676,0.00005677188,0.000009802821,0.00001425042,0.00011980517,0.0000020109117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015011389,0.00091596873,0.00089889864,0.00006764213,0.00014960064,0.000022902535,0.0016326165,0.000010061655,0.9807784,0.000048933394,0.00004849752,0.0004150989],"study_design_scores_gemma":[0.09060602,0.011691148,0.07493146,0.000095202915,0.001057807,0.00010541613,0.00481093,0.00031982464,0.7749831,0.00019475461,0.039524704,0.0016796044],"about_ca_topic_score_codex":0.000026308919,"about_ca_topic_score_gemma":0.00008161652,"teacher_disagreement_score":0.20579526,"about_ca_system_score_codex":0.000016786656,"about_ca_system_score_gemma":0.0000634025,"threshold_uncertainty_score":0.6313023},"labels":[],"label_agreement":null},{"id":"W4308154018","doi":"10.1016/j.jtct.2022.10.022","title":"Bortezomib Maintenance After Allogeneic Transplantation in Newly Diagnosed Myeloma Patients Results in Decreased Incidence and Severity of Chronic GVHD","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Fonds de Recherche du Québec - Santé; Université de Montréal","keywords":"Medicine; Multiple myeloma; Incidence (geometry); Bortezomib; Internal medicine; Gastroenterology; Graft-versus-host disease; Clinical endpoint; Immunosuppression; Transplantation; Tacrolimus; Retrospective cohort study; Discontinuation; Surgery; Clinical trial","score_opus":0.011641333878656637,"score_gpt":0.25310032472843347,"score_spread":0.24145899084977684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308154018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727905,0.0012988785,0.00018646632,0.00010504702,0.000026389896,0.00079383026,0.00022924741,0.000010903635,0.000070173715],"genre_scores_gemma":[0.9887835,0.010031355,0.00016717306,0.00010831922,0.000007343897,0.00017475625,0.0006877466,0.000013370185,0.000026482183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863344,0.00018980545,0.00035087738,0.000297172,0.00030154496,0.00022715158],"domain_scores_gemma":[0.9995781,0.00009501691,0.00007066467,0.00011961574,0.000034055214,0.00010250126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024987911,0.00014272892,0.00023590679,0.00019841858,0.00005370579,0.000008105894,0.000050947354,0.000048248756,0.00008729215],"category_scores_gemma":[0.00000910609,0.00013132064,0.000036540776,0.00021890234,0.00006360802,0.00009312138,0.0000061992528,0.00015688971,8.191355e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020841049,0.0007636768,0.89118385,0.00031672753,0.000040052684,0.0014202346,0.004467795,0.000056964112,0.013375414,0.000012203247,0.0000027671294,0.06751924],"study_design_scores_gemma":[0.02841034,0.0007237532,0.9589335,0.0000857742,0.000023104425,0.000028732595,0.000101616904,0.0006620535,0.010842405,0.000031817624,0.000042288495,0.00011464139],"about_ca_topic_score_codex":0.000778591,"about_ca_topic_score_gemma":0.0010115748,"teacher_disagreement_score":0.0677496,"about_ca_system_score_codex":0.00009849021,"about_ca_system_score_gemma":0.00009146017,"threshold_uncertainty_score":0.53551},"labels":[],"label_agreement":null},{"id":"W4308368676","doi":"10.1016/j.jtct.2022.10.028","title":"Primary Preventive Care of Hematopoietic Stem Cell Transplantation Survivors: Time to Educate and Empower Recipients and Providers","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Cancer survivorship and care","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Ottawa Hospital; University of Ottawa","funders":"Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Survivorship curve; Attendance; Transplantation; Population; Hematopoietic stem cell transplantation; Psychological intervention; Hematopoietic cell; Disease; Primary care physician; Intensive care medicine; Family medicine; Stem cell; Internal medicine; Primary care; Nursing; Haematopoiesis; Environmental health","score_opus":0.007946598233729268,"score_gpt":0.22535095958537224,"score_spread":0.21740436135164298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308368676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297833,0.004645742,0.00026925348,0.00020234413,0.00010518605,0.0007591464,0.00013138552,0.000023033961,0.00088559045],"genre_scores_gemma":[0.995523,0.0026173922,0.000048475493,0.00031256294,0.000014599334,0.00007355072,0.0003161404,0.000023131579,0.0010711957],"study_design_codex":"qualitative","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900144,0.00012462086,0.00021397349,0.00028113782,0.0002452968,0.0001335308],"domain_scores_gemma":[0.9996312,0.000040796094,0.000064786465,0.00010510078,0.000047319467,0.000110796456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014549494,0.00014664035,0.00023793062,0.000113593574,0.0001129059,0.000016124432,0.000039639162,0.00004070562,0.0001572471],"category_scores_gemma":[2.6842943e-7,0.00014263329,0.000044312525,0.0001364673,0.00004490432,0.00007227182,0.0000071862823,0.0001032245,0.0000021585097],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009895399,0.00051480386,0.036305383,0.006425834,0.00022653189,0.00011935098,0.5762252,0.000028937002,0.2936896,0.0000687469,0.00012069665,0.07637949],"study_design_scores_gemma":[0.028581938,0.0080593685,0.20932154,0.001311622,0.0016292536,0.00071713876,0.09234716,0.00007964864,0.6413543,0.0002195265,0.014387029,0.0019914643],"about_ca_topic_score_codex":0.00015259205,"about_ca_topic_score_gemma":0.00005232882,"teacher_disagreement_score":0.48387805,"about_ca_system_score_codex":0.000029479457,"about_ca_system_score_gemma":0.0000559059,"threshold_uncertainty_score":0.5816417},"labels":[],"label_agreement":null},{"id":"W4308987982","doi":"10.1016/j.jtct.2022.11.007","title":"Clinical Outcomes of Umbilical Cord Blood Transplantation Using Ex Vivo Expansion: A Systematic Review and Meta-Analysis of Controlled Studies","year":2022,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Ottawa Hospital; University of Ottawa","funders":"Ottawa Hospital Research Institute","keywords":"Medicine; Ex vivo; Umbilical Cord Blood Transplantation; Umbilical cord; Transplantation; Stem cell; CD34; Internal medicine; Cord blood; Oncology; Hematopoietic stem cell transplantation; Immunology; In vivo; Biology","score_opus":0.24620403150363632,"score_gpt":0.4383533494280599,"score_spread":0.1921493179244236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308987982","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002838158,0.9898565,0.0007675753,0.00003085558,0.000051987918,0.0058107213,0.0005825594,0.000029826497,0.00003184519],"genre_scores_gemma":[0.0011276391,0.996986,0.00043731416,0.00020596234,0.000009239073,0.0004050621,0.00069406925,0.000054624248,0.000080093174],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9927451,0.0018171055,0.0038553549,0.00064562215,0.00072517776,0.00021164071],"domain_scores_gemma":[0.99476653,0.0027683298,0.0016446754,0.0005062267,0.0001717339,0.00014253029],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.002179109,0.00064103457,0.016266683,0.0005650521,0.00008614225,0.000012123408,0.0001417815,0.00027149738,0.00044685227],"category_scores_gemma":[0.000054311124,0.00041540887,0.0035647505,0.0007472499,0.00021640152,0.00006968608,0.00000766481,0.00031587254,6.603504e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004389255,0.00028728604,0.000047509195,0.7379287,0.2594325,0.00008790382,0.00082894764,0.0000011633047,0.000054016284,0.00005600134,7.628357e-7,0.0008363103],"study_design_scores_gemma":[0.004746962,0.00043723878,0.000021877106,0.019690221,0.97392964,0.00036958305,0.00017990723,0.000022866077,0.00008036037,0.0000059974627,0.00019319695,0.0003221197],"about_ca_topic_score_codex":0.000031300275,"about_ca_topic_score_gemma":0.000010127612,"teacher_disagreement_score":0.7182385,"about_ca_system_score_codex":0.000021070166,"about_ca_system_score_gemma":0.00013754597,"threshold_uncertainty_score":0.99982977},"labels":[],"label_agreement":null},{"id":"W4310065131","doi":"10.1016/j.jtct.2022.11.019","title":"Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Health Resources and Services Administration","keywords":"Medicine; Comorbidity; Hematopoietic cell; Transplantation; Hematopoietic stem cell transplantation; Body mass index; Percentile; Young adult; Internal medicine; Hazard ratio; Population; Hematologic Neoplasms; Pediatrics; Oncology; Haematopoiesis; Stem cell; Confidence interval","score_opus":0.020307888964133047,"score_gpt":0.22099914548673905,"score_spread":0.200691256522606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310065131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95754415,0.0025586956,0.03717908,0.00038109886,0.00006792733,0.0017963366,0.0001844031,0.00009930119,0.00018904044],"genre_scores_gemma":[0.9866658,0.010041045,0.0014029632,0.00044475676,0.00002945379,0.00040054836,0.0009118637,0.000052241852,0.000051340598],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983241,0.00015464425,0.00039293233,0.0004383936,0.00036495275,0.00032496112],"domain_scores_gemma":[0.99931407,0.00018867671,0.00015128165,0.0001820117,0.000059379894,0.00010456763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030049632,0.00028773677,0.00030763805,0.000120689285,0.0008210908,0.00004953048,0.000092774855,0.00007564021,0.00004757736],"category_scores_gemma":[0.000002294693,0.0002170494,0.0000908164,0.00019937415,0.00011866978,0.000090555666,0.0000055689643,0.00021256106,0.000002540431],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024237465,0.0019125608,0.49614668,0.020480493,0.0009314991,0.0008055293,0.12661028,0.0011417819,0.30765155,0.013378001,0.000106819105,0.006597352],"study_design_scores_gemma":[0.08759046,0.0066483407,0.35803318,0.0045568957,0.004554191,0.035932116,0.042255748,0.001937343,0.4527634,0.0023444244,0.00032142378,0.0030624461],"about_ca_topic_score_codex":0.000040651525,"about_ca_topic_score_gemma":0.000056727058,"teacher_disagreement_score":0.14511189,"about_ca_system_score_codex":0.000027721504,"about_ca_system_score_gemma":0.00007803926,"threshold_uncertainty_score":0.88510174},"labels":[],"label_agreement":null},{"id":"W4310641319","doi":"10.1016/j.jtct.2022.11.025","title":"A Multicenter, Retrospective Study Evaluating Clinical Outcomes of Ruxolitinib Therapy In Heavily Pretreated Chronic GVHD Patients With Steroid Failure","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Saskatchewan Cancer Agency; London Health Sciences Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Ruxolitinib; Prednisone; Internal medicine; Population; Hematopoietic stem cell transplantation; Transplantation; Clinical trial; Salvage therapy; Graft-versus-host disease; Refractory (planetary science); Retrospective cohort study; Adverse effect; Chemotherapy; Bone marrow","score_opus":0.03390349540065966,"score_gpt":0.3283268832030288,"score_spread":0.2944233878023691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310641319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99644464,0.000238049,0.0001975135,0.000060583578,0.00007890217,0.0027720537,0.00007687897,0.00004025387,0.00009110083],"genre_scores_gemma":[0.99864507,0.0004581244,0.0002274695,0.00009738903,0.000014391786,0.00016582082,0.00031532478,0.000038126458,0.000038287864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974093,0.0005720354,0.0007114724,0.00042216707,0.00065754127,0.00022751969],"domain_scores_gemma":[0.9992099,0.00014081153,0.00021744736,0.00022966474,0.00012070277,0.00008151822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067195937,0.00023330668,0.0005574887,0.00017201909,0.000107785614,0.000012784613,0.00008423308,0.0000618319,0.00032106345],"category_scores_gemma":[0.0000060571806,0.00018329147,0.00009014405,0.00027310953,0.00006728011,0.0000814784,0.000005819815,0.0003104183,0.0000015034731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050673047,0.0023163778,0.97253644,0.000104750296,0.00027160178,0.000049915176,0.0105517125,0.000029090636,0.0037103358,0.000009642854,7.9409295e-7,0.0053520394],"study_design_scores_gemma":[0.04684767,0.010005024,0.93717307,0.00006263861,0.00012075499,0.000008658856,0.0017108195,0.00016615896,0.003720701,0.0000073015085,0.000008188944,0.00016898364],"about_ca_topic_score_codex":0.00010721938,"about_ca_topic_score_gemma":0.00007256268,"teacher_disagreement_score":0.041780367,"about_ca_system_score_codex":0.000094999814,"about_ca_system_score_gemma":0.000096655254,"threshold_uncertainty_score":0.74744093},"labels":[],"label_agreement":null},{"id":"W4312156831","doi":"10.1016/j.jtct.2022.12.013","title":"An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Hematopoietic stem cell transplantation; Medicine; Myeloid leukemia; Transplantation; Incidence (geometry); Disease; Disease burden; Internal medicine; Immunology","score_opus":0.023644774512006722,"score_gpt":0.29340580692847884,"score_spread":0.2697610324164721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312156831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9664546,0.0004590967,0.031602263,0.00013391307,0.000042615968,0.0008296294,0.0003359953,0.000020939984,0.000120893936],"genre_scores_gemma":[0.9953084,0.0028836003,0.00026247377,0.00015408586,0.0000114912955,0.0000892592,0.00097285287,0.000024166167,0.00029368876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985786,0.00019468501,0.0003962064,0.00024384895,0.0004257271,0.00016095089],"domain_scores_gemma":[0.9992727,0.00010147737,0.0001807401,0.00027779458,0.00010222104,0.00006506531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037100873,0.0001354086,0.00035453148,0.00031720707,0.00017657867,0.000009009731,0.00015868124,0.000054849676,0.00012783273],"category_scores_gemma":[7.024603e-7,0.00010697101,0.00020637446,0.00085568306,0.00008048631,0.00007577255,0.000005216881,0.00014097664,2.7704502e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046197097,0.00024920868,0.01049275,0.00068504835,0.0010722028,0.000014989604,0.01600303,0.0040737386,0.9526646,0.00082814175,0.000016560563,0.009279987],"study_design_scores_gemma":[0.00542126,0.0006749868,0.03528252,0.000029490835,0.0036946961,0.000033922246,0.0019298127,0.022624187,0.929862,0.0000735255,0.0002119581,0.00016163177],"about_ca_topic_score_codex":0.0000616548,"about_ca_topic_score_gemma":0.000018765504,"teacher_disagreement_score":0.031339787,"about_ca_system_score_codex":0.000090610774,"about_ca_system_score_gemma":0.00017058029,"threshold_uncertainty_score":0.43621513},"labels":[],"label_agreement":null},{"id":"W4313252429","doi":"10.1016/j.jtct.2022.12.017","title":"Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Kite Pharma; Sanofi Genzyme; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; TG Therapeutics; StemCyte; Actinium Pharmaceuticals; CareDx; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; HistoGenetics; Atara Biotherapeutics; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; Mallinckrodt Pharmaceuticals; Astellas Pharma US; CSL Behring; Eli Lilly and Company; Bristol-Myers Squibb; Amgen; Medac; Jazz Pharmaceuticals; Be The Match Foundation","keywords":"Medicine; Cyclophosphamide; Internal medicine; Transplantation; Incidence (geometry); Bone marrow; Clinical trial; Prospective cohort study; Clinical endpoint; Surgery; Hematopoietic stem cell transplantation; Hematopoietic cell; Gastroenterology; Oncology; Chemotherapy; Haematopoiesis; Stem cell","score_opus":0.04516008171446839,"score_gpt":0.3226275748341489,"score_spread":0.2774674931196805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313252429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904444,0.0004110203,0.002335218,0.0001845365,0.00074888376,0.004341577,0.0012492308,0.00013059181,0.00015449677],"genre_scores_gemma":[0.99098027,0.0018793636,0.0030454772,0.00015748687,0.00006715725,0.00039919183,0.0033072103,0.00008145444,0.00008237516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953656,0.00053546723,0.0016829293,0.0008143039,0.0011609225,0.0004407678],"domain_scores_gemma":[0.9983123,0.0005346641,0.0004404108,0.00027037808,0.00023489182,0.00020738442],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012512328,0.0004694568,0.0010365667,0.00043710845,0.0002167356,0.000036509904,0.00018074001,0.0003082656,0.00040970073],"category_scores_gemma":[0.000024726738,0.00045774775,0.0003617809,0.00058581954,0.00016024387,0.00022092363,0.000008356725,0.0005915781,0.000007186475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3177208,0.0031657077,0.51444995,0.0005547054,0.0008722571,0.0005435695,0.012121305,0.00015654363,0.14735796,0.0002617717,0.000007387688,0.0027880142],"study_design_scores_gemma":[0.33955926,0.004607268,0.59461445,0.0007032659,0.0012259076,0.000257772,0.001364158,0.0022563147,0.05311251,0.0011971953,0.00006219814,0.0010397411],"about_ca_topic_score_codex":0.0007124218,"about_ca_topic_score_gemma":0.00033138858,"teacher_disagreement_score":0.09424544,"about_ca_system_score_codex":0.00016355887,"about_ca_system_score_gemma":0.0003430145,"threshold_uncertainty_score":0.99978745},"labels":[],"label_agreement":null},{"id":"W4313887581","doi":"10.1016/j.jtct.2023.01.004","title":"Multi-Stakeholder Qualitative Interviews to Inform Measurement of Patient Reported Outcomes After CAR-T","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Kite Pharma; Health Resources and Services Administration; MorphoSys; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; TG Therapeutics; Medac; Jazz Pharmaceuticals; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; StemCyte; Bristol-Myers Squibb; AstraZeneca; CSL Behring; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; Novartis Pharmaceuticals Corporation; Amgen; Mallinckrodt Pharmaceuticals; Astellas Pharma US","keywords":"Medicine; Anxiety; Family medicine; Health care; Psychology; Psychiatry","score_opus":0.2083465041368138,"score_gpt":0.38663325994693726,"score_spread":0.17828675581012346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313887581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651337,0.00042372738,0.0009939524,0.000614114,0.00007714876,0.0010197955,0.00003364675,0.0000579767,0.0002662681],"genre_scores_gemma":[0.99653804,0.0013030549,0.00032519054,0.00049081555,0.000009719982,0.00015386513,0.000112588255,0.000021876183,0.001044863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982709,0.00012684257,0.00050448196,0.00022629958,0.000659851,0.0002116141],"domain_scores_gemma":[0.9992581,0.00005183891,0.00008551949,0.00023511593,0.0002284074,0.0001410093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007777422,0.0001640602,0.00032924625,0.00024908417,0.000041204243,0.000013467931,0.00004965929,0.000059948696,0.0006079199],"category_scores_gemma":[0.000016136335,0.00012476416,0.00011910767,0.00037536223,0.000049176186,0.00005433881,0.0000075167177,0.000109887456,0.00003426825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033868558,0.0002537437,0.009556095,0.00036864154,0.0004592435,0.00015075569,0.19561644,0.0000089640835,0.73456883,0.00001790097,0.00010653321,0.055505995],"study_design_scores_gemma":[0.014485794,0.0018802762,0.14616656,0.00044226839,0.00017443117,0.000039348794,0.020510234,0.00013825977,0.79335046,0.000050815837,0.022210086,0.00055145763],"about_ca_topic_score_codex":0.00009107384,"about_ca_topic_score_gemma":0.000059848848,"teacher_disagreement_score":0.1751062,"about_ca_system_score_codex":0.000043550608,"about_ca_system_score_gemma":0.000045950103,"threshold_uncertainty_score":0.6656296},"labels":[],"label_agreement":null},{"id":"W4319262037","doi":"10.1016/s2666-6367(23)00653-x","title":"Business in the Pre-COVID Vs Post-COVID Era","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Earthquake Detection and Analysis","field":"Earth and Planetary Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ionosonde; Ionosphere; Depth sounding; Geophysics; Aeronomy; Geology; Meteorology; Atmospheric sciences; Physics; Plasma; Electron density; Oceanography","score_opus":0.015070857612650554,"score_gpt":0.22386167378192687,"score_spread":0.2087908161692763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319262037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99664485,0.00033333217,0.00035910885,0.0014930002,0.00007785077,0.00017898397,0.00004292913,0.00008790831,0.0007820456],"genre_scores_gemma":[0.99254674,0.0046174033,0.000024483505,0.0019577069,0.00004023084,0.000004361795,0.0005854839,0.0000029452228,0.00022065727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915624,0.00015609441,0.00015421756,0.00018057977,0.00018962269,0.00016324996],"domain_scores_gemma":[0.99968016,0.00010998336,0.000030409095,0.00010186714,0.000020687698,0.000056870012],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003881331,0.00009723877,0.0000985501,0.00015797252,0.0001708267,0.000081271995,0.0001143537,0.000048087677,0.0009948298],"category_scores_gemma":[0.0000049447976,0.00006462834,0.000042942396,0.0007339116,0.000041152256,0.00011300571,7.021391e-7,0.00010297602,0.00015175474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013687927,0.00009473846,0.59111035,0.00017304636,0.00007536985,0.00035660237,0.020392057,0.008729355,0.0060186475,0.00015680079,0.000161292,0.37136295],"study_design_scores_gemma":[0.00070317276,0.00008660657,0.98879236,0.000005581385,0.000009977402,0.00001688704,0.0003790764,0.0034450646,0.00041318737,0.00014961443,0.005887709,0.000110759174],"about_ca_topic_score_codex":0.0014606754,"about_ca_topic_score_gemma":0.003386201,"teacher_disagreement_score":0.397682,"about_ca_system_score_codex":0.0000010871285,"about_ca_system_score_gemma":0.000024678006,"threshold_uncertainty_score":0.9999184},"labels":[],"label_agreement":null},{"id":"W4319262176","doi":"10.1016/s2666-6367(23)00539-0","title":"Can You Spare 100 Days? Allogeneic Hematopoietic Cell Transplant Caregiver Requirements from the Perspective of Recipients and Caregivers","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Microfluidic and Bio-sensing Technologies","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ionosonde; Ionosphere; Depth sounding; Anomaly (physics); Geophysics; Geology; Physics; Plasma; Electron density; Oceanography","score_opus":0.02054284468544151,"score_gpt":0.21737027243238327,"score_spread":0.19682742774694176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319262176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99319446,0.005092432,0.00051317416,0.0002606736,0.0001234753,0.00018886701,0.00024237938,0.00019025148,0.00019427529],"genre_scores_gemma":[0.958908,0.040828105,0.00003472332,0.000025766212,0.000014533125,0.000004653335,0.00012088336,0.000018417686,0.00004486976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99932325,0.000032197222,0.00014534664,0.00019896029,0.00013673455,0.0001634908],"domain_scores_gemma":[0.9997143,0.000042940777,0.000029575287,0.000152538,0.000026122469,0.00003452672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000071004164,0.00015522448,0.00015583096,0.00006293016,0.00008909541,0.000016943544,0.00010890477,0.00008983929,0.000016814976],"category_scores_gemma":[8.1324134e-7,0.0001175372,0.000039911014,0.00014487414,0.00012336521,0.000037582373,0.000005691465,0.00008853419,0.0000030127105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015010977,0.000033732864,0.009871838,0.00016894238,0.00020680508,0.000070200724,0.09205362,0.00014228415,0.8928178,0.00033370705,0.00063309487,0.0035178557],"study_design_scores_gemma":[0.0023121266,0.00011346546,0.010021798,0.00017741045,0.00014101586,0.000014688506,0.0226699,0.00029405707,0.96218866,0.0007857727,0.000902137,0.00037897922],"about_ca_topic_score_codex":0.0003910921,"about_ca_topic_score_gemma":0.00005666585,"teacher_disagreement_score":0.06938372,"about_ca_system_score_codex":0.00002320112,"about_ca_system_score_gemma":0.000009504178,"threshold_uncertainty_score":0.47930282},"labels":[],"label_agreement":null},{"id":"W4319263057","doi":"10.1016/s2666-6367(23)00379-2","title":"A Portrait of Cord Blood Units Distributed from Canadian Blood Services’ Cord Blood Bank: First Analysis","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cord blood; Blood bank; Portrait; Medicine; Internal medicine; Emergency medicine; Art; Art history","score_opus":0.016916443020039237,"score_gpt":0.2153423351963516,"score_spread":0.19842589217631235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319263057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954738,0.000407674,0.00032937233,0.0008505137,0.00011856697,0.0002633453,0.0006044919,0.00015596139,0.0017962469],"genre_scores_gemma":[0.9886446,0.0032560867,0.00004316809,0.00083623256,0.00010050434,0.000017379536,0.0069879275,0.000026765834,0.00008731724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985761,0.00003181587,0.00042422404,0.00036380076,0.00032361053,0.0002804343],"domain_scores_gemma":[0.9991652,0.00009931788,0.0002433387,0.00021159618,0.00021195468,0.00006861297],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025662384,0.00023546295,0.00032495003,0.000692115,0.00029766798,0.00018760812,0.0002088268,0.00012661438,0.001177046],"category_scores_gemma":[0.000005528636,0.00023000863,0.000116373376,0.0026554447,0.000046880632,0.00055816653,0.000008450454,0.00013590162,0.000035550336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003094947,0.0024894737,0.86388063,0.0023004839,0.019575674,0.0018811957,0.0053841947,0.0007453508,0.050130688,0.026662137,0.00030811815,0.023547119],"study_design_scores_gemma":[0.027099214,0.00035072645,0.8017945,0.00031416793,0.030629408,0.000031823896,0.0032836788,0.0070644943,0.031230742,0.0018887413,0.09426369,0.002048775],"about_ca_topic_score_codex":0.08135969,"about_ca_topic_score_gemma":0.14238064,"teacher_disagreement_score":0.09395557,"about_ca_system_score_codex":0.000003323075,"about_ca_system_score_gemma":0.0000535877,"threshold_uncertainty_score":0.999736},"labels":[],"label_agreement":null},{"id":"W4319263092","doi":"10.1016/s2666-6367(23)00302-0","title":"Impact of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Peripheral Blood Progenitor Cell Collections in Canada","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Peripheral blood; 2019-20 coronavirus outbreak; Progenitor cell; Virology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Haematopoiesis; Immunology; Medicine; Hematopoietic cell; Progenitor; Biology; Stem cell; Pathology; Genetics; Disease; Infectious disease (medical specialty); Outbreak","score_opus":0.051257535245755936,"score_gpt":0.3321415772461172,"score_spread":0.28088404200036127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319263092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775666,0.0003811896,0.00002725151,0.00091955176,0.00008127872,0.0006486093,0.000056398956,0.00003841964,0.00009062616],"genre_scores_gemma":[0.9957211,0.0026888486,0.0000038984626,0.0010901972,0.000019616275,0.000025389896,0.000058548256,0.000016536826,0.00037588447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990319,0.00011680371,0.00024683017,0.00016812627,0.0002190611,0.00021727204],"domain_scores_gemma":[0.9994342,0.00013141782,0.00006072112,0.00014558443,0.000030281886,0.00019784429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000147478,0.00013074384,0.00020467813,0.00013241329,0.00013376161,0.000007787924,0.000054016575,0.00007569249,0.00010791444],"category_scores_gemma":[0.000012582731,0.00008878481,0.00008569773,0.00071021926,0.000034860597,0.000018197668,0.0000024652243,0.00017479912,0.0000014698413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011229231,0.00017943294,0.87566006,0.000449299,0.00010606611,0.00013372586,0.004548072,0.0009417642,0.11616558,0.000015072031,0.00022457723,0.00045339737],"study_design_scores_gemma":[0.015374617,0.0013284449,0.9357401,0.00017213344,0.000185795,0.00031299592,0.0007144713,0.00048494828,0.04434358,0.00011061636,0.0009156969,0.00031657526],"about_ca_topic_score_codex":0.3285485,"about_ca_topic_score_gemma":0.28400525,"teacher_disagreement_score":0.071822,"about_ca_system_score_codex":0.00034694117,"about_ca_system_score_gemma":0.003042042,"threshold_uncertainty_score":0.7290598},"labels":[],"label_agreement":null},{"id":"W4319264249","doi":"10.1016/s2666-6367(23)00553-5","title":"High Dose Total Marrow Irradiation (TMI) Does Not Increase the Risk of Long-Term Toxicity to Myeloablative Fludarabine/Busulfan Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Busulfan; Fludarabine; Regimen; Surgery; Retrospective cohort study; Transplantation; Hematopoietic stem cell transplantation; Emergency medicine; General surgery; Chemotherapy; Cyclophosphamide","score_opus":0.0132074456085375,"score_gpt":0.24390298216779774,"score_spread":0.23069553655926023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319264249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938315,0.00015994303,0.0033021108,0.00071076304,0.00008552505,0.0014366573,0.00027124517,0.00007241994,0.00012984316],"genre_scores_gemma":[0.99554515,0.0023232114,0.00016968942,0.00034324484,0.00003252759,0.000117155796,0.0010244615,0.000031528074,0.0004130304],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980233,0.00037992967,0.0005254541,0.00036842632,0.00044905188,0.0002538452],"domain_scores_gemma":[0.9990997,0.00022093943,0.00021441747,0.00025154118,0.00006223989,0.00015117205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007018328,0.00024495117,0.0003543453,0.00031163136,0.00013262773,0.0000347472,0.00009703153,0.00007597366,0.00012717482],"category_scores_gemma":[0.0000069498033,0.00017787771,0.00010161453,0.00045313,0.000078714475,0.00015476056,0.0000067475257,0.0001551125,0.000020062],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01747994,0.0011929558,0.15532605,0.0047048978,0.000830166,0.0012746747,0.06451797,0.007741135,0.7147006,0.001620781,0.00008609434,0.030524775],"study_design_scores_gemma":[0.0065816664,0.00028524493,0.8004471,0.00019568636,0.00038360714,0.000014762369,0.0011640859,0.00074696814,0.18980385,0.00013775851,0.0000050942863,0.00023417718],"about_ca_topic_score_codex":0.00016670903,"about_ca_topic_score_gemma":0.000064307285,"teacher_disagreement_score":0.64512104,"about_ca_system_score_codex":0.00003697027,"about_ca_system_score_gemma":0.00004734545,"threshold_uncertainty_score":0.7253642},"labels":[],"label_agreement":null},{"id":"W4321201295","doi":"10.1016/j.jtct.2023.02.014","title":"Elevated ADA2 Enzyme Activity at the Onset of Chronic Graft-versus-Host Disease in Children","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba; BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; University of British Columbia; Michael Smith Health Research BC; Arthritis Society","keywords":"Immunology; Immune system; Adenosine deaminase; Graft-versus-host disease; Medicine; Hematopoietic stem cell transplantation; Context (archaeology); Biomarker; Transplantation; Internal medicine; Biology; Adenosine","score_opus":0.011657672517541585,"score_gpt":0.24193280608978712,"score_spread":0.23027513357224555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321201295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586505,0.0034848768,0.00022892671,0.00012974354,0.00003226693,0.00016126702,0.00006507492,0.000010304113,0.000022519138],"genre_scores_gemma":[0.9908132,0.008197106,0.000002254868,0.000040124418,0.000046714973,0.00001241824,0.00065750035,0.000010469774,0.00022022985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994775,0.000068551875,0.000097792545,0.00015721294,0.00008078236,0.000118168435],"domain_scores_gemma":[0.9997721,0.000019228219,0.00003697863,0.00012400474,0.000011716047,0.00003602833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010219724,0.000088643435,0.00007403823,0.00003246444,0.000057959634,0.000005807151,0.00006681251,0.000048029353,0.000040128827],"category_scores_gemma":[0.0000020896216,0.00006773571,0.000041883926,0.00011796036,0.000050983246,0.0000035209323,0.000008783079,0.00004679385,0.000004219378],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017541657,0.000049003156,0.019246712,0.000023418499,0.00006532032,0.000010303421,0.00016726134,0.00039247092,0.977346,0.000018851104,0.00022783357,0.0006986763],"study_design_scores_gemma":[0.0026007502,0.0001687255,0.114259824,0.000014003943,0.000024163186,0.0000045107377,0.00001723999,0.00028108474,0.8817901,0.0000131022225,0.0007013004,0.00012522006],"about_ca_topic_score_codex":0.00006802263,"about_ca_topic_score_gemma":0.000037214093,"teacher_disagreement_score":0.09555591,"about_ca_system_score_codex":0.000006155672,"about_ca_system_score_gemma":0.000032072778,"threshold_uncertainty_score":0.2762182},"labels":[],"label_agreement":null},{"id":"W4323663940","doi":"10.1016/j.jtct.2023.03.005","title":"Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Children's Hospital; Wellcome Trust; National Cancer Institute; Bill and Melinda Gates Foundation","keywords":"Medicine; Immunology; Immunogenicity; Vaccination; Internal medicine; Population; Interquartile range; Antibody","score_opus":0.03830271334259059,"score_gpt":0.3009766478217383,"score_spread":0.26267393447914766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323663940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934336,0.0036452245,0.00011310198,0.00015179739,0.0002736731,0.0012172583,0.00012394326,0.00029063458,0.0007508003],"genre_scores_gemma":[0.90213525,0.09113406,0.00007210264,0.0005560655,0.0000952214,0.000080839185,0.00082623505,0.00010596359,0.004994277],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997555,0.00024582175,0.00045650054,0.00057708006,0.0006133458,0.00055220525],"domain_scores_gemma":[0.9989538,0.00008652898,0.00012147468,0.00047259874,0.00010234631,0.0002632459],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055122137,0.00036865496,0.0004986981,0.00032879342,0.00026662412,0.000057242374,0.00020739774,0.00021941795,0.0035451301],"category_scores_gemma":[0.000002460676,0.00032337927,0.00020744535,0.00080159295,0.00010800693,0.00018163462,0.000015962645,0.0003990638,0.0002974808],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048343157,0.0002182262,0.05111765,0.000064006315,0.00043552773,0.00041060988,0.001679782,0.000008506768,0.9108535,0.0000045480724,0.0002687497,0.030104594],"study_design_scores_gemma":[0.015893798,0.0017339365,0.47776332,0.000101028585,0.000086213025,0.00019571565,0.0001815529,0.000099534016,0.4804767,0.00003655643,0.022870172,0.0005614622],"about_ca_topic_score_codex":0.00011663334,"about_ca_topic_score_gemma":0.00000764098,"teacher_disagreement_score":0.43037677,"about_ca_system_score_codex":0.00006308633,"about_ca_system_score_gemma":0.00008967059,"threshold_uncertainty_score":0.9999218},"labels":[],"label_agreement":null},{"id":"W4361010814","doi":"10.1016/j.jtct.2023.03.024","title":"Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; SickKids Foundation; Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"Cancer Moonshot; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Legend Biotech; Sangamo Therapeutics; Astellas Pharma; Adaptive Biotechnologies; Kiadis Pharma; bluebird bio; TG Therapeutics; Jazz Pharmaceuticals; StemCyte; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; Leukemia and Lymphoma Society; Moonshot Research and Development Program; Sanofi; GlaxoSmithKline; Incyte; Pfizer; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Amgen; Mallinckrodt Pharmaceuticals; Astellas Pharma US","keywords":"Medicine; Quartile; Proportional hazards model; CD34; Hematopoietic stem cell transplantation; Autologous stem-cell transplantation; Oncology; Internal medicine; Transplantation; Surgery; Retrospective cohort study; Clinical endpoint; Stem cell; Clinical trial; Confidence interval; Biology","score_opus":0.013249870744490145,"score_gpt":0.2514878160864732,"score_spread":0.23823794534198306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361010814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762946,0.00038270213,0.00011336559,0.000047352474,0.00013797639,0.001445794,0.00007038188,0.00010520458,0.00006777128],"genre_scores_gemma":[0.9984442,0.0010006373,0.000017139635,0.000027775977,0.000021193038,0.00014063535,0.00029413478,0.000031975942,0.000022335276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863446,0.00011581155,0.00043532954,0.0002781831,0.00022399596,0.00031221088],"domain_scores_gemma":[0.9992764,0.00036395722,0.00010609264,0.00012878864,0.000020639225,0.000104127554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021499005,0.00022713385,0.00046193996,0.00028438756,0.00005918825,0.00001187504,0.000049222454,0.00009297876,0.0000039139254],"category_scores_gemma":[0.0000012199383,0.00016982836,0.00015687634,0.0002609551,0.000019120364,0.0000308914,0.000001763118,0.000080264384,0.000007938743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041166097,0.00082765374,0.96495575,0.010006163,0.00009859101,0.0006729353,0.005557293,0.00045786024,0.0043138308,0.00025770548,0.000010590876,0.008725011],"study_design_scores_gemma":[0.046102457,0.007851198,0.7352302,0.00080944924,0.0007072333,0.000046401605,0.00036649607,0.0018717269,0.20657443,0.000017402277,0.00001201363,0.00041100147],"about_ca_topic_score_codex":0.000022633965,"about_ca_topic_score_gemma":0.000008044323,"teacher_disagreement_score":0.22972557,"about_ca_system_score_codex":0.000045809447,"about_ca_system_score_gemma":0.00002662312,"threshold_uncertainty_score":0.69254},"labels":[],"label_agreement":null},{"id":"W4361201146","doi":"10.1016/j.jtct.2023.03.027","title":"HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Sanofi Genzyme; Takeda Oncology; Genentech; Health Resources and Services Administration; MorphoSys; Astellas Pharma; Adaptive Biotechnologies; Kiadis Pharma; bluebird bio; TG Therapeutics; Omeros Corporation; Vertex Pharmaceuticals; Medical College of Wisconsin; StemCyte; CSL Behring; St. Jude Children's Research Hospital; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; Servier; Gilead Sciences; AbbVie; Sanofi; GlaxoSmithKline; Bristol-Myers Squibb; Pharmacyclics; Agios Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Moderna; Incyte; Pfizer; Medac; Jazz Pharmaceuticals; Be The Match Foundation","keywords":"NPM1; Hazard ratio; Cumulative incidence; Internal medicine; Oncology; Hematopoietic stem cell transplantation; Transplantation; Myeloid leukemia; Medicine; Proportional hazards model; Human leukocyte antigen; Immunology; Genotype; Leukemia; Myeloid; Gastroenterology; Confidence interval; Biology; Genetics; Antigen; Gene","score_opus":0.015983639303900243,"score_gpt":0.2546206635783839,"score_spread":0.2386370242744837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361201146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990104,0.0006647875,0.0057943068,0.00039472568,0.00007621559,0.0015349156,0.00090650684,0.00028219816,0.0002423125],"genre_scores_gemma":[0.9587454,0.032125287,0.00036364235,0.00070140493,0.0000632793,0.0002902332,0.003659627,0.00011967582,0.003931443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977834,0.00018772931,0.00040740258,0.0005768465,0.00048899645,0.0005556207],"domain_scores_gemma":[0.99892807,0.00022599261,0.00015088177,0.00026460632,0.00019854443,0.00023189545],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004933822,0.00036143986,0.0004325777,0.0002978879,0.00023941671,0.000055819815,0.00012029132,0.00030667114,0.000106765976],"category_scores_gemma":[0.00000282159,0.00029308393,0.00014784522,0.00062814704,0.000111614834,0.00015286665,0.0000047637755,0.00038310653,0.00007397475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05056844,0.0003002976,0.021824371,0.0012849243,0.0027213034,0.0031207465,0.029722666,0.00033798584,0.8577089,0.00006260019,0.0014522343,0.030895578],"study_design_scores_gemma":[0.043913994,0.0030836107,0.10484307,0.00034639856,0.0025227885,0.0002859015,0.00087000703,0.009927394,0.8293226,0.00017042193,0.0035929764,0.001120844],"about_ca_topic_score_codex":0.000060889917,"about_ca_topic_score_gemma":0.00004858722,"teacher_disagreement_score":0.0830187,"about_ca_system_score_codex":0.00020676295,"about_ca_system_score_gemma":0.0002884637,"threshold_uncertainty_score":0.99995214},"labels":[],"label_agreement":null},{"id":"W4366607243","doi":"10.1016/j.jtct.2023.04.011","title":"Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Sierra Oncology; Incyte; Astex Pharmaceuticals; Astellas Pharma; TG Therapeutics; Karyopharm Therapeutics; Alexion Pharmaceuticals; Sunesis; Teva Pharmaceutical Industries; Bristol-Myers Squibb; AstraZeneca; Agios Pharmaceuticals","keywords":"Medicine; Myeloid leukemia; Transplantation; Myelodysplastic syndromes; Internal medicine; Disease registry; Comorbidity; Referral; Hematopoietic stem cell transplantation; Disease; Cancer registry; Myeloid; Cancer; Family medicine; Bone marrow","score_opus":0.020178349425369124,"score_gpt":0.2748081163798595,"score_spread":0.2546297669544904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366607243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947673,0.0004010637,0.0006088804,0.00083303766,0.000052057185,0.0019586538,0.001292338,0.000073884854,0.000012771856],"genre_scores_gemma":[0.98025084,0.014253434,0.000087278284,0.00048777222,0.000045416116,0.0002602063,0.0044977847,0.000049981598,0.00006731108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803966,0.00043662995,0.00030021253,0.00041267526,0.00040304541,0.00040775738],"domain_scores_gemma":[0.99861526,0.0005312135,0.00008859351,0.0002620807,0.00007110353,0.00043172823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034125432,0.00030980137,0.0003315126,0.00023079777,0.0006630504,0.00006367498,0.00016047482,0.00016031538,0.000019748266],"category_scores_gemma":[0.000034210963,0.00022438339,0.000051662857,0.0002990209,0.00016457634,0.00015920954,0.000016702881,0.0006275337,0.000002722785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034669694,0.00011310905,0.8374869,0.0025567675,0.0004268934,0.0010742717,0.08413879,0.00025898966,0.030272743,0.00006908196,0.00016099015,0.008771729],"study_design_scores_gemma":[0.019830314,0.0014572592,0.9700449,0.00029699865,0.00053854793,0.000076928154,0.004815882,0.0004955122,0.0018634326,0.000052676114,0.00015562789,0.00037191086],"about_ca_topic_score_codex":0.0002666032,"about_ca_topic_score_gemma":0.00021613498,"teacher_disagreement_score":0.13255797,"about_ca_system_score_codex":0.000116733514,"about_ca_system_score_gemma":0.00013501852,"threshold_uncertainty_score":0.9150089},"labels":[],"label_agreement":null},{"id":"W4377195290","doi":"10.1016/j.jtct.2023.05.013","title":"Impact of Public Reporting of Center-Specific Survival Analysis Scores on Patient Volumes at Hematopoietic Cell Transplant Centers","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Patient Satisfaction in Healthcare","field":"Health Professions","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"National Cancer Institute","keywords":"Medicine; Hematopoietic cell; Single Center; Transplantation; Hematopoietic stem cell transplantation; Internal medicine; Survival analysis; Surgery; Pediatrics; Haematopoiesis; Stem cell","score_opus":0.110565337782545,"score_gpt":0.38251080814725785,"score_spread":0.27194547036471284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377195290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971121,0.00027873061,0.00065489236,0.00009004426,0.000323489,0.0006092229,0.00052030536,0.00008095705,0.0003302923],"genre_scores_gemma":[0.9933738,0.0054171244,0.000024206618,0.00002918606,0.000018026174,0.000042339707,0.0010006008,0.000027223308,0.000067477245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99634594,0.00066349166,0.0017735796,0.00033676415,0.0004711352,0.00040909156],"domain_scores_gemma":[0.9975131,0.00035526784,0.0015116151,0.0002935515,0.0001656485,0.00016083015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006751261,0.0002107004,0.00056753715,0.00055106514,0.0003180954,0.0000058079513,0.00009092154,0.0001339794,0.00039535586],"category_scores_gemma":[0.0000112811,0.00017391666,0.00031574318,0.00079221104,0.00007155041,0.00008118958,0.000008224161,0.00021484261,0.000020659334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053549494,0.00008928514,0.966223,0.0005588234,0.00022962026,0.000015832873,0.015290175,0.00019668644,0.015218449,0.00006700306,0.000042459047,0.0015331452],"study_design_scores_gemma":[0.0019887679,0.00044956713,0.98280233,0.00023427274,0.000080609585,0.0000022750257,0.0015307866,0.00025660478,0.01237911,0.000025368807,0.000070918,0.00017940126],"about_ca_topic_score_codex":0.0004252282,"about_ca_topic_score_gemma":0.00014959714,"teacher_disagreement_score":0.016579293,"about_ca_system_score_codex":0.00010047801,"about_ca_system_score_gemma":0.00007602893,"threshold_uncertainty_score":0.7092115},"labels":[],"label_agreement":null},{"id":"W4379145009","doi":"10.1016/j.jtct.2023.05.020","title":"Serious Stem Cell Donation Events and Recipient Adverse Reactions Related to Severe Acute Respiratory Syndrome Coronavirus 2: Review of Reports to the World Marrow Donor Association","year":2023,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Héma-Québec","funders":"","keywords":"Donation; Adverse effect; Medicine; Transplantation; Pandemic; Intensive care medicine; Hematopoietic stem cell transplantation; Stem cell; Coronavirus disease 2019 (COVID-19); Surgery; Internal medicine; Biology; Disease; Infectious disease (medical specialty)","score_opus":0.04537334388549042,"score_gpt":0.3365159270234865,"score_spread":0.29114258313799607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379145009","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047265757,0.98809683,0.00005774893,0.0025544423,0.00050669233,0.003665925,0.00017220662,0.000066978144,0.00015259623],"genre_scores_gemma":[0.0006186715,0.9910485,0.000046509584,0.0007957322,0.000032723736,0.00016154152,0.0007452122,0.000049789025,0.0065012854],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99732023,0.0003581496,0.0010970869,0.0004266328,0.0006153933,0.0001824956],"domain_scores_gemma":[0.9984393,0.00018111154,0.00071920187,0.00030130538,0.00016251882,0.00019653665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016476533,0.00027901304,0.00086921896,0.00029959725,0.00013804136,0.000012108319,0.000069842965,0.0003786834,0.000054793607],"category_scores_gemma":[0.00001178543,0.00019227642,0.00021050964,0.00086726004,0.00004429448,0.00005874036,0.000013681539,0.00044866872,0.000024380484],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024722924,0.00016616212,0.0000845762,0.08685997,0.0010940172,0.00036440883,0.0012188968,0.000005926374,0.00058738486,0.00012008954,0.000976038,0.9082753],"study_design_scores_gemma":[0.0008134227,0.00028754672,0.001079428,0.054557282,0.0018440599,0.00038881254,0.000029911444,0.0000039348934,0.000074488205,0.00004408154,0.94059014,0.0002868839],"about_ca_topic_score_codex":0.000023985966,"about_ca_topic_score_gemma":0.000033210243,"teacher_disagreement_score":0.9396141,"about_ca_system_score_codex":0.00017789296,"about_ca_system_score_gemma":0.00017004157,"threshold_uncertainty_score":0.78408045},"labels":[],"label_agreement":null},{"id":"W4380234055","doi":"10.1016/j.jtct.2023.06.007","title":"Leukapheresis and Tisagenlecleucel Manufacturing Outcomes in Patients Age <3 Years with Relapsed/Refractory Acute Lymphoblastic Leukemia","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"Novartis Pharmaceuticals Corporation","keywords":"Leukapheresis; Medicine; Blinatumomab; Leukemia; Lymphoblastic Leukemia; Immunology; Stem cell","score_opus":0.01585269188541878,"score_gpt":0.25388425744362353,"score_spread":0.23803156555820476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380234055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99862003,0.00019775891,0.00005540608,0.000056429268,0.00004234722,0.00046498125,0.000017556604,0.00008088146,0.00046460552],"genre_scores_gemma":[0.99057347,0.005974123,0.00006772849,0.00015357466,0.00001725036,0.000025155752,0.00016929068,0.000047212692,0.0029722254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878544,0.0000663697,0.00020420746,0.00030916242,0.0003482668,0.00028654208],"domain_scores_gemma":[0.9995525,0.0000948939,0.000039778337,0.00016692866,0.000018387811,0.00012755218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014697471,0.00018550175,0.00028323173,0.00025525445,0.00006315201,0.000036758007,0.000057817597,0.00009813706,0.00023848358],"category_scores_gemma":[0.0000020705663,0.00015178142,0.000052722913,0.0001850128,0.000086197564,0.000095399446,0.0000075845674,0.00017430139,0.000024248795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0127965445,0.00040604587,0.44601142,0.00049938186,0.0010076271,0.0036705914,0.010891954,0.0000740094,0.33951074,0.00004311847,0.00011154852,0.18497702],"study_design_scores_gemma":[0.013921883,0.00067234965,0.95258003,0.00009412645,0.000075678596,0.000019166257,0.00012839965,0.000077799035,0.03155514,0.000041186267,0.00062402367,0.00021021352],"about_ca_topic_score_codex":0.00009257146,"about_ca_topic_score_gemma":0.00006827865,"teacher_disagreement_score":0.5065686,"about_ca_system_score_codex":0.00008472265,"about_ca_system_score_gemma":0.000051188345,"threshold_uncertainty_score":0.6189467},"labels":[],"label_agreement":null},{"id":"W4382700748","doi":"10.1016/j.jtct.2023.06.019","title":"Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"Coins for Alzheimer's Research Trust; Swedish Orphan Biovitrum; Government of South Australia; Juno Therapeutics; Novartis; NIH Clinical Center; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Cart; Chimeric antigen receptor; Medicine; CD19; Internal medicine; Antigen; T cell; Immunology; Oncology; Immune system","score_opus":0.020929212730782583,"score_gpt":0.28457628878529995,"score_spread":0.26364707605451737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382700748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98920655,0.003167348,0.000879049,0.001743166,0.00042691987,0.0028486182,0.00023771505,0.00038854752,0.0011020706],"genre_scores_gemma":[0.7574631,0.21095058,0.0020451322,0.0024189362,0.0007256603,0.00036709307,0.004500963,0.00035585059,0.02117267],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99707687,0.00021972293,0.0005125848,0.00077923026,0.0006315089,0.0007800567],"domain_scores_gemma":[0.99858475,0.00022824718,0.00014777502,0.0004829116,0.0002011135,0.00035523085],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059566466,0.00049907656,0.0006129848,0.0004409093,0.00034690002,0.000105973886,0.00025473733,0.0002813196,0.00554263],"category_scores_gemma":[0.000006689229,0.00043545756,0.0003531191,0.00086737453,0.0001666978,0.00017065632,0.0000119081515,0.00035824196,0.0007349366],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038361475,0.00026126532,0.0010896239,0.0002022204,0.00024270047,0.000038615108,0.004238713,0.0000063240386,0.94443876,0.000029826057,0.0022308829,0.043384943],"study_design_scores_gemma":[0.007982999,0.0016108028,0.0027311516,0.000058527105,0.00003797606,0.00002239691,0.00072116486,0.00011708453,0.80790496,0.00005061907,0.17830284,0.0004594924],"about_ca_topic_score_codex":0.00012439572,"about_ca_topic_score_gemma":0.000007782056,"teacher_disagreement_score":0.23174345,"about_ca_system_score_codex":0.00004287011,"about_ca_system_score_gemma":0.00018647184,"threshold_uncertainty_score":0.99980974},"labels":[],"label_agreement":null},{"id":"W4382932713","doi":"10.1016/j.jtct.2023.06.020","title":"Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid Leukemia","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; TG Therapeutics; Jazz Pharmaceuticals; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; StemCyte; Bristol-Myers Squibb; AstraZeneca; CSL Behring; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Amgen; Mallinckrodt Pharmaceuticals; Astellas Pharma US","keywords":"Medicine; Hazard ratio; Cumulative incidence; Transplantation; Myeloid leukemia; Internal medicine; Cohort; Hematopoietic stem cell transplantation; Hematopoietic cell; Surgery; Incidence (geometry); Retrospective cohort study; Confidence interval; Graft-versus-host disease; Haematopoiesis; Stem cell","score_opus":0.014020429118387346,"score_gpt":0.28286693127397733,"score_spread":0.26884650215559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382932713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977409,0.00014611417,0.00045816595,0.00014094755,0.000023478091,0.00095059024,0.00007988014,0.00007620972,0.00038368357],"genre_scores_gemma":[0.98641866,0.011970546,0.00015719047,0.00011424656,0.000016070493,0.000065443084,0.000775472,0.00004806115,0.00043433],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99846846,0.000095227384,0.00034697112,0.000354022,0.00039082702,0.0003444713],"domain_scores_gemma":[0.99939007,0.000119474156,0.00008023752,0.00022439675,0.000049182894,0.0001366459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002096763,0.00026708475,0.00044123107,0.00043332615,0.000050557803,0.000016490732,0.000096363394,0.0001374926,0.00009074547],"category_scores_gemma":[0.0000014645223,0.00018549415,0.00013346536,0.00048728616,0.00008636956,0.00008683177,0.000002969688,0.00024894436,0.00002811764],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03268531,0.0008015557,0.33179772,0.0021905114,0.0008053781,0.0068434584,0.036082163,0.000731831,0.57764417,0.00010109767,0.00007954743,0.010237277],"study_design_scores_gemma":[0.020434735,0.001605187,0.8094896,0.00034191928,0.00013509288,0.00014641417,0.00036293085,0.00024147198,0.16695279,0.000024828129,0.000008711288,0.00025632596],"about_ca_topic_score_codex":0.00027099825,"about_ca_topic_score_gemma":0.00005610122,"teacher_disagreement_score":0.4776919,"about_ca_system_score_codex":0.0001260298,"about_ca_system_score_gemma":0.00019442334,"threshold_uncertainty_score":0.7564232},"labels":[],"label_agreement":null},{"id":"W4383226811","doi":"10.1016/j.jtct.2023.06.012","title":"ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Transplantation; ThioTEPA; Oncology; Lymphoma; Rituximab; Hematopoietic cell; Chimeric antigen receptor; Salvage therapy; Internal medicine; CHOP; Chemotherapy; Cancer; Haematopoiesis; Immunotherapy; Stem cell; Cyclophosphamide","score_opus":0.06321421224880473,"score_gpt":0.3757907171074914,"score_spread":0.31257650485868665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383226811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98258066,0.0020606434,0.008002174,0.004562314,0.00018806725,0.0014879173,0.00014863983,0.000136216,0.0008333629],"genre_scores_gemma":[0.8762243,0.11710369,0.0016386715,0.0011012877,0.00015499581,0.00018958408,0.0016088532,0.00007482001,0.0019038157],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978411,0.00035813628,0.0005820601,0.00048802458,0.00031446642,0.00041617945],"domain_scores_gemma":[0.9984254,0.0009630198,0.00010932622,0.00022118472,0.00010568208,0.00017534655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015301215,0.00024660048,0.00038000185,0.00032580402,0.00019636152,0.00007075508,0.000084459556,0.00020212495,0.0001965152],"category_scores_gemma":[0.000021823489,0.00022718539,0.00013081581,0.00039892757,0.00009683022,0.00024792567,0.0000060302755,0.00022039599,0.000021010534],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020890525,0.007194937,0.012726423,0.0016080634,0.0005128767,0.00064919854,0.040060144,0.0000057135007,0.5521014,0.0017241698,0.000827255,0.36169934],"study_design_scores_gemma":[0.25119445,0.004154929,0.05333885,0.0005261868,0.0007803914,0.00036188005,0.011766059,0.0060064546,0.2709965,0.0016540774,0.39767006,0.0015501465],"about_ca_topic_score_codex":0.00005434518,"about_ca_topic_score_gemma":0.000045185727,"teacher_disagreement_score":0.3968428,"about_ca_system_score_codex":0.00003012538,"about_ca_system_score_gemma":0.00007862707,"threshold_uncertainty_score":0.9264351},"labels":[],"label_agreement":null},{"id":"W4383742862","doi":"10.1016/j.jtct.2023.07.007","title":"Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Hemorrhagic cystitis; Medicine; Busulfan; Internal medicine; Anti-thymocyte globulin; Cumulative incidence; Transplantation; Gastroenterology; Hazard ratio; Cyclophosphamide; Hematopoietic stem cell transplantation; BK virus; Graft-versus-host disease; Surgery; Chemotherapy; Kidney transplantation; Confidence interval","score_opus":0.009778044169796824,"score_gpt":0.23744384972689908,"score_spread":0.22766580555710225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383742862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950979,0.0018196893,0.00091783016,0.0004989585,0.00020900866,0.0006432513,0.00032625854,0.00021518549,0.00027195876],"genre_scores_gemma":[0.9447337,0.051488567,0.000105908955,0.00048609442,0.00010546564,0.00006297991,0.002745296,0.00005479444,0.00021718559],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99838054,0.00010054916,0.00040773346,0.00046550436,0.00031422515,0.0003314503],"domain_scores_gemma":[0.9993138,0.00011680358,0.0000984991,0.00016478384,0.0000554382,0.0002506889],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013681999,0.00033192534,0.00034429488,0.00031134544,0.00018277182,0.000056269477,0.000054557186,0.0002142347,0.00011949591],"category_scores_gemma":[0.0000021575772,0.00029105687,0.00010056098,0.00026906555,0.0001051533,0.00017162622,0.0000029160344,0.00024591314,0.000092042814],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025731904,0.0010164143,0.063141786,0.006039318,0.0006880185,0.0083627505,0.025631031,0.0003874482,0.7466167,0.00046522586,0.00005169469,0.12186771],"study_design_scores_gemma":[0.008558112,0.0011798419,0.78057426,0.0005142215,0.00092864776,0.0005788574,0.00042866796,0.000106756284,0.20612918,0.00029963485,0.00016767446,0.00053412607],"about_ca_topic_score_codex":0.00020179196,"about_ca_topic_score_gemma":0.000019611703,"teacher_disagreement_score":0.7174325,"about_ca_system_score_codex":0.000028201672,"about_ca_system_score_gemma":0.000044094057,"threshold_uncertainty_score":0.99995416},"labels":[],"label_agreement":null},{"id":"W4385074099","doi":"10.1016/j.jtct.2023.07.013","title":"Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Pharmacyclics; Sanofi Genzyme; Takeda Oncology; Genentech; Health Resources and Services Administration; MorphoSys; Adaptive Biotechnologies; Astellas Pharma; bluebird bio; Kiadis Pharma; Omeros Corporation; Pfizer; Incyte; Medac; Jazz Pharmaceuticals; StemCyte; Bristol-Myers Squibb; CSL Behring; Karyopharm Therapeutics; CareDx; Actinium Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Amgen; Accenture; Sanofi; GlaxoSmithKline; Seagen; Astellas Pharma US","keywords":"Medicine; Transplantation; Population; Demography; Socioeconomic status; Hematopoietic stem cell transplantation; Ethnic group; Hematopoietic cell; Cohort; Gerontology; Internal medicine; Haematopoiesis; Stem cell; Environmental health","score_opus":0.017621134823836117,"score_gpt":0.2841672491203169,"score_spread":0.2665461142964808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385074099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766266,0.00044470612,0.0009588996,0.00033782216,0.000033069795,0.0004010285,0.000042455693,0.000043191092,0.00007615737],"genre_scores_gemma":[0.9805722,0.018377753,0.0000414828,0.000118665484,0.000018563805,0.00004412095,0.0005643954,0.000022765818,0.00024002064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987486,0.00011310458,0.00033984275,0.00031722503,0.00019860864,0.0002826026],"domain_scores_gemma":[0.9995526,0.0001745017,0.000045115896,0.000118668526,0.00001683914,0.00009229399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031769183,0.00017508614,0.00041316936,0.0006230728,0.00005067052,0.00003619234,0.000059963786,0.00012895538,0.00009904639],"category_scores_gemma":[0.0000021382953,0.00015973949,0.000086559165,0.00038196633,0.000094797004,0.0001012264,0.0000048184393,0.0001473514,0.000023841792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006865367,0.000091350536,0.9816716,0.00049130386,0.0001518314,0.00034001586,0.006457583,0.000053781627,0.009070219,0.000053204287,0.0000017128326,0.00093090045],"study_design_scores_gemma":[0.006901245,0.0000993533,0.9850652,0.000044954075,0.00019548068,0.000017143257,0.00027512395,0.0005275657,0.006634527,0.00007123314,0.0000022512056,0.00016588462],"about_ca_topic_score_codex":0.00045331987,"about_ca_topic_score_gemma":0.0017290439,"teacher_disagreement_score":0.017933046,"about_ca_system_score_codex":0.000072149305,"about_ca_system_score_gemma":0.00006987664,"threshold_uncertainty_score":0.6513987},"labels":[],"label_agreement":null},{"id":"W4385077092","doi":"10.1016/j.jtct.2023.07.015","title":"Younger Matched Unrelated Donors Confer Decreased Relapse Risk Compared to Older Sibling Donors in Older Patients with B Cell Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; TG Therapeutics; Medac; Jazz Pharmaceuticals; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; StemCyte; Bristol-Myers Squibb; AstraZeneca; CSL Behring; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Amgen; Mallinckrodt Pharmaceuticals; Astellas Pharma US","keywords":"Medicine; Hazard ratio; Cumulative incidence; Transplantation; Internal medicine; Cohort; Sibling; Retrospective cohort study; Hematopoietic stem cell transplantation; Confidence interval; Hematopoietic cell; Graft-versus-host disease; Leukemia; Surgery; Incidence (geometry); Cohort study; Haematopoiesis; Stem cell","score_opus":0.009848070875793475,"score_gpt":0.2380813251257432,"score_spread":0.22823325424994972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385077092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98000824,0.000160407,0.017185474,0.0001313301,0.00010306266,0.0018649043,0.00010029205,0.00021435514,0.00023192327],"genre_scores_gemma":[0.98973227,0.0065419273,0.0007117246,0.0004515456,0.000026668786,0.00012756608,0.0019243112,0.00012975426,0.0003542155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99678427,0.00025685466,0.0006952923,0.0007753074,0.0007493273,0.00073892414],"domain_scores_gemma":[0.998301,0.00047318978,0.00017675845,0.00034003743,0.00017235184,0.00053663185],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003694021,0.00051456026,0.00061332487,0.0008190328,0.00021101178,0.00008614594,0.00017209115,0.00028758697,0.00017558331],"category_scores_gemma":[0.000010815819,0.00043549258,0.00011276889,0.0012882479,0.00010695945,0.00023824107,0.000012162358,0.00037195932,0.00012972449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034164295,0.0017320812,0.53054565,0.0033833024,0.0011035523,0.0031465567,0.05594617,0.020573767,0.34750438,0.000059419366,0.00029575796,0.0015450482],"study_design_scores_gemma":[0.13505757,0.0014197056,0.614027,0.0018918818,0.0017264863,0.00017467902,0.0025335439,0.01170374,0.22966124,0.00008151672,0.000054704415,0.0016679255],"about_ca_topic_score_codex":0.0004891275,"about_ca_topic_score_gemma":0.00017867815,"teacher_disagreement_score":0.117843136,"about_ca_system_score_codex":0.00045785218,"about_ca_system_score_gemma":0.00065730937,"threshold_uncertainty_score":0.9998097},"labels":[],"label_agreement":null},{"id":"W4385351242","doi":"10.1016/j.jtct.2023.07.021","title":"Pilot Study of Donor-Engrafted Clonal Hematopoiesis Evolution and Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation Recipients Using a National Registry","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; U.S. Navy; Health Resources and Services Administration; MorphoSys; BeiGene; Astellas Pharma; Adaptive Biotechnologies; Kiadis Pharma; bluebird bio; TG Therapeutics; Jazz Pharmaceuticals; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; StemCyte; Bentham-Moxon Trust; HistoGenetics; U.S. Department of Defense; Moffitt Cancer Center; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen; Actinium Pharmaceuticals; CareDx; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Incyte; Pfizer; Comprehensive Cancer Center, City of Hope; American Cancer Society; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences","keywords":"Medicine; Transplantation; Internal medicine; Sibling; Hematopoietic stem cell transplantation; Haematopoiesis; Myeloid; Oncology; Bone marrow; Immunology; Stem cell; Biology","score_opus":0.06768955839996793,"score_gpt":0.3318854805210957,"score_spread":0.26419592212112775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385351242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958646,0.0002260566,0.0022389444,0.00007800458,0.00014745026,0.001173114,0.00005962591,0.00008232,0.0001298774],"genre_scores_gemma":[0.9960118,0.0029379819,0.0005233,0.00005910087,0.000028490904,0.000046700985,0.00028412743,0.00003872798,0.00006980509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997211,0.00030983193,0.0010328996,0.00051335024,0.0006579461,0.0002750136],"domain_scores_gemma":[0.99892515,0.00038714404,0.0002283795,0.00018730023,0.00013084384,0.00014116749],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00090479193,0.00028510529,0.000592503,0.00049960415,0.00010908888,0.000022881271,0.000082359904,0.00012728448,0.000027432943],"category_scores_gemma":[0.000015161494,0.00026885097,0.000094065275,0.0005605725,0.000117985874,0.0001443911,0.00000608448,0.00022262713,0.0000067035253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025795577,0.0018805169,0.9123468,0.0009634056,0.000176173,0.00018361807,0.004989932,0.00014934708,0.07635735,0.00013535611,0.0000045644215,0.00023339872],"study_design_scores_gemma":[0.01590191,0.0016469664,0.9677572,0.00033736165,0.00033595468,0.0002134012,0.0015875207,0.0010642876,0.010592595,0.0002553572,0.0000035295845,0.00030388977],"about_ca_topic_score_codex":0.00029981395,"about_ca_topic_score_gemma":0.00018018472,"teacher_disagreement_score":0.065764755,"about_ca_system_score_codex":0.00005718608,"about_ca_system_score_gemma":0.0001160996,"threshold_uncertainty_score":0.9999764},"labels":[],"label_agreement":null},{"id":"W4385494067","doi":"10.1016/j.jtct.2023.07.024","title":"Financial Hardship in Childhood Cancer Survivors Treated with Hematopoietic Cell Transplantation: A Report from the Childhood Cancer Survivor Study","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Finance; Childhood cancer; Logistic regression; Medicine; Confidence interval; Population; Sibling; Demography; Cancer; Psychology; Gerontology; Internal medicine; Developmental psychology; Environmental health; Economics","score_opus":0.02332530855306462,"score_gpt":0.2823294569169502,"score_spread":0.2590041483638856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385494067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914487,0.0027901295,0.00014704831,0.0023981882,0.00024110646,0.002182966,0.00038065505,0.00023540862,0.00017580991],"genre_scores_gemma":[0.98411286,0.012791644,0.000029690553,0.0010251674,0.00028521862,0.00051054265,0.0009183009,0.00008692113,0.00023964442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967158,0.00042374476,0.0007712955,0.00080537784,0.0008041477,0.00047965103],"domain_scores_gemma":[0.99872833,0.0003046276,0.00023100793,0.00047961398,0.00009421101,0.00016219771],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076853257,0.00047760637,0.0006974597,0.00019151876,0.00025883567,0.00007106078,0.00019856839,0.00016286531,0.00024677406],"category_scores_gemma":[0.000009576399,0.00034316044,0.00013444669,0.0010323944,0.0001158364,0.00015371152,0.000007776143,0.00044674356,0.000016606165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023098388,0.001310624,0.88811266,0.00026189777,0.00031350032,0.0017841004,0.10133779,0.00013041415,0.001467285,0.000017581611,0.00009801974,0.002856287],"study_design_scores_gemma":[0.012052965,0.00042523586,0.9733633,0.00046436174,0.00039257293,0.000108863824,0.0035506852,0.000021270982,0.008834755,0.000065714274,0.00026377983,0.00045648546],"about_ca_topic_score_codex":0.033681203,"about_ca_topic_score_gemma":0.05615026,"teacher_disagreement_score":0.097787105,"about_ca_system_score_codex":0.000053602347,"about_ca_system_score_gemma":0.00037489625,"threshold_uncertainty_score":0.99990207},"labels":[],"label_agreement":null},{"id":"W4385777563","doi":"10.1016/j.jtct.2023.08.009","title":"Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic Syndrome","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Princess Margaret Hospital Foundation","keywords":"Medicine; Incidence (geometry); Transplantation; Myeloid leukemia; Univariate analysis; Internal medicine; Surgery; Graft-versus-host disease; Hematopoietic stem cell transplantation; Retrospective cohort study; Myeloid; Gastroenterology; Multivariate analysis","score_opus":0.041071983829680324,"score_gpt":0.3277367237472593,"score_spread":0.286664739917579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385777563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951761,0.0008091273,0.0023698003,0.00031872702,0.000111186,0.0010150397,0.00004953064,0.00009331152,0.000057214093],"genre_scores_gemma":[0.9820853,0.016433317,0.0006781975,0.00008641228,0.000018726809,0.000042504806,0.0005221545,0.00005888039,0.000074516196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967896,0.0002472203,0.0015703969,0.00060485816,0.00037627292,0.0004116861],"domain_scores_gemma":[0.99848604,0.0008022086,0.00025595145,0.00019710902,0.000046866942,0.00021183738],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00081638084,0.00039553997,0.0013222059,0.00062791526,0.00007961407,0.000040407507,0.0000900697,0.0003921767,0.000035412002],"category_scores_gemma":[0.000006314684,0.00036515747,0.000111849775,0.0006477978,0.00016662815,0.0002087622,0.000007893363,0.00043210314,0.000010448944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009908741,0.00015092817,0.93261945,0.0021730233,0.00020896003,0.0004997405,0.013792788,0.000121323166,0.04826313,0.000026217529,0.000001277105,0.0011523049],"study_design_scores_gemma":[0.014085468,0.00028526835,0.94881964,0.0008552058,0.0005463814,0.00025463977,0.0011236253,0.00093884434,0.032641675,0.00008448504,0.0000040013406,0.0003607568],"about_ca_topic_score_codex":0.00013717866,"about_ca_topic_score_gemma":0.000057969417,"teacher_disagreement_score":0.016200218,"about_ca_system_score_codex":0.000037809885,"about_ca_system_score_gemma":0.00009525008,"threshold_uncertainty_score":0.99988},"labels":[],"label_agreement":null},{"id":"W4385788680","doi":"10.1016/j.jtct.2023.08.008","title":"Immunogenicity and Safety of Booster SARS-CoV-2 mRNA Vaccine Dose in Allogeneic Hematopoietic Stem Cell Transplantation Recipients","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Public Health Agency; Public Health Agency of Canada","keywords":"Medicine; Immunogenicity; Hematopoietic stem cell transplantation; Internal medicine; Booster dose; Transplantation; Population; Immunology; Univariate analysis; Adverse effect; Titer; Antibody; Multivariate analysis","score_opus":0.03783581721152567,"score_gpt":0.3075975760535613,"score_spread":0.2697617588420356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385788680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630105,0.0020781904,0.0002803391,0.00011076381,0.000074004856,0.0006750641,0.0000378824,0.000052346164,0.00039037535],"genre_scores_gemma":[0.9903369,0.0076038577,0.0000350536,0.0018162279,0.00002279563,0.000030223378,0.00009032046,0.00003057149,0.000034052515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842525,0.00013330072,0.00048152683,0.00034597123,0.0003274309,0.0002865268],"domain_scores_gemma":[0.9995226,0.000098116994,0.00008111526,0.00019766453,0.000066275934,0.000034196542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004436374,0.00020910079,0.00036743324,0.0003204381,0.00006962624,0.000018928551,0.000086812,0.00014109554,0.000008529077],"category_scores_gemma":[0.0000018533964,0.00018436498,0.00008305025,0.00043303033,0.000056509703,0.00008573994,0.000007383537,0.00017787445,0.000016059626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055118096,0.00014336324,0.050630584,0.0007008878,0.00005738998,0.00015278338,0.005189159,0.0000015681675,0.931135,0.0000333629,0.000008362228,0.006435732],"study_design_scores_gemma":[0.0100146085,0.00030112115,0.08490281,0.00017557573,0.00006677196,0.000054407832,0.00021352367,0.00013159834,0.9030014,0.00006616128,0.0009016438,0.00017035258],"about_ca_topic_score_codex":0.00012521344,"about_ca_topic_score_gemma":0.000064567364,"teacher_disagreement_score":0.034272224,"about_ca_system_score_codex":0.00002684163,"about_ca_system_score_gemma":0.000052823347,"threshold_uncertainty_score":0.75181854},"labels":[],"label_agreement":null},{"id":"W4386609802","doi":"10.1016/j.jtct.2023.09.005","title":"Consolidative Autotransplantation Achieves High Cure Rates in Adverse-Risk Large B Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Autologous stem-cell transplantation; International Prognostic Index; Salvage therapy; Diffuse large B-cell lymphoma; Transplantation; Retrospective cohort study; Oncology; Lymphoma; Chemotherapy","score_opus":0.011949575277734369,"score_gpt":0.25717679271407673,"score_spread":0.24522721743634235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386609802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969459,0.00081965374,0.0002709419,0.0003839066,0.000086318214,0.00052601576,0.0002430749,0.00012323275,0.00060096115],"genre_scores_gemma":[0.9562746,0.041296992,0.0001227047,0.00023075612,0.00003254719,0.00007763955,0.0016229096,0.000022351607,0.00031948127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988865,0.00011475542,0.00025506548,0.0002981716,0.00018674262,0.00025875418],"domain_scores_gemma":[0.9995603,0.00012219284,0.00007419063,0.00011852248,0.000030508918,0.000094287076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017652301,0.00020228139,0.0002590949,0.00019521402,0.00011832282,0.000018471845,0.00003911027,0.000104668274,0.00010021239],"category_scores_gemma":[0.0000016963198,0.00016543189,0.00007205454,0.00030152418,0.000043479795,0.000113073766,0.000002564458,0.00007065831,0.000116858784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00615396,0.0043565617,0.84921616,0.0008628733,0.0005464697,0.0029153528,0.033939816,0.00015710211,0.06484881,0.0041947165,0.00042356487,0.032384608],"study_design_scores_gemma":[0.03534864,0.0004108269,0.7449419,0.00014046587,0.00018534147,0.00003475033,0.00096975174,0.00063314714,0.21549016,0.00026018795,0.0013320429,0.0002527705],"about_ca_topic_score_codex":0.0001841131,"about_ca_topic_score_gemma":0.00006562594,"teacher_disagreement_score":0.15064135,"about_ca_system_score_codex":0.00003637293,"about_ca_system_score_gemma":0.000054047745,"threshold_uncertainty_score":0.6746117},"labels":[],"label_agreement":null},{"id":"W4386806936","doi":"10.1016/j.jtct.2023.08.024","title":"Corrigendum to’ UM171 expansion of cord blood improves donor availability and HLA matching for all patients, including minorities’ [Transplantation and Cellular Therapy 28/7 (2022) 410-410","year":2023,"lang":"en","type":"erratum","venue":"Transplantation and Cellular Therapy","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Human leukocyte antigen; Matching (statistics); Medicine; Transplantation; Cord blood; Surgery; Internal medicine; Immunology; Pathology; Antigen","score_opus":0.04545560470517668,"score_gpt":0.3042861715218077,"score_spread":0.258830566816631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386806936","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654732,0.009022524,0.015276077,0.00027953702,0.004750613,0.0033463754,0.0015035932,0.00016754412,0.00018057328],"genre_scores_gemma":[0.43426317,0.49753374,0.018084472,0.00211313,0.0014381651,0.0007602154,0.026618747,0.00063934753,0.018549021],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963995,0.00027393884,0.001113228,0.001052608,0.000615524,0.00054519303],"domain_scores_gemma":[0.99820256,0.0004055238,0.00042807352,0.00037867748,0.00026160694,0.00032355037],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00082088244,0.0007687485,0.0012164632,0.00047415565,0.00034373804,0.00010088382,0.00016408964,0.00064564554,0.00005387567],"category_scores_gemma":[0.00001629061,0.0006859801,0.00024901287,0.00025745636,0.00018470036,0.0002313446,0.00001537918,0.00056208204,0.0000023478278],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022143424,0.00089845655,0.022586292,0.025740538,0.0019521716,0.00022100512,0.0521817,0.000004398242,0.75125974,0.00053707534,0.003298872,0.119176306],"study_design_scores_gemma":[0.07809417,0.014707126,0.21321172,0.006701507,0.0077836057,0.00031610834,0.00562316,0.00056807656,0.62361014,0.0033054168,0.040845953,0.0052330485],"about_ca_topic_score_codex":0.00046620035,"about_ca_topic_score_gemma":0.00013704949,"teacher_disagreement_score":0.53121,"about_ca_system_score_codex":0.000039025883,"about_ca_system_score_gemma":0.00015337771,"threshold_uncertainty_score":0.99955916},"labels":[],"label_agreement":null},{"id":"W4386959308","doi":"10.1016/j.jtct.2023.09.014","title":"Continuous Elotuzumab, Pomalidomide, and Dexamethasone Maintenance Following Second Autologous Transplantation for Multiple Myeloma: Results of a Prospective Phase 2 Multicenter Trial","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Takeda Pharmaceuticals U.S.A.; Bristol-Myers Squibb; Multiple Myeloma Research Foundation","keywords":"Medicine; Pomalidomide; Multiple myeloma; Maintenance therapy; Dexamethasone; Salvage therapy; Internal medicine; Melphalan; Transplantation; Autologous stem-cell transplantation; Surgery; Progression-free survival; Oncology; Lenalidomide; Chemotherapy","score_opus":0.028147437791671493,"score_gpt":0.31771735857515937,"score_spread":0.28956992078348787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386959308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919061,0.00044951326,0.0032136664,0.00015014091,0.00010027035,0.0033319967,0.000601411,0.00009016796,0.00015670434],"genre_scores_gemma":[0.9946147,0.0021000314,0.0013815637,0.000050248484,0.000039875133,0.00029072945,0.0010439667,0.000032016338,0.00044683],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99848497,0.00010043088,0.00044352506,0.00040637556,0.00023446226,0.00033022527],"domain_scores_gemma":[0.9990057,0.00049194286,0.00012554391,0.00013683297,0.00009461474,0.00014540621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040524767,0.00021301249,0.00045515923,0.00018815849,0.00013078966,0.000024888739,0.000045908073,0.000109331064,0.000014652099],"category_scores_gemma":[0.000059356105,0.00017444795,0.00014674789,0.00018008216,0.00009670135,0.0001171417,0.0000035253618,0.00010665781,0.0000031045208],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62592477,0.0008402424,0.0073868674,0.0008154629,0.00081544043,0.0007314847,0.008077582,0.0000042110178,0.30601382,0.000091098016,0.000043950073,0.049255036],"study_design_scores_gemma":[0.66604656,0.0042355764,0.046379343,0.00021470775,0.0002895692,0.00007492648,0.00053547724,0.0034741312,0.27800196,0.000104967345,0.00039584597,0.0002469237],"about_ca_topic_score_codex":0.000071740746,"about_ca_topic_score_gemma":0.0000592087,"teacher_disagreement_score":0.04900811,"about_ca_system_score_codex":0.000026641219,"about_ca_system_score_gemma":0.000049780396,"threshold_uncertainty_score":0.7113781},"labels":[],"label_agreement":null},{"id":"W4387082132","doi":"10.1016/j.jtct.2023.09.017","title":"Incidence and Impact of Fungal Infections in Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis and Haploidentical Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Gilead Sciences; National Cancer Institute; bluebird bio; Kiadis Pharma; Astellas Pharma; Adaptive Biotechnologies; Incyte; National Heart, Lung, and Blood Institute; Actinium Pharmaceuticals; CareDx; Office of Naval Research; Jazz Pharmaceuticals; Atara Biotherapeutics; Bristol-Myers Squibb; CSL Behring; BeiGene; HistoGenetics; Gateway for Cancer Research; GlaxoSmithKline; Health Resources and Services Administration; Astellas Pharma US; Amgen","keywords":"Medicine; Cumulative incidence; Internal medicine; Transplantation; Incidence (geometry); Proportional hazards model; Graft-versus-host disease; Hematopoietic stem cell transplantation; Cyclophosphamide; Immunology; Calcineurin; Gastroenterology; Chemotherapy","score_opus":0.024553743561290056,"score_gpt":0.3286458289797422,"score_spread":0.3040920854184522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387082132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944475,0.0009773672,0.002545717,0.0002304046,0.00006199392,0.00088458776,0.0007894658,0.00003619075,0.000026771597],"genre_scores_gemma":[0.97991663,0.018686157,0.00013261559,0.000031706968,0.000026146601,0.00007954295,0.0010757754,0.000020902973,0.00003052353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981924,0.00015592549,0.00044578096,0.00049352687,0.00041908337,0.0002932381],"domain_scores_gemma":[0.9987674,0.00048124162,0.00006991626,0.00014335841,0.00030445843,0.0002336667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006226692,0.00022281767,0.00036400484,0.0006558236,0.0001652401,0.000057489884,0.000060170514,0.00012247663,0.000037273036],"category_scores_gemma":[0.000033520453,0.00019560412,0.00015700368,0.00065551786,0.00029367945,0.00020333385,0.0000044041954,0.0002154732,9.416171e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014822014,0.0003984411,0.9183576,0.0017312841,0.0003158481,0.00021506134,0.0039086095,0.000045447512,0.059618298,0.00009752189,0.0000016606773,0.00048818137],"study_design_scores_gemma":[0.009829938,0.0011358748,0.9756994,0.00021863375,0.0007983213,0.0000311501,0.00029660974,0.0010548906,0.010633159,0.00009939126,0.0000038189887,0.00019878882],"about_ca_topic_score_codex":0.00025861955,"about_ca_topic_score_gemma":0.0006039464,"teacher_disagreement_score":0.05734179,"about_ca_system_score_codex":0.000027313072,"about_ca_system_score_gemma":0.00012162702,"threshold_uncertainty_score":0.79765046},"labels":[],"label_agreement":null},{"id":"W4387340133","doi":"10.1016/j.jtct.2023.09.021","title":"Propensity Score Matching Analysis Comparing the Efficacy and Steroid Tapering Benefit of Extracorporeal Photopheresis to Best Available Therapy in Third-Line or Beyond Treatment for Chronic GvHD","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Prednisone; Discontinuation; Extracorporeal Photopheresis; Propensity score matching; Graft-versus-host disease; Internal medicine; Hazard ratio; Hematopoietic stem cell transplantation; Cohort; Corticosteroid; Calcineurin; Photopheresis; Transplantation; Surgery; Disease; Confidence interval","score_opus":0.1002552356861403,"score_gpt":0.30414121188683363,"score_spread":0.20388597620069332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387340133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944719,0.00084641244,0.002360491,0.00014806348,0.00003404935,0.00187431,0.00003763784,0.000041891915,0.0001852562],"genre_scores_gemma":[0.9875448,0.011158464,0.00040012068,0.00006876602,0.000030819774,0.000134845,0.00025491422,0.000028180688,0.0003791124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987575,0.000051821342,0.0004188451,0.0003395274,0.00019552546,0.00023681081],"domain_scores_gemma":[0.99928236,0.00029210493,0.00009206842,0.00019856251,0.000045692617,0.00008921725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033733132,0.00021462972,0.0005122614,0.00024160316,0.00012689397,0.00003505837,0.00006781395,0.0000702794,0.00008664789],"category_scores_gemma":[0.000002403764,0.00013814344,0.00009055485,0.0005546674,0.000047355756,0.00006533541,0.0000043270306,0.000076051285,0.000005065807],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011645032,0.0005281721,0.110710345,0.0010819203,0.0012245297,0.00012599428,0.025900872,0.0039006688,0.7856952,0.000108239976,0.0000061475657,0.059072893],"study_design_scores_gemma":[0.022847634,0.0032521798,0.38478214,0.0005450746,0.0010791555,0.00005682284,0.0009799169,0.005877305,0.5799391,0.00007159645,0.0001566995,0.00041233219],"about_ca_topic_score_codex":0.00044505243,"about_ca_topic_score_gemma":0.0012131267,"teacher_disagreement_score":0.27407178,"about_ca_system_score_codex":0.000044057415,"about_ca_system_score_gemma":0.00005003312,"threshold_uncertainty_score":0.5633326},"labels":[],"label_agreement":null},{"id":"W4387643382","doi":"10.1016/j.jtct.2023.10.010","title":"Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Swedish Orphan Biovitrum; Vertex Pharmaceuticals; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; TG Therapeutics; Medac; Jazz Pharmaceuticals; Bristol-Myers Squibb; AstraZeneca; CSL Behring; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Amgen; Mallinckrodt Pharmaceuticals; Astellas Pharma US","keywords":"Hematologic malignancy; Hazard ratio; Medicine; Cumulative incidence; Internal medicine; Graft-versus-host disease; Transplantation; Hematologic disease; Gastroenterology; Malignancy; Hematopoietic stem cell transplantation; Incidence (geometry); Confidence interval; Proportional hazards model; Hematopoietic cell; Retrospective cohort study; Surgery; Disease; Haematopoiesis; Stem cell","score_opus":0.012811193121885453,"score_gpt":0.2469745155800355,"score_spread":0.23416332245815005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387643382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837062,0.002442509,0.011390639,0.00014113322,0.00012481312,0.0018887367,0.000085042106,0.00014453525,0.0000763886],"genre_scores_gemma":[0.9845491,0.013607786,0.00061176263,0.00006011089,0.000025669082,0.00020039319,0.000820532,0.000052314954,0.00007232852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99843484,0.00008405605,0.0003875658,0.00045744737,0.0003061049,0.00033001276],"domain_scores_gemma":[0.9991029,0.00032353686,0.00012380713,0.00018651478,0.00005651164,0.00020675255],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021490884,0.00030603143,0.00046665288,0.00017487835,0.00013486057,0.000019857931,0.00006218063,0.00012774499,0.000013868544],"category_scores_gemma":[0.0000037029042,0.00025570052,0.00013888246,0.00028095406,0.00009072898,0.00012264385,0.000002727925,0.00009595632,0.000005668698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03902832,0.00069928565,0.059370283,0.074368656,0.0008809354,0.0023425904,0.024742646,0.00012848855,0.7919153,0.0008724039,0.000013067842,0.0056380434],"study_design_scores_gemma":[0.04957224,0.0028496203,0.16096142,0.0035552753,0.002309777,0.00021091403,0.0006699654,0.0014352533,0.77725047,0.0003302091,0.000042740103,0.0008120926],"about_ca_topic_score_codex":0.000015527537,"about_ca_topic_score_gemma":0.000017699682,"teacher_disagreement_score":0.10159114,"about_ca_system_score_codex":0.000020480657,"about_ca_system_score_gemma":0.00008029757,"threshold_uncertainty_score":0.9999895},"labels":[],"label_agreement":null},{"id":"W4388036682","doi":"10.1016/j.jtct.2023.10.018","title":"Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation","year":2023,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Genentech; Health Resources and Services Administration; Swedish Orphan Biovitrum; National Institute of Environmental Health Sciences; Servier; Gateway for Cancer Research; Astellas Pharma; Sanofi; MacroGenics; Incyte; Leukemia and Lymphoma Society","keywords":"Hematopoietic stem cell transplantation; Medicine; Transplantation; Genetic testing; Germline; Oncology; CEBPA; Immunology; Internal medicine; Genetics; Biology; Mutation; Gene","score_opus":0.09424667534191573,"score_gpt":0.33992686670146655,"score_spread":0.24568019135955083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388036682","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41483054,0.5827012,0.0004553959,0.000023491757,0.000052129584,0.0016182386,0.00023839383,0.000037272406,0.00004330382],"genre_scores_gemma":[0.054425985,0.9436996,0.00023785271,0.000038618615,0.00003288438,0.00017733074,0.0012054782,0.00010769107,0.000074582465],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970295,0.00039768007,0.0010739593,0.00069453265,0.0004166529,0.00038770866],"domain_scores_gemma":[0.99888384,0.00024798998,0.0003293491,0.00026210322,0.00006808395,0.0002086255],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003741112,0.0005594503,0.0014190954,0.00057762867,0.00008943513,0.000041298044,0.00011142673,0.00047967356,0.00002466788],"category_scores_gemma":[0.000001372677,0.00048694044,0.00017757862,0.00040504325,0.00017444513,0.000093090144,0.00000944697,0.00044947225,0.000008906328],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013864724,0.00026563896,0.0012379406,0.1595044,0.0004450964,0.0013294013,0.014946911,0.000015854446,0.012153485,0.000070229624,0.0000077631985,0.8086368],"study_design_scores_gemma":[0.13379663,0.014321304,0.047472924,0.19440608,0.0385301,0.016215473,0.0104431715,0.0018041859,0.45475605,0.0012203607,0.07367151,0.013362196],"about_ca_topic_score_codex":0.0002261321,"about_ca_topic_score_gemma":0.000077568046,"teacher_disagreement_score":0.7952746,"about_ca_system_score_codex":0.000067811176,"about_ca_system_score_gemma":0.00021885274,"threshold_uncertainty_score":0.99975824},"labels":[],"label_agreement":null},{"id":"W4388837413","doi":"10.1016/j.jtct.2023.11.011","title":"Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Chronic Disease Prevention and Health Promotion; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Kite Pharma; Takeda Oncology; University of California, San Francisco; Health Resources and Services Administration; Centers for Disease Control and Prevention; National Institutes of Health; Kiadis Pharma; bluebird bio; TG Therapeutics; Medac; Jazz Pharmaceuticals; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; StemCyte; BeiGene; National Center for Advancing Translational Sciences; HistoGenetics; Comprehensive Cancer Center, University of California, Davis; Mallinckrodt Pharmaceuticals; Astellas Pharma US; University of Southern California; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Astellas Pharma; Adaptive Biotechnologies; MorphoSys; California Department of Public Health; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Amgen; Incyte; Pfizer","keywords":"Medicine; Hematopoietic cell; Transplantation; Cancer; Hematopoietic stem cell transplantation; Bone transplantation; Cancer registry; Retrospective cohort study; Oncology; Internal medicine; Surgery; Haematopoiesis; Stem cell; Biology","score_opus":0.08516922950651006,"score_gpt":0.3718964781740521,"score_spread":0.286727248667542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388837413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924206,0.0015529487,0.0010628233,0.00026258294,0.00016621311,0.0010914733,0.0033760516,0.000021977758,0.000045340465],"genre_scores_gemma":[0.9683179,0.027844045,0.00055429805,0.00004361361,0.000036001158,0.00011349921,0.0029523734,0.000033419525,0.00010480066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981294,0.00008953574,0.0005996104,0.00048012045,0.00039206646,0.00030921624],"domain_scores_gemma":[0.99908966,0.000261077,0.00010047001,0.00020893128,0.00016032625,0.00017956336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005060137,0.00020968314,0.00043797187,0.00038064743,0.000059732272,0.000026343976,0.000092689224,0.00015069211,0.0000209952],"category_scores_gemma":[0.000008584164,0.0001963397,0.000034273886,0.0002212286,0.00014552652,0.00012561274,0.000009899197,0.00016686467,0.0000012209247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077202227,0.0003349183,0.71031696,0.0056128046,0.00017780105,0.00009699236,0.027315622,0.000007834721,0.247069,0.000064073436,0.000052194697,0.0012315704],"study_design_scores_gemma":[0.037552446,0.0015828266,0.5363268,0.003107594,0.0008832544,0.0002148946,0.003145192,0.0017238904,0.41362858,0.00022429731,0.00093628356,0.0006739108],"about_ca_topic_score_codex":0.0003925673,"about_ca_topic_score_gemma":0.0005264517,"teacher_disagreement_score":0.17399013,"about_ca_system_score_codex":0.000015950598,"about_ca_system_score_gemma":0.000051151826,"threshold_uncertainty_score":0.80065},"labels":[],"label_agreement":null},{"id":"W4389346648","doi":"10.1016/j.jtct.2023.11.019","title":"Genetic Findings of Potential Donor Origin following Hematopoietic Cell Transplantation: Recommendations on Donor Disclosure and Genetic Testing from the World Marrow Donor Association","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Transplantation; Hematopoietic cell; Medicine; Disease; Genetic testing; Hematopoietic stem cell transplantation; Transplantation Chimera; Haematopoiesis; Intensive care medicine; Bioinformatics; Stem cell; Internal medicine; Genetics; Biology","score_opus":0.02365778249594678,"score_gpt":0.25895338810614327,"score_spread":0.2352956056101965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389346648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915502,0.00059370976,0.0036874926,0.0022014668,0.0002931162,0.0009346806,0.00021036537,0.00012130724,0.0004076683],"genre_scores_gemma":[0.98961663,0.0057697594,0.002777403,0.00032094936,0.00012804028,0.00006670955,0.00074125605,0.000058182442,0.0005210387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776703,0.0002234728,0.00067706266,0.00048310525,0.0005042381,0.00034510568],"domain_scores_gemma":[0.9983177,0.001006136,0.00021972336,0.00024162096,0.00007581478,0.00013896415],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037426868,0.00032264984,0.00041663082,0.00023582701,0.0002992423,0.00008380589,0.00011958198,0.00015692058,0.0001351774],"category_scores_gemma":[0.000012698214,0.00026428117,0.00015390954,0.00063772796,0.0000610343,0.00011431767,0.000005503977,0.00025632285,0.000032692333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001162748,0.0002798085,0.5993707,0.0013376216,0.00049914257,0.00042510388,0.011957611,0.00039398382,0.37444788,0.00015840933,0.00039426508,0.0095727155],"study_design_scores_gemma":[0.01110678,0.00047902516,0.83167124,0.0011948886,0.0015865953,0.00018509169,0.00091821264,0.001579382,0.1494733,0.0004907096,0.0006548361,0.0006599195],"about_ca_topic_score_codex":0.00014038784,"about_ca_topic_score_gemma":0.00009024857,"teacher_disagreement_score":0.23230056,"about_ca_system_score_codex":0.00004841276,"about_ca_system_score_gemma":0.00006585139,"threshold_uncertainty_score":0.9999809},"labels":[],"label_agreement":null},{"id":"W4390978933","doi":"10.1016/j.jtct.2024.01.067","title":"Subjective Oral Dryness following Hematopoietic Cell Transplantation: A Report from the Orastem Study","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"KWF Kankerbestrijding","keywords":"Medicine; Internal medicine; Transplantation; Regimen; Observational study; Hematopoietic cell; Quality of life (healthcare); Saliva; Longitudinal study; Prospective cohort study; Haematopoiesis; Pathology; Stem cell","score_opus":0.019931597107514604,"score_gpt":0.26830477951332776,"score_spread":0.24837318240581316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390978933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767265,0.0054839114,0.014488723,0.00048366413,0.00046300617,0.00072935905,0.000032274478,0.00014037784,0.0014522034],"genre_scores_gemma":[0.99717003,0.0014356538,0.00006799672,0.00025033267,0.000105471,0.00006404542,0.0004023452,0.000028351848,0.0004757775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988933,0.0000965757,0.00026798862,0.00034017628,0.00025541944,0.00014652655],"domain_scores_gemma":[0.99952143,0.00016276396,0.00003111752,0.00018616221,0.000027552951,0.00007095113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022691667,0.00017837898,0.00021772069,0.000058601527,0.00019924105,0.00009380041,0.000050729304,0.00006321531,0.00015339053],"category_scores_gemma":[0.0000015371224,0.000114916314,0.00013363488,0.0002390417,0.000033662855,0.00011323083,0.0000020374914,0.00016296735,0.000020024714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053018373,0.002231541,0.70434755,0.0009188911,0.0021848364,0.02554225,0.19170149,0.000040780676,0.04856073,0.0006855774,0.00053047226,0.017954063],"study_design_scores_gemma":[0.030325513,0.0024520715,0.841947,0.0009261129,0.005499492,0.0032037417,0.06091242,0.0010210499,0.041465823,0.002370541,0.008447356,0.0014288884],"about_ca_topic_score_codex":0.00033634904,"about_ca_topic_score_gemma":0.00007597653,"teacher_disagreement_score":0.13759947,"about_ca_system_score_codex":0.000011222602,"about_ca_system_score_gemma":0.00006362467,"threshold_uncertainty_score":0.4686151},"labels":[],"label_agreement":null},{"id":"W4391280907","doi":"10.1016/j.jtct.2024.01.075","title":"Outcomes of Antithymocyte Globulin-Post-Transplantation Cyclophosphamide-Cyclosporine-Based versus Antithymocyte Globulin-Based Prophylaxis for 10/10 HLA-Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Graft-versus-host disease; Internal medicine; Gastroenterology; Hematopoietic stem cell transplantation; Cyclophosphamide; Transplantation; Regimen; Immunology; Chemotherapy","score_opus":0.01777045957085485,"score_gpt":0.2683120655163892,"score_spread":0.2505416059455344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391280907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9113156,0.0038304226,0.07863638,0.00048781082,0.0007161036,0.0030763815,0.00097253127,0.0004587452,0.00050600315],"genre_scores_gemma":[0.9794966,0.007411697,0.0053333887,0.00019030356,0.000085291365,0.00025306473,0.0065619154,0.00018703693,0.00048068402],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955337,0.00021373693,0.0015224178,0.001117028,0.000916126,0.00069697795],"domain_scores_gemma":[0.9974343,0.00093169947,0.00033960925,0.0005079335,0.0004460324,0.0003404301],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006450525,0.000880298,0.0011606577,0.00059877016,0.00023639905,0.00011678212,0.00024493862,0.00058375375,0.00068982295],"category_scores_gemma":[0.000016008791,0.0007927319,0.0006017588,0.00078237563,0.000240262,0.0002956207,0.0000037458183,0.0003565281,0.000085913205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.084848136,0.0018968493,0.032205332,0.049025934,0.0017884559,0.0019801864,0.008338982,0.0031055922,0.80799294,0.00078152254,0.000059684644,0.007976411],"study_design_scores_gemma":[0.032110788,0.0031811965,0.03799975,0.0014421868,0.0025456494,0.00015637757,0.00023362567,0.0034363442,0.91734296,0.00007555404,0.000419258,0.0010562856],"about_ca_topic_score_codex":0.00013905854,"about_ca_topic_score_gemma":0.000046375986,"teacher_disagreement_score":0.10935008,"about_ca_system_score_codex":0.000112042224,"about_ca_system_score_gemma":0.0005408648,"threshold_uncertainty_score":0.99945235},"labels":[],"label_agreement":null},{"id":"W4391379613","doi":"10.1016/j.jtct.2024.01.057","title":"The Arc of Connectedness","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Chaos, Complexity, and Education","field":"Computer Science","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Social connectedness; Arc (geometry); Psychology; Mathematics; Social psychology; Geometry","score_opus":0.02597799149677042,"score_gpt":0.2565443688217218,"score_spread":0.23056637732495142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391379613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5166974,0.008123989,0.4713476,0.0018952972,0.0008778157,0.000121911726,0.0000035239357,0.00010159144,0.0008308768],"genre_scores_gemma":[0.9941551,0.005212135,0.0003763808,0.000064312735,0.00004312572,0.000005777505,0.000008648183,0.0000036797753,0.00013083061],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995686,0.00003890981,0.00010313799,0.000119337456,0.000094017305,0.00007603908],"domain_scores_gemma":[0.99969906,0.00011243933,0.000016633005,0.00012398412,0.000024363477,0.000023552038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015890926,0.00005201528,0.00004917879,0.00003437068,0.00009740815,0.00010529596,0.00015089515,0.000018219609,0.000010221378],"category_scores_gemma":[9.263077e-7,0.000034981385,0.00002633806,0.00013961084,0.0000443736,0.000108789194,0.000003410529,0.000041211624,0.0000058422793],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005409843,0.000054880056,0.00020980727,0.00018590663,0.00005318338,0.000010787037,0.03287999,0.0000146101065,0.048410453,0.59520644,0.00023218826,0.32268766],"study_design_scores_gemma":[0.0025280386,0.0004963771,0.019735828,0.00032253188,0.000057842284,0.00016546906,0.0025109428,0.11044334,0.5804156,0.19101317,0.09150357,0.0008072586],"about_ca_topic_score_codex":0.000025019463,"about_ca_topic_score_gemma":0.000009798388,"teacher_disagreement_score":0.5320052,"about_ca_system_score_codex":0.0000040020377,"about_ca_system_score_gemma":0.000030000114,"threshold_uncertainty_score":0.14264995},"labels":[],"label_agreement":null},{"id":"W4391518814","doi":"10.1016/j.jtct.2024.01.079","title":"A Day 14 Endpoint for Acute GVHD Clinical Trials","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; National Cancer Institute; José Carreras Leukämie-Stiftung","keywords":"Clinical endpoint; Medicine; Internal medicine; Oncology; Clinical trial; Gastroenterology; Immunology","score_opus":0.18292945475509767,"score_gpt":0.49800593960517,"score_spread":0.31507648485007234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391518814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7962645,0.008508034,0.1845717,0.0038416346,0.0006049336,0.0019817792,0.00018401787,0.00013998253,0.003903412],"genre_scores_gemma":[0.9351252,0.054710176,0.0023289914,0.0009272495,0.00048268714,0.00018816678,0.00046100092,0.000032365562,0.005744221],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99868137,0.00033178544,0.00046165683,0.00022796911,0.00013806952,0.00015913897],"domain_scores_gemma":[0.99845314,0.0012462554,0.00003440467,0.00010092138,0.00003997793,0.0001252965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00332137,0.000100962796,0.000506536,0.00007568655,0.000058545327,0.000030069425,0.000035202735,0.00013265626,0.00056113594],"category_scores_gemma":[0.00004723371,0.000068374495,0.000195041,0.00006718673,0.000081211445,0.0000386721,0.0000017794099,0.00015880437,0.000028670262],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014481945,0.0005978988,0.015912058,0.0012122405,0.0049673216,0.0011514756,0.0068172747,5.5259125e-7,0.09132741,0.012571259,0.004921566,0.846039],"study_design_scores_gemma":[0.08914083,0.014308867,0.14020218,0.00085720245,0.013170134,0.00087795133,0.000931405,0.024052303,0.14365916,0.014825655,0.5565612,0.0014131311],"about_ca_topic_score_codex":0.0000044382946,"about_ca_topic_score_gemma":0.0000015390485,"teacher_disagreement_score":0.8446259,"about_ca_system_score_codex":0.000011097066,"about_ca_system_score_gemma":0.00012864712,"threshold_uncertainty_score":0.6144045},"labels":[],"label_agreement":null},{"id":"W4391598130","doi":"10.1016/j.jtct.2023.12.620","title":"Impact of Letermovir on Outcomes in Cytomegalovirus Seropositive Patients Undergoing Allogeneic HCT: Exploring Outcomes across Ethnicities","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Serostatus; Medicine; Clinical endpoint; Cumulative incidence; Internal medicine; Population; Incidence (geometry); Cohort; Cytomegalovirus; Retrospective cohort study; Immunology; Oncology; Viral load; Clinical trial; Herpesviridae; Viral disease; Virus","score_opus":0.06293496947414659,"score_gpt":0.36208649345239585,"score_spread":0.2991515239782493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391598130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978308,0.00088028185,0.00010653127,0.00010977352,0.000098233366,0.00043946176,0.00015498075,0.00005341818,0.00032649474],"genre_scores_gemma":[0.99230146,0.0071294387,0.000025249143,0.00013005546,0.000021986358,0.00003917039,0.00009346779,0.000041186417,0.0002179577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998528,0.00008372361,0.00036741202,0.00031392896,0.00037109072,0.0003358331],"domain_scores_gemma":[0.9993673,0.00027735243,0.000042648477,0.00015754388,0.000049664584,0.0001054986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022099877,0.0002460217,0.0004451888,0.0003173907,0.00007665841,0.000060012753,0.00007049418,0.00009558576,0.000083622916],"category_scores_gemma":[0.000007819473,0.00017598028,0.00023227937,0.0002304471,0.00009274141,0.00020805684,0.000009416318,0.00026915365,0.000019526067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021865873,0.00039900176,0.9047824,0.00044953823,0.0005140055,0.0002365576,0.014191621,0.0000620387,0.044705193,0.00021554178,0.000004040168,0.032253485],"study_design_scores_gemma":[0.004651637,0.0012496188,0.95378965,0.00033915875,0.000033259923,0.000007004573,0.00036445385,0.00009934918,0.03914471,0.000056993496,0.0000618065,0.00020235428],"about_ca_topic_score_codex":0.000518477,"about_ca_topic_score_gemma":0.00016375234,"teacher_disagreement_score":0.049007263,"about_ca_system_score_codex":0.000115946896,"about_ca_system_score_gemma":0.00008600205,"threshold_uncertainty_score":0.71762675},"labels":[],"label_agreement":null},{"id":"W4391599535","doi":"10.1016/j.jtct.2023.12.391","title":"A Single Center Experience of Central Nervous System Manifestations of Graft Versus Host Disease.","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Central nervous system; Host (biology); Single Center; Center (category theory); Disease; Graft-versus-host disease; Medicine; Biology; Pathology; Surgery; Internal medicine; Chemistry","score_opus":0.023183696105271212,"score_gpt":0.261176226916612,"score_spread":0.2379925308113408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391599535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952749,0.0032312796,0.00055236573,0.00011259134,0.00016523962,0.00023768643,0.000104072744,0.00003240125,0.0002894678],"genre_scores_gemma":[0.9982096,0.0014817138,0.0000803272,0.000013260613,0.000018119339,0.000021968333,0.00014471207,0.000010054631,0.000020224308],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99946785,0.00001978295,0.00016287528,0.0001255429,0.00013092381,0.00009302685],"domain_scores_gemma":[0.99975044,0.00003497665,0.00002851867,0.00008129126,0.000025604233,0.000079181766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000021084505,0.00008051136,0.00011903959,0.000062635394,0.000024144145,0.00001099162,0.000021168797,0.000021540709,0.000035684818],"category_scores_gemma":[7.188745e-7,0.00006284592,0.000068058915,0.000082789564,0.00004317651,0.000043648248,0.0000011699103,0.000024995097,0.0000020297514],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005236099,0.0020494328,0.06233989,0.004280657,0.000679181,0.0034135624,0.029729137,0.000029417499,0.8662297,0.0101023,0.000038413426,0.01587219],"study_design_scores_gemma":[0.014343411,0.0015377227,0.24022682,0.0020792433,0.00082110544,0.00032685164,0.0041042645,0.0013801003,0.7334183,0.0000310458,0.001420901,0.00031024034],"about_ca_topic_score_codex":0.00004097415,"about_ca_topic_score_gemma":0.000005120441,"teacher_disagreement_score":0.17788693,"about_ca_system_score_codex":0.000016744621,"about_ca_system_score_gemma":0.000020852753,"threshold_uncertainty_score":0.25627822},"labels":[],"label_agreement":null},{"id":"W4391601089","doi":"10.1016/j.jtct.2023.12.352","title":"Favorable Outcomes with Low Dose Anti Thymocyte Globulin Based Graft Versus Host Disease Prophylaxis after Mismatched Unrelated Donor Allogenic Hematopoietic Cell Transplantation","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Anti-thymocyte globulin; Graft-versus-host disease; Hematopoietic cell; Hematopoietic stem cell transplantation; Globulin; Transplantation; Haematopoiesis; Immunology; Medicine; Host (biology); Graft vs Host Reaction; Surgery; Bone marrow transplantation; Biology; Stem cell","score_opus":0.011048939481255701,"score_gpt":0.23730560130772538,"score_spread":0.22625666182646967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391601089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751716,0.0049155597,0.016374277,0.00065705244,0.00031862163,0.0016753996,0.0002178551,0.00038695525,0.00028265163],"genre_scores_gemma":[0.99033546,0.006385229,0.0010043785,0.00032617102,0.000044412453,0.00020528356,0.0012297599,0.00012159233,0.0003477238],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99729836,0.00016388693,0.0006019294,0.0007947181,0.0006509407,0.00049018755],"domain_scores_gemma":[0.9987797,0.00023588305,0.00009142217,0.00037488795,0.00009749908,0.00042057157],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002616139,0.0005835286,0.0005695649,0.00030095855,0.00014911909,0.00015631234,0.00011541894,0.00024551904,0.00034404435],"category_scores_gemma":[0.0000026440518,0.00044748682,0.00024594826,0.0005001505,0.00015013177,0.00026099582,0.0000026657979,0.0003516922,0.00010744963],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10718039,0.0026727177,0.09056594,0.041328825,0.002108965,0.02188681,0.025971092,0.0010302773,0.702078,0.0004417739,0.000038751034,0.0046964753],"study_design_scores_gemma":[0.06321439,0.0032339443,0.20521645,0.004324166,0.0047735306,0.00044288064,0.0007476799,0.0054846467,0.7094333,0.000105437735,0.0006692003,0.0023543648],"about_ca_topic_score_codex":0.00005409219,"about_ca_topic_score_gemma":0.000022947144,"teacher_disagreement_score":0.11465052,"about_ca_system_score_codex":0.00006216657,"about_ca_system_score_gemma":0.00030530448,"threshold_uncertainty_score":0.9997977},"labels":[],"label_agreement":null},{"id":"W4391603136","doi":"10.1016/j.jtct.2023.12.148","title":"Outcomes Following Matched Sibling Donor Transplant for Severe Combined Immunodeficiency: A Report from the Pidtc","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Sibling; Medicine; Psychology; Developmental psychology","score_opus":0.014289644032126713,"score_gpt":0.2450036477096053,"score_spread":0.2307140036774786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391603136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88971096,0.092118576,0.01471092,0.00094744976,0.0013103238,0.00059340586,0.00016196044,0.00019011452,0.0002562999],"genre_scores_gemma":[0.99460286,0.0024064733,0.00004492954,0.0003532034,0.0000056356157,0.0000896287,0.0015342432,0.000032510437,0.00093051704],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866235,0.00011315596,0.000440462,0.0003933627,0.00005988373,0.0003307708],"domain_scores_gemma":[0.99915427,0.0004958084,0.00006618789,0.00025313415,0.00002287893,0.000007729289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004687323,0.00026174815,0.0003153489,0.000073980955,0.00052201527,0.00010651162,0.00022162963,0.00016992928,0.0001223986],"category_scores_gemma":[0.000006278947,0.00017471096,0.00030407557,0.00016202254,0.00010822442,0.00014958017,0.000005887699,0.0002371542,0.000035047175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008637757,0.00017277552,0.0037724357,0.00010825281,0.0010270434,0.00009454828,0.022655373,0.000036684007,0.94341505,0.0018638662,0.00006023628,0.025929963],"study_design_scores_gemma":[0.045220632,0.0012670277,0.09777958,0.0017104567,0.00276003,0.0009866515,0.01714768,0.0014148084,0.6338188,0.012959852,0.18089685,0.0040376107],"about_ca_topic_score_codex":0.00029011592,"about_ca_topic_score_gemma":0.000008144806,"teacher_disagreement_score":0.30959624,"about_ca_system_score_codex":0.000011494609,"about_ca_system_score_gemma":0.00005926472,"threshold_uncertainty_score":0.7124506},"labels":[],"label_agreement":null},{"id":"W4391606427","doi":"10.1016/j.jtct.2023.12.325","title":"Limited Impact of Donor-Recipient Weight Difference on Outcomes of Allogeneic Hematopoietic Cell Transplantation","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Hematopoietic cell; Hematopoietic stem cell transplantation; Transplantation; Medicine; Haematopoiesis; Immunology; Oncology; Internal medicine; Biology; Stem cell; Genetics","score_opus":0.02064369111817055,"score_gpt":0.27812108117827083,"score_spread":0.2574773900601003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391606427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986145,0.0017930273,0.009995334,0.00011876261,0.00014710281,0.0006210286,0.00015878867,0.00007844251,0.00094251696],"genre_scores_gemma":[0.9850596,0.013871741,0.0003108344,0.00006093012,0.000021988923,0.000026038995,0.00040902503,0.000042099353,0.00019774248],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982578,0.000099475445,0.0006267944,0.00036515784,0.00042586276,0.00022491181],"domain_scores_gemma":[0.99916095,0.00028263862,0.00011669212,0.00023253007,0.00007425957,0.00013292377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019574899,0.00030976394,0.00053855503,0.00032780037,0.000040974934,0.000018795641,0.00008308228,0.0001552678,0.00024856685],"category_scores_gemma":[0.000001958238,0.00022556007,0.00030565893,0.00026318332,0.00009774675,0.000069919064,0.000001717567,0.00016187617,0.000018725865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023513888,0.00059061387,0.079733565,0.004555063,0.00047954894,0.00018552544,0.01095609,0.00009619393,0.8936523,0.0011455008,0.000010001363,0.00624418],"study_design_scores_gemma":[0.0036658517,0.0011322132,0.27268085,0.0008042502,0.00045269923,0.0001355396,0.00009020953,0.00030633868,0.7203234,0.00015020296,0.000022864622,0.00023561828],"about_ca_topic_score_codex":0.000056760324,"about_ca_topic_score_gemma":0.000003705112,"teacher_disagreement_score":0.19294728,"about_ca_system_score_codex":0.000032486496,"about_ca_system_score_gemma":0.0000931963,"threshold_uncertainty_score":0.9198073},"labels":[],"label_agreement":null},{"id":"W4391607782","doi":"10.1016/j.jtct.2023.12.308","title":"Transfusion Independence after Exagamglogene Autotemcel in Patients with Transfusion-Dependent β-Thalassemia","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Thalassemia; Independence (probability theory); Medicine; Blood transfusion; Pediatrics; Internal medicine; Mathematics; Statistics","score_opus":0.004682653198413886,"score_gpt":0.2073122597410256,"score_spread":0.20262960654261172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391607782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909882,0.0045838477,0.0026379512,0.00029939885,0.0001283803,0.000672998,0.000021548734,0.00008534493,0.0005823232],"genre_scores_gemma":[0.9791541,0.020216104,0.00007497272,0.00019236849,0.000018835699,0.000037263482,0.00009369065,0.000033612916,0.00017906274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987411,0.000049507893,0.00025095817,0.0003661504,0.0003715494,0.00022072656],"domain_scores_gemma":[0.9996978,0.000022053737,0.000016434506,0.000119797915,0.00003380777,0.0001101295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001422193,0.000204123,0.000207628,0.00017683541,0.00005303565,0.000034985587,0.000041169245,0.0002063517,0.00028259167],"category_scores_gemma":[5.949052e-7,0.0001433187,0.000059550148,0.00023961492,0.000051306473,0.00011865483,0.0000017370861,0.0003288156,0.000014571408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019212937,0.0017881389,0.5163813,0.0020217716,0.00041437277,0.0030733105,0.02652158,0.00015001353,0.13970841,0.0002528011,0.000023021874,0.29045233],"study_design_scores_gemma":[0.023566002,0.0019845492,0.92007077,0.0018003258,0.00031816892,0.00016747079,0.0005943499,0.0007860847,0.048460085,0.00013405188,0.0013641348,0.00075403124],"about_ca_topic_score_codex":0.00009066629,"about_ca_topic_score_gemma":0.00006673631,"teacher_disagreement_score":0.40368944,"about_ca_system_score_codex":0.00003229282,"about_ca_system_score_gemma":0.00007300225,"threshold_uncertainty_score":0.58443666},"labels":[],"label_agreement":null},{"id":"W4391615065","doi":"10.1016/j.jtct.2023.12.167","title":"Differential Impact of CD34+ Cell Dose for Different Age Groups in Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia: A Machine Learning-Based Discovery","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Digital Imaging for Blood Diseases","field":"Computer Science","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Polytechnique Montréal; University of Toronto","funders":"","keywords":"Hematopoietic cell; Acute leukemia; Transplantation; Haematopoiesis; Medicine; Hematopoietic stem cell transplantation; Differential effects; CD34; Leukemia; Oncology; Cell; Immunology; Internal medicine; Stem cell; Biology; Cell biology; Genetics","score_opus":0.010825408711565992,"score_gpt":0.2554688386290458,"score_spread":0.2446434299174798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391615065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57336247,0.0009836754,0.4247028,0.00002628502,0.00007879843,0.00048097625,0.00027941258,0.00006480343,0.00002077111],"genre_scores_gemma":[0.9961009,0.0014275203,0.00078587385,0.00003304358,0.000020632368,0.00013154207,0.0013635338,0.00003541916,0.000101511745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868375,0.00006124873,0.0003459458,0.00043410633,0.00019298628,0.0002819654],"domain_scores_gemma":[0.9994337,0.00020846038,0.000079357465,0.00016488814,0.000025788833,0.000087832326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008455001,0.0002809265,0.00030592646,0.00022770408,0.00006370196,0.00029460454,0.00023807643,0.00007165176,0.0000062914423],"category_scores_gemma":[0.0000010810294,0.00022488824,0.0003325494,0.00016956287,0.00005028654,0.00055745913,0.000006224535,0.00010554259,8.5457594e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033943304,0.0013725868,0.004460922,0.005228997,0.0003534172,0.00029368504,0.007038035,0.0065125595,0.9582048,0.0028922535,0.000021008083,0.010227421],"study_design_scores_gemma":[0.013622489,0.0019015092,0.010858737,0.0003438157,0.0004959912,0.000031868523,0.000040126048,0.16069843,0.80821246,0.002972447,0.000048023903,0.0007741264],"about_ca_topic_score_codex":0.00003887441,"about_ca_topic_score_gemma":0.000018098015,"teacher_disagreement_score":0.42391694,"about_ca_system_score_codex":0.000048578142,"about_ca_system_score_gemma":0.00009492185,"threshold_uncertainty_score":0.9170676},"labels":[],"label_agreement":null},{"id":"W4392165940","doi":"10.1016/j.jtct.2023.12.001","title":"International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update","year":2024,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Dalhousie University; University of Calgary; University of Saskatchewan","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; University of Texas MD Anderson Cancer Center; National Heart, Lung, and Blood Institute; Office of Naval Research; National Center for Advancing Translational Sciences; Health Resources and Services Administration; Gateway for Cancer Research; Patient-Centered Outcomes Research Institute; Nagoya City University; University of Pennsylvania; National Institute of Environmental Health Sciences; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Survivorship curve; Transplantation; Hematopoietic cell; Intensive care medicine; Disease; MEDLINE; Family medicine; Pediatrics; Stem cell; Cancer; Internal medicine; Haematopoiesis","score_opus":0.10551534827834494,"score_gpt":0.3960425183423122,"score_spread":0.2905271700639672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392165940","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062678815,0.88925344,0.096037924,0.00059518596,0.00039626294,0.005097493,0.0021596965,0.00006757259,0.00012454604],"genre_scores_gemma":[0.0017268921,0.9808435,0.004967198,0.000072443,0.00013762573,0.00066302076,0.011127132,0.00010894998,0.00035324306],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99757403,0.00021881444,0.0009641738,0.00069708994,0.00028833418,0.00025753526],"domain_scores_gemma":[0.99798447,0.00080700725,0.0007411767,0.00017226704,0.00015635618,0.0001387109],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007090823,0.0005276496,0.0010921434,0.00043180666,0.00014879071,0.00010809796,0.00011427305,0.00031839265,0.00007110035],"category_scores_gemma":[0.000011655347,0.00044278507,0.00030990446,0.0002041236,0.0001240457,0.00027116368,0.0000058977066,0.00025395147,0.0000024548992],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021528858,0.00021410585,0.00023200794,0.07641886,0.002303142,0.000052223884,0.006490113,6.947444e-7,0.0023362038,0.0006245161,0.000048824208,0.9091264],"study_design_scores_gemma":[0.041456945,0.003855253,0.0008461742,0.07734974,0.03316402,0.0023009013,0.002163208,0.0010135885,0.034066748,0.0010038728,0.79928374,0.003495788],"about_ca_topic_score_codex":0.00004660712,"about_ca_topic_score_gemma":0.000035790967,"teacher_disagreement_score":0.90563065,"about_ca_system_score_codex":0.000025040232,"about_ca_system_score_gemma":0.00011155833,"threshold_uncertainty_score":0.9998024},"labels":[],"label_agreement":null},{"id":"W4392603341","doi":"10.1016/j.jtct.2024.03.004","title":"Pretransplant Blinatumomab Improves Outcomes in B Cell Acute Lymphoblastic Leukemia Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Blinatumomab; Lymphoblastic Leukemia; Hematopoietic stem cell transplantation; Medicine; Hematopoietic cell; Oncology; Transplantation; Leukemia; Immunology; Internal medicine; Haematopoiesis; Stem cell; Biology; Genetics","score_opus":0.009077638604916694,"score_gpt":0.2499690770481742,"score_spread":0.2408914384432575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392603341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840869,0.002376243,0.0105459485,0.00024134271,0.00025521038,0.0011375559,0.00017117508,0.00016435258,0.0010213032],"genre_scores_gemma":[0.97624004,0.021084463,0.00024153959,0.00031781147,0.000043968535,0.00009288934,0.00064754667,0.00009952691,0.00123222],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99714994,0.00014103527,0.0006568433,0.0007431304,0.0007032865,0.00060573616],"domain_scores_gemma":[0.99903435,0.0002714608,0.000073998395,0.00027437788,0.000080028076,0.00026580394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023959775,0.0004922609,0.0005761795,0.00052553817,0.00011227042,0.00012051196,0.00017617128,0.00030935148,0.000091416056],"category_scores_gemma":[0.0000035279054,0.00040143434,0.00019135191,0.0004611905,0.00013218838,0.00028675035,0.000008398743,0.00040566508,0.000068209505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008926858,0.0017562325,0.06301487,0.014540228,0.00088570226,0.007039932,0.022944514,0.00022512152,0.8605668,0.0006289766,0.0001473384,0.01932343],"study_design_scores_gemma":[0.055484254,0.003017066,0.20845102,0.00224056,0.0017501229,0.0009958796,0.00052922405,0.01757684,0.70713836,0.00064026465,0.00040400476,0.0017723972],"about_ca_topic_score_codex":0.000110497705,"about_ca_topic_score_gemma":0.000026092146,"teacher_disagreement_score":0.15342842,"about_ca_system_score_codex":0.0004230689,"about_ca_system_score_gemma":0.0005445634,"threshold_uncertainty_score":0.9998438},"labels":[],"label_agreement":null},{"id":"W4392613097","doi":"10.1016/j.jtct.2024.03.006","title":"Gut Immunomodulation with Vedolizumab prior to Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Inflammatory Bowel Disease","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Vedolizumab; Hematopoietic stem cell transplantation; Medicine; Inflammatory bowel disease; Transplantation; Stem cell; Immunology; Disease; Haematopoiesis; Internal medicine; Biology","score_opus":0.007515011372400853,"score_gpt":0.2153247245900678,"score_spread":0.20780971321766695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392613097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823425,0.0015489766,0.013569686,0.00016968814,0.00009321232,0.0018744034,0.000055604654,0.00015458952,0.00019136813],"genre_scores_gemma":[0.99515414,0.0032061636,0.00042284073,0.00013997484,0.00005091257,0.00015761476,0.00066047645,0.00008611069,0.000121770485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979466,0.00010194665,0.000489345,0.0005776038,0.0005495314,0.00033498145],"domain_scores_gemma":[0.99924004,0.00008495431,0.00007090805,0.00023709313,0.000084850224,0.0002821511],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017802746,0.00036635261,0.0002985082,0.00047715715,0.00009272428,0.00008192413,0.00007816122,0.00011402613,0.00004591142],"category_scores_gemma":[5.698727e-7,0.00028717192,0.000063970125,0.0004442483,0.00004376973,0.00026607036,0.0000023187317,0.00019793081,0.000039658287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023306055,0.00090721075,0.8712651,0.017388321,0.00019888011,0.0023370082,0.038337167,0.001826702,0.027977532,0.00046057257,0.00001112609,0.015984336],"study_design_scores_gemma":[0.009380703,0.000748529,0.9764714,0.0009773872,0.00050910935,0.000074046904,0.00019027718,0.00034967868,0.010686592,0.000027994043,0.00007605729,0.0005082216],"about_ca_topic_score_codex":0.0000104783785,"about_ca_topic_score_gemma":0.000024125333,"teacher_disagreement_score":0.10520631,"about_ca_system_score_codex":0.00007134436,"about_ca_system_score_gemma":0.00018917509,"threshold_uncertainty_score":0.99995804},"labels":[],"label_agreement":null},{"id":"W4393236813","doi":"10.1016/j.jtct.2024.03.022","title":"A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Center for Advancing Translational Sciences; José Carreras Leukämie-Stiftung; St. Baldrick's Foundation; Pediatric Transplantation and Cellular Therapy Consortium; Pediatric Cancer Foundation","keywords":"Medicine; Cohort; Risk stratification; Biomarker; Risk assessment; Internal medicine; Receiver operating characteristic; Cohort study; Disease; Transplantation; Hematopoietic stem cell transplantation; Oncology; Area under the curve; Hematopoietic cell; Intensive care medicine; Haematopoiesis","score_opus":0.01914716508611906,"score_gpt":0.2567879448052287,"score_spread":0.23764077971910966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393236813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897122,0.0006351719,0.0077529885,0.00012029518,0.0001304511,0.0010808646,0.00014173263,0.0001475027,0.00027878536],"genre_scores_gemma":[0.9895413,0.0076588416,0.00040246185,0.00004738779,0.000020480795,0.000043965443,0.002158519,0.00004150755,0.00008551558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855405,0.00011254198,0.00035062144,0.00040494374,0.00036931373,0.00020854097],"domain_scores_gemma":[0.9994606,0.00010659541,0.00009721092,0.00016929564,0.00005327646,0.00011306477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002037527,0.00025440007,0.00027309114,0.00034401726,0.000055273886,0.00008396879,0.000059242495,0.00012376046,0.00009038894],"category_scores_gemma":[0.0000015827356,0.00018692377,0.00005598415,0.00041010894,0.000054591274,0.00023215241,0.0000017311262,0.00017704662,0.000019949088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088464195,0.00021335232,0.9881042,0.00069686514,0.00027343992,0.00032637265,0.0018772493,0.000004462132,0.0033804646,0.000047246125,0.000003228203,0.0041884333],"study_design_scores_gemma":[0.0052742274,0.00030966333,0.966673,0.0001454203,0.0006058574,0.00003393569,0.00004599863,0.0001941159,0.026438838,0.00006176538,0.0000037129535,0.00021347175],"about_ca_topic_score_codex":0.000025130577,"about_ca_topic_score_gemma":0.000026583128,"teacher_disagreement_score":0.023058373,"about_ca_system_score_codex":0.00003185243,"about_ca_system_score_gemma":0.00007946673,"threshold_uncertainty_score":0.762253},"labels":[],"label_agreement":null},{"id":"W4394009899","doi":"10.1016/j.jtct.2024.03.030","title":"The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration; National Institutes of Health; Harvard Medical School; Leukemia and Lymphoma Society","keywords":"Adverse effect; Medicine; Stem cell; Event (particle physics); Oncology; Internal medicine; Biology; Genetics","score_opus":0.029890563141934397,"score_gpt":0.27621580935351864,"score_spread":0.24632524621158425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394009899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9529017,0.013769582,0.030864965,0.00033569505,0.0002826508,0.0011511369,0.00019615033,0.00013378922,0.0003643382],"genre_scores_gemma":[0.96069896,0.038078416,0.00009340966,0.000059616366,0.000053622192,0.00010014968,0.00018119278,0.000049514794,0.0006851299],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981017,0.00013211566,0.0006342686,0.00036716848,0.00042526232,0.00033947965],"domain_scores_gemma":[0.9983351,0.0011591356,0.00010555076,0.00019084787,0.00008335906,0.00012598767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006931177,0.00027826492,0.00037183886,0.00013607473,0.00021150817,0.00005652004,0.0001211279,0.00016203086,0.000040918163],"category_scores_gemma":[0.0000023423984,0.00019967697,0.00026587758,0.00021158463,0.00010769883,0.0001733558,0.0000016306312,0.00018855353,0.000006792702],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007844243,0.0004554581,0.024360169,0.01064654,0.0012509158,0.00055501703,0.108121224,0.00013911891,0.8159567,0.0031065797,0.000121067606,0.027442971],"study_design_scores_gemma":[0.008891656,0.0017853309,0.024354445,0.008039858,0.0017259592,0.00028554944,0.002248765,0.0058963266,0.94446903,0.00026690715,0.0013130264,0.0007231418],"about_ca_topic_score_codex":0.000025179683,"about_ca_topic_score_gemma":0.000032239277,"teacher_disagreement_score":0.12851234,"about_ca_system_score_codex":0.000027199052,"about_ca_system_score_gemma":0.000112646456,"threshold_uncertainty_score":0.8142591},"labels":[],"label_agreement":null},{"id":"W4394989815","doi":"10.1016/j.jtct.2024.04.014","title":"Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Treosulfan; Medicine; Busulfan; Fludarabine; Internal medicine; Hematopoietic stem cell transplantation; Transplantation; Retrospective cohort study; Surgery; Propensity score matching; Total body irradiation; Cohort; Oncology; Gastroenterology; Cyclophosphamide; Chemotherapy","score_opus":0.03490330538985548,"score_gpt":0.26560867691918305,"score_spread":0.23070537152932757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394989815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9595582,0.00046864076,0.03398443,0.00013503624,0.00039328687,0.0047478373,0.00016229902,0.00020680197,0.00034346464],"genre_scores_gemma":[0.99657553,0.0005768107,0.00044068394,0.00009189014,0.000042269286,0.0005867884,0.0015092012,0.00008938713,0.00008743389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973599,0.00018536241,0.00069368794,0.00083398056,0.00050962006,0.00041750548],"domain_scores_gemma":[0.9990009,0.00037991226,0.00010504816,0.00023547148,0.00011779584,0.00016084616],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005494132,0.00043102863,0.00066629524,0.00042038306,0.00015593569,0.0001240469,0.000089660265,0.00019161386,0.00011375916],"category_scores_gemma":[0.000007635527,0.00040359187,0.00016127013,0.00046308467,0.000101370635,0.00020330522,0.000002418342,0.00027192928,0.00002068379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016126242,0.00294049,0.7291102,0.007892722,0.0006595984,0.0037229974,0.017334942,0.0003471195,0.22024676,0.00026429273,0.000012698945,0.0013419776],"study_design_scores_gemma":[0.036885727,0.0040899576,0.8075433,0.0017124517,0.0014205487,0.00086127786,0.0007865572,0.0016251656,0.14414394,0.00010385057,0.000029929619,0.0007972851],"about_ca_topic_score_codex":0.000044270273,"about_ca_topic_score_gemma":0.000101170874,"teacher_disagreement_score":0.078433156,"about_ca_system_score_codex":0.00017095351,"about_ca_system_score_gemma":0.00014666686,"threshold_uncertainty_score":0.9998416},"labels":[],"label_agreement":null},{"id":"W4395053589","doi":"10.1016/j.jtct.2024.04.016","title":"Clinical Outcomes and Treatment Patterns in Adults With FLT3-ITDmut+ Acute Myeloid Leukemia Undergoing Allogeneic Hemopoietic Cell Transplantation in the United States and Canada","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; Astellas Pharma Global Development; Astellas Pharma","keywords":"Myeloid leukemia; Medicine; Haematopoiesis; Transplantation; Hematopoietic cell; Leukemia; Oncology; Myeloid; Immunology; Internal medicine; Stem cell; Biology; Genetics","score_opus":0.016557995111714734,"score_gpt":0.2796812041758545,"score_spread":0.2631232090641398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395053589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960307,0.0012552234,0.0005022038,0.001314032,0.000032660195,0.0007181474,0.00007873258,0.00002413436,0.000044188786],"genre_scores_gemma":[0.85304147,0.14534976,0.00009084488,0.000593221,0.000017854203,0.000040804658,0.0007587327,0.000024182073,0.00008312459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985392,0.00022297926,0.00034675596,0.0003754632,0.00025554697,0.00026005483],"domain_scores_gemma":[0.999166,0.0005433897,0.000033704462,0.00012688321,0.000020748272,0.00010923752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029317994,0.00023429617,0.0002938361,0.00020157182,0.00006659178,0.000057587727,0.000057927056,0.00009275494,0.000012394682],"category_scores_gemma":[0.0000015038327,0.00014222505,0.00003337099,0.00021338763,0.00008580082,0.00007869292,0.0000027890292,0.0002744304,7.50436e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044324724,0.00015319708,0.9417007,0.0014433302,0.0003407835,0.00520394,0.026279636,0.00012607496,0.0024525202,0.000059557136,0.00001683504,0.017790955],"study_design_scores_gemma":[0.02390013,0.001714297,0.9547755,0.0008859035,0.00037550484,0.000576399,0.005580144,0.0049790745,0.006408821,0.000045128392,0.00035437566,0.00040470946],"about_ca_topic_score_codex":0.14610618,"about_ca_topic_score_gemma":0.39369774,"teacher_disagreement_score":0.24759157,"about_ca_system_score_codex":0.00018990699,"about_ca_system_score_gemma":0.00044921244,"threshold_uncertainty_score":0.85958},"labels":[],"label_agreement":null},{"id":"W4399419913","doi":"10.1016/j.jtct.2024.06.001","title":"Trends in Outcomes After Upfront Autologous Transplant for Multiple Myeloma Over Three Decades","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Cancer Institute; National Institutes of Health; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Paula and Rodger Riney Foundation; University of Texas MD Anderson Cancer Center; Leukemia and Lymphoma Society","keywords":"Lenalidomide; Medicine; Multiple myeloma; Carfilzomib; Internal medicine; Bortezomib; Oncology; Transplantation; Autologous stem-cell transplantation; Hematopoietic stem cell transplantation; Surgery","score_opus":0.02872631718296677,"score_gpt":0.3155118879821562,"score_spread":0.2867855707991894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399419913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98840564,0.0054577896,0.0045143166,0.00050752243,0.00009517375,0.000581912,0.00020407683,0.00009241166,0.00014113491],"genre_scores_gemma":[0.9962214,0.0018057304,0.0005486957,0.00012655872,0.000034654604,0.00026310363,0.00049495493,0.00003132995,0.0004735608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989325,0.000031774063,0.00022863735,0.00032067197,0.00019076945,0.00029565502],"domain_scores_gemma":[0.99958867,0.00014204078,0.000014518144,0.00011600187,0.000015924992,0.00012285514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001162692,0.00019880205,0.00027170047,0.0003189467,0.000047428257,0.000040723502,0.00004168866,0.00010584072,0.00023656733],"category_scores_gemma":[0.0000021051176,0.00014078243,0.0001481344,0.0001409121,0.000048304013,0.00009234183,0.000001765883,0.00012433031,0.000009873205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056401063,0.00024438003,0.7191893,0.00039904466,0.00034189827,0.0011027935,0.0026404213,0.0000032552346,0.013273216,0.00021554802,0.00002618862,0.25692388],"study_design_scores_gemma":[0.00878679,0.0003276086,0.9736255,0.00014768764,0.00008794105,0.00006055045,0.000027001564,0.0048384196,0.010638886,0.00015225812,0.0011416376,0.0001657397],"about_ca_topic_score_codex":0.00012757769,"about_ca_topic_score_gemma":0.0007833746,"teacher_disagreement_score":0.25675815,"about_ca_system_score_codex":0.000033180837,"about_ca_system_score_gemma":0.000030592724,"threshold_uncertainty_score":0.5740941},"labels":[],"label_agreement":null},{"id":"W4399654151","doi":"10.1016/j.jtct.2024.06.010","title":"Leveraging Hematopoietic Cell Transplant Data and Biorepository Resources at the Center for International Blood and Marrow Transplant Research to Improve Patient Outcomes","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; National Heart, Lung, and Blood Institute; Legend Biotech; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; Health Resources and Services Administration; Syndax Pharmaceuticals; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Gateway for Cancer Research; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen","keywords":"Biorepository; Hematopoietic cell; Medicine; Bone marrow transplant; Intensive care medicine; Bone transplantation; Haematopoiesis; Hematologic Neoplasms; Bone marrow; Bone marrow transplantation; Immunology; Internal medicine; Transplantation; Stem cell; Bioinformatics; Surgery; Biology","score_opus":0.038812023546319865,"score_gpt":0.3062114087726352,"score_spread":0.26739938522631534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399654151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855283,0.004556651,0.0033427705,0.0032708722,0.0004667592,0.0014644153,0.000920014,0.00007030553,0.00037994655],"genre_scores_gemma":[0.99075496,0.0068446803,0.0004126946,0.00048319157,0.00010259451,0.00011862961,0.00077007414,0.00004957198,0.0004635813],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979147,0.00012746568,0.00042455446,0.0007088152,0.0004931213,0.00033138364],"domain_scores_gemma":[0.99884367,0.00047988765,0.00003861452,0.00034068743,0.00010099115,0.00019614074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069413066,0.0002606833,0.00027628135,0.0002139854,0.00029777267,0.00017046418,0.00017107438,0.00010853868,0.000040283536],"category_scores_gemma":[0.0000059534877,0.00017886572,0.00006564901,0.00011978758,0.0001533083,0.00012741705,0.000022053968,0.00022824007,0.0000058402443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035087299,0.00038460217,0.03900056,0.004414019,0.0007360878,0.00055778265,0.14459908,0.0000050171907,0.7874705,0.00025948585,0.00045030742,0.018613774],"study_design_scores_gemma":[0.015537502,0.0017179478,0.014440913,0.0025909988,0.0013966379,0.0021678035,0.005055698,0.0030585413,0.89365864,0.00023915425,0.05906913,0.001067048],"about_ca_topic_score_codex":0.00004373258,"about_ca_topic_score_gemma":0.000022317188,"teacher_disagreement_score":0.13954338,"about_ca_system_score_codex":0.000024412053,"about_ca_system_score_gemma":0.000036890327,"threshold_uncertainty_score":0.72939324},"labels":[],"label_agreement":null},{"id":"W4399767333","doi":"10.1016/j.jtct.2024.05.012","title":"Diagnosis of Post-Hematopoietic Stem Cell Transplantation Bronchiolitis Obliterans Syndrome in Children: Time for a Rethink?","year":2024,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital","funders":"National Institutes of Health","keywords":"Bronchiolitis obliterans; Hematopoietic stem cell transplantation; Medicine; Stem cell; Transplantation; Bronchiolitis; Intensive care medicine; Internal medicine; Biology; Lung transplantation; Respiratory system; Genetics","score_opus":0.0278699518766755,"score_gpt":0.31068345491709254,"score_spread":0.282813503040417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399767333","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031330224,0.96076965,0.0017282786,0.00008494511,0.00014318102,0.0034378404,0.0023032739,0.000094012474,0.000108568194],"genre_scores_gemma":[0.005121183,0.98746455,0.0014108462,0.000102664104,0.00005167965,0.0005018033,0.004772588,0.00013460143,0.000440101],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99706787,0.00030299474,0.0012587545,0.00067767734,0.00033144327,0.00036124518],"domain_scores_gemma":[0.99873674,0.0004926086,0.00026757168,0.00028021823,0.00007243225,0.00015043079],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048641016,0.0006410829,0.0020174899,0.00067406375,0.00006465558,0.00004980782,0.00015056459,0.00050797244,0.000075944205],"category_scores_gemma":[0.0000017072373,0.0005092528,0.0007692778,0.0004313775,0.00008579639,0.00012508986,0.0000030199842,0.0004268381,0.000022283546],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007619812,0.00040438195,0.0007914763,0.22379358,0.00091104856,0.000516413,0.011397692,0.0000019101558,0.00034651568,0.00063092343,0.000013596764,0.76043046],"study_design_scores_gemma":[0.09296192,0.012923148,0.03608814,0.45548397,0.11870823,0.04240042,0.001248042,0.0002615269,0.0259743,0.0032643012,0.19827415,0.012411853],"about_ca_topic_score_codex":0.000047802067,"about_ca_topic_score_gemma":0.000007713387,"teacher_disagreement_score":0.7480186,"about_ca_system_score_codex":0.000045152217,"about_ca_system_score_gemma":0.0001826282,"threshold_uncertainty_score":0.9997359},"labels":[],"label_agreement":null},{"id":"W4399880973","doi":"10.1016/j.jtct.2024.06.018","title":"Applying Implementation Science in the Field of Transplant and Cellular Therapy","year":2024,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Health Policy Implementation Science","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; NYU Grossman School of Medicine; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Seagen; BeiGene; Astellas Pharma; Adaptive Biotechnologies; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; Amgen; Rush University; HistoGenetics; U.S. Public Health Service; U.S. Department of Defense; Sanofi; GlaxoSmithKline; National Institute on Aging; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; U.S. Navy; Gateway for Cancer Research; Actinium Pharmaceuticals; CareDx; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Incyte; Pfizer; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences","keywords":"Field (mathematics); Computer science; Mathematics","score_opus":0.4059776011179404,"score_gpt":0.6240151996592307,"score_spread":0.2180375985412903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399880973","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013764389,0.9770785,0.00093405286,0.0008593529,0.0004002192,0.006193975,0.00023649207,0.00004337945,0.000489667],"genre_scores_gemma":[0.0153960865,0.9802899,0.00007894005,0.0027007626,0.00008799578,0.001268895,0.000109573615,0.00003147994,0.0000363645],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99579054,0.0011477576,0.0013526271,0.0005379402,0.0006103205,0.00056079193],"domain_scores_gemma":[0.99741125,0.0017124908,0.00040638208,0.00028591734,0.00006415235,0.00011982011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004025744,0.00034506147,0.00072306616,0.0005927024,0.00056947174,0.00005786669,0.0004093948,0.00019999099,0.0001785166],"category_scores_gemma":[0.000015421434,0.00021935873,0.00010444561,0.001080359,0.00022950108,0.00021854058,0.000014978622,0.00066537195,0.000017824374],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051642928,0.00002577568,0.00024979815,0.01423665,0.000030994306,0.000020198864,0.053695742,1.3403269e-7,0.00093395653,0.002248384,0.00012660079,0.92838013],"study_design_scores_gemma":[0.0022078305,0.00028307532,0.00019337273,0.0048307884,0.00022708492,0.00002297936,0.0057095736,0.00001815563,0.00091419334,0.00036583215,0.9847842,0.00044295465],"about_ca_topic_score_codex":0.00044709397,"about_ca_topic_score_gemma":0.00017314545,"teacher_disagreement_score":0.9846576,"about_ca_system_score_codex":0.000058104357,"about_ca_system_score_gemma":0.0007858134,"threshold_uncertainty_score":0.894519},"labels":[],"label_agreement":null},{"id":"W4400094794","doi":"10.1016/j.jtct.2024.06.021","title":"Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Seagen; Swedish Orphan Biovitrum; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Gateway for Cancer Research; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Data collection; Family medicine; Statistics","score_opus":0.10707180535396116,"score_gpt":0.3926015508572358,"score_spread":0.28552974550327465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400094794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853495,0.0021030596,0.00060028036,0.0106904525,0.00017648927,0.00091659353,0.00011670471,0.000014568727,0.000032347925],"genre_scores_gemma":[0.976904,0.021169035,0.0000324349,0.00017826198,0.000033212633,0.00009595111,0.0015466957,0.00001267595,0.000027746994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838096,0.0003184103,0.00031216172,0.000366277,0.00043939258,0.00018279302],"domain_scores_gemma":[0.99924374,0.00041914414,0.000050126993,0.00018083464,0.00006834957,0.00003778071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001662284,0.00014844944,0.0001968711,0.000501974,0.000121265715,0.000095936266,0.000115542425,0.00011670286,0.0000069621715],"category_scores_gemma":[0.00001705923,0.00008257465,0.00003283157,0.00057008764,0.00021496664,0.00012782602,0.000009619276,0.00051717117,7.78385e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00464616,0.002173079,0.6927004,0.0007125183,0.00043939106,0.0003271529,0.107068166,0.000008409957,0.020670563,0.0014715045,0.00009811315,0.16968456],"study_design_scores_gemma":[0.016742894,0.0007138337,0.9468377,0.00064243237,0.000100900135,0.00009056984,0.002570158,0.018563444,0.004246286,0.0021491768,0.0070514046,0.00029115108],"about_ca_topic_score_codex":0.0004267639,"about_ca_topic_score_gemma":0.00043623763,"teacher_disagreement_score":0.25413737,"about_ca_system_score_codex":0.00003211558,"about_ca_system_score_gemma":0.000045763347,"threshold_uncertainty_score":0.33672962},"labels":[],"label_agreement":null},{"id":"W4400345395","doi":"10.1016/j.jtct.2024.06.030","title":"Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group Database","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Memorial University of Newfoundland; University of Alberta; Université de Montréal; University of Saskatchewan; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Saskatchewan Cancer Agency; CancerCare Manitoba; Ottawa Hospital; Ottawa Regional Cancer Foundation; Juravinski Cancer Centre; Institute of Cancer Research; Saint John Regional Hospital; BC Cancer Agency; University of Calgary; Princess Margaret Cancer Centre; University of British Columbia; Alberta Cancer Foundation; McGill University","funders":"","keywords":"Medicine; Multiple myeloma; Transplantation; Autologous stem-cell transplantation; Internal medicine; Oncology; Bortezomib; Regimen; Maintenance therapy; Cyclophosphamide; Cohort; Surgery; Chemotherapy","score_opus":0.03335916754604702,"score_gpt":0.2918436707820194,"score_spread":0.2584845032359724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400345395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98908985,0.0008234343,0.00011593502,0.003001268,0.00018332253,0.0015447121,0.0040673367,0.000059100974,0.0011150534],"genre_scores_gemma":[0.9681422,0.024823356,0.00013737947,0.00033771293,0.000120986784,0.00013856556,0.0056992653,0.000038915103,0.0005616357],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966589,0.00068764226,0.0004773406,0.00064589485,0.00088983536,0.000640347],"domain_scores_gemma":[0.9980509,0.0010540861,0.000065258406,0.00046137086,0.00011675701,0.00025157796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013902003,0.0002830608,0.00026999685,0.0003493622,0.0006220265,0.00022427397,0.00026798103,0.0001361322,0.000054959964],"category_scores_gemma":[0.000010634964,0.0001478386,0.000084966,0.0006122147,0.00019058431,0.00019200683,0.000007400393,0.0008167627,0.000042477095],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025028603,0.0011805466,0.3448961,0.000934967,0.00084429374,0.011114915,0.07673422,0.000044466924,0.019487917,0.008116768,0.0011606285,0.51045656],"study_design_scores_gemma":[0.00896657,0.00042334225,0.97246206,0.00038739742,0.00012513115,0.000019307627,0.00074391847,0.0007010739,0.013913974,0.0004299261,0.0016036842,0.00022363343],"about_ca_topic_score_codex":0.30135328,"about_ca_topic_score_gemma":0.65967524,"teacher_disagreement_score":0.6275659,"about_ca_system_score_codex":0.00020316405,"about_ca_system_score_gemma":0.00022448102,"threshold_uncertainty_score":0.70329905},"labels":[],"label_agreement":null},{"id":"W4400363329","doi":"10.1016/j.jtct.2024.06.029","title":"Reproductive Health Assessment and Reports of Fertility Counseling in Pediatric and Adolescent Patients with Sickle Cell Disease After Hematopoietic Cell Transplantation","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; bluebird bio; National Institutes of Health; Abraham J. and Phyllis Katz Foundation","keywords":"Disease; Fertility; Transplantation; Fertility preservation; Hematopoietic cell; Savior sibling; Medicine; Hematopoietic stem cell transplantation; Cell; Pediatrics; Haematopoiesis; Intensive care medicine; Stem cell; Internal medicine; Biology; Genetics; Population; Environmental health","score_opus":0.005454379419548169,"score_gpt":0.23549461215626172,"score_spread":0.23004023273671353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400363329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734091,0.024346747,0.0011666768,0.0002690277,0.000046666606,0.00067529967,0.000023901308,0.000022204775,0.000040376086],"genre_scores_gemma":[0.9550851,0.044492275,0.00012454674,0.00011093788,0.000010339077,0.000017136768,0.0001267855,0.000016001586,0.000016896593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989215,0.00006263112,0.00031985284,0.000366747,0.00019608483,0.00013317565],"domain_scores_gemma":[0.9996442,0.00002044832,0.00006732649,0.00010769323,0.00003775099,0.00012257749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022618404,0.0001391853,0.0002041905,0.000104175844,0.000040151892,0.000017425375,0.000010898774,0.000048900205,0.000008861869],"category_scores_gemma":[5.918317e-7,0.000105366256,0.000025624273,0.00013274889,0.000051586067,0.00007740132,0.0000014764762,0.00014298061,2.1416929e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003115358,0.0007855042,0.962723,0.012955414,0.000027950759,0.00042691478,0.0149193555,0.000035397654,0.0012593889,0.000009577916,0.00000664567,0.0037354855],"study_design_scores_gemma":[0.0029525813,0.0003709148,0.99346,0.0004886175,0.00018268659,0.00002158702,0.00034951116,0.00015638085,0.0017808543,0.00007367123,0.000020799933,0.00014241388],"about_ca_topic_score_codex":0.000026622198,"about_ca_topic_score_gemma":0.0000053727713,"teacher_disagreement_score":0.030736975,"about_ca_system_score_codex":0.000020390738,"about_ca_system_score_gemma":0.0001039095,"threshold_uncertainty_score":0.4296711},"labels":[],"label_agreement":null},{"id":"W4400390802","doi":"10.1016/j.jtct.2024.06.025","title":"Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society for Transplantation and Cellular Therapy and the European Society for Blood and Marrow Transplantation","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Follicular lymphoma; Transplantation; Chimeric antigen receptor; Lymphoma; Hematopoietic cell; Hematopoietic stem cell transplantation; Cell therapy; Oncology; Intensive care medicine; Immunology; Internal medicine; Stem cell; Haematopoiesis; T cell; Biology; Immune system","score_opus":0.02285975617575238,"score_gpt":0.3010973140132257,"score_spread":0.27823755783747334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400390802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96095455,0.016482038,0.01228291,0.004995322,0.00010854985,0.0044042226,0.00067338056,0.000041862808,0.000057173886],"genre_scores_gemma":[0.8072185,0.1866235,0.003953213,0.0008225914,0.00006953724,0.0005645845,0.0006598383,0.000057613008,0.00003064054],"study_design_codex":"qualitative","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977288,0.00036794483,0.0007150499,0.00065106276,0.00025844597,0.0002786991],"domain_scores_gemma":[0.99737847,0.0019041977,0.00028807242,0.00018550313,0.00013731548,0.000106421634],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014547136,0.00040890943,0.00059878075,0.00008557908,0.0004212679,0.00013496126,0.00007667659,0.00014466561,0.0000028559605],"category_scores_gemma":[0.000007327409,0.00026966786,0.00040272492,0.00025476638,0.00049844914,0.0002289983,0.000004009709,0.00013907313,1.8661923e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053005014,0.0050997343,0.022951597,0.017403705,0.007712387,0.00019543248,0.345907,0.000053518394,0.25684798,0.017105116,0.00042196646,0.27329654],"study_design_scores_gemma":[0.26411602,0.011655712,0.09096674,0.0032326323,0.018403832,0.0008622653,0.027045673,0.00668006,0.557115,0.0039573875,0.013689865,0.0022747703],"about_ca_topic_score_codex":0.00007934985,"about_ca_topic_score_gemma":0.000036127876,"teacher_disagreement_score":0.31886134,"about_ca_system_score_codex":0.000027462835,"about_ca_system_score_gemma":0.00009380038,"threshold_uncertainty_score":0.99997556},"labels":[],"label_agreement":null},{"id":"W4400856110","doi":"10.1016/j.jtct.2024.07.009","title":"Impact of Race and Ethnicity on Outcomes After Umbilical Cord Blood Transplantation","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Pharmacyclics; Takeda Oncology; Genentech; Health Resources and Services Administration; MorphoSys; Seagen; Legend Biotech; Sangamo Therapeutics; BeiGene; Astellas Pharma; Adaptive Biotechnologies; Kiadis Pharma; bluebird bio; Jazz Pharmaceuticals; CSL Behring; St. Jude Children's Research Hospital; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; Bristol-Myers Squibb; AstraZeneca; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Incyte; Pfizer; Gateway for Cancer Research; American Society of Hematology","keywords":"Umbilical cord; Race (biology); Umbilical Cord Blood Transplantation; Ethnic group; Medicine; Transplantation; Surgery; Political science; Hematopoietic stem cell transplantation; Gender studies; Sociology; Immunology","score_opus":0.02096434626511588,"score_gpt":0.31129659666820964,"score_spread":0.29033225040309374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400856110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99284524,0.0017114627,0.0039978484,0.00023276055,0.000075015414,0.00049934187,0.000116236624,0.00008670318,0.00043541443],"genre_scores_gemma":[0.98488754,0.014329729,0.00025945436,0.00012444798,0.000026708647,0.000029304825,0.00016211656,0.000031829077,0.0001488781],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99876785,0.000086000764,0.00035265827,0.0003372164,0.00028050627,0.00017578452],"domain_scores_gemma":[0.9994153,0.00023527555,0.00004020051,0.00013936435,0.00003799673,0.00013185633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019881217,0.00023046162,0.0003594092,0.00016862938,0.000039000974,0.000029464489,0.000033356297,0.00014199427,0.00018041125],"category_scores_gemma":[0.0000025803097,0.00017069763,0.00015868172,0.00015036082,0.00009912992,0.0001003193,0.0000012066238,0.00018434292,0.00000970775],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02084106,0.0010223088,0.3232966,0.0067079975,0.0014398297,0.001697913,0.023030244,0.000025508956,0.5772894,0.001891817,0.000021786367,0.042735532],"study_design_scores_gemma":[0.006539303,0.0019754989,0.83851945,0.0007622178,0.00081844354,0.00077580236,0.000077916375,0.00038342836,0.14961804,0.00017958706,0.000048173148,0.00030213193],"about_ca_topic_score_codex":0.0000636928,"about_ca_topic_score_gemma":0.000009053263,"teacher_disagreement_score":0.51522285,"about_ca_system_score_codex":0.000014689883,"about_ca_system_score_gemma":0.000049013095,"threshold_uncertainty_score":0.69608474},"labels":[],"label_agreement":null},{"id":"W4401015063","doi":"10.1016/j.jtct.2024.07.011","title":"In Pursuit of Optimal Outcomes: A Framework for Quality Standards in Immune Effector Cell Therapy","year":2024,"lang":"en","type":"editorial","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Accreditation; Quality assurance; Transformative learning; Medicine; Quality (philosophy); Multidisciplinary approach; Process management; Business; Medical education; Psychology; External quality assessment; Political science","score_opus":0.026715483915577723,"score_gpt":0.38192068123047324,"score_spread":0.3552051973148955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401015063","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7454265,0.03887847,0.006817237,0.0008493848,0.19484638,0.007958449,0.004515456,0.00012189349,0.00058626494],"genre_scores_gemma":[0.24602708,0.47332013,0.006097032,0.00074622757,0.24086161,0.0033161002,0.011531511,0.0013300701,0.01677026],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960404,0.00034387977,0.0009858236,0.000644629,0.0015243442,0.0004609162],"domain_scores_gemma":[0.99703985,0.0019965938,0.00018708651,0.00042788213,0.00023308,0.000115473216],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028775684,0.0004958799,0.0013788838,0.000557997,0.0000367012,0.000068282534,0.00025860392,0.0010237937,0.0007449775],"category_scores_gemma":[0.00007554647,0.00040926755,0.0004129225,0.00038681418,0.00013461622,0.00007800608,0.000011164352,0.0013046588,0.000005260642],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.103471875,0.0026102709,0.002694139,0.020276733,0.0013618895,0.00060594373,0.025390845,0.000033689837,0.7866073,0.0006011962,0.026752697,0.029593399],"study_design_scores_gemma":[0.052588318,0.0047574835,0.0027484542,0.0028211954,0.00021234734,0.0000073553897,0.0005381401,0.00008652641,0.27848604,0.0013284379,0.6552438,0.0011819007],"about_ca_topic_score_codex":0.00040468917,"about_ca_topic_score_gemma":0.000058314294,"teacher_disagreement_score":0.6284911,"about_ca_system_score_codex":0.00021161427,"about_ca_system_score_gemma":0.00058641436,"threshold_uncertainty_score":0.9998359},"labels":[],"label_agreement":null},{"id":"W4402031327","doi":"10.1016/j.jtct.2024.08.015","title":"CAST Regimen for GvHD Prophylaxis: A CIBMTR Propensity Score-Matched Analysis","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; NYU Grossman School of Medicine; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Seagen; BeiGene; Astellas Pharma; Adaptive Biotechnologies; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; Amgen; Rush University; HistoGenetics; U.S. Public Health Service; U.S. Department of Defense; Sanofi; GlaxoSmithKline; National Institute on Aging; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; U.S. Navy; Gateway for Cancer Research; Actinium Pharmaceuticals; CareDx; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Incyte; Pfizer; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences","keywords":"Propensity score matching; Regimen; Medicine; Internal medicine; Oncology","score_opus":0.11625762325215465,"score_gpt":0.3826355467407397,"score_spread":0.266377923488585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402031327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95283675,0.0046839924,0.037414603,0.0013831668,0.00043303808,0.002204441,0.00014811815,0.00020788745,0.0006880045],"genre_scores_gemma":[0.99278414,0.0040167905,0.00020001351,0.00048684957,0.0003177729,0.00016054246,0.00040605853,0.000027176138,0.0016006663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855167,0.0002617066,0.00035953,0.00034040547,0.00016575766,0.00032090707],"domain_scores_gemma":[0.99937886,0.00017148821,0.00006914942,0.0001526132,0.000095302305,0.00013257771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005428642,0.00015892189,0.0002907784,0.0001940775,0.00044083287,0.000029171655,0.00007175989,0.00018827435,0.00026147152],"category_scores_gemma":[0.0000044192857,0.000121851655,0.0001232195,0.00048473576,0.000030939937,0.00010119624,0.0000044756216,0.00030457898,0.00004355194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005379571,0.00036214496,0.54640615,0.023160849,0.0025504502,0.00036769366,0.16584125,0.00004328301,0.013166785,0.008772658,0.003817131,0.23013204],"study_design_scores_gemma":[0.02743975,0.0038481725,0.6778856,0.0020750698,0.0069652484,0.0000465098,0.015606171,0.012461524,0.011823599,0.0062211803,0.23131453,0.0043126405],"about_ca_topic_score_codex":0.00019219128,"about_ca_topic_score_gemma":0.00015415327,"teacher_disagreement_score":0.22749738,"about_ca_system_score_codex":0.000036735077,"about_ca_system_score_gemma":0.0001910693,"threshold_uncertainty_score":0.49689662},"labels":[],"label_agreement":null},{"id":"W4403464661","doi":"10.1016/j.jtct.2024.10.008","title":"A Pilot Study of UM171-Expanded Cord Blood Grafts for Tandem Auto/Allogeneic Hematopoietic Cell Transplant in High and Ultra-High-Risk Myeloma Patients","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Multiple myeloma; Cord blood; Transplantation; Internal medicine; CD34; Hematopoietic stem cell transplantation; Gastroenterology; Oncology; Surgery; Immunology; Stem cell; Biology","score_opus":0.021304694824276976,"score_gpt":0.2703610820459259,"score_spread":0.24905638722164894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403464661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99478126,0.0020357054,0.000622967,0.00003418846,0.00007580792,0.0021575834,0.00021599035,0.000047606532,0.000028903154],"genre_scores_gemma":[0.9910656,0.008054048,0.0001466457,0.000024267369,0.00001976905,0.00017820812,0.00040398535,0.00003631587,0.00007113705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984985,0.000120276825,0.00039048638,0.00040938397,0.00030566147,0.00027566895],"domain_scores_gemma":[0.9994116,0.00018470903,0.000058610658,0.00014314767,0.00005002095,0.00015195837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019265624,0.00024024954,0.0004016706,0.00022285218,0.00008314765,0.000030814623,0.00005605529,0.00005794676,0.000028034983],"category_scores_gemma":[0.000003144724,0.00018591246,0.000055658045,0.00017759042,0.000055596036,0.000066886096,0.0000023934706,0.0001500287,0.0000019131019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012843061,0.007972536,0.7486913,0.0020900883,0.00087669713,0.00061076635,0.012028027,0.000007368877,0.19327989,0.0001353526,0.00000621284,0.021458698],"study_design_scores_gemma":[0.06614607,0.026537541,0.7080974,0.00044306248,0.0008448743,0.00005758514,0.0004932524,0.0002216295,0.19647054,0.0003261084,0.00002116512,0.00034078624],"about_ca_topic_score_codex":0.0005397493,"about_ca_topic_score_gemma":0.00027308657,"teacher_disagreement_score":0.053303007,"about_ca_system_score_codex":0.00001651107,"about_ca_system_score_gemma":0.00004675887,"threshold_uncertainty_score":0.75812906},"labels":[],"label_agreement":null},{"id":"W4403634972","doi":"10.1016/j.jtct.2024.10.011","title":"Real-World Outcomes of Upfront Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma With Deletion 17p","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Leukemia and Lymphoma Society","keywords":"Multiple myeloma; Medicine; Hematopoietic stem cell transplantation; Stem cell; Autologous stem-cell transplantation; Transplantation; Oncology; Internal medicine; Biology; Genetics","score_opus":0.013130217495050202,"score_gpt":0.25231359619047644,"score_spread":0.23918337869542625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403634972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952452,0.00043714105,0.002701776,0.00009706034,0.000032443775,0.00107294,0.000072184266,0.000072918134,0.0002683381],"genre_scores_gemma":[0.9959495,0.002350481,0.0006551773,0.000030635754,0.000008047522,0.000076205564,0.0006842022,0.000036303147,0.00020941786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986503,0.00008642151,0.00030748188,0.00032149893,0.00039225142,0.00024200666],"domain_scores_gemma":[0.999471,0.00014758261,0.000059673665,0.00014535224,0.000060126647,0.000116284675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099484,0.00022700014,0.00035198004,0.00029439028,0.000048999493,0.0000259506,0.000045374287,0.00006854298,0.000038914335],"category_scores_gemma":[6.6219394e-7,0.00014870832,0.000054378248,0.00026724103,0.00006912238,0.00013034463,0.0000015840427,0.00013759757,0.0000064922683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008924519,0.0006295527,0.9562074,0.0011935297,0.00021473672,0.00078282173,0.004871222,0.00006664811,0.0038124588,0.000084129875,0.0000032634414,0.023209749],"study_design_scores_gemma":[0.018772723,0.0012036213,0.937961,0.0003893421,0.00014552989,0.000016276164,0.00015993675,0.0006323549,0.0405119,0.000010598887,0.000025618363,0.00017109547],"about_ca_topic_score_codex":0.00044456264,"about_ca_topic_score_gemma":0.00071193837,"teacher_disagreement_score":0.03669944,"about_ca_system_score_codex":0.000049046375,"about_ca_system_score_gemma":0.00007196154,"threshold_uncertainty_score":0.6064149},"labels":[],"label_agreement":null},{"id":"W4404289579","doi":"10.1016/j.jtct.2024.11.004","title":"Systematic Review and Meta-Analysis of Extracorporeal Photopheresis for the Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease","year":2024,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Extracorporeal Photopheresis; Medicine; Refractory (planetary science); Graft-versus-host disease; Photopheresis; Meta-analysis; Extracorporeal; Disease; Steroid use; Surgery; Internal medicine; Biology","score_opus":0.1024581382061332,"score_gpt":0.36045173390868324,"score_spread":0.25799359570255004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404289579","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007045173,0.99070305,0.0008337143,0.00005356955,0.000050591545,0.0067691365,0.0014818533,0.000019596075,0.000018032557],"genre_scores_gemma":[0.0005644619,0.9964906,0.000049971306,0.000033012835,0.00001917033,0.0013234112,0.0011151823,0.000053112937,0.00035109784],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9976355,0.0002436011,0.0012512548,0.00041198,0.00030298816,0.00015468961],"domain_scores_gemma":[0.99784493,0.0009234303,0.0005677861,0.0004654594,0.00007592217,0.00012249235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034706338,0.00048290822,0.0046729916,0.00025365845,0.000049082733,0.000017795208,0.000094680356,0.0001332559,0.00016347198],"category_scores_gemma":[0.0000042001666,0.00024354298,0.0023665829,0.0003917196,0.000108473214,0.000035551348,0.0000018765054,0.00008508346,0.0000022076144],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022967295,0.00014379277,4.966313e-7,0.8359631,0.15990615,0.000021065862,0.00041889798,3.953088e-7,0.000045198954,0.00006096719,0.0000034647003,0.0032068407],"study_design_scores_gemma":[0.0012513489,0.000550091,0.000004629522,0.025315795,0.96734047,0.000015424448,0.00003097513,0.000033944838,0.00012985517,0.0000032084417,0.005137486,0.0001867891],"about_ca_topic_score_codex":0.000028025646,"about_ca_topic_score_gemma":0.000024851455,"teacher_disagreement_score":0.81064725,"about_ca_system_score_codex":0.000053581716,"about_ca_system_score_gemma":0.00015056398,"threshold_uncertainty_score":0.99313945},"labels":[],"label_agreement":null},{"id":"W4404360519","doi":"10.1016/j.jtct.2024.11.006","title":"Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDS","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; Juravinski Cancer Centre; Hamilton Health Sciences; Population Health Research Institute; McMaster University; Ontario Clinical Oncology Group","funders":"","keywords":"Stem cell; Immunology; Medicine; Oncology; Biology; Genetics","score_opus":0.019292194187998435,"score_gpt":0.25565027323182016,"score_spread":0.23635807904382172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404360519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766757,0.0040938007,0.016537154,0.00034098758,0.0001233959,0.0017403648,0.00022995124,0.0000906526,0.00016797682],"genre_scores_gemma":[0.99109554,0.007329556,0.000659625,0.00016771325,0.00004760997,0.00022719696,0.00022951573,0.000055181667,0.00018808234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846935,0.000083566694,0.00041928486,0.0004988536,0.000221099,0.00030784938],"domain_scores_gemma":[0.99939924,0.00023919316,0.000053636955,0.00011886764,0.000024356443,0.00016470632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024181837,0.00028336188,0.00036030888,0.00026030096,0.00007753204,0.000068994304,0.000056678244,0.00017260361,0.000049401206],"category_scores_gemma":[6.784707e-7,0.00024557806,0.00009269711,0.00018436991,0.000084326886,0.00012611726,0.00000175886,0.00019694914,0.000010166377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057658185,0.0006083926,0.10054329,0.012006395,0.00073291565,0.0009662944,0.17434664,0.000011356005,0.6520825,0.0016010685,0.000049166352,0.05128615],"study_design_scores_gemma":[0.0163576,0.0017255303,0.15590836,0.0017260457,0.0009042993,0.00036779515,0.0015842104,0.002575995,0.8170004,0.0003284279,0.0007270324,0.0007943277],"about_ca_topic_score_codex":0.00006161195,"about_ca_topic_score_gemma":0.000018133864,"teacher_disagreement_score":0.17276244,"about_ca_system_score_codex":0.00002322173,"about_ca_system_score_gemma":0.00008233628,"threshold_uncertainty_score":0.99999964},"labels":[],"label_agreement":null},{"id":"W4405256727","doi":"10.1016/j.jtct.2024.10.012","title":"Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; California Department of Fish and Game; Else Kröner-Fresenius-Stiftung; Swedish Orphan Biovitrum; José Carreras Leukämie-Stiftung; Deutsche Forschungsgemeinschaft; National Institutes of Health; Incyte; bluebird bio; Sanofi; Pfizer; Pediatric Cancer Foundation","keywords":"Biomarker; Host (biology); Medicine; Disease; Graft-versus-host disease; Internal medicine; Oncology; Biology; Genetics","score_opus":0.05700109801051992,"score_gpt":0.34065139158781654,"score_spread":0.28365029357729665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405256727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99261165,0.0030474954,0.002155084,0.000039374896,0.0010294869,0.0005806803,0.00028090083,0.00019258414,0.00006274191],"genre_scores_gemma":[0.9373101,0.061565723,0.00017554879,0.000005249544,0.00039691184,0.00003827502,0.0004099371,0.000047203095,0.000051024846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980921,0.00029751938,0.0005009704,0.0005893106,0.0002693754,0.00025071995],"domain_scores_gemma":[0.9989706,0.00033941664,0.00008282941,0.00021895723,0.00003412189,0.00035406553],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042814974,0.000301378,0.00032176354,0.0001306541,0.00031044232,0.00018670862,0.000053277003,0.00012139279,0.00005027496],"category_scores_gemma":[0.000012727217,0.00024832133,0.00013158328,0.0001351642,0.00014254116,0.00030524004,0.0000027997467,0.0001872839,0.000008813179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017101929,0.0005446762,0.56397927,0.0023309772,0.00095015735,0.0012996165,0.008663153,0.000009194562,0.37455428,0.00010972559,0.0000022807362,0.030454742],"study_design_scores_gemma":[0.013690801,0.0007261286,0.8647047,0.0008611157,0.0014988933,0.0000651767,0.0008132987,0.00086463173,0.11617227,0.000096692056,0.000074952484,0.000431313],"about_ca_topic_score_codex":0.00016432682,"about_ca_topic_score_gemma":0.0000721583,"teacher_disagreement_score":0.30072543,"about_ca_system_score_codex":0.000034343986,"about_ca_system_score_gemma":0.00005021949,"threshold_uncertainty_score":0.9999969},"labels":[],"label_agreement":null},{"id":"W4405493927","doi":"10.1016/j.jtct.2024.12.011","title":"Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part I. Phases of Chronic GVHD, Supportive Care, and Systemic Therapy Discontinuation","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Hospital for Sick Children","funders":"National Heart, Lung, and Blood Institute; National Cancer Institute; National Institutes of Health; Pediatric Blood and Marrow Transplant Consortium; Pediatric Transplantation and Cellular Therapy Consortium; U.S. Department of Veterans Affairs","keywords":"Medicine; Hematopoietic cell; Discontinuation; Hematopoietic stem cell transplantation; Disease; Transplantation; Graft-versus-host disease; Survivorship curve; Intensive care medicine; Chronic disease; Immunology; Haematopoiesis; Stem cell; Internal medicine; Cancer; Biology","score_opus":0.021388944430643254,"score_gpt":0.26042968998053306,"score_spread":0.2390407455498898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405493927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8659496,0.12757501,0.0029207286,0.000138542,0.00044842946,0.002051148,0.0005527255,0.00013925273,0.0002245993],"genre_scores_gemma":[0.69199437,0.30658096,0.00002781964,0.000042623662,0.00023607805,0.00020065649,0.0007779328,0.00007097137,0.00006859072],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962805,0.0003695314,0.001035506,0.0010356256,0.00074356265,0.0005352863],"domain_scores_gemma":[0.9983311,0.00046406352,0.0002475705,0.00037261835,0.00016464907,0.00041994298],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042796083,0.0007082677,0.0007612388,0.0004831413,0.00017970258,0.00013460004,0.0001252133,0.00026512725,0.00035200935],"category_scores_gemma":[0.0000031589223,0.0005987689,0.00021981848,0.00042409793,0.00026353003,0.00029387377,0.0000045942907,0.00036058115,0.000012331542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08265867,0.0038729869,0.2151133,0.10126852,0.0017128,0.006906127,0.15296894,0.0001736295,0.39100417,0.0048707817,0.00007391469,0.039376155],"study_design_scores_gemma":[0.07228865,0.014890586,0.12900002,0.0048605558,0.0060619367,0.0007580065,0.0038552096,0.0013613929,0.7626786,0.00025385147,0.0004593243,0.003531827],"about_ca_topic_score_codex":0.000059174934,"about_ca_topic_score_gemma":0.000043985085,"teacher_disagreement_score":0.37167448,"about_ca_system_score_codex":0.00009351227,"about_ca_system_score_gemma":0.00046409646,"threshold_uncertainty_score":0.99964637},"labels":[],"label_agreement":null},{"id":"W4405730724","doi":"10.1016/j.jtct.2024.12.016","title":"Early Engraftment and Immune Kinetics Following Allogeneic Transplant Using a Novel Reduced-Toxicity Transplant Strategy in Children/Adolescents with High-Risk Transfusion-Dependent Thalassemia: Early Results of the ThalFAbS Trial","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; London Health Sciences Centre; University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"Garron Family Cancer Centre; Thalassemia Foundation of Canada","keywords":"Thalassemia; Medicine; Pediatrics; Immune system; Intensive care medicine; Immunology; Internal medicine","score_opus":0.015443717093452538,"score_gpt":0.24277285338761997,"score_spread":0.22732913629416743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405730724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99001205,0.0019064264,0.0048273336,0.00009439235,0.00019247056,0.0024224252,0.0004406025,0.000060345916,0.00004395386],"genre_scores_gemma":[0.9921081,0.0073016803,0.00024132477,0.000024606254,0.000053538595,0.000040784056,0.00014463218,0.000067014334,0.000018342225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99707806,0.00023412763,0.0009318534,0.0006619131,0.0006999402,0.00039408327],"domain_scores_gemma":[0.9992561,0.00010059803,0.00015596568,0.0002991863,0.000038573515,0.00014962189],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054363074,0.00045620702,0.00061400275,0.0002441408,0.00013659333,0.00007219712,0.00014112695,0.00027252614,0.000007329935],"category_scores_gemma":[0.000001964917,0.0003143168,0.00021607538,0.00037776702,0.00013170458,0.00014588646,0.0000039231572,0.0005125037,7.0956503e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02965505,0.00063904806,0.046917055,0.0006899891,0.00048865256,0.00020015542,0.0105357515,0.00027833646,0.90930384,0.00007710643,8.99033e-8,0.001214895],"study_design_scores_gemma":[0.06723399,0.0015597125,0.365228,0.00354096,0.0011908739,0.0005083801,0.00015328305,0.00026252487,0.5599077,0.000041175626,9.999573e-7,0.00037239428],"about_ca_topic_score_codex":0.0015441426,"about_ca_topic_score_gemma":0.00016712757,"teacher_disagreement_score":0.34939617,"about_ca_system_score_codex":0.000052244373,"about_ca_system_score_gemma":0.00012924017,"threshold_uncertainty_score":0.9999309},"labels":[],"label_agreement":null},{"id":"W4405851213","doi":"10.1016/j.jtct.2024.12.019","title":"Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part IV. Patient Important Outcomes","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"National Heart, Lung, and Blood Institute","keywords":"Hematopoietic cell; Survivorship curve; Hematopoietic stem cell transplantation; Graft-versus-host disease; Disease; Medicine; Transplantation; Intensive care medicine; Haematopoiesis; Immunology; Stem cell; Internal medicine; Biology; Cancer","score_opus":0.022106264620687655,"score_gpt":0.252709471311589,"score_spread":0.23060320669090134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405851213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95961064,0.033801705,0.0018553254,0.0007148599,0.0008631919,0.0019172113,0.0005525253,0.00029811254,0.00038641284],"genre_scores_gemma":[0.82256675,0.17553315,0.000067831694,0.00029586875,0.00023944212,0.00026087055,0.0007525544,0.00011059637,0.00017296366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955356,0.00031805923,0.0012199611,0.0012096755,0.0009938688,0.00072283857],"domain_scores_gemma":[0.998033,0.00047214387,0.00019564807,0.000488363,0.00010822886,0.00070264586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046774448,0.000852195,0.0007682832,0.0004951151,0.00023808627,0.00019971811,0.00014977498,0.00029804715,0.00059827813],"category_scores_gemma":[0.000003824477,0.0007006305,0.0003226447,0.00047017072,0.00018027927,0.0002514319,0.000005714717,0.00051535026,0.00006963983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067330875,0.0041457955,0.69077575,0.044819154,0.0015055032,0.026891569,0.069996454,0.00011485521,0.07984222,0.007952687,0.00024344206,0.006381714],"study_design_scores_gemma":[0.083968624,0.013118852,0.5135858,0.004254229,0.0122063635,0.0013457006,0.00228064,0.0026637476,0.35344812,0.0012080999,0.0039951787,0.00792466],"about_ca_topic_score_codex":0.000048763777,"about_ca_topic_score_gemma":0.000041946107,"teacher_disagreement_score":0.2736059,"about_ca_system_score_codex":0.00007685757,"about_ca_system_score_gemma":0.0003611906,"threshold_uncertainty_score":0.9995445},"labels":[],"label_agreement":null},{"id":"W4405941401","doi":"10.1016/j.jtct.2024.12.023","title":"Outcomes of Standard-Risk Multiple Myeloma Patients Who Undergo Upfront Autologous Hematopoietic Stem Cell Transplantation","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Cancer Institute; Paula and Rodger Riney Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","keywords":"Medicine; Multiple myeloma; Hematopoietic stem cell transplantation; Oncology; Stem cell; Transplantation; Internal medicine; Biology","score_opus":0.01573033053922362,"score_gpt":0.26431313494168557,"score_spread":0.24858280440246194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405941401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854524,0.002955592,0.009611449,0.0001053647,0.00011367242,0.0007835546,0.00044993105,0.00010195867,0.00042604367],"genre_scores_gemma":[0.9847122,0.013877215,0.000320862,0.000040791696,0.000014310602,0.00003584177,0.00052701397,0.000037423,0.00043436597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998437,0.00012414112,0.00038085814,0.00033695073,0.00046008104,0.00026097067],"domain_scores_gemma":[0.9993205,0.00019459482,0.000073403404,0.00017197189,0.00007872686,0.00016080089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015089783,0.0002390417,0.00040109458,0.00018269214,0.0001021025,0.000037381233,0.00005947529,0.00011150587,0.000092279435],"category_scores_gemma":[0.0000024207452,0.00017897556,0.00014526724,0.00014336688,0.00007929789,0.000119541415,0.0000031924433,0.00016539023,0.000019690591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006460696,0.00072931475,0.7949983,0.0035524408,0.0008958652,0.00063581835,0.01465428,0.00003214367,0.016288942,0.00032059025,0.00005798141,0.16137363],"study_design_scores_gemma":[0.017117184,0.0015570124,0.7233472,0.0003555043,0.00044881387,0.000051429553,0.000424905,0.0015446781,0.25422126,0.00017077956,0.00044790676,0.00031334997],"about_ca_topic_score_codex":0.000091066766,"about_ca_topic_score_gemma":0.00003556596,"teacher_disagreement_score":0.23793232,"about_ca_system_score_codex":0.000044629225,"about_ca_system_score_gemma":0.00007678152,"threshold_uncertainty_score":0.7298412},"labels":[],"label_agreement":null},{"id":"W4406071558","doi":"10.1016/j.jtct.2024.12.021","title":"Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Memorial University of Newfoundland","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Hematopoietic cell; Medicine; Graft-versus-host disease; Cyclophosphamide; Hematopoietic stem cell transplantation; Disease; Transplantation; Surgery; Oncology; Immunology; Haematopoiesis; Internal medicine; Chemotherapy; Stem cell; Biology","score_opus":0.009559379953059416,"score_gpt":0.24674539727977898,"score_spread":0.23718601732671957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406071558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98117405,0.00095920986,0.01356898,0.0011885802,0.00044884346,0.0018667452,0.0002963672,0.00027816015,0.00021904605],"genre_scores_gemma":[0.9925765,0.003193708,0.0009749943,0.0007373916,0.00004813578,0.00009422157,0.0019847716,0.000093888724,0.00029642382],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99691933,0.00018385984,0.00070709485,0.0009071962,0.00066135207,0.0006211526],"domain_scores_gemma":[0.99837714,0.00022978598,0.00017639312,0.0004923163,0.00026610235,0.00045827875],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032573758,0.0007192217,0.0007671379,0.00040449775,0.0003439899,0.000110817055,0.00018244745,0.00029130475,0.000110933586],"category_scores_gemma":[0.000006704403,0.0005118066,0.000391429,0.0006271622,0.00016695008,0.00022200865,0.0000040114646,0.00041328874,0.00002238245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07066461,0.00066538266,0.1385911,0.004707988,0.00082528853,0.002402622,0.004757544,0.00031578296,0.7761336,0.00014818161,0.000010621562,0.00077728],"study_design_scores_gemma":[0.021428494,0.001943121,0.18606083,0.001732975,0.0025777887,0.00013174124,0.00040525378,0.00018254212,0.7843218,0.00005993581,0.00013904119,0.0010165218],"about_ca_topic_score_codex":0.00020357154,"about_ca_topic_score_gemma":0.0001338345,"teacher_disagreement_score":0.049236115,"about_ca_system_score_codex":0.0000949221,"about_ca_system_score_gemma":0.0004896102,"threshold_uncertainty_score":0.9997333},"labels":[],"label_agreement":null},{"id":"W4406079829","doi":"10.1016/j.jtct.2024.12.024","title":"Impact of Underlying Disease and Total Body Irradiation on the Incidence of Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; Alberta Health Services","funders":"","keywords":"Total body irradiation; Disease; Incidence (geometry); Transplantation; Hematopoietic cell; Graft-versus-host disease; Host (biology); Hematopoietic stem cell transplantation; Haematopoiesis; Medicine; Immunology; Biology; Stem cell; Internal medicine; Genetics; Chemotherapy","score_opus":0.019820441626644914,"score_gpt":0.2865268012815014,"score_spread":0.26670635965485645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406079829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991717,0.001847025,0.0048786206,0.00028841826,0.00007026816,0.00084608764,0.00012093768,0.000024902676,0.00020678254],"genre_scores_gemma":[0.99259466,0.0069031743,0.000066802226,0.000111395486,0.000012048451,0.000050122846,0.00018612447,0.000020173267,0.000055483182],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986365,0.000140016,0.0004292842,0.00029785847,0.00031980828,0.0001765451],"domain_scores_gemma":[0.9990572,0.00033514146,0.00013322219,0.0002326593,0.00007482976,0.0001669749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020623169,0.00023415592,0.00028585037,0.00018976883,0.00008712463,0.00002040173,0.00006189611,0.0000763774,0.00007396914],"category_scores_gemma":[0.000007765379,0.00017215412,0.0001530875,0.00022678914,0.00014652152,0.00010816458,0.000002797583,0.00011602083,0.000002163895],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050322786,0.00091578864,0.29279137,0.00772358,0.00061449886,0.0002507512,0.012371844,0.00037472064,0.6282518,0.0045228153,0.000009980975,0.0018501128],"study_design_scores_gemma":[0.0050141807,0.0004347673,0.94194573,0.00068669295,0.0007456364,0.0000139296735,0.00022140809,0.0005105138,0.049985114,0.00026323827,0.0000021730946,0.00017661283],"about_ca_topic_score_codex":0.000047106485,"about_ca_topic_score_gemma":0.000005615955,"teacher_disagreement_score":0.64915437,"about_ca_system_score_codex":0.000029470126,"about_ca_system_score_gemma":0.00014787988,"threshold_uncertainty_score":0.7020241},"labels":[],"label_agreement":null},{"id":"W4406715041","doi":"10.1016/j.jtct.2025.01.885","title":"Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for Children with Chronic Graft-versus-Host Disease after Hematopoietic Cell Transplantation","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; BC Children's Hospital; University of British Columbia","funders":"Janssen Pharmaceuticals; National Heart, Lung, and Blood Institute; NHLBI Division of Intramural Research; Jazz Pharmaceuticals","keywords":"Hematopoietic cell; Medicine; Graft-versus-host disease; Survivorship curve; Transplantation; Immune system; Hematopoietic stem cell transplantation; Chronic disease; Disease; Organ transplantation; Immunology; Organ dysfunction; Intensive care medicine; Haematopoiesis; Stem cell; Biology; Pathology; Sepsis; Cancer; Internal medicine","score_opus":0.016670695269091193,"score_gpt":0.23486785926744067,"score_spread":0.21819716399834949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406715041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585718,0.019723969,0.013837516,0.0008666489,0.000647877,0.004794954,0.0011391692,0.00023374462,0.00018434103],"genre_scores_gemma":[0.8983229,0.09723669,0.00022448131,0.00023465151,0.00027186473,0.0010526086,0.0023649994,0.00011564567,0.00017614735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951699,0.00040730895,0.0012784132,0.0015493,0.0007524687,0.00084262405],"domain_scores_gemma":[0.9973644,0.00066473207,0.00036959615,0.0006114357,0.00027405444,0.0007157748],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051916816,0.0010848907,0.0009220951,0.0006770854,0.00085755595,0.00022793563,0.00015071308,0.00039621012,0.00032123033],"category_scores_gemma":[0.000010185094,0.0009904305,0.00027562934,0.0005821055,0.00046353383,0.00049636606,0.000009053101,0.0005286073,0.00001598705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37409136,0.0062727467,0.40709946,0.060714807,0.0022777903,0.0031747983,0.03344972,0.0007283444,0.09704579,0.01302649,0.00014407735,0.0019746234],"study_design_scores_gemma":[0.13785817,0.008164332,0.61643827,0.0030807517,0.015981343,0.00049980404,0.0007406431,0.000761147,0.21116415,0.0009581672,0.00019348213,0.004159725],"about_ca_topic_score_codex":0.00007590777,"about_ca_topic_score_gemma":0.0002850646,"teacher_disagreement_score":0.23623319,"about_ca_system_score_codex":0.00016984117,"about_ca_system_score_gemma":0.00091296824,"threshold_uncertainty_score":0.9992546},"labels":[],"label_agreement":null},{"id":"W4407317707","doi":"10.1016/j.jtct.2025.02.005","title":"Improvement in Skin Fibrosis and Lung Function with Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; University of Ottawa; Jewish General Hospital; McGill University; Ottawa Hospital","funders":"Canadian Arthritis Network; Fonds de Recherche du Québec - Santé; Actelion Pharmaceuticals; Canadian Institutes of Health Research; Pfizer; Scleroderma Society of Ontario; Jewish General Hospital; Scleroderma Foundation","keywords":"Medicine; Hematopoietic stem cell transplantation; Transplantation; Lung; Stem cell; Haematopoiesis; Pulmonary fibrosis; Scleroderma (fungus); Fibrosis; Lung transplantation; Lung function; Multiple sclerosis; Pathology; Immunology; Internal medicine; Biology","score_opus":0.008796583721531744,"score_gpt":0.20986359642012362,"score_spread":0.20106701269859187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407317707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776225,0.018397762,0.002658,0.00010248601,0.00006912213,0.0008590827,0.000011317689,0.00004127993,0.00023843184],"genre_scores_gemma":[0.9650748,0.034426812,0.000030414802,0.000157815,0.00000885223,0.000099247634,0.000070434326,0.000014876025,0.00011675897],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988849,0.00008431107,0.00038068465,0.00031907912,0.00015452328,0.00017646168],"domain_scores_gemma":[0.99967813,0.00005307279,0.00006997847,0.000110096364,0.00002526074,0.000063436884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016976312,0.00018135128,0.00030025377,0.00027106892,0.000058649784,0.000029250108,0.00003072532,0.00013679435,0.000012314833],"category_scores_gemma":[3.083549e-7,0.00014091427,0.000038899612,0.00028436616,0.00004019308,0.0000795092,0.0000018640686,0.00011944163,0.0000012242215],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052100625,0.00036857347,0.0885806,0.0053623193,0.00013923741,0.00008339317,0.0096679395,0.0001647943,0.846744,0.00022848324,0.0000121262065,0.043438453],"study_design_scores_gemma":[0.027902192,0.0009731169,0.6177088,0.01319726,0.00070576166,0.00016044523,0.0062996093,0.0018191556,0.33071786,0.000041170948,0.000012763041,0.000461856],"about_ca_topic_score_codex":0.0001585337,"about_ca_topic_score_gemma":0.000045819528,"teacher_disagreement_score":0.5291282,"about_ca_system_score_codex":0.000050420913,"about_ca_system_score_gemma":0.00004731223,"threshold_uncertainty_score":0.57463175},"labels":[],"label_agreement":null},{"id":"W4407406247","doi":"10.1016/j.jtct.2025.01.891","title":"Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part III. Long-Term Impact of Chronic Graft-versus-Host Disease on Endocrinologic, Cardiovascular, and Metabolic Outcomes in Survivors of Pediatric Hematopoietic Cell Transplantation","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"NHLBI Division of Intramural Research; National Heart, Lung, and Blood Institute","keywords":"Hematopoietic cell; Medicine; Hematopoietic stem cell transplantation; Graft-versus-host disease; Survivorship curve; Disease; Transplantation; Haematopoiesis; Pediatrics; Intensive care medicine; Stem cell; Internal medicine; Cancer; Biology","score_opus":0.0230099039606154,"score_gpt":0.2701087599831934,"score_spread":0.247098856022578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407406247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93752897,0.056449864,0.0014325589,0.0001184407,0.00049018406,0.0029314137,0.0007899623,0.00010794745,0.00015068856],"genre_scores_gemma":[0.6999715,0.29888234,0.000022619335,0.000038637394,0.00011538952,0.00023231009,0.00060854445,0.000077781646,0.000050854815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99381876,0.0008060807,0.0017671307,0.0014685349,0.0011857777,0.0009537277],"domain_scores_gemma":[0.9968297,0.00095989014,0.0004983881,0.0008399764,0.00020265658,0.00066938624],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00069914304,0.0012026994,0.0018329062,0.0013351837,0.0002132219,0.00007945784,0.00030400627,0.00035696317,0.00017158613],"category_scores_gemma":[0.000010322729,0.0010450962,0.00080595945,0.0010164902,0.00035628845,0.00029489977,0.000012976233,0.00061762007,0.0000091174625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046847373,0.0023825297,0.91132724,0.021068718,0.00086959684,0.0018630681,0.005416893,0.00047494142,0.008701081,0.00060166285,0.000003611885,0.0004433076],"study_design_scores_gemma":[0.043323275,0.002320355,0.8924775,0.00062470685,0.0060383426,0.000044461223,0.00018977335,0.00011831648,0.053665854,0.00005908981,0.000006410709,0.0011319215],"about_ca_topic_score_codex":0.00033747038,"about_ca_topic_score_gemma":0.000248048,"teacher_disagreement_score":0.24243248,"about_ca_system_score_codex":0.00014294023,"about_ca_system_score_gemma":0.0006971686,"threshold_uncertainty_score":0.9991999},"labels":[],"label_agreement":null},{"id":"W4407974384","doi":"10.1016/j.jtct.2025.01.847","title":"Change Management across Disciplines: Implementation of Standardized Outpatient Clinical Trial Procedures","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Health Policy Implementation Science","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medical physics; Medicine","score_opus":0.4497855385416673,"score_gpt":0.6607254208282808,"score_spread":0.21093988228661348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407974384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983464,0.000119600096,0.008837559,0.0019394543,0.0007171047,0.0040071723,0.00022843262,0.000046458397,0.0006401924],"genre_scores_gemma":[0.9892478,0.004697576,0.00048245548,0.004180882,0.00012578123,0.0008608646,0.0000961216,0.00001157185,0.00029695834],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969565,0.00072477054,0.0013100532,0.00030210448,0.0003331843,0.00037333378],"domain_scores_gemma":[0.9987986,0.00040998412,0.00037322837,0.00018120793,0.0001385061,0.00009848668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023300848,0.00013802786,0.00029355768,0.00012465661,0.0004904653,0.000013731421,0.00013051646,0.00009866249,0.00018402662],"category_scores_gemma":[0.000022167724,0.000114806426,0.00006762882,0.00031572074,0.00010047215,0.00015649678,0.000022991915,0.00016532632,0.000008430224],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05998848,0.00053226633,0.22091772,0.0062119723,0.0003795941,0.000011163046,0.2959364,0.0000026531554,0.0020331182,0.019311871,0.0017715867,0.39290318],"study_design_scores_gemma":[0.34996897,0.0020424225,0.47933617,0.00076330284,0.00017496043,9.200053e-7,0.09649493,0.000059235415,0.0076777013,0.0017457269,0.06114917,0.00058649306],"about_ca_topic_score_codex":0.00017244705,"about_ca_topic_score_gemma":0.00054256717,"teacher_disagreement_score":0.39231667,"about_ca_system_score_codex":0.000045288292,"about_ca_system_score_gemma":0.00022848288,"threshold_uncertainty_score":0.468167},"labels":[],"label_agreement":null},{"id":"W4407974582","doi":"10.1016/j.jtct.2025.01.783","title":"Factors Associated with Clinical Trial Participation in Adult Hematopoietic Stem Cell Transplantation (HSCT) Recipients: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Hematopoietic stem cell transplantation; Hematopoietic cell; Bone transplantation; Medicine; Transplantation; Stem cell; Oncology; Haematopoiesis; Internal medicine; Biology; Surgery; Genetics","score_opus":0.09978028766462434,"score_gpt":0.3969811117618344,"score_spread":0.2972008240972101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407974582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99364835,0.00014487823,0.0039073294,0.00026587554,0.0002473081,0.0012698387,0.00016261995,0.000032186395,0.0003216083],"genre_scores_gemma":[0.99327457,0.0048752027,0.000028118133,0.00014289378,0.00004567962,0.00024277727,0.0011663889,0.000015984671,0.00020841249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982215,0.00028062623,0.0005546895,0.00040822665,0.0002952289,0.00023968691],"domain_scores_gemma":[0.99901986,0.0003503159,0.0000945675,0.00012105899,0.00031619737,0.000097987744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062059757,0.00017466139,0.00037912646,0.00047746027,0.00013800905,0.00005421624,0.000061674466,0.00014768071,0.000029739549],"category_scores_gemma":[0.000011142417,0.00013815302,0.00013384214,0.00057178456,0.000095245385,0.000120564684,0.0000020397244,0.00024165925,4.555707e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050662603,0.0020892348,0.9303529,0.0002647732,0.001495368,0.000027643493,0.0060669896,0.000031971293,0.005439093,0.00045630845,0.000014796348,0.0030983104],"study_design_scores_gemma":[0.1739558,0.0023613817,0.77337265,0.0006022712,0.0029274726,0.0000050966783,0.000613346,0.0004691637,0.045041855,0.00008545494,0.00021889339,0.00034664417],"about_ca_topic_score_codex":0.00004369873,"about_ca_topic_score_gemma":0.0005206486,"teacher_disagreement_score":0.15698029,"about_ca_system_score_codex":0.000040800056,"about_ca_system_score_gemma":0.00007062758,"threshold_uncertainty_score":0.56337166},"labels":[],"label_agreement":null},{"id":"W4407974813","doi":"10.1016/j.jtct.2025.01.754","title":"Unlocking Gene Therapy for Sickle Cell Disease: Addressing the Resource Gap for Patients","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Disease; Genetic enhancement; Medicine; Resource (disambiguation); Intensive care medicine; Gene; Internal medicine; Genetics; Computer science; Biology","score_opus":0.01805442768508194,"score_gpt":0.29424402617808726,"score_spread":0.27618959849300534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407974813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75905275,0.009644257,0.23003809,0.00017298818,0.00010927347,0.0007408849,0.00006827018,0.00001343444,0.00016005085],"genre_scores_gemma":[0.9941267,0.0036491214,0.0004556369,0.0004943681,0.00009751258,0.00012129459,0.00060814,0.000019279856,0.0004279559],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994563,0.000023991917,0.000120426696,0.00020063434,0.000055311462,0.00014336687],"domain_scores_gemma":[0.9997238,0.00003511081,0.000029168048,0.00013719004,0.00003947359,0.000035244084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099442965,0.00011419461,0.00007567456,0.000024416053,0.0001836636,0.00003246299,0.00008571993,0.000051834122,0.0000026568478],"category_scores_gemma":[0.0000031616355,0.00008824787,0.00007417853,0.00003920007,0.000026273106,0.0000024876178,0.000004246597,0.00003058357,1.6060085e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014862391,0.000103446866,0.001400391,0.00015767434,0.00006650812,4.1241583e-7,0.0004261653,0.00068162754,0.9615642,0.0001255212,0.00048199177,0.033505812],"study_design_scores_gemma":[0.0034246822,0.00016489963,0.0020481336,0.000022485494,0.00003002904,2.7940504e-7,0.000054943168,0.000543041,0.9135989,0.00013943498,0.07982837,0.00014481752],"about_ca_topic_score_codex":0.000001714303,"about_ca_topic_score_gemma":0.0000013157918,"teacher_disagreement_score":0.23507394,"about_ca_system_score_codex":0.0000030710173,"about_ca_system_score_gemma":0.0000203557,"threshold_uncertainty_score":0.35986438},"labels":[],"label_agreement":null},{"id":"W4407974989","doi":"10.1016/j.jtct.2025.01.855","title":"The Importance of Quality Manager Onboarding","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Quality and Supply Management","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Onboarding; Quality (philosophy); Business; Psychology; Social psychology; Philosophy","score_opus":0.023309284254109965,"score_gpt":0.26725650112918303,"score_spread":0.24394721687507306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407974989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9274358,0.0015028851,0.01783092,0.0048539843,0.00023575043,0.00033719421,0.0000027556325,0.000059674767,0.047741022],"genre_scores_gemma":[0.9947724,0.0014787544,0.00004140185,0.002650112,0.000050493232,0.000012631916,0.000023913484,0.0000054782668,0.000964836],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993353,0.000025332854,0.00026029043,0.00013392918,0.00013221982,0.00011291305],"domain_scores_gemma":[0.9996502,0.000067209825,0.000094316725,0.00014840299,0.000035800418,0.000004094634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006632938,0.000084017825,0.00011417842,0.00006969025,0.00021877179,0.00009951487,0.000119849086,0.000027235666,0.00004543562],"category_scores_gemma":[0.000004916264,0.000060756152,0.00005251798,0.00018961211,0.000068065885,0.00019532822,0.000012025358,0.000052103333,0.000006975],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028751467,0.00004853794,0.026228676,0.0005306839,0.000093574374,0.0000044622698,0.00021310558,0.00002432271,0.004001182,0.9349281,0.0003671391,0.033272665],"study_design_scores_gemma":[0.005797162,0.000028530587,0.34437996,0.00020118595,0.00022124156,8.3034996e-7,0.0037320473,0.001916384,0.013990256,0.12963776,0.4994284,0.0006662518],"about_ca_topic_score_codex":0.00011706006,"about_ca_topic_score_gemma":0.00009268893,"teacher_disagreement_score":0.80529034,"about_ca_system_score_codex":0.0000042509405,"about_ca_system_score_gemma":0.0000047929307,"threshold_uncertainty_score":0.24775639},"labels":[],"label_agreement":null},{"id":"W4407975076","doi":"10.1016/j.jtct.2025.01.710","title":"Thriving Beyond Treatment: First Annual Allogeneic Blood and Marrow Transplant Survivorship Day","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Thriving; Survivorship curve; Bone transplantation; Bone marrow transplant; Medicine; Bone marrow transplantation; Bone marrow; Blood cancer; Oncology; Internal medicine; Psychology; Cancer; Psychotherapist; Surgery","score_opus":0.012704187227462131,"score_gpt":0.24196602730484046,"score_spread":0.22926184007737832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407975076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851399,0.004917397,0.005388561,0.0008430761,0.00013735254,0.00070810976,0.00014290928,0.00010527811,0.002617409],"genre_scores_gemma":[0.9652619,0.032797344,0.00026383664,0.00034310913,0.000040667775,0.000049418784,0.00037598205,0.000029088344,0.0008386543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986128,0.000119383236,0.00035457715,0.00043344087,0.00019575657,0.00028404428],"domain_scores_gemma":[0.99933094,0.00023195517,0.0000527175,0.00019242935,0.00004168103,0.00015027338],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026002663,0.00030595844,0.00038634115,0.0001941213,0.0002086075,0.00003973801,0.00005832082,0.00017134666,0.00008951143],"category_scores_gemma":[0.000002135599,0.00025765793,0.00008911175,0.0001874125,0.00010596035,0.00010520924,0.000002163282,0.00011467451,0.0000056019708],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038629505,0.00109976,0.44305846,0.0030834635,0.0016077418,0.0010909495,0.048608173,0.000015670179,0.4598655,0.006365948,0.000031436946,0.031309944],"study_design_scores_gemma":[0.029983493,0.0018715722,0.16044539,0.0013257477,0.0025437772,0.0010125436,0.0012542399,0.0002741076,0.7957414,0.00073000917,0.0038946238,0.00092312245],"about_ca_topic_score_codex":0.00015215881,"about_ca_topic_score_gemma":0.00029880874,"teacher_disagreement_score":0.33587587,"about_ca_system_score_codex":0.000019187266,"about_ca_system_score_gemma":0.000059640523,"threshold_uncertainty_score":0.99998754},"labels":[],"label_agreement":null},{"id":"W4407975106","doi":"10.1016/j.jtct.2025.01.774","title":"Health-Related Quality of Life of Adults and Adolescents with Sickle Cell Disease after Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Hematopoietic stem cell transplantation; Transplantation; Disease; Medicine; Stem cell; Quality of life (healthcare); Haematopoiesis; Hematopoietic cell; Immunology; Oncology; Internal medicine; Biology; Genetics","score_opus":0.0070806613689179945,"score_gpt":0.2305232754962659,"score_spread":0.2234426141273479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407975106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850516,0.010496235,0.003111081,0.0002992067,0.000031559626,0.0007524025,0.00006306019,0.000019242754,0.00017562507],"genre_scores_gemma":[0.9810526,0.018395782,0.0000666491,0.00025105718,0.0000032948353,0.000016873242,0.00010442279,0.000015885098,0.00009347112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998695,0.00013090739,0.0005568931,0.00025780077,0.0001979557,0.00016142504],"domain_scores_gemma":[0.9993814,0.000032496122,0.00020142038,0.00013501402,0.000073852054,0.00017577125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016162779,0.00018515917,0.00043800735,0.00011500801,0.000055714543,0.000005761217,0.000036217305,0.000104148865,0.000014933936],"category_scores_gemma":[6.6581845e-7,0.00014355575,0.00006869806,0.00019333069,0.00013462518,0.000052677835,0.0000023717123,0.00012640553,8.977748e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10435338,0.0029657634,0.6126929,0.071418405,0.0005588111,0.000161189,0.084354125,0.0002767564,0.10601697,0.00023137064,0.000016768183,0.016953543],"study_design_scores_gemma":[0.034402736,0.0011650692,0.8343816,0.0049139326,0.0005179445,0.000012971225,0.0041426695,0.0003750434,0.11956134,0.000093850795,0.00001656246,0.00041632864],"about_ca_topic_score_codex":0.00015635186,"about_ca_topic_score_gemma":0.000020020116,"teacher_disagreement_score":0.22168864,"about_ca_system_score_codex":0.000010427257,"about_ca_system_score_gemma":0.0001445002,"threshold_uncertainty_score":0.5854033},"labels":[],"label_agreement":null},{"id":"W4407975585","doi":"10.1016/j.jtct.2025.01.662","title":"The Role of Second-HSCT for Children with Relapsed Hematological Malignancies: A Single Center Experience","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Single Center; Medicine; Center (category theory); Pediatrics; Internal medicine","score_opus":0.010220891432548507,"score_gpt":0.23716373792628598,"score_spread":0.22694284649373747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407975585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500585,0.0029673036,0.0005988634,0.00019558368,0.000016594362,0.00048602582,0.000018213743,0.000013668878,0.00069792016],"genre_scores_gemma":[0.99804056,0.0012384168,0.00019463978,0.00019971255,0.000005430804,0.000107632455,0.000051874926,0.0000044189087,0.00015732353],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99958843,0.000015366937,0.000120658384,0.00011866336,0.00006603145,0.00009082958],"domain_scores_gemma":[0.9997665,0.00006095637,0.000033353757,0.00008737532,0.0000271736,0.000024590112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037440022,0.00007574225,0.00012753776,0.000018793318,0.00008411922,0.000011660377,0.000030825733,0.00003209803,0.000016428565],"category_scores_gemma":[0.0000011409752,0.000039401657,0.00004364822,0.00004736105,0.00006772737,0.000020653573,0.0000012506447,0.000019058116,4.1116306e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062285075,0.0016113532,0.7199804,0.00017428366,0.000640108,0.000022050817,0.0074670734,0.0000013862166,0.20170735,0.019678444,0.00007160592,0.042417414],"study_design_scores_gemma":[0.009096341,0.0007694113,0.106981896,0.0001288025,0.00007552216,0.00007064864,0.0006305925,0.000017348604,0.87859136,0.0002976276,0.0032667252,0.00007375545],"about_ca_topic_score_codex":0.0000068180707,"about_ca_topic_score_gemma":0.000009549041,"teacher_disagreement_score":0.676884,"about_ca_system_score_codex":0.000008395355,"about_ca_system_score_gemma":0.000018854478,"threshold_uncertainty_score":0.16067529},"labels":[],"label_agreement":null},{"id":"W4407975602","doi":"10.1016/j.jtct.2025.01.757","title":"Bridging Generational Differences in Apheresis Nursing Education: Integrating Multigenerational Learners, Enhancing Competency and Collaboration in a Growing Stem Cell Unit","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Aging and Gerontology Research","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bridging (networking); Apheresis; Unit (ring theory); Medical education; Nursing; Psychology; Medicine; Computer science; Mathematics education; Immunology","score_opus":0.02799069416898887,"score_gpt":0.33754733505171025,"score_spread":0.3095566408827214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407975602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737557,0.005186356,0.016152872,0.00069620815,0.000200009,0.000240146,0.0000041179105,0.000019931793,0.0037446439],"genre_scores_gemma":[0.9970914,0.0003662664,0.0008990302,0.00020278292,0.00004719312,0.000060358267,0.00008990862,0.000008079342,0.001234971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873054,0.00036058013,0.00030397964,0.00030684756,0.00011487247,0.0001831961],"domain_scores_gemma":[0.99964803,0.00014093754,0.00005122944,0.00007344632,0.000050033126,0.000036329613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031725722,0.00013072253,0.00016694893,0.00030316762,0.00019504981,0.00008036497,0.000058416306,0.00009872555,0.00006043208],"category_scores_gemma":[0.000002805641,0.0001310053,0.00001701666,0.00032441848,0.00007796188,0.00017823195,0.0000031226084,0.00020250656,0.000001818304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055269565,0.00066262047,0.42746362,0.00018046523,0.000061266255,0.000027986038,0.09089935,0.00014784162,0.11079138,0.1294811,0.00004261268,0.23968905],"study_design_scores_gemma":[0.012621137,0.00034156893,0.6602152,0.0019747806,0.00007325794,0.000060158804,0.20051949,0.038116526,0.08131789,0.0033654482,0.00020467288,0.0011898841],"about_ca_topic_score_codex":0.0002831979,"about_ca_topic_score_gemma":0.0010789421,"teacher_disagreement_score":0.23849916,"about_ca_system_score_codex":0.000038060527,"about_ca_system_score_gemma":0.00020530657,"threshold_uncertainty_score":0.53422415},"labels":[],"label_agreement":null},{"id":"W4407975897","doi":"10.1016/j.jtct.2025.01.495","title":"Non-Myeloablative Matched Sibling Allo-HCT for Adults with Sickle Cell Disease in Canada.","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Sibling; Disease; Medicine; Pediatrics; Oncology; Internal medicine; Psychology; Developmental psychology","score_opus":0.004567564748254494,"score_gpt":0.2082387120577001,"score_spread":0.2036711473094456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407975897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99102384,0.001516071,0.0048472453,0.0008475194,0.00004486143,0.0007940041,0.00002515463,0.000015248365,0.0008860488],"genre_scores_gemma":[0.99494505,0.003481138,0.00016739506,0.0007284959,0.000008679427,0.000042879263,0.00017277554,0.000013119744,0.00044044718],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993817,0.000015032137,0.00015737789,0.00018434832,0.000099140736,0.00016240384],"domain_scores_gemma":[0.9997236,0.000040321538,0.000030062385,0.00007795723,0.000037761394,0.000090299596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054429078,0.00012070434,0.00017251636,0.000083292696,0.00005767426,0.000008722505,0.000029376053,0.000043699252,0.000019804884],"category_scores_gemma":[0.0000011272908,0.00009104527,0.000028765786,0.00017751819,0.000023380766,0.00003433054,0.000001173833,0.00009255255,6.073839e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13378738,0.0021752396,0.55408454,0.013362072,0.0011286816,0.00189477,0.06678855,0.0083867535,0.1463293,0.0012577018,0.0009035182,0.069901474],"study_design_scores_gemma":[0.17939886,0.0021356745,0.33163255,0.0062289434,0.0013230223,0.000025569378,0.03700392,0.07457458,0.35526815,0.0010342763,0.009284087,0.002090336],"about_ca_topic_score_codex":0.056941476,"about_ca_topic_score_gemma":0.064656526,"teacher_disagreement_score":0.22245201,"about_ca_system_score_codex":0.000044191427,"about_ca_system_score_gemma":0.0005106337,"threshold_uncertainty_score":0.95241106},"labels":[],"label_agreement":null},{"id":"W4407975946","doi":"10.1016/j.jtct.2025.01.503","title":"Acute and Chronic Graft Versus Host Disease (GVHD) Management in the Eastern Mediterranean Region: Result of the Worldwide Network for Blood & Marrow Transplantation (WBMT) Global GvHD Survey.","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Graft-versus-host disease; Bone marrow transplantation; Medicine; Disease; Host (biology); Mediterranean climate; Immunology; Transplantation; Bone marrow; Biology; Internal medicine; Ecology","score_opus":0.033021968017291965,"score_gpt":0.2918351584657925,"score_spread":0.25881319044850054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407975946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97021693,0.00343701,0.019435033,0.0021055164,0.00054828724,0.0027263758,0.0003025079,0.000035692716,0.0011926336],"genre_scores_gemma":[0.98474234,0.013240282,0.0002841276,0.00039594772,0.00006187391,0.00013079942,0.00087013945,0.000017882814,0.00025663237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819154,0.00034579838,0.00048384996,0.00036542106,0.00033820418,0.00027516484],"domain_scores_gemma":[0.99907225,0.00034203238,0.00012179321,0.00032659693,0.000056199133,0.00008113422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005930477,0.0002469627,0.00029117032,0.00008362508,0.00015560586,0.00003737967,0.00017204852,0.00009417671,0.000016913718],"category_scores_gemma":[0.0000048355964,0.00017042801,0.00011157663,0.0004588213,0.00014636398,0.000074993,0.0000048067704,0.00013339099,9.575891e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1552802,0.0019966743,0.6353918,0.024678217,0.0059446865,0.0017801448,0.035069045,0.0007779805,0.014285975,0.019288689,0.0010758113,0.1044308],"study_design_scores_gemma":[0.044679035,0.000436649,0.94128495,0.0010645088,0.0035333086,0.000120989076,0.00039586352,0.0008447025,0.0052702376,0.0007810368,0.0011562753,0.00043242902],"about_ca_topic_score_codex":0.00006087385,"about_ca_topic_score_gemma":0.00068375823,"teacher_disagreement_score":0.30589318,"about_ca_system_score_codex":0.000034644683,"about_ca_system_score_gemma":0.00007425048,"threshold_uncertainty_score":0.6949853},"labels":[],"label_agreement":null},{"id":"W4407976013","doi":"10.1016/j.jtct.2025.01.540","title":"Analysis of the Transplantation and Cellular Therapy Health Equity Literature: Trends By Topic and Disparity over Time","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Diverse Approaches in Healthcare and Education Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University","funders":"","keywords":"Equity (law); Transplantation; Psychology; Medicine; Economics; Political science; Internal medicine; Law","score_opus":0.03251883332786308,"score_gpt":0.33157893754247914,"score_spread":0.29906010421461604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407976013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721096,0.02295202,0.0008357813,0.0029314451,0.00008211428,0.00028463817,0.00010957003,0.000019167368,0.0006756542],"genre_scores_gemma":[0.9234122,0.0739291,0.00005241099,0.0013616217,0.000017378938,0.00001409047,0.00039768894,0.0000061331134,0.0008093701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899465,0.0001350874,0.00028158503,0.00026140458,0.00017809981,0.000149159],"domain_scores_gemma":[0.99955595,0.00006978706,0.00009184851,0.0001626212,0.000046268706,0.000073510986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028008982,0.00015075039,0.00035472924,0.00018516381,0.0001898651,0.000033493798,0.000050483217,0.00008637169,0.000046355985],"category_scores_gemma":[0.0000017961099,0.000105684485,0.00008672083,0.0005950358,0.00013080756,0.000072459094,0.000007021009,0.00012641452,2.165575e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021401455,0.00067713833,0.52812374,0.002191803,0.003096756,0.000009570831,0.05473672,0.000006474847,0.04030767,0.0030928855,0.0008277611,0.3647893],"study_design_scores_gemma":[0.0045568133,0.00029359624,0.9617141,0.0002424792,0.001089341,0.000008681651,0.00051425275,0.00043911167,0.027507804,0.0002739069,0.0031348034,0.00022513601],"about_ca_topic_score_codex":0.00020404416,"about_ca_topic_score_gemma":0.000027497663,"teacher_disagreement_score":0.43359032,"about_ca_system_score_codex":0.000019386523,"about_ca_system_score_gemma":0.00004758151,"threshold_uncertainty_score":0.43096882},"labels":[],"label_agreement":null},{"id":"W4407976192","doi":"10.1016/j.jtct.2025.01.400","title":"Favorable Long-Term Outcomes of Umbilical Cord Blood Transplantation in Primary Hemophagocytic Lymphohistiocytosis: A 20-Year Institutional Review","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Hemophagocytic lymphohistiocytosis; Medicine; Umbilical cord; Umbilical Cord Blood Transplantation; Term (time); Pediatrics; Transplantation; Intensive care medicine; Surgery; Internal medicine; Hematopoietic stem cell transplantation; Immunology; Disease","score_opus":0.0208911634058337,"score_gpt":0.2985195248972201,"score_spread":0.2776283614913864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407976192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96217746,0.033009477,0.0015201,0.0004298857,0.00003933146,0.00075976504,0.000023976452,0.000028152253,0.002011834],"genre_scores_gemma":[0.8263148,0.17187165,0.000094878815,0.0007883958,0.0000058593037,0.00005528106,0.00042831985,0.000009562469,0.00043127808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871635,0.00008881855,0.0005179719,0.00023023708,0.00027586837,0.00017074216],"domain_scores_gemma":[0.9996012,0.000055739536,0.00006711565,0.00015933045,0.0000658665,0.00005077624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027833777,0.00015246715,0.00047157457,0.00019892943,0.00006837476,0.000010077517,0.000077276105,0.00009401875,0.00012891472],"category_scores_gemma":[0.0000071521254,0.00013299672,0.000101622754,0.00028995154,0.00013341005,0.00011294953,0.0000038176377,0.0001452006,0.000006194805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070475377,0.0017442777,0.7717027,0.030550797,0.0005496091,0.0004929438,0.0010041469,0.000023370969,0.12988134,0.002521582,0.000051844607,0.054429825],"study_design_scores_gemma":[0.01675468,0.00035294736,0.93617076,0.0037888102,0.00038204785,0.0001043016,0.00004255684,0.000056944937,0.041807007,0.000085012725,0.00024085544,0.00021405438],"about_ca_topic_score_codex":0.000033830525,"about_ca_topic_score_gemma":0.000013168794,"teacher_disagreement_score":0.16446806,"about_ca_system_score_codex":0.000045194345,"about_ca_system_score_gemma":0.00034443729,"threshold_uncertainty_score":0.54234487},"labels":[],"label_agreement":null},{"id":"W4407976290","doi":"10.1016/j.jtct.2025.01.355","title":"Cost and Health Service Utilization Differences between Lymphoma Patients Treated with Commercial CAR-T and Made -in-Alberta Therapies","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Alberta Cancer Foundation; Alberta Health; University of Alberta; University of Calgary","funders":"","keywords":"Lymphoma; Medicine; Service (business); Business; Intensive care medicine; Marketing; Internal medicine","score_opus":0.062273573678095516,"score_gpt":0.32116510208155385,"score_spread":0.25889152840345836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407976290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502933,0.0013390263,0.00028780164,0.0021188848,0.000013985383,0.00086276064,0.000021591602,0.000020507008,0.0003061352],"genre_scores_gemma":[0.98463947,0.013702285,0.0000283954,0.0008329455,0.000015200243,0.000028259352,0.00035042962,0.000015288775,0.00038771235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906415,0.00012332412,0.00019973745,0.00025043968,0.00017001976,0.00019232309],"domain_scores_gemma":[0.99960786,0.00009855763,0.000043971922,0.00009752797,0.000056186298,0.000095883435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013265078,0.00016379764,0.00029977784,0.00016247146,0.00012273378,0.000040656414,0.00003871265,0.00007489324,0.0000476469],"category_scores_gemma":[0.0000010016371,0.00012345327,0.000015097505,0.00028549912,0.000080922786,0.00006687108,0.000004374869,0.0000810614,5.147347e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012108347,0.0001008758,0.82428914,0.00020179087,0.000077899924,0.000003198945,0.004912653,1.7387573e-7,0.0018337474,0.00007336506,0.0000029503744,0.16729338],"study_design_scores_gemma":[0.0098307235,0.00047054663,0.98428935,0.00018315967,0.00003840631,0.000004438312,0.00028718243,0.00009508917,0.004237857,0.000034386052,0.0004176658,0.000111209185],"about_ca_topic_score_codex":0.0030655498,"about_ca_topic_score_gemma":0.0017671495,"teacher_disagreement_score":0.16718218,"about_ca_system_score_codex":0.000033388194,"about_ca_system_score_gemma":0.0000599704,"threshold_uncertainty_score":0.5034278},"labels":[],"label_agreement":null},{"id":"W4407976323","doi":"10.1016/j.jtct.2025.01.450","title":"Gvhd Prophylaxis with ATG and Ptcy Vs Ptcy-Based Regimens in Haploidentical Stem Cell Transplantation: A Cell Therapy Transplant Canada Registry Study","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University of Calgary; Canadian Blood Services; CancerCare Manitoba; Princess Margaret Cancer Centre; University of Manitoba; Juravinski Hospital; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Transplantation; Stem cell; Oncology; Graft-versus-host disease; Internal medicine; Immunology; Biology","score_opus":0.008485943296612716,"score_gpt":0.22513973072756308,"score_spread":0.21665378743095037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407976323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99186635,0.0028436242,0.0031800808,0.00023360041,0.000060897906,0.0012129969,0.00008421784,0.000019168223,0.0004990869],"genre_scores_gemma":[0.990022,0.008184403,0.00010043892,0.00027701905,0.000020796542,0.000109760935,0.000275943,0.00003501644,0.000974611],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978417,0.0003056628,0.00037394735,0.0006948147,0.0003953646,0.00038851437],"domain_scores_gemma":[0.9993258,0.000055719727,0.00007529255,0.00033146952,0.00006979798,0.0001419277],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002814557,0.00034645072,0.00030811568,0.00014241043,0.00016679642,0.000073530355,0.00021010848,0.00017229975,0.000021401607],"category_scores_gemma":[6.304917e-7,0.000294686,0.000051482806,0.0002480706,0.00012461797,0.000014665678,0.00000639304,0.00025094592,9.108891e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015183034,0.0015255042,0.20915878,0.0015269461,0.0002355875,0.0014247734,0.0033341125,0.00036931713,0.76042914,0.000036975838,0.000084567124,0.006691262],"study_design_scores_gemma":[0.01789527,0.0023742623,0.084481195,0.000108821616,0.00007830522,0.000042976342,0.0009265685,0.00014509274,0.89213866,0.000009427711,0.0011939133,0.00060549343],"about_ca_topic_score_codex":0.008199287,"about_ca_topic_score_gemma":0.031840257,"teacher_disagreement_score":0.13170953,"about_ca_system_score_codex":0.000033279703,"about_ca_system_score_gemma":0.000495413,"threshold_uncertainty_score":0.9999505},"labels":[],"label_agreement":null},{"id":"W4407976465","doi":"10.1016/j.jtct.2025.01.520","title":"REMOVED: Genetic Landscape in Myelofibrosis Impacts Post-Hematopoietic Cell Transplantation Outcomes","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Hematopoietic cell; Hematopoietic stem cell transplantation; Transplantation; Medicine; Haematopoiesis; Oncology; Biology; Internal medicine; Stem cell; Genetics; Bone marrow","score_opus":0.008553491637657184,"score_gpt":0.25208421759104016,"score_spread":0.243530725953383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407976465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919219,0.0027447918,0.0010227067,0.0013002331,0.00007550353,0.00067834003,0.000036681024,0.000046687484,0.002173153],"genre_scores_gemma":[0.97541946,0.021946808,0.00064419454,0.0012386566,0.000013759987,0.00007320439,0.00026751246,0.000019512974,0.00037690956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988159,0.00008291029,0.00035947183,0.00032127093,0.00018705758,0.00023341487],"domain_scores_gemma":[0.9995164,0.00011522991,0.00005638606,0.0001581306,0.00005260303,0.000101243655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010794746,0.0002460449,0.000369431,0.00025640256,0.000082325554,0.000037562375,0.00004652106,0.0001164339,0.00014671],"category_scores_gemma":[0.0000027757294,0.00019259677,0.00009939986,0.00021905606,0.00003386672,0.00007460597,0.0000022661673,0.00011822701,0.000015212029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015955286,0.00063994084,0.90077895,0.00090297434,0.00014206051,0.00030723118,0.0045457194,0.000025406553,0.081758484,0.0004277736,0.000029753126,0.008846152],"study_design_scores_gemma":[0.008388278,0.00028392253,0.835634,0.00022486331,0.00016763403,0.000046409124,0.00022617396,0.00006173541,0.15454794,0.00013333095,0.00011626565,0.00016946727],"about_ca_topic_score_codex":0.000085937936,"about_ca_topic_score_gemma":0.000064432075,"teacher_disagreement_score":0.07278947,"about_ca_system_score_codex":0.000028358289,"about_ca_system_score_gemma":0.00007225408,"threshold_uncertainty_score":0.7853868},"labels":[],"label_agreement":null},{"id":"W4407976557","doi":"10.1016/j.jtct.2025.01.167","title":"Fnih MRD in AML Biomarkers Consortium: Evaluation of Methods for Detection of FLT3 internal Tandem Duplication Measurable Residual Disease in Acute Myeloid Leukemia","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Myeloid leukemia; Minimal residual disease; Medicine; Oncology; Leukemia; Disease; Tandem exon duplication; Internal medicine; Gene duplication; Biology; Genetics; Gene","score_opus":0.042111257552073164,"score_gpt":0.3766715540483616,"score_spread":0.33456029649628843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407976557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9071508,0.0016655232,0.089398116,0.00019971072,0.0000475162,0.0013183592,0.000019233388,0.000012079484,0.00018863245],"genre_scores_gemma":[0.9934379,0.0037976014,0.0022993342,0.00004311248,0.000010819348,0.00017662176,0.00014406425,0.000012808385,0.00007777601],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840534,0.00041595477,0.0005029242,0.0002563672,0.0002647598,0.00015464827],"domain_scores_gemma":[0.99917597,0.00020874542,0.00012803487,0.00016477094,0.0002633603,0.00005914798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023194724,0.00012148441,0.00028061724,0.00049078953,0.00003251796,0.000008321695,0.000070575,0.00010564518,0.00001797286],"category_scores_gemma":[0.00006426361,0.00011450083,0.000065196524,0.00042561858,0.00008917484,0.00009509592,0.000004326052,0.00013538313,3.4228069e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069649564,0.00007997306,0.018192751,0.00027861007,0.00014463272,0.000002980442,0.0004737161,0.00009034519,0.8336987,0.00010293584,0.000005216314,0.13996516],"study_design_scores_gemma":[0.010347378,0.00016228938,0.21980049,0.00023468494,0.0002454762,0.0000046674813,0.0001478966,0.026191788,0.742141,0.0005818614,0.000058773203,0.00008371007],"about_ca_topic_score_codex":0.0003989746,"about_ca_topic_score_gemma":0.00011142565,"teacher_disagreement_score":0.20160775,"about_ca_system_score_codex":0.00031751939,"about_ca_system_score_gemma":0.000511749,"threshold_uncertainty_score":0.46692085},"labels":[],"label_agreement":null},{"id":"W4407976599","doi":"10.1016/j.jtct.2025.01.177","title":"Frequency of Deleterious Pathogenic/Likely Pathogenic Germline Variants in Related and Unrelated Allogeneic Hematopoietic Cell Transplant Donors for Patients with Myelodysplastic Syndrome","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Germline; Hematopoietic cell; Myelodysplastic syndromes; Haematopoiesis; Medicine; Immunology; Biology; Genetics; Stem cell; Gene; Bone marrow","score_opus":0.006781966775672861,"score_gpt":0.22707340367844478,"score_spread":0.22029143690277192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407976599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992202,0.0021198497,0.0037001914,0.00009955052,0.000048235484,0.0015568304,0.00018368413,0.00003528756,0.000054370652],"genre_scores_gemma":[0.99221855,0.005988166,0.00083044305,0.000095764866,0.000003854153,0.00008216603,0.0006390263,0.000041322928,0.00010071991],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982612,0.0001201447,0.0005972347,0.00044603093,0.00022893783,0.00034644298],"domain_scores_gemma":[0.99926347,0.0001803369,0.00011650453,0.00020332674,0.00010991026,0.00012643737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026294508,0.0002839608,0.00052062026,0.0003642416,0.00007846297,0.000014614785,0.000094415205,0.0002301611,0.00003285305],"category_scores_gemma":[0.000005912784,0.00022964244,0.00007688304,0.00041291624,0.00013011676,0.00007712943,0.000005401675,0.00024737703,0.000001602853],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070937574,0.00096084166,0.25743052,0.002838414,0.0005652031,0.00092823344,0.0046727112,0.000051150775,0.7199293,0.00040716157,0.0000034247562,0.0051193046],"study_design_scores_gemma":[0.06273907,0.0031597104,0.8873407,0.0014199975,0.0009113019,0.00057276705,0.0001554161,0.0011916801,0.041082524,0.0007320124,0.000020283003,0.00067448907],"about_ca_topic_score_codex":0.00006276973,"about_ca_topic_score_gemma":0.000028645063,"teacher_disagreement_score":0.6788468,"about_ca_system_score_codex":0.00005432912,"about_ca_system_score_gemma":0.00018484674,"threshold_uncertainty_score":0.93645465},"labels":[],"label_agreement":null},{"id":"W4407976601","doi":"10.1016/j.jtct.2025.01.159","title":"Fludarabine during Lymphodepletion Chemotherapy Prior to CAR-T Cell Therapy in Adult Patients with Non-Hodgkin Lymphoma: Evaluation of a Pharmacokinetic Model and Exploration of Optimal Exposure","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Fludarabine; Chemotherapy; Medicine; Pharmacokinetics; Lymphoma; Cyclophosphamide; Oncology; Pharmacology; Internal medicine","score_opus":0.019301962104278456,"score_gpt":0.28665886335044105,"score_spread":0.26735690124616257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407976601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910521,0.0005954611,0.0057704747,0.0001663119,0.00002503667,0.0021917077,0.000018394421,0.000016758715,0.00016377236],"genre_scores_gemma":[0.9921869,0.00641454,0.0008151489,0.00014015884,0.000014118311,0.00015510841,0.00010894566,0.000032552438,0.00013254283],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982741,0.00013853404,0.00043248263,0.00034912297,0.0006113312,0.0001944375],"domain_scores_gemma":[0.99910057,0.000034438737,0.00011410855,0.00019548282,0.00047921727,0.00007616919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004303681,0.00021960911,0.0003650601,0.000412678,0.000050417915,0.000014888007,0.000066231485,0.00009809461,0.000069035836],"category_scores_gemma":[0.0000037807251,0.00018808026,0.000050076527,0.00042534468,0.00006716015,0.00017269762,0.0000052233604,0.000076637785,3.8165007e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016969359,0.00066329807,0.014074264,0.0003673768,0.00008631292,0.0000023855084,0.008332841,0.0053586317,0.858712,0.000010472451,0.0000016075854,0.09542144],"study_design_scores_gemma":[0.060529437,0.0011943378,0.122202694,0.0002647761,0.00008999244,0.0000024127069,0.00028946076,0.029428232,0.78578466,0.000028075745,0.000009370197,0.00017653448],"about_ca_topic_score_codex":0.00007243492,"about_ca_topic_score_gemma":0.000017380455,"teacher_disagreement_score":0.10812843,"about_ca_system_score_codex":0.0000816577,"about_ca_system_score_gemma":0.00015809879,"threshold_uncertainty_score":0.766969},"labels":[],"label_agreement":null},{"id":"W4407976644","doi":"10.1016/j.jtct.2025.01.038","title":"Durable Clinical Benefits in Severe Sickle Cell Disease with Exagamglogene Autotemcel","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Disease; Medicine; Intensive care medicine; Internal medicine","score_opus":0.012532527132351924,"score_gpt":0.2544538505573453,"score_spread":0.2419213234249934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407976644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98541844,0.007725345,0.0006168978,0.0011110376,0.00007157092,0.00039508584,0.000011598692,0.00004320278,0.0046068016],"genre_scores_gemma":[0.96963036,0.027276788,0.00013661075,0.0010894276,0.0000147278315,0.000013395466,0.000097984725,0.00001323948,0.0017274957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991561,0.00005793685,0.00025764044,0.00024579928,0.0001125114,0.0001700087],"domain_scores_gemma":[0.9996341,0.00003911757,0.00003377507,0.00013634624,0.000027540018,0.00012915829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000145137,0.00013276044,0.00021344636,0.0000886435,0.000062408515,0.000013621487,0.000038767612,0.000110576926,0.000074106036],"category_scores_gemma":[0.0000018839116,0.00009783483,0.000054367298,0.00019820913,0.00006104434,0.000043105432,0.0000023979865,0.00018070605,0.000008730615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02154424,0.0033755277,0.80086666,0.002058499,0.0003952806,0.0015233675,0.0033541294,0.001953242,0.026139352,0.0027017691,0.0005162916,0.13557164],"study_design_scores_gemma":[0.05741254,0.0012946597,0.8930212,0.0014024818,0.0005947957,0.00007573054,0.0011983621,0.0026691677,0.030143997,0.00052430475,0.010859113,0.0008036159],"about_ca_topic_score_codex":0.000038375252,"about_ca_topic_score_gemma":0.000018073713,"teacher_disagreement_score":0.13476804,"about_ca_system_score_codex":0.000011204542,"about_ca_system_score_gemma":0.00012004427,"threshold_uncertainty_score":0.39895886},"labels":[],"label_agreement":null},{"id":"W4407976649","doi":"10.1016/j.jtct.2025.01.109","title":"FOXP3 and Helios Expressing CD4+ T Conventional Cells Correlate with T Cell Activation after Orca-T Allogeneic T Cell Immunotherapy","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Immunotherapy; FOXP3; T cell; Immunology; Cell; Cancer research; Biology; Cell biology; Immune system; Genetics","score_opus":0.005212899586179146,"score_gpt":0.19730491884609108,"score_spread":0.19209201925991193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407976649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9607295,0.008226671,0.02750978,0.00012838391,0.00080776715,0.00039159477,0.00000907728,0.0000687118,0.002128548],"genre_scores_gemma":[0.97911924,0.005247453,0.00012043224,0.00072972645,0.000014619394,0.000053723612,0.00028042696,0.000022690007,0.014411678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989528,0.00016812581,0.00027902107,0.0003338744,0.000052390376,0.00021379186],"domain_scores_gemma":[0.99957484,0.00007672266,0.00011871311,0.00014350312,0.000065206215,0.00002104053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001244641,0.00023892148,0.0002030217,0.00017715395,0.00026760966,0.000059956226,0.00006500139,0.00020093175,0.000863468],"category_scores_gemma":[5.666417e-7,0.00020259115,0.00006285167,0.00011715728,0.00012720104,0.00021884785,0.0000064982455,0.00024376468,0.000048218095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034088995,0.00014873322,0.00068996736,0.00007839282,0.00010539983,0.0000042152633,0.00096333574,0.000019301451,0.990063,0.00007481526,0.00021863593,0.0042252894],"study_design_scores_gemma":[0.005973148,0.00022898728,0.0033352638,0.00010437956,0.00005270677,0.000019764657,0.0003166061,0.000034320514,0.9654124,0.000040092422,0.02424932,0.00023301983],"about_ca_topic_score_codex":0.000037776168,"about_ca_topic_score_gemma":0.0000032545563,"teacher_disagreement_score":0.02738935,"about_ca_system_score_codex":0.00002098903,"about_ca_system_score_gemma":0.000037823458,"threshold_uncertainty_score":0.9454369},"labels":[],"label_agreement":null},{"id":"W4407976671","doi":"10.1016/j.jtct.2025.01.041","title":"Quantify Heterogeneity in Treatment Effects; A Case Study for Patients with Acute Myeloid Leukemia (AML)","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Myeloid leukemia; Medicine; Leukemia; Oncology; Internal medicine; Cancer research","score_opus":0.018076507125201025,"score_gpt":0.3114217289121087,"score_spread":0.29334522178690764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407976671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99274385,0.00029646055,0.0030372231,0.000082686,0.000037948546,0.003680865,0.00003202905,0.000034391174,0.00005454004],"genre_scores_gemma":[0.9976084,0.0010466753,0.00035724178,0.00015651753,0.000013511179,0.00041116882,0.00019149619,0.000021616372,0.00019333372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989586,0.00010784834,0.00021014207,0.00033759756,0.0001545241,0.00023132749],"domain_scores_gemma":[0.9994847,0.00014456014,0.000033754794,0.00019283232,0.00006266228,0.00008145989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013682715,0.00020102663,0.0003155431,0.00019781184,0.000107658176,0.000024202931,0.00004399328,0.000075227785,0.000005577077],"category_scores_gemma":[0.0000023937496,0.00014070023,0.000056951325,0.00021407331,0.000042753272,0.00005754313,0.0000034596571,0.000107828404,0.0000017431597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029958626,0.0037357362,0.8164301,0.00076615124,0.002003117,0.011399289,0.010572689,0.000022984113,0.030976096,0.00009987114,0.000018857107,0.09401648],"study_design_scores_gemma":[0.2391293,0.026038494,0.4428662,0.00039810722,0.0016471337,0.0008372918,0.0024299847,0.0017209927,0.28320298,0.00006106244,0.0008987928,0.00076962594],"about_ca_topic_score_codex":0.0005560995,"about_ca_topic_score_gemma":0.0004431441,"teacher_disagreement_score":0.3735639,"about_ca_system_score_codex":0.00026071363,"about_ca_system_score_gemma":0.00018334297,"threshold_uncertainty_score":0.5737589},"labels":[],"label_agreement":null},{"id":"W4407976740","doi":"10.1016/j.jtct.2025.01.039","title":"Reni-Cel, an Investigational AsCas12a Gene-Edited Cell Medicine, Led to Sustained Hemoglobin Normalization and Increased Fetal Hemoglobin in Patients with Severe Sickle Cell Disease Treated in the RUBY Trial","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Fetal hemoglobin; Hemoglobin; Medicine; Disease; Hemoglobin s; Cell; Normalization (sociology); Clinical trial; Internal medicine; Fetus; Sickle cell anemia; Chemistry; Pregnancy; Biology; Biochemistry; Genetics","score_opus":0.005268208090287432,"score_gpt":0.21610902303342722,"score_spread":0.21084081494313978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407976740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99505264,0.00045634728,0.00037353198,0.0011760704,0.000057213634,0.0022076229,0.000044848868,0.00003923808,0.0005925025],"genre_scores_gemma":[0.99502796,0.000500849,0.00010619878,0.0014911108,0.00003671372,0.000071475675,0.002585775,0.000022269081,0.00015763775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982225,0.0003082362,0.0004452798,0.00040164057,0.00035876382,0.00026363356],"domain_scores_gemma":[0.9993058,0.00007086043,0.00008556154,0.00020334596,0.00010336479,0.0002310631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031742518,0.0002829423,0.00032918443,0.00035349786,0.00013304182,0.000037042468,0.000091852424,0.00014934689,0.000036361023],"category_scores_gemma":[0.000015261005,0.00019147832,0.00003576003,0.00080023817,0.00012456307,0.0001550328,0.000005795333,0.00020104207,0.000001326473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30164552,0.0049530156,0.6415111,0.001163035,0.00015880654,0.00045087375,0.018943662,0.0010166066,0.024167402,0.0005872119,0.00046308042,0.0049396893],"study_design_scores_gemma":[0.34824154,0.003528798,0.6292937,0.0004834805,0.00042955237,0.0000143135285,0.003116779,0.0036442638,0.009974842,0.00024094891,0.00035858175,0.00067320344],"about_ca_topic_score_codex":0.0004776031,"about_ca_topic_score_gemma":0.00012689672,"teacher_disagreement_score":0.046596017,"about_ca_system_score_codex":0.00005300223,"about_ca_system_score_gemma":0.0001542247,"threshold_uncertainty_score":0.7808259},"labels":[],"label_agreement":null},{"id":"W4407976789","doi":"10.1016/j.jtct.2025.01.176","title":"Measurable Residual Mutated NPM1 before Allogeneic Transplant for Acute Myeloid Leukemia","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"NPM1; Myeloid leukemia; Minimal residual disease; Medicine; Residual; Cancer research; Leukemia; Oncology; Immunology; Biology; Genetics; Computer science; Gene; Karyotype","score_opus":0.018973425728356492,"score_gpt":0.2948227699665627,"score_spread":0.27584934423820623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407976789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735506,0.0017594626,0.019458398,0.0018232015,0.00011451328,0.0014652679,0.00018849192,0.0001447115,0.0014953178],"genre_scores_gemma":[0.9785769,0.011573489,0.0013514422,0.0012676527,0.00008678766,0.00018891398,0.0015227125,0.000050075185,0.0053820047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840343,0.00008370069,0.0003583726,0.00043308912,0.00029114407,0.00043026547],"domain_scores_gemma":[0.9993132,0.00009330432,0.000049053808,0.0002422771,0.0001447002,0.0001574927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003736647,0.00026432375,0.0003968128,0.00024737464,0.00023451904,0.000042161548,0.00013450976,0.00021191158,0.00008147154],"category_scores_gemma":[0.0000051495326,0.00021983135,0.00013257463,0.0002908551,0.000118308504,0.00009766449,0.0000042898077,0.0002629055,0.0000107762235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011361485,0.00012745998,0.004007265,0.00065504416,0.0014492255,0.00034203072,0.0032859228,0.00003063373,0.93737316,0.0014515782,0.000909601,0.039006606],"study_design_scores_gemma":[0.021463823,0.0009937764,0.01385349,0.0002866567,0.0009261032,0.00025930651,0.00025422414,0.0013166406,0.9509496,0.0009345945,0.008380079,0.0003816749],"about_ca_topic_score_codex":0.000086118285,"about_ca_topic_score_gemma":0.00004939145,"teacher_disagreement_score":0.03862493,"about_ca_system_score_codex":0.00016012532,"about_ca_system_score_gemma":0.00047519658,"threshold_uncertainty_score":0.89644617},"labels":[],"label_agreement":null},{"id":"W4407976889","doi":"10.1016/j.jtct.2025.01.323","title":"Axicabtagene Ciloleucel (Axi-Cel) Versus Standard of Care (SOC) in Patients with Primary Refractory or Early Relapsed Large B-Cell Lymphoma (LBCL)","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Refractory (planetary science); B-cell lymphoma; Standard of care; Lymphoma; Oncology; Internal medicine; Materials science","score_opus":0.011799772427328882,"score_gpt":0.2592529896449002,"score_spread":0.2474532172175713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407976889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914937,0.002292891,0.00034644597,0.000056251258,0.00010087786,0.0008828871,0.00011370137,0.000036953534,0.0046763187],"genre_scores_gemma":[0.9917122,0.0053879963,0.00019002247,0.00015872977,0.000018509196,0.000028282358,0.0004500327,0.000037418766,0.002016783],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983509,0.00012972835,0.00034810416,0.00034347377,0.0005284092,0.00029939297],"domain_scores_gemma":[0.9992215,0.00010843099,0.00008396459,0.0002990119,0.00018511973,0.000101948775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020521798,0.00022163773,0.00043918187,0.000274313,0.00007356693,0.00001911515,0.00010265299,0.00015417386,0.00033455106],"category_scores_gemma":[0.000003678878,0.00017124465,0.000078903984,0.0003756984,0.000092062284,0.00009146936,0.000008422372,0.00018825757,0.0000032636947],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56938696,0.0036962803,0.10722794,0.0027347354,0.00047835943,0.0002742551,0.01440957,0.000004650722,0.18628477,0.000158422,0.0000737044,0.11527037],"study_design_scores_gemma":[0.31147495,0.017126234,0.29201272,0.00077506556,0.00025560835,0.0000033956483,0.0015737008,0.00001620998,0.36216924,0.000022122926,0.014018733,0.0005520235],"about_ca_topic_score_codex":0.000056020872,"about_ca_topic_score_gemma":0.000081422506,"teacher_disagreement_score":0.257912,"about_ca_system_score_codex":0.00016526249,"about_ca_system_score_gemma":0.00031481413,"threshold_uncertainty_score":0.6983154},"labels":[],"label_agreement":null},{"id":"W4407976914","doi":"10.1016/j.jtct.2025.01.098","title":"A CD33-Deleted Allograft (Trem-cel) Enables Post-Hematopoietic Cell Transplant (HCT) Maintenance Dosing of Gemtuzumab Ozogamicin (GO) with Therapeutic Levels of Drug Exposure and Low Hematologic and Hepatic Toxicity in Patients with High-Risk Acute Myeloid Leukemia (AML)","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Gemtuzumab ozogamicin; Dosing; Calicheamicin; Toxicity; Medicine; Therapeutic index; Pharmacology; Hematopoietic cell; Hematopoietic stem cell transplantation; Therapeutic drug monitoring; Drug; CD33; Haematopoiesis; Internal medicine; Transplantation; Stem cell; Myeloid leukemia; CD34; Biology","score_opus":0.005868945256474293,"score_gpt":0.21372117983738542,"score_spread":0.20785223458091112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407976914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932076,0.0019594638,0.0031779225,0.00016084906,0.000015214045,0.0012630462,0.00014280468,0.000032831642,0.00004028646],"genre_scores_gemma":[0.99133325,0.007394335,0.000799077,0.00019407006,0.000004077987,0.000031136675,0.00012270447,0.000036727688,0.00008464758],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979347,0.0002308974,0.000562141,0.00049607584,0.00038930916,0.0003868604],"domain_scores_gemma":[0.9989813,0.00021800846,0.000230109,0.00027672292,0.0001850217,0.000108815824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003050788,0.0003768551,0.00080459635,0.0003475522,0.000101571146,0.000023820901,0.00012088425,0.00016285288,0.000016046677],"category_scores_gemma":[0.0000037442755,0.000258489,0.000056069348,0.00042011577,0.00039543497,0.00013215165,0.000010722782,0.0003589724,2.895566e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01790841,0.0006729627,0.42347577,0.0044633597,0.0007309997,0.00023282372,0.01382762,0.00009033846,0.5329289,0.00021848413,0.0000030983979,0.0054472312],"study_design_scores_gemma":[0.033767164,0.0025304784,0.39771947,0.0020152542,0.0006818784,0.00009666127,0.001043805,0.0008418941,0.56071436,0.00017796787,0.0000049645805,0.00040608138],"about_ca_topic_score_codex":0.0004032182,"about_ca_topic_score_gemma":0.00018850318,"teacher_disagreement_score":0.027785465,"about_ca_system_score_codex":0.00010072242,"about_ca_system_score_gemma":0.00025579924,"threshold_uncertainty_score":0.9999867},"labels":[],"label_agreement":null},{"id":"W4407976926","doi":"10.1016/j.jtct.2025.01.300","title":"Predictors of Inpatient Transfer from the Ambulatory Day Hospital during Outpatient Allogeneic Stem Cell Transplantation","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Ambulatory; Medicine; Transplantation; Stem cell; Emergency medicine; Internal medicine; Biology","score_opus":0.024948004554431715,"score_gpt":0.27485528480649796,"score_spread":0.24990728025206624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407976926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865201,0.0070324517,0.00512763,0.00012481726,0.00021600006,0.000503512,0.00017281644,0.000024559151,0.0002781043],"genre_scores_gemma":[0.9751172,0.024274794,0.000060906856,0.00011862524,0.00003044623,0.000020625383,0.00027616898,0.000013362637,0.00008785884],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989332,0.00010767017,0.0003882448,0.00020676354,0.0002388381,0.00012527507],"domain_scores_gemma":[0.9995299,0.00013042812,0.00006511552,0.00015572953,0.000070144786,0.000048693917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010898773,0.00016218203,0.000268165,0.000078909594,0.000062219864,0.000006335699,0.000074506475,0.00009528966,0.000027471951],"category_scores_gemma":[0.0000011010017,0.000116725765,0.000112216134,0.00012872975,0.000093869734,0.000056310604,0.0000021400322,0.00011061473,9.739928e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021279254,0.00044425653,0.5168839,0.00097448484,0.00046811847,0.000025318624,0.08753935,0.00008713432,0.38532925,0.00016836896,0.000018872688,0.0059330193],"study_design_scores_gemma":[0.0037846593,0.00033565797,0.22646612,0.00049445254,0.00027827598,7.478165e-7,0.0012989616,0.000024840498,0.76673687,0.000016638984,0.00045863958,0.000104165236],"about_ca_topic_score_codex":0.00008475572,"about_ca_topic_score_gemma":0.000014206975,"teacher_disagreement_score":0.3814076,"about_ca_system_score_codex":0.000017973714,"about_ca_system_score_gemma":0.00004312615,"threshold_uncertainty_score":0.47599387},"labels":[],"label_agreement":null},{"id":"W4407977037","doi":"10.1016/j.jtct.2025.01.097","title":"Impact of Graft Versus Host Disease Following Allogeneic Hematopoietic Cell Transplantation on Leukemia Free Survival in Hematologic Malignancies: A CIBMTR Analysis","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Hematopoietic cell; Leukemia; Hematopoietic stem cell transplantation; Disease; Transplantation; Medicine; Graft-versus-host disease; Hematologic disease; Haematopoiesis; Hematologic Neoplasms; Immunology; Oncology; Biology; Internal medicine; Stem cell; Genetics","score_opus":0.018071588872918837,"score_gpt":0.29786048692699296,"score_spread":0.27978889805407414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407977037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918918,0.0010780796,0.005675512,0.00011506277,0.00008180841,0.0005443324,0.00009116473,0.000038240378,0.0004839824],"genre_scores_gemma":[0.99547887,0.0037662631,0.00011689983,0.000076838616,0.00001087177,0.00004069955,0.00038363383,0.000020062062,0.00010589207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981787,0.00016722149,0.0004582689,0.00041251705,0.00045813,0.00032511726],"domain_scores_gemma":[0.998954,0.00037415783,0.000087424334,0.00036392215,0.000056444154,0.00016404178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029018495,0.00026894087,0.00058395014,0.0006831278,0.00006946971,0.000021503833,0.00015867583,0.00013826777,0.00006902534],"category_scores_gemma":[0.000018431898,0.00021852362,0.00043744512,0.0010505762,0.000085422114,0.000072758536,0.0000067511505,0.00016828979,0.00000397823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03683249,0.0009245458,0.6145635,0.0022644815,0.0029501093,0.0022679528,0.00421796,0.0018792509,0.3326235,0.00088440836,0.000027170743,0.00056457793],"study_design_scores_gemma":[0.03746884,0.0009877713,0.86428,0.00050635147,0.0026218847,0.000013942317,0.000368063,0.0014781794,0.09166277,0.00021248852,0.0000060300827,0.00039367567],"about_ca_topic_score_codex":0.0003225644,"about_ca_topic_score_gemma":0.0000788742,"teacher_disagreement_score":0.24971646,"about_ca_system_score_codex":0.00030907252,"about_ca_system_score_gemma":0.00050807535,"threshold_uncertainty_score":0.89111346},"labels":[],"label_agreement":null},{"id":"W4407977051","doi":"10.1016/j.jtct.2025.01.081","title":"Racial Disparity in Myeloablative Hematopoietic Cell Transplantation Outcomes in Patients with Hematological Malignancies Older Than 45 Years","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Medicine; Hematopoietic cell; Hematopoietic stem cell transplantation; Hematologic Neoplasms; Haematopoiesis; Oncology; Transplantation; Internal medicine; Leukemia; Pediatrics; Stem cell; Genetics; Biology","score_opus":0.009334163425579821,"score_gpt":0.24278125901492495,"score_spread":0.23344709558934512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407977051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99096954,0.00023994436,0.0064614215,0.0001920655,0.00006645481,0.0011918886,0.00003365545,0.000050463976,0.0007945393],"genre_scores_gemma":[0.99752444,0.0010159597,0.00066078675,0.00023838278,0.0000051200154,0.00007664259,0.00032965874,0.00002158683,0.00012739406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827665,0.00015501863,0.00050703733,0.0004185591,0.0003346538,0.0003080554],"domain_scores_gemma":[0.9994743,0.00014969677,0.00008374382,0.0001588154,0.000051118976,0.0000823463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022159272,0.00028117804,0.00053497206,0.00033510043,0.000057018802,0.000028047572,0.000075097654,0.00019571964,0.000057242876],"category_scores_gemma":[0.0000033060853,0.00022773855,0.000070293216,0.00039655692,0.00010587213,0.00015116176,0.0000029520277,0.00024215032,0.0000069914336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002442095,0.00069730124,0.98282576,0.0008872756,0.00004021368,0.00020557226,0.0097337905,0.000022683325,0.0019398122,0.0005672912,0.000001640218,0.00063655176],"study_design_scores_gemma":[0.014616043,0.00023397875,0.96162474,0.0005480438,0.00009490134,0.000013758365,0.00037426638,0.000041100793,0.022016795,0.00019342006,0.000009512801,0.00023343581],"about_ca_topic_score_codex":0.00006326745,"about_ca_topic_score_gemma":0.00016327179,"teacher_disagreement_score":0.02120103,"about_ca_system_score_codex":0.000043697102,"about_ca_system_score_gemma":0.00006609105,"threshold_uncertainty_score":0.92869085},"labels":[],"label_agreement":null},{"id":"W4407977109","doi":"10.1016/j.jtct.2025.01.421","title":"Human Regulatory-like Natural Killer Cells Associated with Chronic Graft-Versus-Host Disease Suppression Produce Regulatory Extracellular Vesicles.","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital; Université de Montréal","funders":"","keywords":"Extracellular vesicles; Extracellular; Cell biology; Host (biology); Immunology; Biology; Chemistry; Ecology","score_opus":0.006958306374746223,"score_gpt":0.23450948882948186,"score_spread":0.22755118245473563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407977109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97500867,0.022516657,0.00069894217,0.00014412125,0.0006867487,0.00069159025,0.000030685813,0.000083917024,0.00013865519],"genre_scores_gemma":[0.99180365,0.0011879146,0.00008147772,0.00017460281,0.00013049551,0.00005596366,0.0011451294,0.00006829438,0.0053524505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978335,0.0002443163,0.00036593623,0.0008224555,0.00031262412,0.00042117355],"domain_scores_gemma":[0.998855,0.0000250222,0.00015964058,0.0006500149,0.00007991721,0.00023041594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002768846,0.00041755376,0.00025466157,0.00010792642,0.00036796494,0.00007417425,0.00027571557,0.00021382153,0.000047653448],"category_scores_gemma":[0.000008703374,0.00037799403,0.00014580695,0.00020104971,0.0003146415,0.000029835783,0.000030449653,0.00022551592,0.000004295195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001876385,0.0002522108,0.0010945497,0.00014175731,0.00022779648,0.00006530204,0.00012114313,0.000096507065,0.993907,0.00041874,0.0008678231,0.00093081687],"study_design_scores_gemma":[0.007168121,0.0003189888,0.029584264,0.00022520762,0.0002241157,0.000003207505,0.000050081504,0.00016192862,0.95450425,0.00007870697,0.007075284,0.0006058709],"about_ca_topic_score_codex":0.000008620602,"about_ca_topic_score_gemma":0.000035426925,"teacher_disagreement_score":0.039402746,"about_ca_system_score_codex":0.00005942176,"about_ca_system_score_gemma":0.00018790775,"threshold_uncertainty_score":0.9998672},"labels":[],"label_agreement":null},{"id":"W4407977137","doi":"10.1016/j.jtct.2025.01.383","title":"Durable Clinical Benefits in Transfusion-Dependent Β-Thalassemia with Exagamglogene Autotemcel","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; SickKids Foundation; BC Children's Hospital; University of Toronto","funders":"","keywords":"Thalassemia; Medicine; Blood transfusion; Intensive care medicine; Internal medicine","score_opus":0.0140148346751667,"score_gpt":0.26905360407703804,"score_spread":0.25503876940187137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407977137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873563,0.004876471,0.0018538806,0.001193589,0.00010456316,0.0004642034,0.0000062391564,0.000046702382,0.0040980233],"genre_scores_gemma":[0.9334191,0.064906694,0.00014870931,0.0006536462,0.000014185669,0.000016788934,0.00005389051,0.000013445369,0.0007735009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898946,0.00006859009,0.00033491934,0.0002760507,0.00014736396,0.00018359866],"domain_scores_gemma":[0.99967265,0.00004900699,0.000032168886,0.00013062233,0.0000315539,0.000084002255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024522163,0.00014514184,0.0002660768,0.00012419216,0.000069875605,0.000014427807,0.000043266304,0.00018781255,0.00008057317],"category_scores_gemma":[0.0000019797064,0.000105312676,0.00005796604,0.00022308965,0.000060116006,0.000043243315,0.0000018213177,0.00024957405,0.000005636879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012032329,0.0021797575,0.5690668,0.000869968,0.0005938867,0.0010284336,0.0044542616,0.0006634184,0.13824818,0.0029852926,0.00012566848,0.267752],"study_design_scores_gemma":[0.06162882,0.002037771,0.78765386,0.0018247429,0.00051124836,0.00031865135,0.0019422919,0.001589106,0.1365636,0.0003790899,0.0047835754,0.00076721905],"about_ca_topic_score_codex":0.00009566218,"about_ca_topic_score_gemma":0.00009176187,"teacher_disagreement_score":0.2669848,"about_ca_system_score_codex":0.000015610933,"about_ca_system_score_gemma":0.000096626594,"threshold_uncertainty_score":0.42945263},"labels":[],"label_agreement":null},{"id":"W4407977272","doi":"10.1016/j.jtct.2025.01.182","title":"Significant Inter-Laboratory Variability in Measurable Residual Disease Multiparameter Flow Cytometry Testing Prior to Allogeneic Transplantation Impedes Outcome Prediction: A CIBMTR Analysis","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Transplantation; Residual; Medicine; Outcome (game theory); Flow cytometry; Disease; Oncology; Internal medicine; Immunology; Computer science; Mathematics","score_opus":0.0341221466259357,"score_gpt":0.30346301108468426,"score_spread":0.26934086445874855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407977272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9082287,0.00027908696,0.089311264,0.00029240028,0.00010158846,0.0010367447,0.00046746273,0.00009457203,0.0001881709],"genre_scores_gemma":[0.992636,0.0009696583,0.0048263,0.000558393,0.000025529896,0.00014663456,0.0006735403,0.000021569098,0.00014234638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976957,0.00032214622,0.000737428,0.0006110104,0.0003355172,0.0002982196],"domain_scores_gemma":[0.99881417,0.00040585492,0.000080670434,0.00028740236,0.00014810536,0.0002637858],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071370736,0.00031088002,0.0005259597,0.0008264034,0.00014266405,0.000063541585,0.000088948385,0.00011877772,0.000060717135],"category_scores_gemma":[0.000047453395,0.00026474835,0.0001630648,0.0016492739,0.000056760957,0.0001587905,0.0000038018754,0.00018853655,0.000006283166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037838907,0.00038784006,0.9487739,0.0007926732,0.000755646,0.0002454036,0.0011424192,0.0009299589,0.035797924,0.000038427228,0.0000012855239,0.0073505836],"study_design_scores_gemma":[0.0061583784,0.00020612164,0.9665186,0.00034296804,0.0018523254,0.0000085660795,0.000086298336,0.0023241849,0.022191534,0.000046882888,0.000025079573,0.00023909757],"about_ca_topic_score_codex":0.00011727017,"about_ca_topic_score_gemma":0.00006328361,"teacher_disagreement_score":0.084484965,"about_ca_system_score_codex":0.00009757504,"about_ca_system_score_gemma":0.0001290463,"threshold_uncertainty_score":0.99998045},"labels":[],"label_agreement":null},{"id":"W4407977306","doi":"10.1016/j.jtct.2025.01.068","title":"Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis IV a (Morquio A): An International Retrospective Study of 40 Children","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Mucopolysaccharidosis; Hematopoietic stem cell transplantation; Medicine; Hematopoietic cell; Transplantation; Stem cell; Pediatrics; Retrospective cohort study; Oncology; Haematopoiesis; Internal medicine; Biology; Genetics","score_opus":0.011034979178001645,"score_gpt":0.2672350294210898,"score_spread":0.2562000502430881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407977306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99249697,0.00017691891,0.0048380895,0.000053656753,0.000051848783,0.0020943217,0.0000991291,0.000031121377,0.00015792994],"genre_scores_gemma":[0.9981254,0.0008670853,0.0001497276,0.00006451707,0.000014904506,0.00012211048,0.00052186794,0.00002215449,0.00011226463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988065,0.00006713079,0.00026614268,0.000337824,0.00036686895,0.00015554481],"domain_scores_gemma":[0.9994462,0.000028197714,0.000082229315,0.0001625669,0.00021483033,0.00006593399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118766795,0.0001631088,0.00025709314,0.00021001633,0.00009735837,0.000023893519,0.00011230741,0.00006631892,0.00003986136],"category_scores_gemma":[0.0000010304185,0.00013313892,0.000053705917,0.00020139763,0.00005048,0.00014007717,0.0000031555403,0.000093321534,7.4018766e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010433212,0.0031055396,0.9522546,0.0003002153,0.00043429554,0.000010819208,0.011402202,0.000015196479,0.016049331,0.0001212286,0.0000032574465,0.005870107],"study_design_scores_gemma":[0.021751799,0.0034399023,0.92568725,0.00008000756,0.00028233253,0.000006331905,0.0013422908,0.000095120944,0.04709847,0.00004462881,0.000007657797,0.00016422321],"about_ca_topic_score_codex":0.000102435086,"about_ca_topic_score_gemma":0.000047583908,"teacher_disagreement_score":0.03104914,"about_ca_system_score_codex":0.000036606958,"about_ca_system_score_gemma":0.000047960002,"threshold_uncertainty_score":0.54292476},"labels":[],"label_agreement":null},{"id":"W4407977458","doi":"10.1016/j.jtct.2025.01.432","title":"The Effects of Prior Lines of Therapy on Clinical Outcomes for Patients with Chronic Graft-Versus-Host Disease Receiving Axatilimab: A Post Hoc Analysis of Agave-201","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Post-hoc analysis; Agave; Post hoc; Host (biology); Disease; Medicine; Internal medicine; Biology; Genetics","score_opus":0.021518525905252668,"score_gpt":0.35517419401332295,"score_spread":0.3336556681080703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407977458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959276,0.0017753068,0.0006814845,0.00025880802,0.000070881644,0.0011830308,0.00005750343,0.0000072280754,0.00003816806],"genre_scores_gemma":[0.97982067,0.0196288,0.00012736522,0.00008882014,0.000011898764,0.00005220759,0.00012883905,0.000009152922,0.00013224066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998887,0.00015038747,0.00042916412,0.00017291095,0.00022769764,0.00013286578],"domain_scores_gemma":[0.99664414,0.0026332652,0.00020239517,0.00022003392,0.00023809537,0.00006206782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003358524,0.000121629324,0.0005792844,0.00016875278,0.0000785071,0.000004746414,0.000079222606,0.00006588016,0.000012131479],"category_scores_gemma":[0.00009349498,0.00006658943,0.00021433667,0.00026536023,0.00022964974,0.000023895602,0.0000030718168,0.00008066515,1.8399845e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047178004,0.000756223,0.9215559,0.0005786727,0.0034884477,0.0000023378,0.0006146057,0.000002548446,0.0028608937,0.00018522546,0.000004407249,0.022772767],"study_design_scores_gemma":[0.018948771,0.0066586933,0.96880335,0.00022394165,0.0016913356,5.0963717e-8,0.00004210279,0.00030920826,0.003179297,0.000017429931,0.00006653512,0.000059283466],"about_ca_topic_score_codex":0.000033243614,"about_ca_topic_score_gemma":0.000061647974,"teacher_disagreement_score":0.047247484,"about_ca_system_score_codex":0.00001516066,"about_ca_system_score_gemma":0.00018040222,"threshold_uncertainty_score":0.27154383},"labels":[],"label_agreement":null},{"id":"W4408104540","doi":"10.1016/j.jtct.2025.02.022","title":"Allogeneic Stem Cell Transplantation in Participants With Hematologic Malignancies Following Pembrolizumab Therapy","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme","keywords":"Pembrolizumab; Medicine; Transplantation; Hematologic Neoplasms; Stem cell; Oncology; Hematopoietic stem cell transplantation; Internal medicine; Immunotherapy; Cancer; Biology","score_opus":0.02730352427028122,"score_gpt":0.26765683491686265,"score_spread":0.24035331064658144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408104540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98027706,0.0041557956,0.012265805,0.00030005682,0.0000968411,0.0010651283,0.0000131674615,0.000112053014,0.0017141192],"genre_scores_gemma":[0.9785965,0.01972674,0.00037798288,0.0006125945,0.000011676234,0.00014374245,0.00015568007,0.000034214077,0.00034086074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980718,0.00016789502,0.00052162143,0.00047794092,0.00032193895,0.00043883696],"domain_scores_gemma":[0.9993997,0.00013218018,0.00008820441,0.0002196586,0.000046277786,0.00011394977],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030722728,0.0003352069,0.00050746655,0.00030894004,0.000120793324,0.00004279161,0.00009157727,0.00017981112,0.000041585867],"category_scores_gemma":[6.9784613e-7,0.0002651566,0.00011305431,0.00038047304,0.0000731584,0.00014962212,0.0000019074052,0.0001799796,0.000009343916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010744301,0.00074918114,0.2080046,0.0025320766,0.00033705193,0.0020789185,0.016816415,0.00016161021,0.74473375,0.0015260777,0.000008267992,0.012307752],"study_design_scores_gemma":[0.023343535,0.0005591319,0.102822065,0.0009287734,0.0002948759,0.0002428364,0.0008973054,0.00020682132,0.8699342,0.00016408938,0.00017649928,0.0004298867],"about_ca_topic_score_codex":0.000044509463,"about_ca_topic_score_gemma":0.000048270755,"teacher_disagreement_score":0.12520042,"about_ca_system_score_codex":0.00004020468,"about_ca_system_score_gemma":0.00013176662,"threshold_uncertainty_score":0.9999801},"labels":[],"label_agreement":null},{"id":"W4409798211","doi":"10.1016/j.jtct.2025.03.011","title":"Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell Lymphoma","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Cytokine release syndrome; CD19; Neurotoxicity; Lymphoma; Cytokine; Immunology; Medicine; Cancer research; T cell; Antigen; Chimeric antigen receptor; Internal medicine; Toxicity; Immune system","score_opus":0.014777245316883587,"score_gpt":0.2716196132885174,"score_spread":0.25684236797163384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409798211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429613,0.0018901641,0.00045084808,0.00040784627,0.00006789664,0.00071000005,0.000008697171,0.000045623623,0.0021227717],"genre_scores_gemma":[0.98967254,0.006863708,0.000070123155,0.0006641983,0.000014457361,0.00003618979,0.000049286056,0.000021981126,0.0026075013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988772,0.00011173909,0.00023796113,0.00032204948,0.00021325385,0.00023777192],"domain_scores_gemma":[0.9995773,0.00008572263,0.000025774016,0.00017783947,0.000021353017,0.000111997855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024509418,0.0001692807,0.00028799337,0.00025351014,0.00007815616,0.000033045744,0.00005708414,0.00010017408,0.00013145038],"category_scores_gemma":[0.000003999107,0.00015740859,0.00007875404,0.00030193856,0.000057700487,0.00007293193,0.0000069760795,0.00015388726,0.000003960175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001647363,0.00028847952,0.020575067,0.00029190406,0.000059401205,0.0012403869,0.0008543532,0.0000031291743,0.953839,0.00009216862,0.000008717126,0.0211],"study_design_scores_gemma":[0.04135805,0.0008122021,0.1618972,0.0003931832,0.00013852652,0.00038569,0.00031232001,0.0010336703,0.78794336,0.00031512778,0.004994617,0.00041605876],"about_ca_topic_score_codex":0.00017702895,"about_ca_topic_score_gemma":0.000027393036,"teacher_disagreement_score":0.16589569,"about_ca_system_score_codex":0.00003707342,"about_ca_system_score_gemma":0.0000674258,"threshold_uncertainty_score":0.6418936},"labels":[],"label_agreement":null},{"id":"W4410452393","doi":"10.1016/j.jtct.2025.05.008","title":"Outcomes of Multiple Myeloma Patients With Prior Solid Tumors Undergoing Autologous Transplantation","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Cancer Institute; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Paula and Rodger Riney Foundation; American Honda Motor; University of Texas MD Anderson Cancer Center; Leukemia and Lymphoma Society","keywords":"Multiple myeloma; Medicine; Autologous stem-cell transplantation; Transplantation; Oncology; Surgery; Internal medicine","score_opus":0.01285890529037351,"score_gpt":0.27360771933720934,"score_spread":0.2607488140468358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410452393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926875,0.00021822799,0.00561958,0.0001271906,0.000032079675,0.00073494366,0.000047623605,0.00004641878,0.0004863947],"genre_scores_gemma":[0.9972296,0.0011289464,0.000834807,0.0001166295,0.000005004585,0.000029855973,0.00042464063,0.000015123645,0.00021539447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990142,0.00005572629,0.00026394194,0.00022082118,0.00025063026,0.00019468299],"domain_scores_gemma":[0.9994741,0.00015660998,0.000069582675,0.00013040961,0.000086600274,0.00008270045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068559195,0.00016647424,0.00031285224,0.00017710884,0.000103677216,0.000013008959,0.00004621891,0.00006285106,0.000029763842],"category_scores_gemma":[0.000007357676,0.000117482734,0.000059993286,0.00014934396,0.000078985475,0.00008009667,0.0000021571784,0.000086167674,0.0000028901263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004687188,0.00041994438,0.95908976,0.0005359055,0.00037585874,0.0000814671,0.0010448756,0.000012736231,0.008620939,0.0001451354,0.0000021950798,0.024984019],"study_design_scores_gemma":[0.01768438,0.00050801795,0.9019084,0.00019936783,0.00012076598,0.000009040446,0.00007944045,0.00018294598,0.07916267,0.00003265005,0.000015321433,0.00009701309],"about_ca_topic_score_codex":0.00005977717,"about_ca_topic_score_gemma":0.000073068935,"teacher_disagreement_score":0.07054173,"about_ca_system_score_codex":0.000021514921,"about_ca_system_score_gemma":0.00009308516,"threshold_uncertainty_score":0.47908068},"labels":[],"label_agreement":null},{"id":"W4410556138","doi":"10.1016/j.jtct.2025.05.016","title":"NIH Chronic Graft-Versus-Host Disease Consensus Conference 2025 Update","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Alberta Children's Hospital","funders":"National Cancer Institute; National Institutes of Health; Center for Cancer Research","keywords":"Interim; Consensus conference; Medicine; Graft-versus-host disease; Chronic disease; Host (biology); Clinical trial; Disease; Political science; Intensive care medicine; Pathology","score_opus":0.02513238874102067,"score_gpt":0.2850020786359679,"score_spread":0.2598696898949472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410556138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9583615,0.0053785956,0.02330854,0.0037779962,0.00045784895,0.000977439,0.00009319875,0.00017199884,0.0074728504],"genre_scores_gemma":[0.98219895,0.014969837,0.00026808766,0.0006461147,0.000043276897,0.000035590165,0.0004207643,0.00001856167,0.0013988166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988244,0.000082555714,0.00030629052,0.00034018198,0.00021307416,0.00023346563],"domain_scores_gemma":[0.9993443,0.000111561676,0.000052184616,0.0002267244,0.00008276691,0.0001824495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013621258,0.00021373744,0.00025976397,0.00013809482,0.000121090685,0.000038151997,0.000067278714,0.000094158626,0.00042243328],"category_scores_gemma":[0.0000041461212,0.00019541783,0.00008187141,0.00019217633,0.00013148332,0.000048491256,0.0000030321353,0.0001459571,0.000059236685],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03644015,0.00090976385,0.024386391,0.007358702,0.0014013544,0.0018460194,0.0049746167,0.000053821364,0.7989728,0.080565855,0.001161578,0.041928977],"study_design_scores_gemma":[0.08353786,0.0012503801,0.11295979,0.002998141,0.0026533406,0.00015984659,0.00095654896,0.00501032,0.7490117,0.002299563,0.03758393,0.0015785699],"about_ca_topic_score_codex":0.000023603077,"about_ca_topic_score_gemma":0.000021509688,"teacher_disagreement_score":0.088573396,"about_ca_system_score_codex":0.00003819336,"about_ca_system_score_gemma":0.00026730995,"threshold_uncertainty_score":0.7968908},"labels":[],"label_agreement":null},{"id":"W4411196962","doi":"10.1016/j.jtct.2025.05.024","title":"Association of Cyclosporine Exposure Post-Allogeneic Hematopoietic Cell Transplant With Graft Failure and Relapse Risk in Hematological Malignancies","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hematopoietic cell; Haematopoiesis; Oncology; Hematological disorders; Hematopoietic stem cell transplantation; Internal medicine; Immunology; Transplantation; Stem cell; Biology","score_opus":0.006000650660324599,"score_gpt":0.21376642803722554,"score_spread":0.20776577737690094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411196962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99223703,0.0023176267,0.0034504025,0.0007689891,0.000035827066,0.000686742,0.00006314908,0.000047512935,0.0003927263],"genre_scores_gemma":[0.9855594,0.012824535,0.00093375717,0.00014552746,0.0000081384815,0.000038477923,0.00017224454,0.000019598341,0.00029832675],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984368,0.000149831,0.000518602,0.0003567824,0.00029410046,0.00024386114],"domain_scores_gemma":[0.99927527,0.00020353073,0.00017599946,0.00016215115,0.00009811639,0.00008492526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036448773,0.00025374032,0.0005208211,0.00022742832,0.00006880142,0.000016393702,0.00005687096,0.00023748267,0.00004029468],"category_scores_gemma":[0.0000054594134,0.00019703433,0.0000685396,0.00029552754,0.00008524831,0.00007926364,0.0000027236104,0.00023295173,0.0000017835666],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022292132,0.00032594468,0.7936674,0.0022608778,0.00015880013,0.00028681557,0.0062915976,0.00001961997,0.19347104,0.0008170204,0.000007883853,0.00046378843],"study_design_scores_gemma":[0.017042272,0.0009793765,0.43744916,0.0013283072,0.0007610511,0.0004225958,0.0017151445,0.000059202972,0.53930706,0.0003912494,0.00014221591,0.00040233938],"about_ca_topic_score_codex":0.000070293114,"about_ca_topic_score_gemma":0.00015779343,"teacher_disagreement_score":0.35621822,"about_ca_system_score_codex":0.0000281597,"about_ca_system_score_gemma":0.00006495767,"threshold_uncertainty_score":0.80348265},"labels":[],"label_agreement":null},{"id":"W4411201645","doi":"10.1016/j.jtct.2025.06.007","title":"Conditioning Regimens for Second Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Primary Graft Failure","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Stem cell; Transplantation; Medicine; Hematopoietic stem cell transplantation; Haematopoiesis; Conditioning; Oncology; Internal medicine; Biology; Genetics","score_opus":0.008816965430143634,"score_gpt":0.2277409205978301,"score_spread":0.21892395516768648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411201645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7963206,0.00046671194,0.19852696,0.00027749588,0.00009917905,0.0030553434,0.00042675773,0.00009189906,0.00073501875],"genre_scores_gemma":[0.98660254,0.00070250814,0.0047709555,0.0007509471,0.000032136064,0.0005228205,0.0053734244,0.000057072364,0.0011876065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849147,0.000054602107,0.00044435414,0.00046559607,0.00023561988,0.00030837525],"domain_scores_gemma":[0.9991004,0.00027568417,0.0001320477,0.00018713603,0.00019484622,0.00010988027],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001856686,0.00030506015,0.00041232634,0.00020249371,0.0002443393,0.000046762467,0.00007053208,0.00017646552,0.00005041961],"category_scores_gemma":[8.1417846e-7,0.00026588442,0.00012795973,0.00017197049,0.000074407086,0.00014445782,0.0000013522105,0.00010939135,0.0000028315606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04102156,0.0026792502,0.08433896,0.066128545,0.0019607686,0.00013475878,0.031460796,0.00016221026,0.7400062,0.011713101,0.0013207736,0.019073049],"study_design_scores_gemma":[0.061489783,0.0022836267,0.043141272,0.0014739223,0.0019505803,0.000113181864,0.0010224272,0.00014770603,0.88134354,0.00082691864,0.0052837417,0.0009232933],"about_ca_topic_score_codex":0.0000030438773,"about_ca_topic_score_gemma":0.000015381349,"teacher_disagreement_score":0.193756,"about_ca_system_score_codex":0.0000409583,"about_ca_system_score_gemma":0.00011195508,"threshold_uncertainty_score":0.9999793},"labels":[],"label_agreement":null},{"id":"W4411330472","doi":"10.1016/j.jtct.2025.05.009","title":"Corrigendum to Diagnosis of post-hematopoietic stem cell transplant bronchiolitis obliterans syndrome in children: time for a rethink? Transplantation and Cellular Therapy. 2024 Aug;30(8):760-769","year":2025,"lang":"en","type":"erratum","venue":"Transplantation and Cellular Therapy","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Bronchiolitis obliterans; Hematopoietic stem cell transplantation; Medicine; Stem cell; Transplantation; Biology; Internal medicine; Lung transplantation; Genetics","score_opus":0.015871635841724845,"score_gpt":0.25954081471582824,"score_spread":0.2436691788741034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411330472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88176703,0.061196458,0.023863696,0.0017820256,0.0050382996,0.010922659,0.012747653,0.00033494993,0.0023472402],"genre_scores_gemma":[0.5512401,0.36175632,0.003767461,0.0022572062,0.00040089458,0.0015208977,0.024358388,0.00045107852,0.054247677],"study_design_codex":"qualitative","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99520725,0.00045245196,0.0015748772,0.0013070691,0.00069892016,0.0007594214],"domain_scores_gemma":[0.99811566,0.00042603115,0.00036716045,0.0005324413,0.00021180739,0.00034689595],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007267241,0.001087194,0.0019480173,0.0010971565,0.00021618858,0.00010332011,0.0003096255,0.0010445019,0.0003076729],"category_scores_gemma":[0.0000039735028,0.0009987808,0.0005313635,0.00057915057,0.00016895933,0.00020205493,0.0000073677293,0.0009057011,0.0000107962505],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048828974,0.006462652,0.082329184,0.11777378,0.007931615,0.005188411,0.31640577,0.00010079841,0.19570874,0.002821808,0.019319767,0.19712852],"study_design_scores_gemma":[0.13578561,0.018267933,0.23141375,0.042049937,0.014497936,0.005469137,0.0037789466,0.0012379731,0.4814449,0.0022578756,0.052790616,0.011005389],"about_ca_topic_score_codex":0.0003168169,"about_ca_topic_score_gemma":0.00007879716,"teacher_disagreement_score":0.33052695,"about_ca_system_score_codex":0.000068560235,"about_ca_system_score_gemma":0.00034212993,"threshold_uncertainty_score":0.99924624},"labels":[],"label_agreement":null},{"id":"W4411437072","doi":"10.1016/j.jtct.2025.06.015","title":"Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital Research Institute of Manitoba","funders":"Children's Discovery Institute","keywords":"Medicine; Abatacept; Prednisone; Internal medicine; Transplantation; Hematopoietic stem cell transplantation; Graft-versus-host disease; Rituximab; Surgery; Immunology; Lymphoma","score_opus":0.01234951854423958,"score_gpt":0.28114367092450765,"score_spread":0.26879415238026805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411437072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781064,0.0018738694,0.017000694,0.00009721115,0.00014780878,0.001928611,0.00030105375,0.000044849203,0.00049952976],"genre_scores_gemma":[0.9870959,0.011577293,0.00030796166,0.000047819936,0.00003728836,0.00013032492,0.0006409199,0.000029995696,0.00013248436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983958,0.00010188763,0.000569508,0.00039827908,0.0002631002,0.00027143842],"domain_scores_gemma":[0.99914503,0.0002467376,0.00013604728,0.00019955254,0.00012204427,0.00015060132],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023422552,0.00028070546,0.00040926546,0.0004523142,0.00008194002,0.000018499308,0.0000879966,0.00014773197,0.000029388822],"category_scores_gemma":[0.000002953383,0.00024931022,0.00021476917,0.00048974005,0.000058360605,0.0001368686,0.0000029544517,0.00014258317,0.0000030091428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12122958,0.0024619629,0.43699276,0.025392473,0.0004142116,0.00044466477,0.028144334,0.0004271363,0.3620529,0.0013778246,0.000038759812,0.021023398],"study_design_scores_gemma":[0.04777439,0.0034014292,0.6769741,0.00059215754,0.0011755013,0.000026329055,0.0007073217,0.0007182801,0.26774526,0.00023304136,0.00005033805,0.00060186436],"about_ca_topic_score_codex":0.000060630475,"about_ca_topic_score_gemma":0.000019556997,"teacher_disagreement_score":0.23998132,"about_ca_system_score_codex":0.000078912424,"about_ca_system_score_gemma":0.00028792757,"threshold_uncertainty_score":0.9999959},"labels":[],"label_agreement":null},{"id":"W4411671051","doi":"10.1016/j.jtct.2025.05.022","title":"Corrigendum to ‘Clinical Practice Recommendations for Hematopoietic Cell Transplantation.’ Transplant Cell Ther. 2024 Sep;30(9):832-843.","year":2025,"lang":"en","type":"erratum","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Hematopoietic cell; Clinical Practice; Hematopoietic stem cell transplantation; Medicine; Transplantation; Haematopoiesis; Internal medicine; Biology; Family medicine; Stem cell; Cell biology","score_opus":0.04656888237135004,"score_gpt":0.3416320022526177,"score_spread":0.29506311988126765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411671051","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005640898,0.023414414,0.5880898,0.023012996,0.082012355,0.023297427,0.013797176,0.0012037618,0.23953114],"genre_scores_gemma":[0.021937253,0.33912385,0.028689884,0.01522953,0.0029619446,0.0021571335,0.045606665,0.00072093605,0.5435728],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99343425,0.00058392854,0.0023226487,0.0017345785,0.0009776914,0.00094687764],"domain_scores_gemma":[0.9960688,0.001153523,0.00061168027,0.0008543956,0.00057661213,0.00073502836],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013517848,0.0012294507,0.0017161844,0.0006992833,0.0005015902,0.00019450768,0.00043630667,0.0014671563,0.001325409],"category_scores_gemma":[0.00003091381,0.0011880473,0.00077087973,0.0006333326,0.00015719343,0.00026901037,0.000010823441,0.0015687749,0.00022964158],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012048528,0.0035923775,0.00045660164,0.032023545,0.0016377929,0.001247819,0.032898925,0.000027338248,0.010197281,0.0010376617,0.88967144,0.015160693],"study_design_scores_gemma":[0.015767144,0.0019229341,0.0004244904,0.00377421,0.0060921567,0.0006115511,0.0019361825,0.0002499616,0.033229053,0.00023581788,0.9339013,0.0018552066],"about_ca_topic_score_codex":0.00009619853,"about_ca_topic_score_gemma":0.000037800994,"teacher_disagreement_score":0.55939996,"about_ca_system_score_codex":0.00012033528,"about_ca_system_score_gemma":0.001004279,"threshold_uncertainty_score":0.9998292},"labels":[],"label_agreement":null},{"id":"W4411710914","doi":"10.1016/j.jtct.2025.06.028","title":"Improving Patient Access through Value-Based CAR T Delivery: Examples Using a Micro-costing Tool","year":2025,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Kite Pharma","keywords":"Activity-based costing; Computer science; Operations management; Business; Engineering; Marketing","score_opus":0.1110565043690317,"score_gpt":0.36560730706037725,"score_spread":0.25455080269134556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411710914","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021681111,0.96748686,0.0075714057,0.000018880539,0.0001677018,0.0025556989,0.00015469549,0.00009430041,0.0002693347],"genre_scores_gemma":[0.00044681638,0.99565506,0.0019847152,0.0003512674,0.00012448429,0.00011033092,0.0010326171,0.00009679853,0.00019789241],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972865,0.00038825377,0.0007267988,0.000684493,0.00046291546,0.00045102363],"domain_scores_gemma":[0.9986603,0.0004189063,0.00027148574,0.00041142805,0.00012977673,0.00010810681],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032326972,0.00055894314,0.0013122235,0.00033789806,0.00024825652,0.00017905177,0.00022239759,0.00034053298,0.00033739844],"category_scores_gemma":[0.000012959094,0.0004678595,0.0004738765,0.00048081914,0.00009265951,0.00015444186,0.000023299299,0.00051936443,0.000004437349],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003535081,0.00011044945,0.00004037952,0.031117683,0.0003038047,0.0001590181,0.00056916603,0.000013250907,0.025445007,0.000019696645,0.000006331884,0.9418617],"study_design_scores_gemma":[0.010923544,0.0009104729,0.000022226877,0.058400176,0.004921992,0.00038912328,0.00025883442,0.0014361662,0.073423706,0.00004763372,0.84723085,0.0020352677],"about_ca_topic_score_codex":0.000741394,"about_ca_topic_score_gemma":0.000008018172,"teacher_disagreement_score":0.9398264,"about_ca_system_score_codex":0.00018418235,"about_ca_system_score_gemma":0.00085335906,"threshold_uncertainty_score":0.9997773},"labels":[],"label_agreement":null},{"id":"W4412463040","doi":"10.1016/j.jtct.2025.07.010","title":"Effect of Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide on Graft-Versus-Host Disease Outcomes in Female Donor-to-Male Recipient Matched Unrelated Donor Allogeneic Stem Cell Transplantation for Acute Leukemia","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; U.S. Public Health Service; Office of Naval Research; Health Resources and Services Administration; National Cancer Institute; Medical College of Wisconsin; National Marrow Donor Program","keywords":"Anti-thymocyte globulin; Cyclophosphamide; Transplantation; Globulin; Thymocyte; Immunology; Leukemia; Stem cell; Medicine; Oncology; Internal medicine; Biology; T cell; Chemotherapy; Immune system; Genetics","score_opus":0.009994106245814273,"score_gpt":0.271785113986954,"score_spread":0.2617910077411397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412463040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888832,0.0011986278,0.004960497,0.0004274691,0.0002881391,0.003338412,0.00067319063,0.000076334414,0.0001541388],"genre_scores_gemma":[0.9819649,0.015578492,0.00037649806,0.00037985516,0.000014657351,0.0002534839,0.0010639533,0.000054240598,0.00031394014],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974568,0.00023057024,0.0008294955,0.0007050253,0.00035002516,0.00042807808],"domain_scores_gemma":[0.9984359,0.00073226844,0.00015325691,0.00029919372,0.00009205591,0.00028733502],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005113683,0.0005170562,0.00089610735,0.00046427434,0.00012491719,0.000034504556,0.00012837816,0.0002456436,0.000023331995],"category_scores_gemma":[0.0000045804513,0.00044259304,0.00020852697,0.00038225946,0.000089584515,0.00011590383,0.0000044169647,0.00021354298,0.000007632366],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10774519,0.0004938897,0.24301103,0.006862125,0.0007944615,0.0005785295,0.008068714,0.00052866695,0.62453467,0.0003209353,0.000005640913,0.007056153],"study_design_scores_gemma":[0.027641313,0.00222862,0.3410323,0.0011278519,0.0015917242,0.00003155619,0.00019096455,0.00020064422,0.62547743,0.000011128213,0.00004811839,0.00041832824],"about_ca_topic_score_codex":0.00013276323,"about_ca_topic_score_gemma":0.000050308357,"teacher_disagreement_score":0.09802128,"about_ca_system_score_codex":0.00010685044,"about_ca_system_score_gemma":0.00012853571,"threshold_uncertainty_score":0.9998026},"labels":[],"label_agreement":null},{"id":"W4412891869","doi":"10.1016/j.jtct.2025.07.023","title":"Outcomes of Patients With Multiple Myeloma With deletion 1p Following Autologous Stem Cell Transplant","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Cancer Institute; Paula and Rodger Riney Foundation; University of Texas MD Anderson Cancer Center; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Leukemia and Lymphoma Society","keywords":"Medicine; Multiple myeloma; Internal medicine; Hazard ratio; Concomitant; Propensity score matching; Hematopoietic stem cell transplantation; Single Center; Oncology; Retrospective cohort study; Progression-free survival; Transplantation; Overall survival; Proportional hazards model; Surgery; Gastroenterology; Confidence interval","score_opus":0.010592422072602824,"score_gpt":0.2443225478716972,"score_spread":0.23373012579909436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412891869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907857,0.000368683,0.007506577,0.00008241556,0.000027897488,0.00075900165,0.0000539865,0.000041803938,0.00037390293],"genre_scores_gemma":[0.99821997,0.00042708445,0.00055306475,0.00007883213,0.0000032873338,0.000036569993,0.00037757662,0.000016693384,0.0002869051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990225,0.000054738466,0.00020470242,0.00022904798,0.00029018216,0.00019882873],"domain_scores_gemma":[0.9995745,0.00008004145,0.000054813823,0.000142099,0.00006280672,0.000085778294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000064298365,0.00017927011,0.00031534382,0.00013928965,0.00008846943,0.0000116817755,0.000045198467,0.00006480609,0.000015351046],"category_scores_gemma":[6.2492484e-7,0.00011140901,0.00006972895,0.00014738382,0.00005324246,0.00006712754,0.0000016926473,0.00009009394,0.0000018616463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006418266,0.0004551303,0.96357954,0.00026811508,0.0004440637,0.00013355605,0.0010225938,0.0000087515455,0.0076180995,0.000031548698,0.0000015385837,0.020018827],"study_design_scores_gemma":[0.02022878,0.0008654661,0.8861991,0.00015009608,0.00020771594,0.0000047861413,0.00010840944,0.00014599082,0.09191103,0.0000050992508,0.000060341692,0.00011316097],"about_ca_topic_score_codex":0.000058912825,"about_ca_topic_score_gemma":0.00003849128,"teacher_disagreement_score":0.08429293,"about_ca_system_score_codex":0.00001884603,"about_ca_system_score_gemma":0.00005455337,"threshold_uncertainty_score":0.45431277},"labels":[],"label_agreement":null},{"id":"W4412957745","doi":"10.1016/j.jtct.2025.07.021","title":"Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: A CIBMTR Analysis","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Chimeric antigen receptor; Cytokine release syndrome; Internal medicine; Cumulative incidence; Oncology; Immunotherapy; Gastroenterology; Immunology; Transplantation; Cancer","score_opus":0.020433082632561664,"score_gpt":0.3003773014187984,"score_spread":0.27994421878623676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412957745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91110307,0.0054659215,0.07420385,0.001450223,0.00010795075,0.0017145723,0.000053714615,0.00009037996,0.0058102943],"genre_scores_gemma":[0.93577415,0.053983964,0.00078791246,0.0013552246,0.00008054235,0.0001851017,0.0008785098,0.00003201526,0.0069225803],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868304,0.00009027275,0.00034746484,0.00033757984,0.0002598397,0.00028180232],"domain_scores_gemma":[0.99938494,0.00009533378,0.00005483991,0.00024514878,0.000113912174,0.00010584226],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033081928,0.00021970725,0.000402673,0.00048884674,0.00017240742,0.000056360645,0.00009853622,0.00012629632,0.001853932],"category_scores_gemma":[0.00000139882,0.00018278557,0.0003188212,0.00091735146,0.00007061299,0.000104898754,0.0000019625604,0.00014487105,0.00001234541],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005047772,0.00035584703,0.0072057974,0.00021442246,0.0015295098,0.0000056474796,0.003883344,0.000013536386,0.8329876,0.00026786746,0.0001667664,0.14832187],"study_design_scores_gemma":[0.018505305,0.0007518182,0.022623705,0.000051969637,0.0006179769,0.000007960041,0.00031945956,0.0011722175,0.85742337,0.0001653775,0.097999305,0.0003615386],"about_ca_topic_score_codex":0.000029636418,"about_ca_topic_score_gemma":0.0000071282034,"teacher_disagreement_score":0.14796034,"about_ca_system_score_codex":0.000027836275,"about_ca_system_score_gemma":0.00008122663,"threshold_uncertainty_score":0.9990585},"labels":[],"label_agreement":null},{"id":"W4413270583","doi":"10.1016/j.jtct.2025.08.006","title":"Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec; Hôpital Maisonneuve-Rosemont","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Stem Cell Network","keywords":"Medicine; Cord blood; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Graft-versus-host disease; Stem cell; Bone marrow; Propensity score matching; Oncology; Surgery; Biology","score_opus":0.01940186235804729,"score_gpt":0.298586978199582,"score_spread":0.2791851158415347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413270583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9617609,0.0023380567,0.034213524,0.0007225013,0.000058279682,0.00046049058,0.00020345292,0.000038831848,0.00020396111],"genre_scores_gemma":[0.9953552,0.0025453467,0.0005208088,0.00044578995,0.000017007802,0.000042769643,0.0006847709,0.000014600365,0.00037371484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854326,0.00012709932,0.0005578934,0.0003232962,0.00028625672,0.00016219854],"domain_scores_gemma":[0.9990946,0.0003813977,0.00013835519,0.00024797296,0.000060458347,0.00007723149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018244803,0.00022232998,0.0006145749,0.00014555149,0.0000950832,0.000031979347,0.00008620305,0.00014090336,0.00021462272],"category_scores_gemma":[0.0000032651615,0.00016021762,0.00019343679,0.00029562582,0.00016678344,0.00005315905,0.0000031625682,0.00015797102,0.0000021799835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032755537,0.00029047733,0.9478673,0.0004555622,0.0023635782,0.000026948366,0.00537631,0.000009947366,0.038592413,0.0002110497,0.000012421108,0.0015184471],"study_design_scores_gemma":[0.010575189,0.00015983672,0.8833235,0.00036639374,0.006368032,0.000028708244,0.0014084744,0.0005104655,0.096583374,0.00015546093,0.000292236,0.00022832568],"about_ca_topic_score_codex":0.0002324654,"about_ca_topic_score_gemma":0.00013042697,"teacher_disagreement_score":0.06454379,"about_ca_system_score_codex":0.000007689832,"about_ca_system_score_gemma":0.00004246962,"threshold_uncertainty_score":0.6533485},"labels":[],"label_agreement":null},{"id":"W4414263546","doi":"10.1016/j.jtct.2025.09.023","title":"Efficacy and Safety of Allogeneic Hematopoietic Stem Cell Transplantation in Curing Sickle Cell Disease: A Systematic Review and Meta-Analysis of Single-Arm Studies","year":2025,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Chester","keywords":"Stem cell; Disease; Hematopoietic stem cell transplantation; Transplantation; Systematic review; Clinical trial; Meta-analysis; Sickle cell trait","score_opus":0.05026619355042959,"score_gpt":0.31007104154027365,"score_spread":0.25980484798984405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414263546","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017805204,0.99471503,0.00015463596,0.00005124081,0.000014127449,0.003033092,0.00017788398,0.00001424139,0.000059249604],"genre_scores_gemma":[0.011027097,0.9882639,0.00002897944,0.000071128256,0.0000020449331,0.000111837406,0.00030994558,0.000024440524,0.00016063667],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.997338,0.00043251144,0.0014138584,0.00041452912,0.00023765421,0.00016345919],"domain_scores_gemma":[0.99862576,0.00041911114,0.0005308783,0.00025748732,0.00006752558,0.00009921642],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045726736,0.0004274305,0.0051863384,0.00046662567,0.000047659294,0.00000952804,0.00007144414,0.00016839629,0.000025323876],"category_scores_gemma":[0.000004467082,0.00028675178,0.0007058464,0.00063304906,0.000108461216,0.000040591534,0.0000068398917,0.00016814118,4.6716278e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001466107,0.00030391073,0.0000073922142,0.9729822,0.022446787,0.000041589545,0.0019120781,0.000009385275,0.000064802676,0.000025483341,5.74482e-7,0.0020591528],"study_design_scores_gemma":[0.0020871717,0.00018634209,0.000014538109,0.11096098,0.88558114,0.00002291095,0.00034303527,0.0000075524817,0.00028064073,0.0000059741324,0.00020802241,0.00030168044],"about_ca_topic_score_codex":0.0000074276295,"about_ca_topic_score_gemma":0.000004710808,"teacher_disagreement_score":0.8631344,"about_ca_system_score_codex":0.000019521109,"about_ca_system_score_gemma":0.00007171368,"threshold_uncertainty_score":0.99995846},"labels":[],"label_agreement":null},{"id":"W4414591243","doi":"10.1016/j.jtct.2025.09.038","title":"Performance of Treatment Response Assessment at Day 7 by Baseline Acute Graft-versus-Host Disease Severity","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Pediatric Cancer Foundation","keywords":"Baseline (sea); Risk assessment; Clinical trial; Disease; Clinical Practice","score_opus":0.01423745841909701,"score_gpt":0.2896893983147716,"score_spread":0.27545193989567457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414591243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99236834,0.00060703896,0.0047646435,0.00068408705,0.00011981142,0.0006030813,0.00026068534,0.000044533583,0.00054775376],"genre_scores_gemma":[0.97991365,0.016676703,0.0003493271,0.00018758434,0.0000110898145,0.000048534323,0.0008271295,0.000015376707,0.0019705852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988357,0.00020975518,0.00031987243,0.0002688685,0.00020525196,0.0001605962],"domain_scores_gemma":[0.9993123,0.00021561995,0.000067172274,0.00021641777,0.000052547304,0.00013596306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035710915,0.00019545041,0.00027637975,0.000101477584,0.00010468072,0.000009234256,0.00004599462,0.00006853395,0.00015635332],"category_scores_gemma":[0.0000024541798,0.00016233724,0.00008522954,0.00014896091,0.00007324819,0.00006493756,0.000002822015,0.00006376601,0.0000054576103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060038794,0.00049544,0.041735932,0.00069012435,0.00048771032,0.00008888593,0.0015435828,0.000012565731,0.8903946,0.00008924591,0.000088259054,0.0043348502],"study_design_scores_gemma":[0.023082579,0.0017408599,0.21037985,0.00037667603,0.0011951313,0.000022800386,0.00011582223,0.0044352147,0.7538867,0.000007390829,0.0044630375,0.00029394496],"about_ca_topic_score_codex":0.000019858604,"about_ca_topic_score_gemma":0.000004707628,"teacher_disagreement_score":0.16864392,"about_ca_system_score_codex":0.00012413485,"about_ca_system_score_gemma":0.00016069258,"threshold_uncertainty_score":0.661992},"labels":[],"label_agreement":null},{"id":"W4414687421","doi":"10.1016/j.jtct.2025.09.042","title":"Cytokines Induced by Antithymocyte Globulin in Transplantation Conditioning and Associated Infusional Side Effects","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Neurological Complications and Syndromes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Calgary Laboratory Services; Alberta Health Services","funders":"Alberta Cancer Foundation; Sanofi","keywords":"Cytokine; Transplantation; Globulin; Hematopoietic stem cell transplantation; Haematopoiesis; Antagonist; Conditioning; Heart transplantation","score_opus":0.013099562334427998,"score_gpt":0.2632431181822272,"score_spread":0.2501435558477992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414687421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956501,0.0008949783,0.001468191,0.0007468405,0.000033495486,0.00035356262,0.00002915135,0.00004224421,0.00078139466],"genre_scores_gemma":[0.993713,0.004643808,0.00007603775,0.0008969015,0.000006117448,0.000029180801,0.00052677974,0.0000066374605,0.000101512254],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99927944,0.000088055494,0.00020289034,0.00020996659,0.000103872226,0.00011575777],"domain_scores_gemma":[0.999674,0.00015548927,0.000037810587,0.000058413392,0.000028582208,0.000045664157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011107623,0.000115593175,0.00019596338,0.00011962187,0.000098976685,0.0000244105,0.00002770255,0.0000958673,0.0000151073045],"category_scores_gemma":[0.000007849647,0.000099735385,0.0000271775,0.00019973575,0.00004204613,0.00006535196,0.000002150671,0.00012924918,0.0000013470919],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005932081,0.00019182655,0.03605772,0.00021135778,0.000051226383,0.000112794376,0.00042650852,0.0000041203875,0.9554471,0.0015654692,0.000014083453,0.005324637],"study_design_scores_gemma":[0.0065480387,0.00031618087,0.8798389,0.0001911357,0.00007431145,0.00006515091,0.000026086322,0.00028508427,0.1114851,0.0008695459,0.00016423523,0.0001362224],"about_ca_topic_score_codex":0.000031077834,"about_ca_topic_score_gemma":0.000014039873,"teacher_disagreement_score":0.84396195,"about_ca_system_score_codex":0.000011015296,"about_ca_system_score_gemma":0.000020666395,"threshold_uncertainty_score":0.4067091},"labels":[],"label_agreement":null},{"id":"W4414780684","doi":"10.1016/j.jtct.2025.09.034","title":"Identification of Distinct Subtypes in Immune Tolerance after Hematopoietic Cell Transplantation Using the Prospective ABLE1.0 Pediatric Study Cohort","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Montreal Children's Hospital; University of Manitoba; CancerCare Manitoba; Centre Hospitalier Universitaire Sainte-Justine; BC Children's Hospital; Pancreas Centre (Canada); Hospital for Sick Children; College of Veterinarians of British Columbia; University of British Columbia","funders":"National Cancer Institute; Metabolomics Innovation Centre; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Immune system; Lymphocyte; Hematopoietic stem cell transplantation; Immune tolerance; Transplantation; Graft-versus-host disease; T cell; Immune dysregulation; Cohort; Disease","score_opus":0.009392649816628136,"score_gpt":0.25830149671651276,"score_spread":0.24890884689988463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414780684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97966,0.0021073273,0.015447451,0.00005944838,0.00010763852,0.002275583,0.000029654015,0.000030898806,0.00028200957],"genre_scores_gemma":[0.9962566,0.0032267277,0.00009421643,0.000038554568,0.000022790422,0.00017207031,0.00007532699,0.00002126755,0.00009243801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816734,0.00018287949,0.00078177877,0.0003629457,0.0003163969,0.0001886729],"domain_scores_gemma":[0.9992933,0.00012930922,0.0001738747,0.0002593368,0.00010630731,0.000037834765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056977465,0.00021637559,0.00037120888,0.00024806705,0.00009998773,0.0000292045,0.00009122683,0.00009289837,0.000029690056],"category_scores_gemma":[0.0000033277665,0.00017127892,0.00007847635,0.0005881604,0.00007757069,0.00011845632,0.000002763424,0.00017207296,0.0000024522255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020066192,0.0005774205,0.8870445,0.0015334056,0.00006031352,0.000062523904,0.013034573,0.00010443306,0.095294364,0.000089431596,4.7139378e-7,0.00019197242],"study_design_scores_gemma":[0.0041549904,0.00011903075,0.797888,0.0001554201,0.0005018569,0.000030762312,0.001042099,0.00044591015,0.19542232,0.00010084323,0.0000018229416,0.00013693619],"about_ca_topic_score_codex":0.00016885305,"about_ca_topic_score_gemma":0.000056681558,"teacher_disagreement_score":0.100127965,"about_ca_system_score_codex":0.00003913741,"about_ca_system_score_gemma":0.00008176687,"threshold_uncertainty_score":0.69845515},"labels":[],"label_agreement":null},{"id":"W4414806654","doi":"10.1016/j.jtct.2025.05.020","title":"Umbilical Cord Blood Transplantation Provides an Alternative for Patients With Chronic Granulomatous Disease Lacking HLA-Matched Donors: A PIDTC Report","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital; Hospital for Sick Children","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; Office of Naval Research; National Center for Advancing Translational Sciences; Health Resources and Services Administration; California Institute of Regenerative Medicine; Horizon Therapeutics; St. Baldrick's Foundation; Medac; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Umbilical Cord Blood Transplantation; Cumulative incidence; Incidence (geometry); Busulfan; Transplantation; Myeloid; Umbilical cord","score_opus":0.010643599670276201,"score_gpt":0.24414327545346556,"score_spread":0.23349967578318936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414806654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95816743,0.00081243966,0.03907915,0.00011612968,0.00017357062,0.0013273829,0.00019293147,0.000091223585,0.0000397677],"genre_scores_gemma":[0.9941455,0.0015810827,0.0002969594,0.00021379706,0.000028489554,0.00025229427,0.0032502927,0.000026843463,0.0002047212],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864125,0.00017734332,0.00033726095,0.00050223817,0.00006697902,0.00027490096],"domain_scores_gemma":[0.99939346,0.000101035606,0.00013066715,0.00020087378,0.00012022381,0.00005371394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014915413,0.0002641277,0.0002889985,0.00012220745,0.0002796071,0.000041993906,0.0001217018,0.00011349327,0.00004307538],"category_scores_gemma":[0.000004023679,0.00021006398,0.000075008065,0.00011486186,0.0001312305,0.00022672022,0.000003860868,0.00013374285,0.0000043317373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02482673,0.0015725554,0.023832772,0.0008757855,0.0009370995,0.0002926758,0.0034809392,0.000033689073,0.9138747,0.006492527,0.00001447111,0.02376607],"study_design_scores_gemma":[0.022998948,0.002739513,0.03196793,0.00034058312,0.0006895017,0.00007575937,0.00015470978,0.000054059088,0.9370733,0.002358298,0.0009755701,0.0005718202],"about_ca_topic_score_codex":0.000071996335,"about_ca_topic_score_gemma":0.00007167742,"teacher_disagreement_score":0.03878219,"about_ca_system_score_codex":0.000023490222,"about_ca_system_score_gemma":0.00009313256,"threshold_uncertainty_score":0.8566161},"labels":[],"label_agreement":null},{"id":"W4414980364","doi":"10.1016/j.jtct.2025.10.007","title":"Acute Toxicities of Bone Marrow Donation in Unrelated Donors with Sickle Cell Trait: A Center for International Blood and Marrow Transplantation Research Analysis","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"Center for International Blood and Marrow Transplant Research; National Institute of Allergy and Infectious Diseases; National Cancer Institute; Health Resources and Services Administration; Office of Naval Research; National Heart, Lung, and Blood Institute; U.S. Public Health Service","keywords":"Donation; Univariate analysis; Bone marrow; Population; Transplantation; Logistic regression; Bone pain; Stem cell","score_opus":0.011882084660066896,"score_gpt":0.27437561068950433,"score_spread":0.26249352602943743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414980364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902538,0.0012602598,0.0056920117,0.0008845002,0.000043254833,0.00062199146,0.00015144223,0.000017629935,0.0010751198],"genre_scores_gemma":[0.9779482,0.02001024,0.00044405682,0.000104403276,0.000008480868,0.000042369637,0.0009700065,0.000011764835,0.00046050333],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896455,0.000075707576,0.0003252318,0.00024341064,0.00022394785,0.00016714931],"domain_scores_gemma":[0.99955463,0.00009254892,0.00006278567,0.00007789453,0.00016566043,0.00004647414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003241392,0.00012908856,0.00026506116,0.0007370978,0.000073508476,0.000021871894,0.000041595657,0.00013336517,0.00003507867],"category_scores_gemma":[0.0000027596168,0.00010499142,0.00007122364,0.0005771327,0.000114722294,0.00009241454,0.0000021166,0.00016317338,2.091112e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02634596,0.0016941635,0.110102735,0.0021439805,0.004478599,0.0002175353,0.02807696,0.0005955047,0.80797344,0.002618029,0.000051241845,0.015701866],"study_design_scores_gemma":[0.09095813,0.002557526,0.114037015,0.0012597572,0.005109007,0.00013817323,0.0072657596,0.010735419,0.764872,0.0012917091,0.0010434623,0.00073202775],"about_ca_topic_score_codex":0.00011271403,"about_ca_topic_score_gemma":0.00018439532,"teacher_disagreement_score":0.06461217,"about_ca_system_score_codex":0.000016930226,"about_ca_system_score_gemma":0.000047048514,"threshold_uncertainty_score":0.42814258},"labels":[],"label_agreement":null},{"id":"W4415027490","doi":"10.1016/j.jtct.2025.10.002","title":"Size Does Not Always Matter: Limited Impact of Donor-recipient Weight Difference on Outcomes of Adult Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplantation","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cumulative incidence; Hematopoietic stem cell transplantation; Stem cell; Transplantation; Incidence (geometry); Cohort; Retrospective cohort study; Survival analysis; Graft-versus-host disease","score_opus":0.010174857721161567,"score_gpt":0.24477890371454605,"score_spread":0.2346040459933845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415027490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992307,0.00038154854,0.0041891253,0.0002286601,0.00016800065,0.0010179194,0.00029725605,0.000058990736,0.0013514735],"genre_scores_gemma":[0.9897098,0.008144174,0.00043429612,0.00038318112,0.000016886208,0.00005477146,0.0002469978,0.000044946966,0.00096493197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974859,0.00018736653,0.0009721397,0.0005159763,0.0004938111,0.00034480565],"domain_scores_gemma":[0.99852955,0.00044022076,0.00030577448,0.00039021566,0.00018092494,0.00015333427],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001687124,0.00047941424,0.0008514413,0.00028737492,0.0000904781,0.000023862269,0.00016406784,0.00023783561,0.00027378008],"category_scores_gemma":[0.0000020749799,0.0003365717,0.00038035095,0.000287706,0.00013368978,0.000079971156,0.0000041284716,0.00021006695,0.000008333002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033456127,0.00096555613,0.23104575,0.0032542832,0.00034572135,0.000048761172,0.0063473815,0.0000564409,0.75352716,0.0002099492,0.0000052487126,0.00084810634],"study_design_scores_gemma":[0.008401454,0.0006605697,0.26235554,0.000471637,0.00064603117,0.000030445599,0.00023032501,0.00006796906,0.72684884,0.000044708842,0.0000037689285,0.00023872257],"about_ca_topic_score_codex":0.00013385137,"about_ca_topic_score_gemma":0.00001600127,"teacher_disagreement_score":0.031309795,"about_ca_system_score_codex":0.00004242524,"about_ca_system_score_gemma":0.000112456044,"threshold_uncertainty_score":0.9999086},"labels":[],"label_agreement":null},{"id":"W4415063297","doi":"10.1016/j.jtct.2025.09.010","title":"William Osler and the Mentoring of Stem Cell Transplant Physicians","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Mentoring and Academic Development","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Stem cell; Transplantation; MEDLINE; Disease","score_opus":0.01526566245734048,"score_gpt":0.26136848720586375,"score_spread":0.24610282474852327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415063297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9693919,0.006738285,0.0051620374,0.00032511423,0.00076294295,0.0002813987,0.000011754535,0.000027245265,0.017299335],"genre_scores_gemma":[0.98510695,0.008772621,0.000032898326,0.0002300627,0.000025294932,0.00003160597,0.00001011094,0.000007269834,0.0057832086],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927557,0.00010146135,0.00020934409,0.00016832608,0.00009876945,0.0001465482],"domain_scores_gemma":[0.9997076,0.00010241409,0.000055703782,0.00009787823,0.000011292208,0.000025133446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029779845,0.00010650559,0.00015841406,0.000045659322,0.00008300261,0.000012093867,0.0000768806,0.0000563396,0.000034006745],"category_scores_gemma":[1.278755e-7,0.00007413356,0.000033883804,0.00008030168,0.00008567637,0.000027211305,0.0000024776434,0.000099063385,0.0000025601198],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004034645,0.00036475476,0.013008194,0.00076173554,0.00082147954,0.000024246974,0.315364,0.000022175223,0.20008402,0.0794691,0.0005768062,0.38546884],"study_design_scores_gemma":[0.036963567,0.00023111867,0.034723245,0.0007883778,0.0004711079,0.000017665216,0.009729158,0.00013536817,0.81425893,0.0019476931,0.09997248,0.00076130166],"about_ca_topic_score_codex":0.000027895623,"about_ca_topic_score_gemma":0.0000011709405,"teacher_disagreement_score":0.6141749,"about_ca_system_score_codex":0.0000054075545,"about_ca_system_score_gemma":0.000008101888,"threshold_uncertainty_score":0.30230787},"labels":[],"label_agreement":null},{"id":"W4415071401","doi":"10.1016/j.jtct.2025.10.006","title":"CAR-T for Management of R/R PTLD Following Lung Transplant: A Multi-center Retrospective Study","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Sleep Society; University Health Network; Dalhousie University; Princess Margaret Cancer Centre; Juravinski Hospital; Juravinski Cancer Centre","funders":"","keywords":"Tocilizumab; Immunosuppression; Lung; Retrospective cohort study; Cytokine release syndrome; Lung transplantation; Lymphoproliferative disorders; Malignancy","score_opus":0.026374471961739816,"score_gpt":0.3312877172294737,"score_spread":0.3049132452677339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415071401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96612823,0.0010965351,0.028112246,0.0001338335,0.00012767418,0.0028085269,0.000047313613,0.00004075687,0.0015048562],"genre_scores_gemma":[0.99291736,0.0028652956,0.0005534532,0.000100434016,0.000017100649,0.00016097973,0.00010293289,0.000023320228,0.0032591193],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99887764,0.00006266364,0.00028460732,0.00031163674,0.00025471998,0.00020874212],"domain_scores_gemma":[0.99961895,0.00003550739,0.00003829555,0.00019121473,0.00005952747,0.00005652978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003126258,0.00016441836,0.00032989297,0.00017232068,0.000094317096,0.000016822447,0.00007697797,0.00006195549,0.000092622766],"category_scores_gemma":[7.9893965e-7,0.00014475452,0.00018192483,0.00020669207,0.000036738416,0.00004679102,0.00000388064,0.00011337749,7.6964074e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01675652,0.005136104,0.40382057,0.0030687645,0.0058072503,0.0004343868,0.025299342,0.00000802771,0.5017313,0.0014105235,0.000049320322,0.036477923],"study_design_scores_gemma":[0.19982581,0.0034430905,0.41256878,0.0019098168,0.0025401087,0.00003712963,0.008012866,0.0025965774,0.36536065,0.0002706701,0.0026290151,0.0008054937],"about_ca_topic_score_codex":0.000034906945,"about_ca_topic_score_gemma":0.000019136733,"teacher_disagreement_score":0.18306929,"about_ca_system_score_codex":0.000043911965,"about_ca_system_score_gemma":0.000023567503,"threshold_uncertainty_score":0.5902918},"labels":[],"label_agreement":null},{"id":"W4415535704","doi":"10.1016/j.jtct.2025.10.024","title":"CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World Setting","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; National Heart, Lung, and Blood Institute; Legend Biotech; Takeda Oncology; U.S. Public Health Service; Health Resources and Services Administration; National Institutes of Health; Jazz Pharmaceuticals; Medac; MorphoSys; Astellas Pharma; Adaptive Biotechnologies; Incyte; Kiadis Pharma; bluebird bio; Actinium Pharmaceuticals; CareDx; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences; Bristol-Myers Squibb; AstraZeneca; CSL Behring; BeiGene; HistoGenetics; Gateway for Cancer Research; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen","keywords":"Clinical trial; Cytokine release syndrome; Safety monitoring; Food and drug administration; Data monitoring committee; Confidence interval","score_opus":0.12455555396610758,"score_gpt":0.4200015351121382,"score_spread":0.29544598114603066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415535704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98302007,0.0052642096,0.00059445255,0.0064710397,0.00022431952,0.001376416,0.00037295063,0.00005829082,0.0026182502],"genre_scores_gemma":[0.86076856,0.118148915,0.00038832182,0.0043467926,0.0004491888,0.00009198425,0.0012307469,0.00004101003,0.014534503],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967251,0.001333195,0.0008129034,0.00055086246,0.00033765312,0.00024027994],"domain_scores_gemma":[0.9966204,0.0023100467,0.00016186979,0.0006971614,0.00006702972,0.00014346927],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036698105,0.00022771381,0.0007506313,0.0001381607,0.00018424705,0.00010502913,0.00022759946,0.00016215716,0.0026872207],"category_scores_gemma":[0.00008408568,0.00013496671,0.00012827603,0.00027228845,0.00032761195,0.00010706987,0.00004643542,0.00042374164,0.0000071936893],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14628693,0.00044687907,0.24432695,0.000681552,0.0018850715,0.0006590302,0.0046371385,0.0000022101501,0.07851907,0.00024154701,0.0033046994,0.51900893],"study_design_scores_gemma":[0.113143064,0.000878098,0.720825,0.0016328368,0.0021489034,0.000056156136,0.0024481427,0.0036787223,0.037467018,0.0010842002,0.1157113,0.0009265142],"about_ca_topic_score_codex":0.00032182192,"about_ca_topic_score_gemma":0.0005982639,"teacher_disagreement_score":0.51808244,"about_ca_system_score_codex":0.000017218494,"about_ca_system_score_gemma":0.00013978346,"threshold_uncertainty_score":0.99822444},"labels":[],"label_agreement":null},{"id":"W4415628797","doi":"10.1016/j.jtct.2025.10.028","title":"Herpes Zoster Frequency and Adjuvanted Recombinant Zoster Vaccination after Allogeneic Hematopoietic Cell Transplantation","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research; Takeda Canada; State Government of Victoria; Physicians' Services Incorporated Foundation","keywords":"Vaccination; Transplantation; Retrospective cohort study; Shingles; Clinical trial; Cohort; Hematopoietic cell; Cohort study; Observational study","score_opus":0.008399270328108055,"score_gpt":0.24747196696760493,"score_spread":0.23907269663949687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415628797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98549205,0.004004263,0.006859491,0.00045083908,0.00017152271,0.0006046216,0.00001960231,0.000063754735,0.0023338802],"genre_scores_gemma":[0.9804509,0.01713052,0.00043454132,0.0006255685,0.000016329239,0.00009578269,0.00019151805,0.000020438672,0.0010343975],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990196,0.00007990598,0.00028945942,0.0003108738,0.00012067362,0.00017947663],"domain_scores_gemma":[0.9996332,0.000042079093,0.00005009982,0.00013854704,0.00005585962,0.00008020956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010829938,0.00021206548,0.00023685239,0.00019474722,0.00012574595,0.000041107636,0.000027485297,0.00013522958,0.00024050105],"category_scores_gemma":[9.716364e-7,0.0001745606,0.00006822117,0.00016214815,0.000033529483,0.00013842972,0.000002529252,0.00009154449,0.000014715959],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047894563,0.0018191856,0.18610832,0.0030149098,0.0006630518,0.0007670736,0.009962267,0.000003344182,0.0718812,0.0011172631,0.00006077161,0.71981317],"study_design_scores_gemma":[0.02675289,0.0008785353,0.6302394,0.0007596508,0.0011914092,0.00039898997,0.00033390647,0.00012868454,0.32897145,0.0021674668,0.0074891676,0.0006884213],"about_ca_topic_score_codex":0.000056123128,"about_ca_topic_score_gemma":0.000039947703,"teacher_disagreement_score":0.71912473,"about_ca_system_score_codex":0.000025738447,"about_ca_system_score_gemma":0.000033364955,"threshold_uncertainty_score":0.7118375},"labels":[],"label_agreement":null},{"id":"W4416024141","doi":"10.1016/j.jtct.2025.11.008","title":"Toward Better and More Effective Clinical Trials for Chronic Graft-Versus-Host Disease","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Clinical trial; Observational study; Disease; Biomarker; Intervention (counseling); Precision medicine; Clinical study design; Clinical endpoint","score_opus":0.0921127108918568,"score_gpt":0.4018105976780595,"score_spread":0.3096978867862027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416024141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91129214,0.004430733,0.07742175,0.0030870698,0.0003994162,0.0029512327,0.00010402114,0.00006929746,0.00024435314],"genre_scores_gemma":[0.9865884,0.010798163,0.00056756166,0.0010593825,0.00016721828,0.00025470107,0.00036446244,0.000022705373,0.00017736293],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985032,0.00029105804,0.0005299787,0.00035796323,0.00014129652,0.0001764943],"domain_scores_gemma":[0.99823624,0.0013159784,0.0000849497,0.0001389232,0.00005596566,0.00016796797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010541071,0.00018887703,0.00049892,0.000102573395,0.00008921093,0.000029642915,0.000039330516,0.00012973601,0.000039743885],"category_scores_gemma":[0.00004399673,0.00015211847,0.0001815487,0.00009201403,0.000119206656,0.000062859,0.0000023014538,0.00012639468,0.000003456425],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12890951,0.0011016352,0.08371218,0.01665798,0.0036391777,0.00043565757,0.010546012,0.00001006168,0.25988838,0.00874827,0.0006047815,0.48574635],"study_design_scores_gemma":[0.18033257,0.003787581,0.50216734,0.0023717897,0.006447783,0.00006312629,0.0007933106,0.0033060503,0.28284076,0.0019568573,0.01479113,0.0011417058],"about_ca_topic_score_codex":0.000007124371,"about_ca_topic_score_gemma":0.0000033947006,"teacher_disagreement_score":0.48460466,"about_ca_system_score_codex":0.000023167087,"about_ca_system_score_gemma":0.00008949305,"threshold_uncertainty_score":0.62032115},"labels":[],"label_agreement":null},{"id":"W4416041242","doi":"10.1016/j.jtct.2025.10.037","title":"Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular Therapy","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Saint John Regional Hospital; Foothills Medical Centre; St. Michael's Hospital; Jewish General Hospital; University of Ottawa; McGill University; McGill University Health Centre; Kingston Health Sciences Centre; London Health Sciences Centre; Queen's University; University of Alberta; Juravinski Cancer Centre; Institute of Infection and Immunity; Ottawa Hospital; Vancouver General Hospital; Princess Margaret Cancer Centre","funders":"Public Health Agency of Canada","keywords":"Immunogenicity; Vaccination; Antibody; Immune system; Population; Hematopoietic stem cell transplantation; Transplantation; Immunity; Cellular immunity","score_opus":0.02615614059593367,"score_gpt":0.30678999625245923,"score_spread":0.28063385565652554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416041242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747351,0.020188723,0.0035957901,0.00029471162,0.000039523024,0.00086160103,0.000043327367,0.000020476267,0.00022079397],"genre_scores_gemma":[0.9504111,0.04744962,0.00013283588,0.0018862064,0.00000939866,0.000023256733,0.00005019492,0.000016526703,0.000020872227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839777,0.0001863982,0.0005458742,0.0003759999,0.0002751779,0.00021875935],"domain_scores_gemma":[0.99930614,0.00023903017,0.000118161835,0.00019078734,0.00007221784,0.00007363885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005580037,0.000233317,0.000489332,0.00032515364,0.00009638491,0.000020572199,0.00007634518,0.00015748372,0.000013655351],"category_scores_gemma":[0.00000822851,0.0001998809,0.0000637212,0.000299058,0.00016844104,0.00009815594,0.000008335845,0.00018326161,3.661781e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009821029,0.00025623085,0.17380482,0.0019261522,0.00010762241,0.00006153411,0.0072047147,0.0000027047652,0.80165905,0.00031758554,0.000002532976,0.0048360256],"study_design_scores_gemma":[0.01907041,0.0005116879,0.06788851,0.00027704143,0.00011007152,0.000053687836,0.000511078,0.00013281182,0.91010076,0.0005830648,0.0005746239,0.00018626907],"about_ca_topic_score_codex":0.00048727271,"about_ca_topic_score_gemma":0.00008649196,"teacher_disagreement_score":0.10844169,"about_ca_system_score_codex":0.000030449626,"about_ca_system_score_gemma":0.00013347492,"threshold_uncertainty_score":0.81509066},"labels":[],"label_agreement":null},{"id":"W4416426245","doi":"10.1016/j.jtct.2025.11.026","title":"Impact of Chimeric Antigen Receptor T-Cell Therapy on Health Utilities of Patients Diagnosed with Diffuse Large B-Cell Lymphoma in Canada","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Toronto General Hospital; Toronto Public Health","funders":"Canadian Institutes of Health Research; Ontario Institute for Cancer Research","keywords":"Chimeric antigen receptor; Lymphoma; Population; Baseline (sea); Cancer; Health care; Clinical trial; Health economics; Disease","score_opus":0.01213776183665281,"score_gpt":0.2695603418211101,"score_spread":0.2574225799844573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416426245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579126,0.002338223,0.000056156347,0.00007328875,0.000041444007,0.00091561826,0.00018903583,0.000010291819,0.000584682],"genre_scores_gemma":[0.9633612,0.035688374,0.000027174983,0.00026504468,0.0000074901263,0.000020815336,0.00028583678,0.000024272565,0.00031980412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853015,0.00017088346,0.00037913458,0.00024322844,0.00037466295,0.0003019304],"domain_scores_gemma":[0.99931437,0.00013637598,0.00013089787,0.00023077767,0.000083058745,0.00010450698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017349166,0.00020617826,0.00046617052,0.00023513082,0.000045891713,0.0000066782677,0.00008737992,0.00005355144,0.00031774052],"category_scores_gemma":[0.000001823202,0.00015123285,0.000084515654,0.0003630641,0.000061759856,0.000037544603,0.0000030123217,0.00010969706,6.676925e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019846052,0.007519771,0.79332185,0.000666371,0.00023780794,0.000023859768,0.007492294,0.0000129279615,0.1110323,0.000022462606,0.00013223429,0.05969209],"study_design_scores_gemma":[0.059248168,0.0032142587,0.7042148,0.00023362006,0.000011854707,8.6177994e-7,0.0005939504,0.00006727156,0.23148857,0.000007070086,0.0007546718,0.0001648582],"about_ca_topic_score_codex":0.25170597,"about_ca_topic_score_gemma":0.044447694,"teacher_disagreement_score":0.20725827,"about_ca_system_score_codex":0.00019888581,"about_ca_system_score_gemma":0.0012512266,"threshold_uncertainty_score":0.97298867},"labels":[],"label_agreement":null},{"id":"W4416701844","doi":"10.1016/j.jtct.2025.11.016","title":"Genetic Findings of Potential Donor Origin in Cells Used for Cell and Gene Therapy: Recommendations from the World Marrow Donor Association","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Gene; Haematopoiesis; Cell; Genetic testing; Relevance (law); Genome editing; Transduction (biophysics); Mutation","score_opus":0.01618069703605344,"score_gpt":0.27068831359249373,"score_spread":0.2545076165564403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416701844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974841,0.0018775775,0.010229743,0.012061481,0.00017772143,0.00066207227,0.000083646155,0.00001100276,0.000055732424],"genre_scores_gemma":[0.98264223,0.013908901,0.0015147522,0.000756059,0.00005406037,0.000026124002,0.00031431342,0.000010174294,0.0007734109],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992343,0.000078812365,0.00027232323,0.00017239171,0.00013178964,0.000110351866],"domain_scores_gemma":[0.9994972,0.0002494291,0.000084432984,0.00008477872,0.00004865873,0.00003552817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031185357,0.00009803503,0.00017187616,0.00011017953,0.00008210138,0.000023282188,0.00004312427,0.00012927319,0.00006434737],"category_scores_gemma":[0.0000020004577,0.00007017691,0.000052003226,0.00018716205,0.000074433934,0.000033314183,0.0000026895596,0.00012531574,5.3063746e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007684235,0.00017918013,0.01970577,0.000111854475,0.00010993243,0.0000019114784,0.0018632048,0.000013166793,0.9551065,0.0003763912,0.0002924057,0.02147124],"study_design_scores_gemma":[0.01542431,0.00022151407,0.17222139,0.00017736723,0.00019130092,0.0000012605306,0.00020143145,0.0026954594,0.79122925,0.0026989197,0.014748979,0.0001888359],"about_ca_topic_score_codex":0.00015656686,"about_ca_topic_score_gemma":0.00017327433,"teacher_disagreement_score":0.16387728,"about_ca_system_score_codex":0.000025252171,"about_ca_system_score_gemma":0.00005229716,"threshold_uncertainty_score":0.2861731},"labels":[],"label_agreement":null},{"id":"W4417427609","doi":"10.1016/j.jtct.2025.12.949","title":"Higher HLA-DRB1 Evolutionary Divergence Is Associated with Reduced Relapse and Improved Survival after Matched Unrelated Hematopoietic Cell Transplantation","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; U.S. Public Health Service; Health Resources and Services Administration; MorphoSys; Seagen; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Astellas Pharma; Adaptive Biotechnologies; HistoGenetics; Les Laboratories Pierre Fabre; Medac; Jazz Pharmaceuticals; BeiGene; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Sanofi; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Gateway for Cancer Research; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen","keywords":"Hematopoietic stem cell transplantation; Hematopoietic cell; Human leukocyte antigen; Transplantation; Cohort; Myeloid; Sibling; Confidence interval; Disease; Lymphoblastic lymphoma","score_opus":0.010820437311815782,"score_gpt":0.23193009980077642,"score_spread":0.22110966248896063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417427609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98647624,0.0021676887,0.007468098,0.0007435139,0.00021455383,0.0009326117,0.000101854435,0.00016816314,0.001727273],"genre_scores_gemma":[0.9884394,0.0074298265,0.0005356921,0.0005255363,0.000020144207,0.000079671096,0.00064329285,0.000048289512,0.0022781692],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980514,0.00016712934,0.0005055133,0.00057850534,0.00036122807,0.00033622253],"domain_scores_gemma":[0.9991718,0.00016053433,0.00012943985,0.00023013003,0.00013778683,0.00017033999],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023297341,0.000381607,0.00047458967,0.00020835026,0.00019285647,0.00004500505,0.00007423478,0.00030052607,0.00033848785],"category_scores_gemma":[0.0000027794838,0.0003299856,0.0000872604,0.00041919664,0.0001608857,0.00018154974,0.000004565358,0.0002823602,0.000010609813],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016957624,0.00092467904,0.09233362,0.0037498688,0.0010625789,0.0009424632,0.01994399,0.000018355875,0.86133313,0.00090203393,0.00009317051,0.0017385046],"study_design_scores_gemma":[0.027527008,0.0008361173,0.61765385,0.0019895493,0.0021520308,0.00030715126,0.0007736192,0.00077221205,0.34595227,0.0007333831,0.0002869369,0.0010158839],"about_ca_topic_score_codex":0.000058849913,"about_ca_topic_score_gemma":0.00001163285,"teacher_disagreement_score":0.5253202,"about_ca_system_score_codex":0.00005237442,"about_ca_system_score_gemma":0.000097511824,"threshold_uncertainty_score":0.99991524},"labels":[],"label_agreement":null},{"id":"W4417488439","doi":"10.1016/j.jtct.2025.12.986","title":"Post-transplant outcomes in IgD multiple myeloma:a propensity score-matched analysis","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Cancer Institute; Paula and Rodger Riney Foundation; University of Texas MD Anderson Cancer Center; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Leukemia and Lymphoma Society","keywords":"Propensity score matching; Population; MEDLINE; Component (thermodynamics); Antibody","score_opus":0.030963235935494594,"score_gpt":0.2910458129717718,"score_spread":0.2600825770362772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417488439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99489,0.00055820856,0.0024061184,0.00064522773,0.000032557487,0.0008064074,0.00007496293,0.000050521932,0.0005360151],"genre_scores_gemma":[0.9958456,0.002162579,0.00022868904,0.00038969974,0.000006787625,0.00004993037,0.0006286338,0.00001090735,0.00067717105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987933,0.00009697019,0.00028438272,0.00032322473,0.0002368085,0.00026531192],"domain_scores_gemma":[0.9994689,0.000099650206,0.000035174955,0.00020623153,0.0000687494,0.000121284196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001743617,0.00019271462,0.00048202596,0.00047148133,0.00008808898,0.000030292014,0.00006583067,0.00008965394,0.00008075092],"category_scores_gemma":[0.000008146148,0.00014213605,0.00015241522,0.0004967965,0.000060237857,0.00007808463,0.0000044584353,0.00014989286,0.000010692996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027397238,0.00040172497,0.9349203,0.00013598015,0.0010010647,0.00034776522,0.000943278,0.000010873594,0.05303516,0.00007911535,0.0000014337475,0.006383561],"study_design_scores_gemma":[0.008752802,0.00014244235,0.9392295,0.00006502715,0.00035975396,0.0000088209335,0.00007186351,0.0006328687,0.050535604,0.000030857303,0.000048597125,0.000121898986],"about_ca_topic_score_codex":0.00082381483,"about_ca_topic_score_gemma":0.001134128,"teacher_disagreement_score":0.006261662,"about_ca_system_score_codex":0.000033628166,"about_ca_system_score_gemma":0.0000655762,"threshold_uncertainty_score":0.579614},"labels":[],"label_agreement":null},{"id":"W7116365831","doi":"10.1016/j.jtct.2025.12.993","title":"Quality of Life and Comorbidities of Long-Term Survivors of Allogeneic Hematopoietic Cell Transplant Versus Their Siblings","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northern Alberta Institute of Technology; Alberta Cancer Foundation; University of Calgary","funders":"Arnie Charbonneau Cancer Institute, University of Calgary","keywords":"Comorbidity; Quality of life (healthcare); Survivorship curve; Incidence (geometry); Sibling; Transplantation; Hematopoietic cell; Mental health","score_opus":0.03993872087956443,"score_gpt":0.2935595688698298,"score_spread":0.2536208479902654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116365831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855618,0.0045303334,0.00837585,0.0000862164,0.00010201689,0.0004404957,0.00014389429,0.000021676742,0.0007377539],"genre_scores_gemma":[0.97986484,0.019623697,0.00017020969,0.000050405983,0.000008092914,0.000009565937,0.00020103548,0.000016287124,0.000055889293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844843,0.00014690417,0.0007700205,0.00023159925,0.00025268193,0.00015036296],"domain_scores_gemma":[0.99895436,0.00042466968,0.00022846663,0.0001997068,0.000107336025,0.00008544481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038801922,0.00020538448,0.0006520284,0.00021010663,0.000038526705,0.0000060130023,0.00007770156,0.0001351402,0.000063790336],"category_scores_gemma":[0.00000398757,0.00017550663,0.00012382575,0.00019190121,0.0002570744,0.00005197475,0.0000032191936,0.00009718891,4.89224e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068807597,0.00038393078,0.2570008,0.013803008,0.00035014426,0.000014462098,0.012723252,0.000009005657,0.70580167,0.0014910471,0.000001964634,0.0015399389],"study_design_scores_gemma":[0.008600084,0.00033017033,0.15044868,0.0004911102,0.00019233886,0.000012264469,0.00089425215,0.000021468908,0.8387762,0.00008540383,0.0000055321634,0.0001425502],"about_ca_topic_score_codex":0.0001540141,"about_ca_topic_score_gemma":0.00005588969,"teacher_disagreement_score":0.13297448,"about_ca_system_score_codex":0.0000065693785,"about_ca_system_score_gemma":0.00009347879,"threshold_uncertainty_score":0.71569526},"labels":[],"label_agreement":null},{"id":"W7117430678","doi":"10.1016/j.jtct.2025.12.990","title":"Impact of Extramedullary Disease at Diagnosis on Outcomes Post Allogeneic Hematopoietic Cell Transplant in Children and Young Adults With Acute Myeloid Leukemia: A CIBMTR Report","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; Health Resources and Services Administration; Office of Naval Research; National Heart, Lung, and Blood Institute; U.S. Public Health Service; National Cancer Institute; Medical College of Wisconsin","keywords":"Young adult; Myeloid leukemia; Incidence (geometry); Cohort; Univariate analysis; Bone marrow; Hematopoietic stem cell transplantation; Hematopoietic cell","score_opus":0.006463693318586629,"score_gpt":0.26137805948538856,"score_spread":0.2549143661668019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117430678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956294,0.0021753141,0.00014238537,0.00044808062,0.000020641453,0.0011718442,0.00023383975,0.000032952925,0.00014558362],"genre_scores_gemma":[0.96721613,0.031216849,0.00009400869,0.00022445746,0.000009973863,0.00009769772,0.00086938357,0.00003244338,0.00023903619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837565,0.00008598397,0.00041216478,0.00048188993,0.0003360043,0.00030827726],"domain_scores_gemma":[0.9991988,0.000103146194,0.00009520244,0.00031121075,0.00006231619,0.00022932266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017194143,0.0003109161,0.0004909984,0.0003199731,0.00007846936,0.000017587745,0.00008921783,0.00013179946,0.00004853355],"category_scores_gemma":[0.0000044270273,0.00021711411,0.00013788331,0.0002498809,0.00014825891,0.00008188503,0.000008148617,0.000262106,0.0000018444218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012220745,0.00031535415,0.9589287,0.00035985935,0.00047748702,0.0024513006,0.0019788402,0.000021090216,0.022063639,0.000023972589,0.000015304347,0.0011437205],"study_design_scores_gemma":[0.0110872155,0.0007823733,0.9540129,0.00045553458,0.00033078747,0.00076462555,0.00005989842,0.000048955473,0.032231092,0.000012968898,0.000005426071,0.00020825003],"about_ca_topic_score_codex":0.0007605809,"about_ca_topic_score_gemma":0.00008166296,"teacher_disagreement_score":0.029041534,"about_ca_system_score_codex":0.00018640923,"about_ca_system_score_gemma":0.000361887,"threshold_uncertainty_score":0.8853656},"labels":[],"label_agreement":null},{"id":"W7117713131","doi":"10.1016/j.jtct.2025.12.996","title":"Defining the Limits of Pre-Transplant Risk Prediction in AML: Evidence From Machine Learning and Regression Models","year":2025,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"National Institute of Allergy and Infectious Diseases; Health Resources and Services Administration; Office of Naval Research; National Heart, Lung, and Blood Institute; U.S. Public Health Service; National Cancer Institute; Medical College of Wisconsin","keywords":"Regression; Outcome (game theory); Predictive modelling; Regression analysis; Proportional hazards model; Risk assessment","score_opus":0.022937788611117654,"score_gpt":0.3006910868030822,"score_spread":0.27775329819196454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117713131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9560421,0.02422171,0.018636342,0.00041881876,0.000027142672,0.00035315775,0.000046614256,0.000027126505,0.00022695144],"genre_scores_gemma":[0.8862451,0.11300181,0.0003942467,0.000061077524,0.000010400797,0.000015627918,0.00012787302,0.000009278737,0.00013464567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989425,0.00023701166,0.00027657102,0.00022157285,0.0001958062,0.00012651717],"domain_scores_gemma":[0.9993508,0.00039181535,0.000071924616,0.00011005074,0.000034410485,0.000041038515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004882933,0.00011525104,0.0001927436,0.0001269893,0.00010874601,0.000015071397,0.0000558983,0.000091002454,0.000022200322],"category_scores_gemma":[0.000015291524,0.00007469363,0.00003179179,0.0001764019,0.00007972595,0.00011341385,0.0000051524016,0.00038296604,6.3263235e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010150206,0.0001055209,0.60847074,0.00044014593,0.00018567726,0.00005872572,0.020550484,0.0012881351,0.27832928,0.0006636245,0.000022736558,0.0797347],"study_design_scores_gemma":[0.010326993,0.00061943854,0.34625947,0.004370925,0.00034596265,0.00004047678,0.00074265077,0.303246,0.33205235,0.0014710572,0.00030450252,0.00022017883],"about_ca_topic_score_codex":0.000985984,"about_ca_topic_score_gemma":0.00008818464,"teacher_disagreement_score":0.30195785,"about_ca_system_score_codex":0.000022239441,"about_ca_system_score_gemma":0.000058011276,"threshold_uncertainty_score":0.30459177},"labels":[],"label_agreement":null}]}